WorldWideScience

Sample records for animal product preclinical

  1. Reproducibility of preclinical animal research improves with heterogeneity of study samples

    Science.gov (United States)

    Vogt, Lucile; Sena, Emily S.; Würbel, Hanno

    2018-01-01

    Single-laboratory studies conducted under highly standardized conditions are the gold standard in preclinical animal research. Using simulations based on 440 preclinical studies across 13 different interventions in animal models of stroke, myocardial infarction, and breast cancer, we compared the accuracy of effect size estimates between single-laboratory and multi-laboratory study designs. Single-laboratory studies generally failed to predict effect size accurately, and larger sample sizes rendered effect size estimates even less accurate. By contrast, multi-laboratory designs including as few as 2 to 4 laboratories increased coverage probability by up to 42 percentage points without a need for larger sample sizes. These findings demonstrate that within-study standardization is a major cause of poor reproducibility. More representative study samples are required to improve the external validity and reproducibility of preclinical animal research and to prevent wasting animals and resources for inconclusive research. PMID:29470495

  2. Balancing animal welfare and assisted reproduction: ethics of preclinical animal research for testing new reproductive technologies.

    Science.gov (United States)

    Jans, Verna; Dondorp, Wybo; Goossens, Ellen; Mertes, Heidi; Pennings, Guido; de Wert, Guido

    2018-02-07

    In the field of medically assisted reproduction (MAR), there is a growing emphasis on the importance of introducing new assisted reproductive technologies (ARTs) only after thorough preclinical safety research, including the use of animal models. At the same time, there is international support for the three R's (replace, reduce, refine), and the European Union even aims at the full replacement of animals for research. The apparent tension between these two trends underlines the urgency of an explicit justification of the use of animals for the development and preclinical testing of new ARTs. Considering that the use of animals remains necessary for specific forms of ART research and taking account of different views on the moral importance of helping people to have a genetically related child, we argue that, in principle, the importance of safety research as part of responsible innovation outweighs the limited infringement of animal wellbeing involved in ART research.

  3. Stem Cells for Cartilage Repair: Preclinical Studies and Insights in Translational Animal Models and Outcome Measures

    Directory of Open Access Journals (Sweden)

    Melissa Lo Monaco

    2018-01-01

    Full Text Available Due to the restricted intrinsic capacity of resident chondrocytes to regenerate the lost cartilage postinjury, stem cell-based therapies have been proposed as a novel therapeutic approach for cartilage repair. Moreover, stem cell-based therapies using mesenchymal stem cells (MSCs or induced pluripotent stem cells (iPSCs have been used successfully in preclinical and clinical settings. Despite these promising reports, the exact mechanisms underlying stem cell-mediated cartilage repair remain uncertain. Stem cells can contribute to cartilage repair via chondrogenic differentiation, via immunomodulation, or by the production of paracrine factors and extracellular vesicles. But before novel cell-based therapies for cartilage repair can be introduced into the clinic, rigorous testing in preclinical animal models is required. Preclinical models used in regenerative cartilage studies include murine, lapine, caprine, ovine, porcine, canine, and equine models, each associated with its specific advantages and limitations. This review presents a summary of recent in vitro data and from in vivo preclinical studies justifying the use of MSCs and iPSCs in cartilage tissue engineering. Moreover, the advantages and disadvantages of utilizing small and large animals will be discussed, while also describing suitable outcome measures for evaluating cartilage repair.

  4. Stem Cells for Cartilage Repair: Preclinical Studies and Insights in Translational Animal Models and Outcome Measures.

    Science.gov (United States)

    Lo Monaco, Melissa; Merckx, Greet; Ratajczak, Jessica; Gervois, Pascal; Hilkens, Petra; Clegg, Peter; Bronckaers, Annelies; Vandeweerd, Jean-Michel; Lambrichts, Ivo

    2018-01-01

    Due to the restricted intrinsic capacity of resident chondrocytes to regenerate the lost cartilage postinjury, stem cell-based therapies have been proposed as a novel therapeutic approach for cartilage repair. Moreover, stem cell-based therapies using mesenchymal stem cells (MSCs) or induced pluripotent stem cells (iPSCs) have been used successfully in preclinical and clinical settings. Despite these promising reports, the exact mechanisms underlying stem cell-mediated cartilage repair remain uncertain. Stem cells can contribute to cartilage repair via chondrogenic differentiation, via immunomodulation, or by the production of paracrine factors and extracellular vesicles. But before novel cell-based therapies for cartilage repair can be introduced into the clinic, rigorous testing in preclinical animal models is required. Preclinical models used in regenerative cartilage studies include murine, lapine, caprine, ovine, porcine, canine, and equine models, each associated with its specific advantages and limitations. This review presents a summary of recent in vitro data and from in vivo preclinical studies justifying the use of MSCs and iPSCs in cartilage tissue engineering. Moreover, the advantages and disadvantages of utilizing small and large animals will be discussed, while also describing suitable outcome measures for evaluating cartilage repair.

  5. Development of computational small animal models and their applications in preclinical imaging and therapy research

    NARCIS (Netherlands)

    Xie, Tianwu; Zaidi, Habib

    The development of multimodality preclinical imaging techniques and the rapid growth of realistic computer simulation tools have promoted the construction and application of computational laboratory animal models in preclinical research. Since the early 1990s, over 120 realistic computational animal

  6. Preliminary study for small animal preclinical hadrontherapy facility

    Energy Technology Data Exchange (ETDEWEB)

    Russo, G. [Institute of Molecular Bioimaging and Physiology, IBFM CNR-LATO, Cefalú (Italy); Pisciotta, P., E-mail: pietro.pisciotta@ibfm.cnr.it [Institute of Molecular Bioimaging and Physiology, IBFM CNR-LATO, Cefalú (Italy); National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS, Catania (Italy); Cirrone, G.A.P.; Romano, F. [National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS, Catania (Italy); Cammarata, F.; Marchese, V.; Forte, G.I.; Lamia, D.; Minafra, L.; Bravatá, V. [Institute of Molecular Bioimaging and Physiology, IBFM CNR-LATO, Cefalú (Italy); Acquaviva, R. [University of Catania, Catania (Italy); Gilardi, M.C. [Institute of Molecular Bioimaging and Physiology, IBFM CNR-LATO, Cefalú (Italy); Cuttone, G. [National Institute for Nuclear Physics, Laboratori Nazionali del Sud, INFN-LNS, Catania (Italy)

    2017-02-21

    Aim of this work is the study of the preliminary steps to perform a particle treatment of cancer cells inoculated in small animals and to realize a preclinical hadrontherapy facility. A well-defined dosimetric protocol was developed to explicate the steps needed in order to perform a precise proton irradiation in small animals and achieve a highly conformal dose into the target. A precise homemade positioning and holding system for small animals was designed and developed at INFN-LNS in Catania (Italy), where an accurate Monte Carlo simulation was developed, using Geant4 code to simulate the treatment in order to choose the best animal position and perform accurately all the necessary dosimetric evaluations. The Geant4 application can also be used to realize dosimetric studies and its peculiarity consists in the possibility to introduce the real target composition in the simulation using the DICOM micro-CT image. This application was fully validated comparing the results with the experimental measurements. The latter ones were performed at the CATANA (Centro di AdroTerapia e Applicazioni Nucleari Avanzate) facility at INFN-LNS by irradiating both PMMA and water solid phantom. Dosimetric measurements were performed using previously calibrated EBT3 Gafchromic films as a detector and the results were compared with the Geant4 simulation ones. In particular, two different types of dosimetric studies were performed: the first one involved irradiation of a phantom made up of water solid slabs where a layer of EBT3 was alternated with two different slabs in a sandwich configuration, in order to validate the dosimetric distribution. The second one involved irradiation of a PMMA phantom made up of a half hemisphere and some PMMA slabs in order to simulate a subcutaneous tumour configuration, normally used in preclinical studies. In order to evaluate the accordance between experimental and simulation results, two different statistical tests were made: Kolmogorov test and

  7. Preliminary study for small animal preclinical hadrontherapy facility

    Science.gov (United States)

    Russo, G.; Pisciotta, P.; Cirrone, G. A. P.; Romano, F.; Cammarata, F.; Marchese, V.; Forte, G. I.; Lamia, D.; Minafra, L.; Bravatá, V.; Acquaviva, R.; Gilardi, M. C.; Cuttone, G.

    2017-02-01

    Aim of this work is the study of the preliminary steps to perform a particle treatment of cancer cells inoculated in small animals and to realize a preclinical hadrontherapy facility. A well-defined dosimetric protocol was developed to explicate the steps needed in order to perform a precise proton irradiation in small animals and achieve a highly conformal dose into the target. A precise homemade positioning and holding system for small animals was designed and developed at INFN-LNS in Catania (Italy), where an accurate Monte Carlo simulation was developed, using Geant4 code to simulate the treatment in order to choose the best animal position and perform accurately all the necessary dosimetric evaluations. The Geant4 application can also be used to realize dosimetric studies and its peculiarity consists in the possibility to introduce the real target composition in the simulation using the DICOM micro-CT image. This application was fully validated comparing the results with the experimental measurements. The latter ones were performed at the CATANA (Centro di AdroTerapia e Applicazioni Nucleari Avanzate) facility at INFN-LNS by irradiating both PMMA and water solid phantom. Dosimetric measurements were performed using previously calibrated EBT3 Gafchromic films as a detector and the results were compared with the Geant4 simulation ones. In particular, two different types of dosimetric studies were performed: the first one involved irradiation of a phantom made up of water solid slabs where a layer of EBT3 was alternated with two different slabs in a sandwich configuration, in order to validate the dosimetric distribution. The second one involved irradiation of a PMMA phantom made up of a half hemisphere and some PMMA slabs in order to simulate a subcutaneous tumour configuration, normally used in preclinical studies. In order to evaluate the accordance between experimental and simulation results, two different statistical tests were made: Kolmogorov test and

  8. Preliminary study for small animal preclinical hadrontherapy facility

    International Nuclear Information System (INIS)

    Russo, G.; Pisciotta, P.; Cirrone, G.A.P.; Romano, F.; Cammarata, F.; Marchese, V.; Forte, G.I.; Lamia, D.; Minafra, L.; Bravatá, V.; Acquaviva, R.; Gilardi, M.C.; Cuttone, G.

    2017-01-01

    Aim of this work is the study of the preliminary steps to perform a particle treatment of cancer cells inoculated in small animals and to realize a preclinical hadrontherapy facility. A well-defined dosimetric protocol was developed to explicate the steps needed in order to perform a precise proton irradiation in small animals and achieve a highly conformal dose into the target. A precise homemade positioning and holding system for small animals was designed and developed at INFN-LNS in Catania (Italy), where an accurate Monte Carlo simulation was developed, using Geant4 code to simulate the treatment in order to choose the best animal position and perform accurately all the necessary dosimetric evaluations. The Geant4 application can also be used to realize dosimetric studies and its peculiarity consists in the possibility to introduce the real target composition in the simulation using the DICOM micro-CT image. This application was fully validated comparing the results with the experimental measurements. The latter ones were performed at the CATANA (Centro di AdroTerapia e Applicazioni Nucleari Avanzate) facility at INFN-LNS by irradiating both PMMA and water solid phantom. Dosimetric measurements were performed using previously calibrated EBT3 Gafchromic films as a detector and the results were compared with the Geant4 simulation ones. In particular, two different types of dosimetric studies were performed: the first one involved irradiation of a phantom made up of water solid slabs where a layer of EBT3 was alternated with two different slabs in a sandwich configuration, in order to validate the dosimetric distribution. The second one involved irradiation of a PMMA phantom made up of a half hemisphere and some PMMA slabs in order to simulate a subcutaneous tumour configuration, normally used in preclinical studies. In order to evaluate the accordance between experimental and simulation results, two different statistical tests were made: Kolmogorov test and

  9. Development of computational small animal models and their applications in preclinical imaging and therapy research.

    Science.gov (United States)

    Xie, Tianwu; Zaidi, Habib

    2016-01-01

    The development of multimodality preclinical imaging techniques and the rapid growth of realistic computer simulation tools have promoted the construction and application of computational laboratory animal models in preclinical research. Since the early 1990s, over 120 realistic computational animal models have been reported in the literature and used as surrogates to characterize the anatomy of actual animals for the simulation of preclinical studies involving the use of bioluminescence tomography, fluorescence molecular tomography, positron emission tomography, single-photon emission computed tomography, microcomputed tomography, magnetic resonance imaging, and optical imaging. Other applications include electromagnetic field simulation, ionizing and nonionizing radiation dosimetry, and the development and evaluation of new methodologies for multimodality image coregistration, segmentation, and reconstruction of small animal images. This paper provides a comprehensive review of the history and fundamental technologies used for the development of computational small animal models with a particular focus on their application in preclinical imaging as well as nonionizing and ionizing radiation dosimetry calculations. An overview of the overall process involved in the design of these models, including the fundamental elements used for the construction of different types of computational models, the identification of original anatomical data, the simulation tools used for solving various computational problems, and the applications of computational animal models in preclinical research. The authors also analyze the characteristics of categories of computational models (stylized, voxel-based, and boundary representation) and discuss the technical challenges faced at the present time as well as research needs in the future.

  10. Development of computational small animal models and their applications in preclinical imaging and therapy research

    Energy Technology Data Exchange (ETDEWEB)

    Xie, Tianwu [Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva 4 CH-1211 (Switzerland); Zaidi, Habib, E-mail: habib.zaidi@hcuge.ch [Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva 4 CH-1211 (Switzerland); Geneva Neuroscience Center, Geneva University, Geneva CH-1205 (Switzerland); Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen 9700 RB (Netherlands)

    2016-01-15

    The development of multimodality preclinical imaging techniques and the rapid growth of realistic computer simulation tools have promoted the construction and application of computational laboratory animal models in preclinical research. Since the early 1990s, over 120 realistic computational animal models have been reported in the literature and used as surrogates to characterize the anatomy of actual animals for the simulation of preclinical studies involving the use of bioluminescence tomography, fluorescence molecular tomography, positron emission tomography, single-photon emission computed tomography, microcomputed tomography, magnetic resonance imaging, and optical imaging. Other applications include electromagnetic field simulation, ionizing and nonionizing radiation dosimetry, and the development and evaluation of new methodologies for multimodality image coregistration, segmentation, and reconstruction of small animal images. This paper provides a comprehensive review of the history and fundamental technologies used for the development of computational small animal models with a particular focus on their application in preclinical imaging as well as nonionizing and ionizing radiation dosimetry calculations. An overview of the overall process involved in the design of these models, including the fundamental elements used for the construction of different types of computational models, the identification of original anatomical data, the simulation tools used for solving various computational problems, and the applications of computational animal models in preclinical research. The authors also analyze the characteristics of categories of computational models (stylized, voxel-based, and boundary representation) and discuss the technical challenges faced at the present time as well as research needs in the future.

  11. Development of computational small animal models and their applications in preclinical imaging and therapy research

    International Nuclear Information System (INIS)

    Xie, Tianwu; Zaidi, Habib

    2016-01-01

    The development of multimodality preclinical imaging techniques and the rapid growth of realistic computer simulation tools have promoted the construction and application of computational laboratory animal models in preclinical research. Since the early 1990s, over 120 realistic computational animal models have been reported in the literature and used as surrogates to characterize the anatomy of actual animals for the simulation of preclinical studies involving the use of bioluminescence tomography, fluorescence molecular tomography, positron emission tomography, single-photon emission computed tomography, microcomputed tomography, magnetic resonance imaging, and optical imaging. Other applications include electromagnetic field simulation, ionizing and nonionizing radiation dosimetry, and the development and evaluation of new methodologies for multimodality image coregistration, segmentation, and reconstruction of small animal images. This paper provides a comprehensive review of the history and fundamental technologies used for the development of computational small animal models with a particular focus on their application in preclinical imaging as well as nonionizing and ionizing radiation dosimetry calculations. An overview of the overall process involved in the design of these models, including the fundamental elements used for the construction of different types of computational models, the identification of original anatomical data, the simulation tools used for solving various computational problems, and the applications of computational animal models in preclinical research. The authors also analyze the characteristics of categories of computational models (stylized, voxel-based, and boundary representation) and discuss the technical challenges faced at the present time as well as research needs in the future

  12. Pre-clinical research in small animals using radiotherapy technology. A bidirectional translational approach

    International Nuclear Information System (INIS)

    Tillner, Falk; Buetof, Rebecca; Krause, Mechthild; Enghardt, Wolfgang; Helmholtz-Zentrum Dresden-Rossendorf, Dresden; Technische Univ. Dresden; Helmholtz-Zentrum Dresden-Rossendorf, Dresden

    2014-01-01

    For translational cancer research, pre-clinical in-vivo studies using small animals have become indispensable in bridging the gap between in-vitro cell experiments and clinical implementation. When setting up such small animal experiments, various biological, technical and methodical aspects have to be considered. In this work we present a comprehensive topical review based on relevant publications on irradiation techniques used for pre-clinical cancer research in mice and rats. Clinical radiotherapy treatment devices for the application of external beam radiotherapy and brachytherapy as well as dedicated research irradiation devices are feasible for small animal irradiation depending on the animal model and the experimental goals. In this work, appropriate solutions for the technological transfer of human radiation oncology to small animal radiation research are summarised. Additionally, important information concerning the experimental design is provided such that reliable and clinically relevant results can be attained.

  13. Pre-clinical research in small animals using radiotherapy technology. A bidirectional translational approach

    Energy Technology Data Exchange (ETDEWEB)

    Tillner, Falk; Buetof, Rebecca [Technische Univ. Dresden (Germany). OncoRay - National Center for Radiation Research in Oncology; Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany); Technische Univ. Dresden (Germany). Dept. of Radiation Oncology; Thute, Prasad [Technische Univ. Dresden (Germany). OncoRay - National Center for Radiation Research in Oncology; Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany); Krause, Mechthild [Technische Univ. Dresden (Germany). OncoRay - National Center for Radiation Research in Oncology; Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany); Technische Univ. Dresden (Germany). Dept. of Radiation Oncology; German Cancer Consortium (DKTK), Dresden (Germany); German Cancer Research Center (DKFZ), Heidelberg (Germany); Enghardt, Wolfgang [Technische Univ. Dresden (Germany). OncoRay - National Center for Radiation Research in Oncology; Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany); Technische Univ. Dresden (Germany). Dept. of Radiation Oncology; Helmholtz-Zentrum Dresden-Rossendorf, Dresden (Germany). Inst. of Radiooncology

    2014-07-01

    For translational cancer research, pre-clinical in-vivo studies using small animals have become indispensable in bridging the gap between in-vitro cell experiments and clinical implementation. When setting up such small animal experiments, various biological, technical and methodical aspects have to be considered. In this work we present a comprehensive topical review based on relevant publications on irradiation techniques used for pre-clinical cancer research in mice and rats. Clinical radiotherapy treatment devices for the application of external beam radiotherapy and brachytherapy as well as dedicated research irradiation devices are feasible for small animal irradiation depending on the animal model and the experimental goals. In this work, appropriate solutions for the technological transfer of human radiation oncology to small animal radiation research are summarised. Additionally, important information concerning the experimental design is provided such that reliable and clinically relevant results can be attained.

  14. Pre-clinical research in small animals using radiotherapy technology--a bidirectional translational approach.

    Science.gov (United States)

    Tillner, Falk; Thute, Prasad; Bütof, Rebecca; Krause, Mechthild; Enghardt, Wolfgang

    2014-12-01

    For translational cancer research, pre-clinical in-vivo studies using small animals have become indispensable in bridging the gap between in-vitro cell experiments and clinical implementation. When setting up such small animal experiments, various biological, technical and methodical aspects have to be considered. In this work we present a comprehensive topical review based on relevant publications on irradiation techniques used for pre-clinical cancer research in mice and rats. Clinical radiotherapy treatment devices for the application of external beam radiotherapy and brachytherapy as well as dedicated research irradiation devices are feasible for small animal irradiation depending on the animal model and the experimental goals. In this work, appropriate solutions for the technological transfer of human radiation oncology to small animal radiation research are summarised. Additionally, important information concerning the experimental design is provided such that reliable and clinically relevant results can be attained. Copyright © 2014. Published by Elsevier GmbH.

  15. The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research.

    Science.gov (United States)

    Avey, Marc T; Moher, David; Sullivan, Katrina J; Fergusson, Dean; Griffin, Gilly; Grimshaw, Jeremy M; Hutton, Brian; Lalu, Manoj M; Macleod, Malcolm; Marshall, John; Mei, Shirley H J; Rudnicki, Michael; Stewart, Duncan J; Turgeon, Alexis F; McIntyre, Lauralyn

    2016-01-01

    Incomplete reporting of study methods and results has become a focal point for failures in the reproducibility and translation of findings from preclinical research. Here we demonstrate that incomplete reporting of preclinical research is not limited to a few elements of research design, but rather is a broader problem that extends to the reporting of the methods and results. We evaluated 47 preclinical research studies from a systematic review of acute lung injury that use mesenchymal stem cells (MSCs) as a treatment. We operationalized the ARRIVE (Animal Research: Reporting of In Vivo Experiments) reporting guidelines for pre-clinical studies into 109 discrete reporting sub-items and extracted 5,123 data elements. Overall, studies reported less than half (47%) of all sub-items (median 51 items; range 37-64). Across all studies, the Methods Section reported less than half (45%) and the Results Section reported less than a third (29%). There was no association between journal impact factor and completeness of reporting, which suggests that incomplete reporting of preclinical research occurs across all journals regardless of their perceived prestige. Incomplete reporting of methods and results will impede attempts to replicate research findings and maximize the value of preclinical studies.

  16. Preclinical animal research on therapy dosimetry with dual isotopes

    International Nuclear Information System (INIS)

    Konijnenberg, Mark W.; Jong, Marion de

    2011-01-01

    Preclinical research into radionuclide therapies based on radiation dosimetry will enable the use of any LET-equivalent radionuclide. Radiation dose and dose rate have significant influence on dose effects in the tumour depending on its radiation sensitivity, possibilities for repair of sublethal damage, and repopulation during or after the therapy. Models for radiation response of preclinical tumour models after peptide receptor radionuclide therapy based on the linear quadratic model are presented. The accuracy of the radiation dose is very important for observation of dose-effects. Uncertainties in the radiation dose estimation arise from incomplete assay of the kinetics, low accuracy in volume measurements and absorbed dose S-values for stylized models instead of the actual animal geometry. Normal dose uncertainties in the order of 20% might easily make the difference between seeing a dose-effect or missing it altogether. This is true for the theoretical case of a homogeneous tumour type behaving in vivo in the same way as its cells do in vitro. Heterogeneity of tumours induces variations in clonogenic cell density, radiation sensitivity, repopulation capacity and repair kinetics. The influence of these aspects are analysed within the linear quadratic model for tumour response to radionuclide therapy. Preclinical tumour models tend to be less heterogenic than the clinical conditions they should represent. The results of various preclinical radionuclide therapy experiments for peptide receptor radionuclide therapy are compared to the outcome of theoretical models and the influence of increased heterogeneity is analysed when the results of preclinical research is transferred to the clinic. When the radiation dose and radiobiology of the tumour response is known well enough it may be possible to leave the current phenomenological approach in preclinical radionuclide therapy and start basing these experiments on radiation dose. Then the use of a gamma ray

  17. Preclinical animal research on therapy dosimetry with dual isotopes

    Energy Technology Data Exchange (ETDEWEB)

    Konijnenberg, Mark W.; Jong, Marion de [Nuclear Medicine Department, Erasmus MC, Rotterdam (Netherlands)

    2011-06-15

    Preclinical research into radionuclide therapies based on radiation dosimetry will enable the use of any LET-equivalent radionuclide. Radiation dose and dose rate have significant influence on dose effects in the tumour depending on its radiation sensitivity, possibilities for repair of sublethal damage, and repopulation during or after the therapy. Models for radiation response of preclinical tumour models after peptide receptor radionuclide therapy based on the linear quadratic model are presented. The accuracy of the radiation dose is very important for observation of dose-effects. Uncertainties in the radiation dose estimation arise from incomplete assay of the kinetics, low accuracy in volume measurements and absorbed dose S-values for stylized models instead of the actual animal geometry. Normal dose uncertainties in the order of 20% might easily make the difference between seeing a dose-effect or missing it altogether. This is true for the theoretical case of a homogeneous tumour type behaving in vivo in the same way as its cells do in vitro. Heterogeneity of tumours induces variations in clonogenic cell density, radiation sensitivity, repopulation capacity and repair kinetics. The influence of these aspects are analysed within the linear quadratic model for tumour response to radionuclide therapy. Preclinical tumour models tend to be less heterogenic than the clinical conditions they should represent. The results of various preclinical radionuclide therapy experiments for peptide receptor radionuclide therapy are compared to the outcome of theoretical models and the influence of increased heterogeneity is analysed when the results of preclinical research is transferred to the clinic. When the radiation dose and radiobiology of the tumour response is known well enough it may be possible to leave the current phenomenological approach in preclinical radionuclide therapy and start basing these experiments on radiation dose. Then the use of a gamma ray

  18. The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research.

    Directory of Open Access Journals (Sweden)

    Marc T Avey

    Full Text Available Incomplete reporting of study methods and results has become a focal point for failures in the reproducibility and translation of findings from preclinical research. Here we demonstrate that incomplete reporting of preclinical research is not limited to a few elements of research design, but rather is a broader problem that extends to the reporting of the methods and results. We evaluated 47 preclinical research studies from a systematic review of acute lung injury that use mesenchymal stem cells (MSCs as a treatment. We operationalized the ARRIVE (Animal Research: Reporting of In Vivo Experiments reporting guidelines for pre-clinical studies into 109 discrete reporting sub-items and extracted 5,123 data elements. Overall, studies reported less than half (47% of all sub-items (median 51 items; range 37-64. Across all studies, the Methods Section reported less than half (45% and the Results Section reported less than a third (29%. There was no association between journal impact factor and completeness of reporting, which suggests that incomplete reporting of preclinical research occurs across all journals regardless of their perceived prestige. Incomplete reporting of methods and results will impede attempts to replicate research findings and maximize the value of preclinical studies.

  19. Preclinical Cancer Chemoprevention Studies Using Animal Model of Inflammation-Associated Colorectal Carcinogenesis

    Energy Technology Data Exchange (ETDEWEB)

    Tanaka, Takuji [Cytopatholgy Division, Tohkai Cytopathology Institute, Cancer Research and Prevention (TCI-CaRP), 5-1-2 Minami-uzura, Gifu 500-8285 (Japan); Department of Tumor Pathology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194 (Japan)

    2012-07-16

    Inflammation is involved in all stages of carcinogenesis. Inflammatory bowel disease, such as ulcerative colitis and Crohn’s disease is a longstanding inflammatory disease of intestine with increased risk for colorectal cancer (CRC). Several molecular events involved in chronic inflammatory process are reported to contribute to multi-step carcinogenesis of CRC in the inflamed colon. They include over-production of free radicals, reactive oxygen and nitrogen species, up-regulation of inflammatory enzymes in arachidonic acid biosynthesis pathway, up-regulation of certain cytokines, and intestinal immune system dysfunction. In this article, firstly I briefly introduce our experimental animal models where colorectal neoplasms rapidly develop in the inflamed colorectum. Secondary, data on preclinical cancer chemoprevention studies of inflammation-associated colon carcinogenesis by morin, bezafibrate, and valproic acid, using this novel inflammation-related colorectal carcinogenesis model is described.

  20. Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research.

    Science.gov (United States)

    Sandberg, Kathryn; Umans, Jason G

    2015-05-01

    The U.S. National Institutes of Health (NIH) announced last May that steps will be taken to address the over-reliance on male cells and animals in preclinical research. To further address this announcement, in September 2014, scientists with varying perspectives came together at Georgetown University to discuss the following questions. (1) What metrics should the NIH use to assess tangible progress on policy changes designed to address the over-reliance on male cells and animals in preclinical research? (2) How effective can education be in reducing the over-reliance on male cells and animals in preclinical research and what educational initiatives sponsored by the NIH would most likely effect change? (3) What criteria should the NIH use to determine rigorously defined exceptions to the future proposal requirement of a balance of male and female cells and animals in preclinical studies? (4) What additional strategies in addition to proposal requirements should NIH use to reduce the overreliance of male cells and animals in preclinical research? The resulting consensus presented herein includes input from researchers not only from diverse disciplines of basic and translational science including biology, cell and molecular biology, biochemistry, physiology, pharmacology, neuroscience, cardiology, endocrinology, nephrology, psychiatry, and obstetrics and gynecology, but also from recognized experts in publishing, industry, advocacy, science policy, clinical medicine, and population health. We offer our recommendations to aid the NIH as it selects, implements, monitors, and optimizes strategies to correct the over-reliance on male cells and animals in preclinical research. © FASEB.

  1. Preclinical animal anxiety research - flaws and prejudices.

    Science.gov (United States)

    Ennaceur, Abdelkader; Chazot, Paul L

    2016-04-01

    The current tests of anxiety in mice and rats used in preclinical research include the elevated plus-maze (EPM) or zero-maze (EZM), the light/dark box (LDB), and the open-field (OF). They are currently very popular, and despite their poor achievements, they continue to exert considerable constraints on the development of novel approaches. Hence, a novel anxiety test needs to be compared with these traditional tests, and assessed against various factors that were identified as a source of their inconsistent and contradictory results. These constraints are very costly, and they are in most cases useless as they originate from flawed methodologies. In the present report, we argue that the EPM or EZM, LDB, and OF do not provide unequivocal measures of anxiety; that there is no evidence of motivation conflict involved in these tests. They can be considered at best, tests of natural preference for unlit and/or enclosed spaces. We also argued that pharmacological validation of a behavioral test is an inappropriate approach; it stems from the confusion of animal models of human behavior with animal models of pathophysiology. A behavioral test is developed to detect not to produce symptoms, and a drug is used to validate an identified physiological target. In order to overcome the major methodological flaws in animal anxiety studies, we proposed an open space anxiety test, a 3D maze, which is described here with highlights of its various advantages over to the traditional tests.

  2. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments.

    Directory of Open Access Journals (Sweden)

    Valerie C Henderson

    Full Text Available The vast majority of medical interventions introduced into clinical development prove unsafe or ineffective. One prominent explanation for the dismal success rate is flawed preclinical research. We conducted a systematic review of preclinical research guidelines and organized recommendations according to the type of validity threat (internal, construct, or external or programmatic research activity they primarily address.We searched MEDLINE, Google Scholar, Google, and the EQUATOR Network website for all preclinical guideline documents published up to April 9, 2013 that addressed the design and conduct of in vivo animal experiments aimed at supporting clinical translation. To be eligible, documents had to provide guidance on the design or execution of preclinical animal experiments and represent the aggregated consensus of four or more investigators. Data from included guidelines were independently extracted by two individuals for discrete recommendations on the design and implementation of preclinical efficacy studies. These recommendations were then organized according to the type of validity threat they addressed. A total of 2,029 citations were identified through our search strategy. From these, we identified 26 guidelines that met our eligibility criteria--most of which were directed at neurological or cerebrovascular drug development. Together, these guidelines offered 55 different recommendations. Some of the most common recommendations included performance of a power calculation to determine sample size, randomized treatment allocation, and characterization of disease phenotype in the animal model prior to experimentation.By identifying the most recurrent recommendations among preclinical guidelines, we provide a starting point for developing preclinical guidelines in other disease domains. We also provide a basis for the study and evaluation of preclinical research practice. Please see later in the article for the Editors' Summary.

  3. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments.

    Science.gov (United States)

    Henderson, Valerie C; Kimmelman, Jonathan; Fergusson, Dean; Grimshaw, Jeremy M; Hackam, Dan G

    2013-01-01

    The vast majority of medical interventions introduced into clinical development prove unsafe or ineffective. One prominent explanation for the dismal success rate is flawed preclinical research. We conducted a systematic review of preclinical research guidelines and organized recommendations according to the type of validity threat (internal, construct, or external) or programmatic research activity they primarily address. We searched MEDLINE, Google Scholar, Google, and the EQUATOR Network website for all preclinical guideline documents published up to April 9, 2013 that addressed the design and conduct of in vivo animal experiments aimed at supporting clinical translation. To be eligible, documents had to provide guidance on the design or execution of preclinical animal experiments and represent the aggregated consensus of four or more investigators. Data from included guidelines were independently extracted by two individuals for discrete recommendations on the design and implementation of preclinical efficacy studies. These recommendations were then organized according to the type of validity threat they addressed. A total of 2,029 citations were identified through our search strategy. From these, we identified 26 guidelines that met our eligibility criteria--most of which were directed at neurological or cerebrovascular drug development. Together, these guidelines offered 55 different recommendations. Some of the most common recommendations included performance of a power calculation to determine sample size, randomized treatment allocation, and characterization of disease phenotype in the animal model prior to experimentation. By identifying the most recurrent recommendations among preclinical guidelines, we provide a starting point for developing preclinical guidelines in other disease domains. We also provide a basis for the study and evaluation of preclinical research practice. Please see later in the article for the Editors' Summary.

  4. Guidelines for preclinical animal research in ALS/MND: A consensus meeting.

    Science.gov (United States)

    Ludolph, Albert C; Bendotti, Caterina; Blaugrund, Eran; Chio, Adriano; Greensmith, Linda; Loeffler, Jean-Philippe; Mead, Richard; Niessen, Heiko G; Petri, Susanne; Pradat, Pierre-Francois; Robberecht, Wim; Ruegg, Markus; Schwalenstöcker, Birgit; Stiller, Detlev; van den Berg, Leonard; Vieira, Fernando; von Horsten, Stephan

    2010-01-01

    The development of therapeutics for ALS/MND is largely based on work in experimental animals carrying human SOD mutations. However, translation of apparent therapeutic successes from in vivo to the human disease has proven difficult and a considerable amount of financial resources has been apparently wasted. Standard operating procedures (SOPs) for preclinical animal research in ALS/MND are urgently required. Such SOPs will help to establish SOPs for translational research for other neurological diseases within the next few years. To identify the challenges and to improve the research methodology, the European ALS/MND group held a meeting in 2006 and published guidelines in 2007 (1). A second international conference to improve the guidelines was held in 2009. These second and improved guidelines are dedicated to the memory of Sean F. Scott.

  5. Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol.

    Science.gov (United States)

    Suen, Colin M; Zhai, Alex; Lalu, Manoj M; Welsh, Christopher; Levac, Brendan M; Fergusson, Dean; McIntyre, Lauralyn; Stewart, Duncan J

    2016-05-25

    Pulmonary arterial hypertension (PAH) is a rare disease (15 cases per million) that is characterized by widespread loss of the pulmonary microcirculation and elevated pulmonary vascular resistance leading to pathological right ventricular remodeling and ultimately right heart failure. Regenerative cell therapies (i.e., therapies involving cells with stem or progenitor-like properties) could potentially restore the effective lung microcirculation and provide a curative therapy for PAH. Preclinical evidence suggests that regenerative cell therapy using endothelial progenitor cells or mesenchymal stem cells may be beneficial in the treatment of PAH. These findings have led to the completion of a small number of human clinical trials, albeit with modest effect compared to animal studies. The objective of this systematic review is to compare the efficacy and safety of regenerative cell therapies in preclinical models of PAH as well as assess study quality to inform future clinical studies. We will include preclinical studies of PAH in which a regenerative cell type was administered and outcomes compared to a disease control. The primary outcome will be pulmonary hemodynamics as assessed by measurement of right ventricular systolic pressure and/or mean pulmonary arterial pressure. Secondary outcomes will include mortality, survival, right ventricular remodeling, pulmonary vascular resistance, cardiac output, cardiac index, pulmonary acceleration time, tricuspid annular systolic excursion, and right ventricular wall thickness. Electronic searches of MEDLINE and EMBASE databases will be constructed and reviewed by the Peer Review of Electronic Search Strategies (PRESS) process. Search results will be screened independently in duplicate. Data from eligible studies will be extracted, pooled, and analyzed using random effects models. Risk of bias will be assessed using the SYstematic Review Centre for Laboratory animal Experimentation (SYRCLE) risk of bias tool, and

  6. Annular phased array transducer for preclinical testing of anti-cancer drug efficacy on small animals.

    Science.gov (United States)

    Kujawska, Tamara; Secomski, Wojciech; Byra, Michał; Postema, Michiel; Nowicki, Andrzej

    2017-04-01

    A technique using pulsed High Intensity Focused Ultrasound (HIFU) to destroy deep-seated solid tumors is a promising noninvasive therapeutic approach. A main purpose of this study was to design and test a HIFU transducer suitable for preclinical studies of efficacy of tested, anti-cancer drugs, activated by HIFU beams, in the treatment of a variety of solid tumors implanted to various organs of small animals at the depth of the order of 1-2cm under the skin. To allow focusing of the beam, generated by such transducer, within treated tissue at different depths, a spherical, 2-MHz, 29-mm diameter annular phased array transducer was designed and built. To prove its potential for preclinical studies on small animals, multiple thermal lesions were induced in a pork loin ex vivo by heating beams of the same: 6W, or 12W, or 18W acoustic power and 25mm, 30mm, and 35mm focal lengths. Time delay for each annulus was controlled electronically to provide beam focusing within tissue at the depths of 10mm, 15mm, and 20mm. The exposure time required to induce local necrosis was determined at different depths using thermocouples. Location and extent of thermal lesions determined from numerical simulations were compared with those measured using ultrasound and magnetic resonance imaging techniques and verified by a digital caliper after cutting the tested tissue samples. Quantitative analysis of the results showed that the location and extent of necrotic lesions on the magnetic resonance images are consistent with those predicted numerically and measured by caliper. The edges of lesions were clearly outlined although on ultrasound images they were fuzzy. This allows to conclude that the use of the transducer designed offers an effective noninvasive tool not only to induce local necrotic lesions within treated tissue without damaging the surrounding tissue structures but also to test various chemotherapeutics activated by the HIFU beams in preclinical studies on small animals

  7. Modeling the Western Diet for Preclinical Investigations.

    Science.gov (United States)

    Hintze, Korry J; Benninghoff, Abby D; Cho, Clara E; Ward, Robert E

    2018-05-01

    Rodent models have been invaluable for biomedical research. Preclinical investigations with rodents allow researchers to investigate diseases by using study designs that are not suitable for human subjects. The primary criticism of preclinical animal models is that results are not always translatable to humans. Some of this lack of translation is due to inherent differences between species. However, rodent models have been refined over time, and translatability to humans has improved. Transgenic animals have greatly aided our understanding of interactions between genes and disease and have narrowed the translation gap between humans and model animals. Despite the technological innovations of animal models through advances in genetics, relatively little attention has been given to animal diets. Namely, developing diets that replicate what humans eat will help make animal models more relevant to human populations. This review focuses on commonly used rodent diets that are used to emulate the Western dietary pattern in preclinical studies of obesity and type 2 diabetes, nonalcoholic liver disease, maternal nutrition, and colorectal cancer.

  8. METHODOLOGICAL APPROACHES TO EXPERT EVALUATION OF PRECLINICAL AND CLINICAL TRIALS OF HUMAN IMMUNOGLOBULIN PRODUCTS

    Directory of Open Access Journals (Sweden)

    V. B. Ivanov

    2017-01-01

    Full Text Available The article considers the experience of Russian and leading foreign regulatory agencies in organisation and conduction of preclinical and clinical trials of human immunoglobulin products. The authors suggest a classification of human immunoglobulins and provide updated information on authorization of these products in Russia. The article summarizes methodological approaches, basic scientific principles and criteria relating to expert evaluation of preclinical and clinical trials of blood products. The authors further define the expert body’s requirements for data on preclinical and clinical trials of human normal immuniglobulins and human specific immunoglobulins for the prevention and/or treatment of infectious and non-infectious diseases which are submitted as part of applications for marketing authorization or marketing authorization variation. The article suggests programs of preclinical and clinical trials for human normal immunoglobulins and human specific immunoglobulins for the prevention and/or treatment of infectious and non-infectious diseases that are aligned with the Russian legislation and Eurasian Economic Union’s regulations on medicines circulation, and have been elaborated with respect to the guidelines of the European Medicines Agency.

  9. Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.

    Science.gov (United States)

    Berridge, Brian R; Schultze, A Eric; Heyen, Jon R; Searfoss, George H; Sarazan, R Dustan

    2016-12-01

    Cardiovascular (CV) safety liabilities are significant concerns for drug developers and preclinical animal studies are predominately where those liabilities are characterized before patient exposures. Steady progress in technology and laboratory capabilities is enabling a more refined and informative use of animals in those studies. The application of surgically implantable and telemetered instrumentation in the acute assessment of drug effects on CV function has significantly improved historical approaches that involved anesthetized or restrained animals. More chronically instrumented animals and application of common clinical imaging assessments like echocardiography and MRI extend functional and in-life structural assessments into the repeat-dose setting. A growing portfolio of circulating CV biomarkers is allowing longitudinal and repeated measures of cardiac and vascular injury and dysfunction better informing an understanding of temporal pathogenesis and allowing earlier detection of undesirable effects. In vitro modeling systems of the past were limited by their lack of biological relevance to the in vivo human condition. Advances in stem cell technology and more complex in vitro modeling platforms are quickly creating more opportunity to supplant animals in our earliest assessments for liabilities. Continuing improvement in our capabilities in both animal and nonanimal modeling should support a steady decrease in animal use for primary liability identification and optimize the translational relevance of the animal studies we continue to do. © The Author 2016. Published by Oxford University Press on behalf of the Institute for Laboratory Animal Research. All rights reserved. For permissions, please email: journals.permissions@oup.com.

  10. Animal Production Research Advances

    African Journals Online (AJOL)

    Animal Production Research Advances is a peer-review journal established expressly to promote the production of all animal species utilized as food. The journal has an international scope and is intended for professionals in animal production and related sciences. We solicit contributions from animal production and ...

  11. Rat animal model for preclinical testing of microparticle urethral bulking agents.

    Science.gov (United States)

    Mann-Gow, Travis K; Blaivas, Jerry G; King, Benjamin J; El-Ghannam, Ahmed; Knabe, Christine; Lam, Michael K; Kida, Masatoshi; Sikavi, Cameron S; Plante, Mark K; Krhut, Jan; Zvara, Peter

    2015-04-01

    To develop an economic, practical and readily available animal model for preclinical testing of urethral bulking therapies, as well as to establish feasible experimental methods that allow for complete analysis of hard microparticle bulking agents. Alumina ceramic beads suspended in hyaluronic acid were injected into the proximal urethra of 15 female rats under an operating microscope. We assessed overall lower urinary tract function, bulking material intraurethral integrity and local host tissue response over time. Microphotographs were taken during injection and again 6 months postoperatively, before urethral harvest. Urinary flow rate and voiding frequency were assessed before and after injection. At 6 months, the urethra was removed and embedded in resin. Hard tissue sections were cut using a sawing microtome, and processed for histological analysis using scanning electron microscopy, light microscopy and immunohistochemistry. Microphotographs of the urethra showed complete volume retention of the bulking agent at 6 months. There was no significant difference between average urinary frequency and mean urinary flow rate at 1 and 3 months postinjection as compared with baseline. Scanning electron microscopy proved suitable for evaluation of microparticle size and integrity, as well as local tissue remodeling. Light microscopy and immunohistochemistry allowed for evaluation of an inflammatory host tissue reaction to the bulking agent. The microsurgical injection technique, in vivo physiology and novel hard tissue processing for histology, described in the present study, will allow for future comprehensive preclinical testing of urethral bulking therapy agents containing microparticles made of a hard material. © 2015 The Japanese Urological Association.

  12. Preclinical animal acute toxicity studies of new developed MRI contrast agent based on gadolinium

    Science.gov (United States)

    Nam, I. F.; Zhuk, V. V.

    2015-04-01

    Acute toxicity test of new developed MRI contrast agent based on disodium salt of gadopentetic acid complex were carried out on Mus musculus and Sprague Dawley rats according to guidelines of preclinical studies [1]. Groups of six animals each were selected for experiment. Death and clinical symptoms of animals were recorded during 14 days. As a result the maximum tolerated dose (MTD) for female mice is 2.8 mM/kg of body weight, male mice - 1.4 mM/kg, female rats - 2.8 mM/kg, male rats - 5.6 mM/kg of body weight. No Observed Adverse Effect Dose (NOAEL) for female mice is 1.4 mM/kg, male mice - 0.7 mM/kg, male and female rats - 0.7 mM/kg. According to experimental data new developed MRI contrast agent based on Gd-DTPA complex is low-toxic.

  13. Marker for the pre-clinical development of bone substitute materials

    Directory of Open Access Journals (Sweden)

    de Wild Michael

    2017-09-01

    Full Text Available Thin mechanically stable Ti-cages have been developed for the in-vivo application as X-ray and histology markers for the optimized evaluation of pre-clinical performance of bone graft materials. A metallic frame defines the region of interest during histological investigations and supports the identification of the defect site. This standardization of the procedure enhances the quality of pre-clinical experiments. Different models of thin metallic frameworks were designed and produced out of titanium by additive manufacturing (Selective Laser Melting. The productibility, the mechanical stability, the handling and suitability of several frame geometries were tested during surgery in artificial and in ex-vivo bone before a series of cages was preclinically investigated in the female Göttingen minipigs model. With our novel approach, a flexible process was established that can be adapted to the requirements of any specific animal model and bone graft testing.

  14. Medication of Production Animals – Cure of Malfunctioning Animals or Production Systems?

    Directory of Open Access Journals (Sweden)

    Chrièl Mariann

    2003-03-01

    Full Text Available Medication is used in all intensive animal productions. However, the increasing problems with resistant bacteria in all animal productions and in humans are supported by a number of reports. Special attention is given to the risk for transmitting food-borne (multi resistant zoonotic agents to humans due to failure in antibiotic treatment resulting in lower cure rates or higher case fatality rates. The use of medication in humans per se is capable of selecting for resistance in human pathogens. Nevertheless, the amount of used medication/antimicrobials in treatment of Danish production animals goes far beyond the amount used for human consumption. The increase in consumption has not been followed by a similarly increased mortality, e.g. illustrated by the number of rendered animals, increased use of injection medicine for veterinary treatments of diseased animals, or increased number of remarks on the carcasses from the slaughterhouses. Medication in animal production is facing its limits and relevant economic alternatives have to be developed. The strategy for the future must concentrate on using medication only for clinically diseased animals and not as a strategic treatment of the whole herd in order to maximise growth and camouflage of suboptimal production systems and insufficient management.

  15. Marketing animal-friendly products

    NARCIS (Netherlands)

    Riemsdijk, van Lenka; Ingenbleek, Paul T.M.; Trijp, van Hans C.M.; Veen, van der Gerrita

    2017-01-01

    This article presents a conceptual framework that aims to encourage consumer animal-friendly product choice by introducing positioning strategies for animal-friendly products. These strategies reinforce the animal welfare with different types of consumption values and can therefore reduce

  16. Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies

    Science.gov (United States)

    Hooijmans, Carlijn R.; de Vries, Rob B. M.; Ritskes-Hoitinga, Merel; Rovers, Maroeska M.; Leeflang, Mariska M.; IntHout, Joanna; Wever, Kimberley E.; Hooft, Lotty; de Beer, Hans; Kuijpers, Ton; Macleod, Malcolm R.; Sena, Emily S.; ter Riet, Gerben; Morgan, Rebecca L.; Thayer, Kristina A.; Rooney, Andrew A.; Guyatt, Gordon H.; Schünemann, Holger J.

    2018-01-01

    Laboratory animal studies are used in a wide range of human health related research areas, such as basic biomedical research, drug research, experimental surgery and environmental health. The results of these studies can be used to inform decisions regarding clinical research in humans, for example the decision to proceed to clinical trials. If the research question relates to potential harms with no expectation of benefit (e.g., toxicology), studies in experimental animals may provide the only relevant or controlled data and directly inform clinical management decisions. Systematic reviews and meta-analyses are important tools to provide robust and informative evidence summaries of these animal studies. Rating how certain we are about the evidence could provide important information about the translational probability of findings in experimental animal studies to clinical practice and probably improve it. Evidence summaries and certainty in the evidence ratings could also be used (1) to support selection of interventions with best therapeutic potential to be tested in clinical trials, (2) to justify a regulatory decision limiting human exposure (to drug or toxin), or to (3) support decisions on the utility of further animal experiments. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach is the most widely used framework to rate the certainty in the evidence and strength of health care recommendations. Here we present how the GRADE approach could be used to rate the certainty in the evidence of preclinical animal studies in the context of therapeutic interventions. We also discuss the methodological challenges that we identified, and for which further work is needed. Examples are defining the importance of consistency within and across animal species and using GRADE’s indirectness domain as a tool to predict translation from animal models to humans. PMID:29324741

  17. Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies.

    Science.gov (United States)

    Hooijmans, Carlijn R; de Vries, Rob B M; Ritskes-Hoitinga, Merel; Rovers, Maroeska M; Leeflang, Mariska M; IntHout, Joanna; Wever, Kimberley E; Hooft, Lotty; de Beer, Hans; Kuijpers, Ton; Macleod, Malcolm R; Sena, Emily S; Ter Riet, Gerben; Morgan, Rebecca L; Thayer, Kristina A; Rooney, Andrew A; Guyatt, Gordon H; Schünemann, Holger J; Langendam, Miranda W

    2018-01-01

    Laboratory animal studies are used in a wide range of human health related research areas, such as basic biomedical research, drug research, experimental surgery and environmental health. The results of these studies can be used to inform decisions regarding clinical research in humans, for example the decision to proceed to clinical trials. If the research question relates to potential harms with no expectation of benefit (e.g., toxicology), studies in experimental animals may provide the only relevant or controlled data and directly inform clinical management decisions. Systematic reviews and meta-analyses are important tools to provide robust and informative evidence summaries of these animal studies. Rating how certain we are about the evidence could provide important information about the translational probability of findings in experimental animal studies to clinical practice and probably improve it. Evidence summaries and certainty in the evidence ratings could also be used (1) to support selection of interventions with best therapeutic potential to be tested in clinical trials, (2) to justify a regulatory decision limiting human exposure (to drug or toxin), or to (3) support decisions on the utility of further animal experiments. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach is the most widely used framework to rate the certainty in the evidence and strength of health care recommendations. Here we present how the GRADE approach could be used to rate the certainty in the evidence of preclinical animal studies in the context of therapeutic interventions. We also discuss the methodological challenges that we identified, and for which further work is needed. Examples are defining the importance of consistency within and across animal species and using GRADE's indirectness domain as a tool to predict translation from animal models to humans.

  18. A review of treatment planning for precision image-guided photon beam pre-clinical animal radiation studies

    International Nuclear Information System (INIS)

    Verhaegen, Frank; Hoof, Stefan van; Granton, Patrick V.; Trani, Daniela

    2014-01-01

    Recently, precision irradiators integrated with a high-resolution CT imaging device became available for pre-clinical studies. These research platforms offer significant advantages over older generations of animal irradiators in terms of precision and accuracy of image-guided radiation targeting. These platforms are expected to play a significant role in defining experiments that will allow translation of research findings to the human clinical setting. In the field of radiotherapy, but also others such as neurology, the platforms create unique opportunities to explore e.g. the synergy between radiation and drugs or other agents. To fully exploit the advantages of this new technology, accurate methods are needed to plan the irradiation and to calculate the three-dimensional radiation dose distribution in the specimen. To this end, dedicated treatment planning systems are needed. In this review we will discuss specific issues for precision irradiation of small animals, we will describe the workflow of animal treatment planning, and we will examine several dose calculation algorithms (factorization, superposition-convolution, Monte Carlo simulation) used for animal irradiation with kilovolt photon beams. Issues such as dose reporting methods, photon scatter, tissue segmentation and motion will also be discussed briefly.

  19. Preclinical animal research on therapy dosimetry with dual isotopes

    NARCIS (Netherlands)

    M.W. Konijnenberg (Mark); M. de Jong (Marion)

    2011-01-01

    textabstractPreclinical research into radionuclide therapies based on radiation dosimetry will enable the use of any LET-equivalent radionuclide. Radiation dose and dose rate have significant influence on dose effects in the tumour depending on its radiation sensitivity, possibilities for repair of

  20. Organic Animal Production and Mycotoxins

    Directory of Open Access Journals (Sweden)

    Nurcan Çetinkaya

    2018-03-01

    Full Text Available Organic animal production; is a form of production without using any chemical inputs from production to consumption. In organic livestock production; organic breeding, feedstuff and animal nutrition conditions are stated in the Regulation on the Principles and Implementation of Organic Agriculture. Organic animal products must be prevented from recontamination. There are three different contamination hazards; biological (mold-toxins and pathogenic micro-organisms, chemical (pesticide residues, and physical (broken metal or glass, etc.. Molding and mycotoxin formation in organic feeds is one of the most important problems since they adversly affect animal health and toxines pass through the products. Since any chemical method cannot be applied to the organic feedstuffs especially in the struggle with mycotoxin in organic animal production, this should be considered in the measures to be taken and in the systems to be applied and the system should be planned to include organic agriculture. Countries that have established HACCP and ISO 22000 food safety management systems are able to avoid the problem of mycotoxin pollution in organic animal foods. The establishment of the feed safety system based on HACCP principles and its application in production have been made compulsory by Feed Hygiene Regulation issued in Turkey since 2011. In this review, the relationship between organic animal production and mycotoxin, and the precautions to be taken are discussed.

  1. Animal Research on Nicotine Reduction: Current Evidence and Research Gaps.

    Science.gov (United States)

    Smith, Tracy T; Rupprecht, Laura E; Denlinger-Apte, Rachel L; Weeks, Jillian J; Panas, Rachel S; Donny, Eric C; Sved, Alan F

    2017-09-01

    A mandated reduction in the nicotine content of cigarettes may improve public health by reducing the prevalence of smoking. Animal self-administration research is an important complement to clinical research on nicotine reduction. It can fill research gaps that may be difficult to address with clinical research, guide clinical researchers about variables that are likely to be important in their own research, and provide policy makers with converging evidence between clinical and preclinical studies about the potential impact of a nicotine reduction policy. Convergence between clinical and preclinical research is important, given the ease with which clinical trial participants can access nonstudy tobacco products in the current marketplace. Herein, we review contributions of preclinical animal research, with a focus on rodent self-administration, to the science of nicotine reduction. Throughout this review, we highlight areas where clinical and preclinical research converge and areas where the two differ. Preclinical research has provided data on many important topics such as the threshold for nicotine reinforcement, the likelihood of compensation, moderators of the impact of nicotine reduction, the impact of environmental stimuli on nicotine reduction, the impact of nonnicotine cigarette smoke constituents on nicotine reduction, and the impact of nicotine reduction on vulnerable populations. Special attention is paid to current research gaps including the dramatic rise in alternative tobacco products, including electronic nicotine delivery systems (ie, e-cigarettes). The evidence reviewed here will be critical for policy makers as well as clinical researchers interested in nicotine reduction. This review will provide policy makers and clinical researchers interested in nicotine reduction with an overview of the preclinical animal research conducted on nicotine reduction and the regulatory implications of that research. The review also highlights the utility of

  2. Radioactivity transfer to animal products

    International Nuclear Information System (INIS)

    Coughtrey, P.J.

    1990-01-01

    Information on the behaviour of strontium, caesium, ruthenium, plutonium and americium in a range of domestic animals is reviewed to form a basis for the specification of time-dependent mathematical models describing uptake, distribution and retention in various domestic animals. Transfer factors relating concentration in animal product to daily radioactivity intake are derived after 100 d continuous intake and at equilibrium. These transfer factors are compared with the available published literature and used as a basis for the derivation of feedingstuff conversion factors relating limiting concentrations in animal feedingstuffs to limiting concentrations in human foodstuffs for application to animals receiving commercial feedingstuffs after a nuclear accident. Recommended transfer factors for animal products in conditions of continuous discharge and models for application to field conditions after a nuclear accident are also presented. Transfer of caesium to animal products is more effective than that for the other elements considered here. Transfer to meat of lamb, fattening pig, and chickens is generally more effective than that for other animals and other products

  3. Animal Production Research Advances: Editorial Policies

    African Journals Online (AJOL)

    Focus and Scope. Animal production research advances is a peer-review journal established expressly to promote the production of all animal species utilized as food. The journal has an international scope and is intended for professionals in animal production and related sciences. We solicit contributions from animal ...

  4. Radioisotopes In Animal Production Research

    International Nuclear Information System (INIS)

    Eduvie, L.O.

    1994-05-01

    Animal productivity may be measured among others, in terms of two important physiological processes of reproduction and growth each of which involves a number of integrated disciplines. Both physiological processes are controlled by interactions of genotype and environment. Reproduction essentially involves complex physiological processes controlled by secretions of endocrine glands known as hormones. On the other hand growth is determined largely by availabilty of essential nutrients. In order to achieve good reproductive and growth rates adequate and constant nutrition for livestock include pasture, cereals, tubers and their by-products as well as industrial by-products. While reproduction is essential to provide the required number and replacement of livestock, growth guarantees availability of meat. Another aspect of livestock production is disease control. An animal needs a good health to adequately express its genetic make up and utilize available nutrition. Research in animal production is aimed at improving all aspects of productivity of livestock which include reproduction, growth, milk production, egg production, good semen etc. of livestock. In order to achieve this an understanding of the biochemical and physiological processes occurring in the animal itself, and in the feedstuff fed to the animal as well as the aetiology and control of diseases affecting the animal among other factors, is desirable. A number of methods of investigation have evolved with time. These include colorimetry, spectrophotometry, chromatography, microscopy and raidoisotopic tracer methods. While most of these methods are cumbersome and use equipment with low precision, radioisotopic tracer methods utilize equipment with relatively high precision

  5. In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies

    Directory of Open Access Journals (Sweden)

    Christiane Broichhausen

    2014-01-01

    Full Text Available A new cell-based medicinal product containing human regulatory macrophages, known as Mreg_UKR, has been developed and conforms to expectations of a therapeutic drug. Here, Mreg_UKR was subjected to pharmacokinetic, safety pharmacology, and toxicological testing, which identified no adverse reactions. These results would normally be interpreted as evidence of the probable clinical safety of Mreg_UKR; however, we contend that, owing to their uncertain biological relevance, our data do not fully support this conclusion. This leads us to question whether there is adequate scientific justification for preclinical safety testing of similar novel cell-based medicinal products using animal models. In earlier work, two patients were treated with regulatory macrophages prior to kidney transplantation. In our opinion, the absence of acute or chronic adverse effects in these cases is the most convincing available evidence of the likely safety of Mreg_UKR in future recipients. On this basis, we consider that safety information from previous clinical investigations of related cell products should carry greater weight than preclinical data when evaluating the safety profile of novel cell-based medicinal products. By extension, we argue that omitting extensive preclinical safety studies before conducting small-scale exploratory clinical investigations of novel cell-based medicinal products data may be justifiable in some instances.

  6. Dose evaluation of three-dimensional small animal phantom with film dosimetry

    International Nuclear Information System (INIS)

    Han, Su Chul; Park, Seung Woo

    2017-01-01

    The weight of small animal dosimetry has been continuously increased in pre-clinical studies using radiation in small animals. In this study, three-dimensional(3D) small animal phantom was fabricated using 3D printer which has been continuously used and studied in the various fields. The absorbed dose of 3D animal phantom was evaluated by film dosimetry. Previously, the response of film was obtained from the materials used for production of 3D small animal phantom and compared with the bolus used as the tissue equivalent material in the radiotherapy. When irradiated with gamma rays from 0.5 Gy to 6 Gy, it was confirmed that there was a small difference of less than 1% except 0.5 Gy dose. And when small animal phantom was irradiated with 5 Gy, the difference between the irradiated dose and calculated dose from film was within 2%. Based on this study, it would be possible to increase the reliability of dose in pre-clinical studies using irradiation in small animals by evaluating dose of 3D small animal phantom

  7. Dose evaluation of three-dimensional small animal phantom with film dosimetry

    Energy Technology Data Exchange (ETDEWEB)

    Han, Su Chul [Div. of Medical Radiation Equipment, Korea Institute of Radiological and Medical Sciences, Seoul (Korea, Republic of); Park, Seung Woo [Radilogcial and Medico-Oncological Sciences, University of Sciences and Technology, Daejeon (Korea, Republic of)

    2017-03-15

    The weight of small animal dosimetry has been continuously increased in pre-clinical studies using radiation in small animals. In this study, three-dimensional(3D) small animal phantom was fabricated using 3D printer which has been continuously used and studied in the various fields. The absorbed dose of 3D animal phantom was evaluated by film dosimetry. Previously, the response of film was obtained from the materials used for production of 3D small animal phantom and compared with the bolus used as the tissue equivalent material in the radiotherapy. When irradiated with gamma rays from 0.5 Gy to 6 Gy, it was confirmed that there was a small difference of less than 1% except 0.5 Gy dose. And when small animal phantom was irradiated with 5 Gy, the difference between the irradiated dose and calculated dose from film was within 2%. Based on this study, it would be possible to increase the reliability of dose in pre-clinical studies using irradiation in small animals by evaluating dose of 3D small animal phantom.

  8. Animal health and production

    International Nuclear Information System (INIS)

    Kallfelz, F.A.; Lengemann, F.W.

    1984-01-01

    Some applications of the use of radioisotopes and radiation in animal health and production research are reviewed. These include various techniques associated with both the qualitative localization and quantitative measurements of isotopes in animals; comparator studies in which measurement of the radioactivity in one part of a system will allow computation of the mass or volume in another part; in vivo and in vitro applications of isotope dilution studies; and the use of isotopes in dynamic systems analyses. The use of stable isotopes in mass spectrometry, activation analysis and nuclear magnetic resonance in animal research is also briefly reviewed. Finally some of the successful uses of radiation produced by radioactive sources or various types of generators of electromagnetic radiations in animal production and health studies are described. (U.K.)

  9. Preclinical assessment of a new recombinant ADAMTS-13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura.

    Science.gov (United States)

    Kopić, A; Benamara, K; Piskernik, C; Plaimauer, B; Horling, F; Höbarth, G; Ruthsatz, T; Dietrich, B; Muchitsch, E-M; Scheiflinger, F; Turecek, M; Höllriegl, W

    2016-07-01

    Essentials ADAMTS-13-deficiency is a cause of thrombotic thrombocytopenic purpura (TTP). Preclinical safety of recombinant human ADAMTS-13 (BAX930) was shown in animal models. Preclinical efficacy of BAX930 was shown in a mouse model of TTP. BAX930 showed advantageous efficacy over fresh frozen plasma, the current standard of care. Click to hear Dr Cataland and Prof. Lämmle present a seminar on Thrombotic Thrombocytopenic Purpura (TTP): new Insights in Pathogenesis and Treatment Modalities. Background Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder characterized by microthrombosis in small blood vessels of the body, resulting in a low platelet count. Baxalta has developed a new recombinant ADAMTS-13 (rADAMTS-13) product (BAX930) for on-demand and prophylactic treatment of patients with hereditary TTP (hTTP). Objectives To evaluate the pharmacokinetics, efficacy and safety of BAX930 in different species, by use of an extensive preclinical program. Methods The prophylactic and therapeutic efficacies of BAX930 were tested in a previously established TTP mouse model. Pharmacokinetics were evaluated after single intravenous bolus injection in mice and rats, and after repeated dosing in cynomolgus monkeys. Toxicity was assessed in rats and monkeys, safety pharmacology in monkeys, and local tolerance in rabbits. Results BAX930 was shown to be efficacious, as demonstrated by a stabilized platelet count in ADAMTS-13 knockout mice that were thrombocytopenic when treated. Prophylactic efficacy was dose-dependent and comparable with that achieved by treatment with fresh frozen plasma, the mainstay of hTTP treatment. Therapeutic efficacy was treatment interval-dependent. Safety pharmacology evaluation did not show any deleterious effects of BAX930 on cardiovascular and respiratory functions in monkeys. The compound's pharmacokinetics were similar and dose-proportional in mice, rats, and monkeys. BAX930 was well tolerated in rats, monkeys, and rabbits, even

  10. Carbon dioxide production in animal houses

    DEFF Research Database (Denmark)

    Pedersen, Søren; Blanes-Vidal, Victoria; Joergensen, H.

    2008-01-01

    cellars are emptied regularly in a four weeks interval. Due to a high and variable carbon dioxide production in deep straw litter houses and houses with indoor storage of manure longer than four weeks, we do not recommend to calculate the ventilation flow based on the carbon dioxide concentration......This article deals with carbon dioxide production from farm animals; more specifically, it addresses the possibilities of using the measured carbon dioxide concentration in animal houses as basis for estimation of ventilation flow (as the ventilation flow is a key parameter of aerial emissions from...... animal houses). The investigations include measurements in respiration chambers and in animal houses, mainly for growing pigs and broilers. Over the last decade a fixed carbon dioxide production of 185 litres per hour per heat production unit, hpu (i.e. 1000 W of the total animal heat production at 20o...

  11. Animal Product Safety Information

    Science.gov (United States)

    ... Home Animal & Veterinary Safety & Health Product Safety Information Product Safety Information Share Tweet Linkedin Pin it More ... to report adverse experiences with veterinary drugs. Additional Product Information Questions and Answers: Evanger’s Dog and Cat ...

  12. Animal Production Research Advances: Submissions

    African Journals Online (AJOL)

    Where this is not possible, authors should submit two copies of original article not yet published anywhere and accompanied with a 3.5” diskette containing the article labeled appropriately in MS Word version to: Editor–in–Chief, Animal Production Research Advances Tropical Animal Health and Production Research Lab

  13. Pre-clinical functional magnetic resonance imaging. Pt. I. The kidney

    Energy Technology Data Exchange (ETDEWEB)

    Zoellner, Frank G.; Kalayciyan, Raffi; Chacon-Caldera, Jorge; Zimmer, Fabian; Schad, Lothar R. [Heidelberg Univ., Mannheim (Germany). Computer Assisted Clinical Medicine

    2014-07-01

    The prevalence of chronic kidney disease (CKD) is increasing worldwide. In Europe alone, at least 8% of the population currently has some degree of CKD. CKD is associated with serious comorbidity, reduced life expectancy, and high economic costs; hence, the early detection and adequate treatment of kidney disease is important. Pre-clinical research can not only give insights into the mechanisms of the various kidney diseases but it also allows for investigating the outcome of new drugs developed to treat kidney disease. Functional magnetic resonance imaging provides non-invasive access to tissue and organ function in animal models. Advantages over classical animal research approaches are numerous: the same animal might be repeatedly imaged to investigate a progress or a treatment of disease over time. This has also a direct impact on animal welfare and the refinement of classical animal experiments as the number of animals in the studies might be reduced. In this paper, we review current state of the art in functional magnetic resonance imaging with a focus on pre-clinical kidney imaging.

  14. Pre-clinical functional magnetic resonance imaging. Pt. I. The kidney

    International Nuclear Information System (INIS)

    Zoellner, Frank G.; Kalayciyan, Raffi; Chacon-Caldera, Jorge; Zimmer, Fabian; Schad, Lothar R.

    2014-01-01

    The prevalence of chronic kidney disease (CKD) is increasing worldwide. In Europe alone, at least 8% of the population currently has some degree of CKD. CKD is associated with serious comorbidity, reduced life expectancy, and high economic costs; hence, the early detection and adequate treatment of kidney disease is important. Pre-clinical research can not only give insights into the mechanisms of the various kidney diseases but it also allows for investigating the outcome of new drugs developed to treat kidney disease. Functional magnetic resonance imaging provides non-invasive access to tissue and organ function in animal models. Advantages over classical animal research approaches are numerous: the same animal might be repeatedly imaged to investigate a progress or a treatment of disease over time. This has also a direct impact on animal welfare and the refinement of classical animal experiments as the number of animals in the studies might be reduced. In this paper, we review current state of the art in functional magnetic resonance imaging with a focus on pre-clinical kidney imaging.

  15. Risk mitigation for children exposed to drugs during gestation: A critical role for animal preclinical behavioral testing.

    Science.gov (United States)

    Zucker, Irving

    2017-06-01

    Many drugs with unknown safety profiles are administered to pregnant women, placing their offspring at risk. I assessed whether behavioral outcomes for children exposed during gestation to antidepressants, anxiolytics, anti-seizure, analgesic, anti-nausea and sedative medications can be predicted by more extensive animal studies than are part of the FDA approval process. Human plus rodent data were available for only 8 of 33 CNS-active drugs examined. Similar behavioral and cognitive deficits, including autism and ADHD emerged in human offspring and in animal models of these disorders after exposure to fluoxetine, valproic acid, carbamazepine, phenytoin, phenobarbital and acetaminophen. Rodent data helpful in identifying and predicting adverse effects of prenatal drug exposure in children were first generated many years after drugs were FDA-approved and administered to pregnant women. I recommend that enhanced behavioral testing of rodent offspring exposed to drugs prenatally should begin during preclinical drug evaluation and continue during Phase I clinical trials, with findings communicated to physicians and patients in drug labels. Copyright © 2017 Elsevier Ltd. All rights reserved.

  16. Improving animal productivity by nuclear techniques

    International Nuclear Information System (INIS)

    Garcia, M.; Jayasuriya, M.C.N.; Perera, B.M.A.O.

    1995-01-01

    The IAEA and FAO have run a joint programme for 30 years to assist national agricultural research systems in member states to develop, test and apply nuclear and related techniques for improving the productivity of livestock. Applications of nuclear technologies for improving livestock productivity include: use of radioimmunoassay in animal nutrition researches, animal production, and evaluating feeding and management systems through reproductive performance in a field. Geographic coverage and the type of livestock studies are: grazing animals (cattle, goats and sheep) in Africa, Latin America and Asia, as well as buffalo production in Asia. 6 refs, 8 figs, 6 tabs

  17. Electronic Animal Drug Product Listing Directory

    Data.gov (United States)

    U.S. Department of Health & Human Services — The Electronic Animal Drug Product Listing Directory is a directory of all animal drug products that have been listed electronically since June 1, 2009, to comply...

  18. Companion Animals as a Source of Viruses for Human Beings and Food Production Animals.

    Science.gov (United States)

    Reperant, L A; Brown, I H; Haenen, O L; de Jong, M D; Osterhaus, A D M E; Papa, A; Rimstad, E; Valarcher, J-F; Kuiken, T

    2016-07-01

    Companion animals comprise a wide variety of species, including dogs, cats, horses, ferrets, guinea pigs, reptiles, birds and ornamental fish, as well as food production animal species, such as domestic pigs, kept as companion animals. Despite their prominent place in human society, little is known about the role of companion animals as sources of viruses for people and food production animals. Therefore, we reviewed the literature for accounts of infections of companion animals by zoonotic viruses and viruses of food production animals, and prioritized these viruses in terms of human health and economic importance. In total, 138 virus species reportedly capable of infecting companion animals were of concern for human and food production animal health: 59 of these viruses were infectious for human beings, 135 were infectious for food production mammals and birds, and 22 were infectious for food production fishes. Viruses of highest concern for human health included hantaviruses, Tahyna virus, rabies virus, West Nile virus, tick-borne encephalitis virus, Crimean-Congo haemorrhagic fever virus, Aichi virus, European bat lyssavirus, hepatitis E virus, cowpox virus, G5 rotavirus, influenza A virus and lymphocytic choriomeningitis virus. Viruses of highest concern for food production mammals and birds included bluetongue virus, African swine fever virus, foot-and-mouth disease virus, lumpy skin disease virus, Rift Valley fever virus, porcine circovirus, classical swine fever virus, equine herpesvirus 9, peste des petits ruminants virus and equine infectious anaemia virus. Viruses of highest concern for food production fishes included cyprinid herpesvirus 3 (koi herpesvirus), viral haemorrhagic septicaemia virus and infectious pancreatic necrosis virus. Of particular concern as sources of zoonotic or food production animal viruses were domestic carnivores, rodents and food production animals kept as companion animals. The current list of viruses provides an objective

  19. Ethical Considerations of Preclinical Testing

    Directory of Open Access Journals (Sweden)

    Allen Goldenthal

    2015-12-01

    Full Text Available The numbers of animal tests being conducted are on a sharp incline.  Much of this increase is directly due to our ability to generate transgenic models and knock-outs, thereby increasing the validity of the animal model but not necessarily correlating directly with any translational medical benefits to the human counterpart.  In spite of our best efforts, there still exist species differences that prevent the application directly from animal to human, and in some examples having a completely different and adverse effect from that seen in the animal model. There are several ways in which we can improve the opportunity for a positive test outcome and at the same time reduce the animal usage which is associated with our current animal testing practices. The benefit of the 3R’s is that they encourage us not only to avoid wastage of life but that they require us to provide considerable foresight and extrapolated thought before directly engaging in the preclinical testing phase.

  20. The development of neural stimulators: a review of preclinical safety and efficacy studies.

    Science.gov (United States)

    Shepherd, Robert K; Villalobos, Joel; Burns, Owen; Nayagam, David

    2018-05-14

    Given the rapid expansion of the field of neural stimulation and the rigorous regulatory approval requirements required before these devices can be applied clinically, it is important that there is clarity around conducting preclinical safety and efficacy studies required for the development of this technology. The present review examines basic design principles associated with the development of a safe neural stimulator and describes the suite of preclinical safety studies that need to be considered when taking a device to clinical trial. Neural stimulators are active implantable devices that provide therapeutic intervention, sensory feedback or improved motor control via electrical stimulation of neural or neuro-muscular tissue in response to trauma or disease. Because of their complexity, regulatory bodies classify these devices in the highest risk category (Class III), and they are therefore required to go through a rigorous regulatory approval process before progressing to market. The successful development of these devices is achieved through close collaboration across disciplines including engineers, scientists and a surgical/clinical team, and the adherence to clear design principles. Preclinical studies form one of several key components in the development pathway from concept to product release of neural stimulators. Importantly, these studies provide iterative feedback in order to optimise the final design of the device. Key components of any preclinical evaluation include: in vitro studies that are focussed on device reliability and include accelerated testing under highly controlled environments; in vivo studies using animal models of the disease or injury in order to assess safety and, given an appropriate animal model, the efficacy of the technology under both passive and electrically active conditions; and human cadaver and ex vivo studies designed to ensure the device's form factor conforms to human anatomy, to optimise the surgical approach and to

  1. The green, blue and grey water footprint of animals and animal products

    NARCIS (Netherlands)

    Mekonnen, Mesfin; Hoekstra, Arjen Ysbert

    2010-01-01

    The projected increase in the production and consumption of animal products is likely to put further pressure on the globe’s freshwater resources. The size and characteristics of the water footprint vary across animal types and production systems. The current study provides a comprehensive account

  2. Greenhouse gas mitigation in animal production

    DEFF Research Database (Denmark)

    De Boer, IJM; Cederberg, C; Eady, S

    2011-01-01

    The animal food chain contributes significantly to emission of greenhouse gases (GHGs). We explored studies that addressed options to mitigate GHG emissions in the animal production chain and concluded that most studies focused on production systems in developed countries and on a single GHG...

  3. Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines.

    Science.gov (United States)

    Rice, Andrew S C; Morland, Rosemary; Huang, Wenlong; Currie, Gillian L; Sena, Emily S; Macleod, Malcolm R

    2017-12-29

    Clear reporting of research is crucial to the scientific process. Poorly designed and reported studies are damaging not only to the efforts of individual researchers, but also to science as a whole. Standardised reporting methods, such as those already established for reporting randomised clinical trials, have led to improved study design and facilitated the processes of clinical systematic review and meta-analysis. Such standards were lacking in the pre-clinical field until the development of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines. These were prompted following a survey which highlighted a widespread lack of robust and consistent reporting of pre-clinical in vivo research, with reports frequently omitting basic information required for study replication and quality assessment. The resulting twenty item checklist in ARRIVE covers all aspects of experimental design with particular emphasis on bias reduction and methodological transparency. Influential publishers and research funders have already adopted ARRIVE. Further dissemination and acknowledgement of the importance of these guidelines is vital to their widespread implementation. Conclusions and implications Wide implementation of the ARRIVE guidelines for reporting of in vivo preclinical research, especially pain research, are essential for a much needed increased transparency and quality in publishing such research. ARRIVE will also positively influence improvements in experimental design and quality, assist the conduct of accurate replication studies of important new findings and facilitate meta-analyses of preclinical research.

  4. THE ROMANIAN EXTERNAL TRADE IN LIVE ANIMALS AND ANIMAL PRODUCTS

    Directory of Open Access Journals (Sweden)

    Ionela MiĠuko VLAD

    2012-01-01

    Full Text Available In terms of foreign trade, in Romania there were some major changes over the past 20 years. In this paper we have focused on the Romanian external trade. The products which have been taken into account were live animals and animal products. Thus, we have made an analyse on the Romanian imports and exports at the global level and at the European level. Focused on the animal products, on the global level, there were registered major differences during the first seven years in the analysed period. Breaking by branches, we have pointed out huge distinctions between imports and exports, where the balance of trade was completely negative. Meanwhile, to have a good view on the international trade there were made links, based on some indexes between imports, exports, GDP and investments.

  5. Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism

    Directory of Open Access Journals (Sweden)

    Ke-Jian Zhang

    2017-06-01

    Full Text Available Shexiang Baoxin Pill (SBP originated from a classical TCM Fufang Suhexiang Pill for chest pain with dyspnea in the Southern Song Dynasty (1107–110 AD. Here, we aimed to evaluate preclinical evidence and possible mechanism of SBP for experimental coronary heart disease (CHD. Studies of SBP in animal models with CHD were identified from 6 databases until April 2016. Study quality for each included article was evaluated according to the CAMARADES 10-item checklist. Outcome measures were myocardial infarction area, vascular endothelial growth factor (VEGF and microvessel count (MVC. All the data were analyzed by using RevMan 5.1 software. As a consequence, 25 studies with 439 animals were identified. The quality score of studies ranged from 2 to 5, with the median of 3.6. Meta-analysis of seven studies showed more significant effects of SBP on the reduction of the myocardial infarction area than the control (P < 0.01. Meta-analysis of eight studies showed significant effects of SBP for increasing VEGF expression compared with the control (P < 0.01. Meta-analysis of 10 studies indicated that SBP significantly improved MVC compared with the control (P < 0.01. In conclusion, these findings preliminarily demonstrated that SBP can reduce myocardial infarction area, exerting cardioprotective function largely through promoting angiogenesis.

  6. Large animal models for vaccine development and testing.

    Science.gov (United States)

    Gerdts, Volker; Wilson, Heather L; Meurens, Francois; van Drunen Littel-van den Hurk, Sylvia; Wilson, Don; Walker, Stewart; Wheler, Colette; Townsend, Hugh; Potter, Andrew A

    2015-01-01

    The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response. Studies identifying the mechanisms of immune protection; determining the optimal route and formulation of vaccines; establishing the duration and onset of immunity, as well as the safety and efficacy of new vaccines, must be performed in a living system. Importantly, no single animal model provides all the information required for advancing a new vaccine through the preclinical stage, and research over the last two decades has highlighted that large animals more accurately predict vaccine outcome in humans than do other models. Here we review the advantages and disadvantages of large animal models for human vaccine development and demonstrate that much of the success in bringing a new vaccine to market depends on choosing the most appropriate animal model for preclinical testing. © The Author 2015. Published by Oxford University Press on behalf of the Institute for Laboratory Animal Research. All rights reserved. For permissions, please email: journals.permissions@oup.com.

  7. Premature culling of production animals; ethical questions related to killing animals in food production

    NARCIS (Netherlands)

    Bruijnis, M.R.N.; Meijboom, F.L.B.; Stassen, E.N.

    2016-01-01

    The aim of this chapter is to analyse the importance of longevity in relation to the welfare of production animals. I hypothesize that the concept of longevity helps to support the moral intuition that premature culling of animals is a moral wrong. The analysis shows that the interpretation of the

  8. Harmonization in preclinical epilepsy research: A joint AES/ILAE translational initiative.

    Science.gov (United States)

    Galanopoulou, Aristea S; French, Jacqueline A; O'Brien, Terence; Simonato, Michele

    2017-11-01

    Among the priority next steps outlined during the first translational epilepsy research workshop in London, United Kingdom (2012), jointly organized by the American Epilepsy Society (AES) and the International League Against Epilepsy (ILAE), are the harmonization of research practices used in preclinical studies and the development of infrastructure that facilitates multicenter preclinical studies. The AES/ILAE Translational Task Force of the ILAE has been pursuing initiatives that advance these goals. In this supplement, we present the first reports of the working groups of the Task Force that aim to improve practices of performing rodent video-electroencephalography (vEEG) studies in experimental controls, generate systematic reviews of preclinical research data, and develop preclinical common data elements (CDEs) for epilepsy research in animals. Wiley Periodicals, Inc. © 2017 International League Against Epilepsy.

  9. The Potential of Animal By-Products in Food Systems: Production, Prospects and Challenges

    Directory of Open Access Journals (Sweden)

    Babatunde O. Alao

    2017-06-01

    Full Text Available The consumption of animal by-products has continued to witness tremendous growth over the last decade. This is due to its potential to combat protein malnutrition and food insecurity in many countries. Shortly after slaughter, animal by-products are separated into edible or inedible parts. The edible part accounts for 55% of the production while the remaining part is regarded as inedible by-products (IEBPs. These IEBPs can be re-processed into sustainable products for agricultural and industrial uses. The efficient utilization of animal by-products can alleviate the prevailing cost and scarcity of feed materials, which have high competition between animals and humans. This will also aid in reducing environmental pollution in the society. In this regard, proper utilization of animal by-products such as rumen digesta can result in cheaper feed, reduction in competition and lower cost of production. Over the years, the utilization of animal by-products such as rumen digesta as feed in livestock feed has been successfully carried out without any adverse effect on the animals. However, there are emerging gaps that need to be further addressed regarding the food security and sustainability of the products. Therefore, the objective of this review highlights the efficacy and effectiveness of using animal by-products as alternative sources of feed ingredients, and the constraints associated with their production to boost livestock performance in the industry at large.

  10. Characterization of novel preclinical dose distributions for micro irradiator

    International Nuclear Information System (INIS)

    Kodra, J; Miles, D; Yoon, S W; Kirsch, D G; Oldham, M

    2017-01-01

    This work explores and demonstrates the feasibility of utilizing new 3D printing techniques to implement advanced micro radiation therapy for pre-clinical small animal studies. 3D printed blocks and compensators were designed and printed from a strong x-ray attenuating material at sub-millimeter resolution. These techniques enable a powerful range of new preclinical treatment capabilities including grid therapy, lattice therapy, and IMRT treatment. At small scales, verification of these treatments is exceptionally challenging, and high resolution 3D dosimetry (0.5mm 3 ) is an essential capability to characterize and verify these capabilities, Here, investigate the 2D and 3D dosimetry of several novel pre-clinical treatments using a combination of EBT film and Presage/optical-CT 3D dosimetry in rodent-morphic dosimeters. (paper)

  11. Characterization of novel preclinical dose distributions for micro irradiator

    Science.gov (United States)

    Kodra, J.; Miles, D.; Yoon, S. W.; Kirsch, D. G.; Oldham, M.

    2017-05-01

    This work explores and demonstrates the feasibility of utilizing new 3D printing techniques to implement advanced micro radiation therapy for pre-clinical small animal studies. 3D printed blocks and compensators were designed and printed from a strong x-ray attenuating material at sub-millimeter resolution. These techniques enable a powerful range of new preclinical treatment capabilities including grid therapy, lattice therapy, and IMRT treatment. At small scales, verification of these treatments is exceptionally challenging, and high resolution 3D dosimetry (0.5mm3) is an essential capability to characterize and verify these capabilities, Here, investigate the 2D and 3D dosimetry of several novel pre-clinical treatments using a combination of EBT film and Presage/optical-CT 3D dosimetry in rodent-morphic dosimeters.

  12. Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review.

    Science.gov (United States)

    Gulin, Julián Ernesto Nicolás; Rocco, Daniela Marisa; García-Bournissen, Facundo

    2015-11-01

    Publication of accurate and detailed descriptions of methods in research articles involving animals is essential for health scientists to accurately interpret published data, evaluate results and replicate findings. Inadequate reporting of key aspects of experimental design may reduce the impact of studies and could act as a barrier to translation of research findings. Reporting of animal use must be as comprehensive as possible in order to take advantage of every study and every animal used. Animal models are essential to understanding and assessing new chemotherapy candidates for Chagas disease pathology, a widespread parasitic disease with few treatment options currently available. A systematic review was carried out to compare ARRIVE guidelines recommendations with information provided in publications of preclinical studies for new anti-Trypanosoma cruzi compounds. A total of 83 publications were reviewed. Before ARRIVE guidelines, 69% of publications failed to report any macroenvironment information, compared to 57% after ARRIVE publication. Similar proportions were observed when evaluating reporting of microenvironmental information (56% vs. 61%). Also, before ARRIVE guidelines publication, only 13% of papers described animal gender, only 18% specified microbiological status and 13% reported randomized treatment assignment, among other essential information missing or incomplete. Unfortunately, publication of ARRIVE guidelines did not seem to enhance reporting quality, compared to papers appeared before ARRIVE publication. Our results suggest that there is a strong need for the scientific community to improve animal use description, animal models employed, transparent reporting and experiment design to facilitate its transfer and application to the affected human population. Full compliance with ARRIVE guidelines, or similar animal research reporting guidelines, would be an excellent start in this direction.

  13. Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review.

    Directory of Open Access Journals (Sweden)

    Julián Ernesto Nicolás Gulin

    2015-11-01

    Full Text Available Publication of accurate and detailed descriptions of methods in research articles involving animals is essential for health scientists to accurately interpret published data, evaluate results and replicate findings. Inadequate reporting of key aspects of experimental design may reduce the impact of studies and could act as a barrier to translation of research findings. Reporting of animal use must be as comprehensive as possible in order to take advantage of every study and every animal used. Animal models are essential to understanding and assessing new chemotherapy candidates for Chagas disease pathology, a widespread parasitic disease with few treatment options currently available. A systematic review was carried out to compare ARRIVE guidelines recommendations with information provided in publications of preclinical studies for new anti-Trypanosoma cruzi compounds. A total of 83 publications were reviewed. Before ARRIVE guidelines, 69% of publications failed to report any macroenvironment information, compared to 57% after ARRIVE publication. Similar proportions were observed when evaluating reporting of microenvironmental information (56% vs. 61%. Also, before ARRIVE guidelines publication, only 13% of papers described animal gender, only 18% specified microbiological status and 13% reported randomized treatment assignment, among other essential information missing or incomplete. Unfortunately, publication of ARRIVE guidelines did not seem to enhance reporting quality, compared to papers appeared before ARRIVE publication. Our results suggest that there is a strong need for the scientific community to improve animal use description, animal models employed, transparent reporting and experiment design to facilitate its transfer and application to the affected human population. Full compliance with ARRIVE guidelines, or similar animal research reporting guidelines, would be an excellent start in this direction.

  14. Dissemination bias in systematic reviews of animal research: a systematic review.

    Directory of Open Access Journals (Sweden)

    Katharina F Mueller

    Full Text Available Systematic reviews of preclinical studies, in vivo animal experiments in particular, can influence clinical research and thus even clinical care. Dissemination bias, selective dissemination of positive or significant results, is one of the major threats to validity in systematic reviews also in the realm of animal studies. We conducted a systematic review to determine the number of published systematic reviews of animal studies until present, to investigate their methodological features especially with respect to assessment of dissemination bias, and to investigate the citation of preclinical systematic reviews on clinical research.Eligible studies for this systematic review constitute systematic reviews that summarize in vivo animal experiments whose results could be interpreted as applicable to clinical care. We systematically searched Ovid Medline, Embase, ToxNet, and ScienceDirect from 1st January 2009 to 9th January 2013 for eligible systematic reviews without language restrictions. Furthermore we included articles from two previous systematic reviews by Peters et al. and Korevaar et al.The literature search and screening process resulted in 512 included full text articles. We found an increasing number of published preclinical systematic reviews over time. The methodological quality of preclinical systematic reviews was low. The majority of preclinical systematic reviews did not assess methodological quality of the included studies (71%, nor did they assess heterogeneity (81% or dissemination bias (87%. Statistics quantifying the importance of clinical research citing systematic reviews of animal studies showed that clinical studies referred to the preclinical research mainly to justify their study or a future study (76%.Preclinical systematic reviews may have an influence on clinical research but their methodological quality frequently remains low. Therefore, systematic reviews of animal research should be critically appraised before

  15. Animal production systems in the industrialised world.

    Science.gov (United States)

    Sørensen, J T; Edwards, S; Noordhuizen, J; Gunnarsson, S

    2006-08-01

    The production of food from animal origin is relatively stable in the industrialised world. However, animal production systems are changing dramatically with respect to location, herd size and specialisation. Increased pressure from a critical public is moving animal-based production towards systems such as organic production and loose-housing systems which allow the animals to better express normal behaviour. The focus on food safety promotes systems with a high degree of biosecurity, often associated with an increase in herd size and self-containment. The globalisation of agricultural trade and increased competition also favours an increase in herd size and specialisation. These trends also lead to regions with livestock-dense areas, giving rise to environmental concerns. Therefore, good farming practice regulations and systems to provide a higher level of transparency, such as quality risk management programmes, are being developed.

  16. Whey Based Bioactive Peptides Used in Animal Products

    Directory of Open Access Journals (Sweden)

    Ayse Demet Karaman

    2016-10-01

    Full Text Available Bioactive peptides come out as a result of the hydrolysis of milk proteins and contain nutritional, functional and biological activities. Nowadays, the utilization of whey proteins to provide various features in the animal products such as meat and milk products and animal production has been increasing. In this compilation, after being introduced some general information about their common characteristics, bioactive peptides will be mentioned about their particularly recent usage in animal products.

  17. Systems Biology in Animal Production and Health

    DEFF Research Database (Denmark)

    for improved animal production and health. The book will contain online resources where additional data and programs can be accessed. Some chapters also come with computer programming codes and example datasets to provide readers hands-on (computer) exercises. This second volume deals with integrated modeling...... and analyses of multi-omics datasets from theoretical and computational approaches and presents their applications in animal production and health as well as veterinary medicine to improve diagnosis, prevention and treatment of animal diseases. This book is suitable for both students and teachers in animal...

  18. Global animal production and nitrogen and phosphorus flows

    NARCIS (Netherlands)

    Liu, Qian; Wang, Jingmeng; Bai, Zhaohai; Ma, Lin; Oenema, Oene

    2017-01-01

    Animal production systems provide nutritious food for humans, income and survivability for numerous smallholder farms and transform residues to valuable products. However, animal production is implicated in human health issues (diet-related diseases, zoonosis, antimicrobial resistance) and

  19. Animal production and health newsletter. No. 24

    International Nuclear Information System (INIS)

    1996-07-01

    The Newsletter announces meetings and training programs in animal husbandry and animal health related activities undertaken by the IAEA. Short communications on coordinated research programs in animal production and health are included

  20. Animal production and health newsletter. No. 24

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-07-01

    The Newsletter announces meetings and training programs in animal husbandry and animal health related activities undertaken by the IAEA. Short communications on coordinated research programs in animal production and health are included.

  1. Animal Production and Health Newsletter. No. 14

    International Nuclear Information System (INIS)

    1991-06-01

    This newsletter contains brief reports of the five FAO/IAEA Research Coordination Meetings held in the first half of 1991, focussing on improving animal reproduction research and animal disease diagnosis in Asia through the application of immunoassay techniques, improving the productivity of indiginous African livestock using radioimmunoassay and related techniques, improving the diagnosis and control of trypanosomiasis and other vector-borne diseases of African livestock using immunoassay methods, and an inter-regional network for improving the productivity of camelids. The FAO/IAEA International Symposium on ''Nuclear and Related Techniques in Animal Production and Health'' is summarily described (the Symposium Proceedings should be published in October, 1991), and applications are invited for a new coordinated research programme on the development of supplementation strategies for milk-producing animals in tropical and subtropical environments

  2. Animal Production and Health Newsletter. No. 15

    International Nuclear Information System (INIS)

    1991-12-01

    This newsletter contains brief reviews of the meetings held between September and November, 1991, and a list of the nine co-ordinated research projects (CRPs) organized by the Animal Production and Health Section of the Joint FAO/IAEA Division is given. A tenth CRP, focussing on the development of supplementation strategies for milk-producing animals in tropical and subtropical environments, is currently being planned. Developments at the Animal Production Unit of the IAEA Laboratory, Seibersdorf are detailed

  3. Activities of the Animal Production and Health Laboratory (Animal Production and Health Newsletter, No. 63, January 2016)

    International Nuclear Information System (INIS)

    2016-01-01

    This article provides information on: • Animal Genetics: Genetic variation on the control of resistance to internal parasites in small ruminants for improving animal productivity; Support to MSs for implementation of Global Plan of Action on animal genetic resources (AnGR); • Animal Health: Application of irradiation technology to develop a potential trypanosome vaccine; African swine fever; Study of pox diseases in Ethiopian camels; • Fellows/interns/consultants; • Field suppprt missions

  4. Preliminary Experience with Small Animal SPECT Imaging on Clinical Gamma Cameras

    Directory of Open Access Journals (Sweden)

    P. Aguiar

    2014-01-01

    Full Text Available The traditional lack of techniques suitable for in vivo imaging has induced a great interest in molecular imaging for preclinical research. Nevertheless, its use spreads slowly due to the difficulties in justifying the high cost of the current dedicated preclinical scanners. An alternative for lowering the costs is to repurpose old clinical gamma cameras to be used for preclinical imaging. In this paper we assess the performance of a portable device, that is, working coupled to a single-head clinical gamma camera, and we present our preliminary experience in several small animal applications. Our findings, based on phantom experiments and animal studies, provided an image quality, in terms of contrast-noise trade-off, comparable to dedicated preclinical pinhole-based scanners. We feel that our portable device offers an opportunity for recycling the widespread availability of clinical gamma cameras in nuclear medicine departments to be used in small animal SPECT imaging and we hope that it can contribute to spreading the use of preclinical imaging within institutions on tight budgets.

  5. Nutritional Value of Irradiated Animal Feed By-Products

    International Nuclear Information System (INIS)

    El-Din Farag, M.D.H.

    1998-01-01

    Animal feed by-products, widely used in animal diets, are sources of disease organisms for animals and for human beings. Salmonella is the principal genus of concern.Radiation treatment (radicidation, radurization) is a promising method of decontamination of feed ingredients. Commercial samples of fish, meat, and blood meals were sealed by heat in polyethylene bags and irradiated at dose levels of 5.0, 10, 20 and 50 kGy. Their chemical analysis were carried out according to A. O. A.C [1] and the total protein efficiency (TPE) of the three animal feed by-products was determined according to Wood ham (2) by using one day old Dokki-4 chicks. Radiation induced an insignificant effect on the chemical constituent of meals. Also, the same trend was observed with TPE of both fish and meat meals. However, irradiation treatments improved TPE values of irradiated blood meal samples. From the results, it could be concluded that irradiation of animal feed by-products up to a dose level of 50 Gy has no adverse effects on the nutritional value of animal feed by-products

  6. Automation in Animal Housing and Production

    Science.gov (United States)

    Intensive, controlled environment animal production began modestly in the mid-20th century as poultry were brought indoors. While mankind had utilized structures to provide shelter for their animals for centuries, the availability of relatively inexpensive energy and the electrification of rural are...

  7. Study on Romanian Consumers’ Opinion Regarding the Animal Welfare Labelling of Animal Products

    Directory of Open Access Journals (Sweden)

    Ludovic Toma Cziszter

    2010-10-01

    Full Text Available The aim of the paper was to investigate the influence some factors on the consumers’ opinion regarding the animal welfare labelling of animal products. The analysed question was: “When purchasing eggs, meat or milk can you easily identify from the label those products sourced from animal welfare friendly production systems?” Respondents chosen only one answer out of the five offered: yes, most of the time; yes, some of the time; no, very rarely; no, never; and don’t know. Thirty three percent of females considered they could find sometime information regarding the animal welfare on the labels, while males considered that this information could be found very rarely. Up to 55 years of age, 50% of the consumers consider that the labels do not contain the information about animal welfare, while after this age most of consumers consider they found this information on the labels. Over 50% of Orthodox and Roman Catholic responders considered that the information on animal welfare on the labels was found some of the time or very rarely. Respondents, irrespective of their living area or monthly income, considered that there is scarce information regarding animal welfare on the labels. Internet access significantly influenced the consumers regarding the availability of the information on the labels.

  8. Animal Health and Welfare – Pig Production

    Directory of Open Access Journals (Sweden)

    Hämeenoja Pirkko

    2002-03-01

    Full Text Available Requirements of the organic pig farming create an opportunity to offer good life for animals. The space requirements give animals the possibility to exhibit species-specific behavior and provide them opportunity for more exercise. Bedding and roughage are important in helping to reduce production stress. The most difficult question in a veterinary point of view is how to manage the animal health care. Vaccinations, antibiotics and anthelmintic can be used in organic production but only in a limited way. A lot can be achieved with good management but there are still situations when the use of medicine is necessary. What is the amount of joint inflammations or liver spots to justify the use of medicine? The question has to be solved case by case. The profitability of the production is a crucial point in an organic farm because a poor economy is a great threat to animal welfare.

  9. Assessment of tobacco heating product THP1.0. Part 9: The placement of a range of next-generation products on an emissions continuum relative to cigarettes via pre-clinical assessment studies.

    Science.gov (United States)

    Murphy, James; Liu, Chuan; McAdam, Kevin; Gaҫa, Marianna; Prasad, Krishna; Camacho, Oscar; McAughey, John; Proctor, Christopher

    2018-03-01

    This series of nine papers described the operation and pre-clinical assessment of a tobacco heating product THP1.0. This last paper contextualises the pre-clinical assessment data on THP1.0 with data from other next generation products relative to cigarette smoke. The tobacco and nicotine risk continuum is a concept that ranks products according to their potential harm, with cigarettes at the highest risk extreme and Nicotine Replacement Therapy at the least risky extreme. Data generated in pre-clinical studies on THP1.0 and a range of Next Generation Products (NGPs) may provide some initial indication of potential ranking of these products, although importantly, data from such studies are limited and cannot take into consideration several important aspects for risk such as long term product use patterns. In each of the studies, the responses to the emissions from THP1.0 were substantially reduced relative to cigarette smoke. Additionally, responses from THP1.0 were very similar to those from the other NGP emissions. A comparison of the results clearly showed the emissions from all the NGPs were considerably lower than those from cigarettes and all in around the same emissions level. These results show that THP1.0 could have the potential to be a reduced risk product compared to cigarettes, though further studies assessing the exposure, individual and population risk reduction profile would be required to substantiate this potential. Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

  10. Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B.

    Science.gov (United States)

    Dietrich, Barbara; Schiviz, Alexandra; Hoellriegl, Werner; Horling, Frank; Benamara, Karima; Rottensteiner, Hanspeter; Turecek, Peter L; Schwarz, Hans Peter; Scheiflinger, Friedrich; Muchitsch, Eva-Maria

    2013-11-01

    Baxter has developed a new recombinant factor IX (rFIX) drug product (BAX326) for treating patients with hemophilia B, or congenital FIX deficiency. An extensive preclinical program evaluated the pharmacokinetics, efficacy, and safety of BAX326 in different species. The efficacy of BAX326 was tested in three mouse models of primary pharmacodynamics: tail-tip bleeding, carotid occlusion, and thrombelastography. The pharmacokinetics was evaluated after a single intravenous bolus injection in mice, rats, and macaques. Toxicity was assessed in rats and macaques, safety pharmacology in rabbits and macaques, and immunogenicity in mice. BAX326 was shown to be efficacious in all three primary pharmacodynamic studies (P ≤ 0.0076). Hemostatic efficacy was dose related and similar for the three lots tested. Pharmacokinetic results showed that rFIX activity and rFIX antigen concentrations declined in a bi-phasic manner, similar to a previously licensed rFIX product. BAX326 was well tolerated in rabbits and macaques at all dose levels; no thrombogenic events and no adverse clinical, respiratory, or cardiovascular effects occurred. BAX326 was also shown to have a similar immunogenicity profile to the comparator rFIX product in mice. These results demonstrate that BAX326 has a favorable preclinical safety and efficacy profile, predictive of a comparable effect to that of the previously licensed rFIX in humans.

  11. Sustainable Improvement of Animal Production and Health

    International Nuclear Information System (INIS)

    Odongo, N.E.; Garcia, M.; Viljoen, G.J.

    2010-01-01

    The world's poorest people, some one billion living mostly in Africa and Asia, depend on livestock for their day-to-day livelihood. To reduce poverty, fight hunger and ensure global food security, there is an urgent need to increase livestock production in sustainable ways. However, livestock production in developing countries is constrained by low genetic potential of the animals, poor nutrition and husbandry practices and infectious diseases. Nuclear techniques, when applied in conjunction with conventional methods, can identify constraints to livestock productivity as well as interventions that lead to their reduction or elimination in ways that are economically and socially acceptable. The challenge is how best to exploit these techniques for solving problems faced by livestock keepers within the many agricultural production systems that exist in developing countries and demonstrating their advantages to owners, local communities and government authorities. This publication is a compilation of the contributions emanating from an international Symposium on Sustainable Improvement of Animal Production and Health organised by the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture in cooperation with the Animal Production and Health Division of FAO. It provides invaluable information not only on how nuclear and related techniques can be used to support sustainable livestock production systems, but also about the constraints and opportunities for using these techniques in developing countries; it also attempts to identify specific research needs and gaps and new options for using these techniques for solving established and emerging problems. As such, it is hoped that the information presented and suggestions made will provide valuable guidance to scientists in both the public and private sectors as well as to government and institutional policy and decision makers. The Symposium comprised a plenary session and four thematic sessions, covering (i

  12. Sustainable Improvement of Animal Production and Health

    Energy Technology Data Exchange (ETDEWEB)

    Odongo, N E; Garcia, M; Viljoen, G J [Animal Production and Health Subprogramme, Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Agency, Vienna (Austria)

    2010-07-01

    The world's poorest people, some one billion living mostly in Africa and Asia, depend on livestock for their day-to-day livelihood. To reduce poverty, fight hunger and ensure global food security, there is an urgent need to increase livestock production in sustainable ways. However, livestock production in developing countries is constrained by low genetic potential of the animals, poor nutrition and husbandry practices and infectious diseases. Nuclear techniques, when applied in conjunction with conventional methods, can identify constraints to livestock productivity as well as interventions that lead to their reduction or elimination in ways that are economically and socially acceptable. The challenge is how best to exploit these techniques for solving problems faced by livestock keepers within the many agricultural production systems that exist in developing countries and demonstrating their advantages to owners, local communities and government authorities. This publication is a compilation of the contributions emanating from an international Symposium on Sustainable Improvement of Animal Production and Health organised by the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture in cooperation with the Animal Production and Health Division of FAO. It provides invaluable information not only on how nuclear and related techniques can be used to support sustainable livestock production systems, but also about the constraints and opportunities for using these techniques in developing countries; it also attempts to identify specific research needs and gaps and new options for using these techniques for solving established and emerging problems. As such, it is hoped that the information presented and suggestions made will provide valuable guidance to scientists in both the public and private sectors as well as to government and institutional policy and decision makers. The Symposium comprised a plenary session and four thematic sessions, covering (i

  13. Combustion of animal or vegetable based liquid waste products

    International Nuclear Information System (INIS)

    Wikman, Karin; Berg, Magnus

    2002-04-01

    In this project experiences from combustion of animal and vegetable based liquid waste products have been compiled. Legal aspects have also been taken into consideration and the potential for this type of fuel on the Swedish energy market has been evaluated. Today the supply of animal and vegetable based liquid waste products for energy production in Sweden is limited. The total production of animal based liquid fat is about 10,000 tonnes annually. The animal based liquid waste products origin mainly from the manufacturing of meat and bone meal. Since meat and bone meal has been banned from use in animal feeds it is possible that the amount of animal based liquid fat will decrease. The vegetable based liquid waste products that are produced in the processing of vegetable fats are today used mainly for internal energy production. This result in limited availability on the commercial market. The potential for import of animal and vegetable based liquid waste products is estimated to be relatively large since the production of this type of waste products is larger in many other countries compared to Sweden. Vegetable oils that are used as food or raw material in industries could also be imported for combustion, but this is not reasonable today since the energy prices are relatively low. Restrictions allow import of SRM exclusively from Denmark. This is today the only limit for increased imports of animal based liquid fat. The restrictions for handle and combustion of animal and vegetable based liquid waste products are partly unclear since this is covered in several regulations that are not easy to interpret. The new directive for combustion of waste (2000/76/EG) is valid for animal based waste products but not for cadaver or vegetable based waste products from provisions industries. This study has shown that more than 27,400 tonnes of animal based liquid waste products and about 6,000 tonnes of vegetable based liquid waste products were used for combustion in Sweden

  14. Present Status and Future Challenges of New Therapeutic Targets in Preclinical Models of Stroke in Aged Animals with/without Comorbidities

    Directory of Open Access Journals (Sweden)

    Aurel Popa-Wagner

    2018-01-01

    Full Text Available The aging process, comorbidities, and age-associated diseases are closely dependent on each other. Cerebral ischemia impacts a wide range of systems in an age-dependent manner. However, the aging process has many facets which are influenced by the genetic background and epigenetic or environmental factors, which can explain why some people age differently than others. Therefore, there is an urgent need to identify age-related changes in body functions or structures that increase the risk for stroke and which are associated with a poor outcome. Multimodal imaging, electrophysiology, cell biology, proteomics, and transcriptomics, offer a useful approach to link structural and functional changes in the aging brain, with or without comorbidities, to post-stroke rehabilitation. This can help us to improve our knowledge about senescence firstly, and in this context, aids in elucidating the pathophysiology of age-related diseases that allows us to develop therapeutic strategies or prevent diseases. These processes, including potential therapeutical interventions, need to be studied first in relevant preclinical models using aged animals, with and without comorbidities. Therefore, preclinical research on ischemic stroke should consider age as the most important risk factor for cerebral ischemia. Furthermore, the identification of effective therapeutic strategies, corroborated with successful translational studies, will have a dramatic impact on the lives of millions of people with cerebrovascular diseases.

  15. Preclinical experimental stress studies: protocols, assessment and comparison.

    Science.gov (United States)

    Bali, Anjana; Jaggi, Amteshwar Singh

    2015-01-05

    Stress is a state of threatened homeostasis during which a variety of adaptive processes are activated to produce physiological and behavioral changes. Preclinical models are pivotal for understanding these physiological or pathophysiological changes in the body in response to stress. Furthermore, these models are also important for the development of novel pharmacological agents for stress management. The well described preclinical stress models include immobilization, restraint, electric foot shock and social isolation stress. Stress assessment in animals is done at the behavioral level using open field, social interaction, hole board test; at the biochemical level by measuring plasma corticosterone and ACTH; at the physiological level by measuring food intake, body weight, adrenal gland weight and gastric ulceration. Furthermore the comparison between different stressors including electric foot shock, immobilization and cold stressor is described in terms of intensity, hormonal release, protein changes in brain, adaptation and sleep pattern. This present review describes these preclinical stress protocols, and stress assessment at different levels. Copyright © 2014 Elsevier B.V. All rights reserved.

  16. Nuclear techniques in Australian animal production

    International Nuclear Information System (INIS)

    1976-01-01

    In tropical and sub-tropical regions, the production of domestic animals is frequently depressed by the climatic and ecological conditions. These negative effects can be overcome to a great extent by improved methods of animal and land management. In animal research, nuclear techniques are playing an important role in the study of different aspects of nutrition, metabolism, reproduction and health of domestic animals. In response to the need expressed by Member States for more information on these techniques, the Joint FAO/IAEA Division of Atomic Energy in Food and Agriculture and the IAEA's Division of Technical Assistance organized a study tour to Australia, a country which has developed considerable expertise in agricultural and animal research. The purpose of the study tour was to enable veterinary and animal scientists and administrators from developing countries in Asia and the Far East to observe at first hand the ways in which animal production, particularly meat, milk and wool, can be increased in tropical and sub-tropical areas. Fourteen senior scientists and research directors from seven Asian countries (Bangladesh, India, Republic of Korea, Malaysia, Philippines, Sri Lanka and Thailand) participated. The counterpart organizations in Australia were the Australian Development Assistance Agency (ADAA) and the Commonwealth Scientific and Industrial Research Organization (CSIRO). The chief programmer and co-ordinator of the study tour was John E. Vercoe, officer-in-charge of CSIRO's Tropical Cattle Research Centre in Rockhampton, and a former IAEA staff member. The tour was financed by the United Nations Development Programme. The participants visited research facilities of universities, national and state laboratories and commercial cattle producers. The tour started at Sydney and proceeded north along the east coast of Australia to Townsville. On the way, major stops were made in Armidale, Grafton, Wollongbar, Brisbane and Rockhampton. In Rockhampton, a

  17. Treatment of TBI with Hormonal and Pharmacological Support, Preclinical Validation Using Diffuse and Mechanical TBI Animal Models

    Science.gov (United States)

    2016-05-01

    Award Number: PT075653 (grant) W81XWH-08-2-0153 (contract) TITLE: Treatment of TBI with Hormonal and Pharmacological Support, Preclinical...TITLE AND SUBTITLE 5a. CONTRACT NUMBER W81XWH-08-2-0153 Treatment of TBI with Hormonal and Pharmacological Support, Preclinical Validation Using...rats. Our in vivo tests also included MRI imaging, focusing on edema resolution and reduction of diffuse axonal damage (fractional anisotropy

  18. The Potential of Adaptive Design in Animal Studies

    Directory of Open Access Journals (Sweden)

    Arshad Majid

    2015-10-01

    Full Text Available Clinical trials are the backbone of medical research, and are often the last step in the development of new therapies for use in patients. Prior to human testing, however, preclinical studies using animal subjects are usually performed in order to provide initial data on the safety and effectiveness of prospective treatments. These studies can be costly and time consuming, and may also raise concerns about the ethical treatment of animals when potentially harmful procedures are involved. Adaptive design is a process by which the methods used in a study may be altered while it is being conducted in response to preliminary data or other new information. Adaptive design has been shown to be useful in reducing the time and costs associated with clinical trials, and may provide similar benefits in preclinical animal studies. The purpose of this review is to summarize various aspects of adaptive design and evaluate its potential for use in preclinical research.

  19. The Potential of Adaptive Design in Animal Studies.

    Science.gov (United States)

    Majid, Arshad; Bae, Ok-Nam; Redgrave, Jessica; Teare, Dawn; Ali, Ali; Zemke, Daniel

    2015-10-12

    Clinical trials are the backbone of medical research, and are often the last step in the development of new therapies for use in patients. Prior to human testing, however, preclinical studies using animal subjects are usually performed in order to provide initial data on the safety and effectiveness of prospective treatments. These studies can be costly and time consuming, and may also raise concerns about the ethical treatment of animals when potentially harmful procedures are involved. Adaptive design is a process by which the methods used in a study may be altered while it is being conducted in response to preliminary data or other new information. Adaptive design has been shown to be useful in reducing the time and costs associated with clinical trials, and may provide similar benefits in preclinical animal studies. The purpose of this review is to summarize various aspects of adaptive design and evaluate its potential for use in preclinical research.

  20. Forage based animal production systems and sustainability, an invited keynote

    Directory of Open Access Journals (Sweden)

    Abdul Shakoor Chaudhry

    2008-07-01

    Full Text Available Forages are essential for the successful operation of animal production systems. This is more relevant to ruminants which are heavily dependant upon forages for their health and production in a cost-effective and sustainable manner. While forages are an economical source of nutrients for animal production, they also help conserve the soil integrity, water supply and air quality. Although the role of these forages for animal production could vary depending upon the regional preferences for the animal and forage species, climate and resources, their importance in the success of ruminant production is acknowledged. However with the increasing global human population and urbanisation, the sustainability of forage based animal production systems is sometimes questioned due to the interrelationship between animal production and the environment. It is therefore vital to examine the suitability of these systems for their place in the future to supply quality food which is safe for human consumption and available at a competitive price to the growing human population. Grassland and forage crops are recognised for their contribution to the environment, recreation and efficiency of meat and milk production,. To maintain sustainability, it is crucial that such farming systems remain profitable and environmentally friendly while producing nutritious foods of high economical value. Thus, it is pertinent to improve the nutritive value of grasses and other forage plants in order to enhance animal production to obtain quality food. It is also vital to develop new forages which are efficiently utilised and wasted less by involving efficient animals. A combination of forage legumes, fresh or conserved grasses, crop residues and other feeds could help develop an animal production system which is economically efficient, beneficial and viable. Also, it is crucial to use efficient animals, improved forage conservation methods, better manure handling, and minimum

  1. Small animal imaging. Basics and practical guide

    Energy Technology Data Exchange (ETDEWEB)

    Kiessling, Fabian [Aachen Univ. (RWTH) (Germany). Chair of Experimental Molecular Imaging; Pichler, Bernd J. (eds.) [Tuebingen Univ. (Germany). Lab. for Preclinical Imaging and Imaging Technology of the Werner Siemens-Foundation

    2011-07-01

    Small animal imaging has been recognized as an important tool in preclinical research. Nevertheless, the results of non-invasive imaging are often disappointing owing to choice of a suboptimal imaging modality and/or shortcomings in study design, experimental setup, and data evaluation. This textbook is a practical guide to the use of non-invasive imaging in preclinical research. Each of the available imaging modalities is discussed in detail, with the assistance of numerous informative illustrations. In addition, many useful hints are provided on the installation of a small animal unit, study planning, animal handling, and the cost-effective performance of small animal imaging. Cross-calibration methods, data postprocessing, and special imaging applications are also considered in depth. This is the first book to cover all the practical basics in small animal imaging, and it will prove an invaluable aid for researchers, students, and technicians. (orig.)

  2. Small animal imaging. Basics and practical guide

    International Nuclear Information System (INIS)

    Kiessling, Fabian; Pichler, Bernd J.

    2011-01-01

    Small animal imaging has been recognized as an important tool in preclinical research. Nevertheless, the results of non-invasive imaging are often disappointing owing to choice of a suboptimal imaging modality and/or shortcomings in study design, experimental setup, and data evaluation. This textbook is a practical guide to the use of non-invasive imaging in preclinical research. Each of the available imaging modalities is discussed in detail, with the assistance of numerous informative illustrations. In addition, many useful hints are provided on the installation of a small animal unit, study planning, animal handling, and the cost-effective performance of small animal imaging. Cross-calibration methods, data postprocessing, and special imaging applications are also considered in depth. This is the first book to cover all the practical basics in small animal imaging, and it will prove an invaluable aid for researchers, students, and technicians. (orig.)

  3. New Breed of Mice May Improve Accuracy for Preclinical Testing of Cancer Drugs | FNLCR Staging

    Science.gov (United States)

    A new breed of lab animals, dubbed “glowing head mice,” may do a better job than conventional mice in predicting the success of experimental cancer drugs—while also helping to meet an urgent need for more realistic preclinical animal models. Th

  4. Animal production and health newsletter. No.21

    International Nuclear Information System (INIS)

    1995-01-01

    This newsletter contains brief reports on 7 meetings, workshops and training courses held between september and december 1994, the status of the 6 co-ordinated research programmes organized by the Animal Production and Health Section of the Joint FAO/IAEA Division, recent developments at the Animal Production Unit at the IAEA Laboratory Seibersdorf and a presentation of 5 forthcoming meetings, workshops and training courses

  5. The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.

    Science.gov (United States)

    Dickinson, Michael G; Bartelds, Beatrijs; Borgdorff, Marinus A J; Berger, Rolf M F

    2013-07-01

    Pulmonary arterial hypertension (PAH) is a progressive pulmonary vasoproliferative disorder characterized by the development of unique neointimal lesions, including concentric laminar intima fibrosis and plexiform lesions. Although the histomorphology of neointimal lesions is well described, the pathogenesis of PAH and neointimal development is largely unknown. After three decades of PAH pathobiology research the focus has shifted from vasoconstriction towards a mechanism of cancer-like angioproliferation. In this concept the role of disturbed blood flow is seen as an important trigger in the development of vascular remodeling. For instance, in PAH associated with congenital heart disease, increased pulmonary blood flow (i.e., systemic-to-pulmonary shunt) is an essential trigger for the occurrence of neointimal lesions and PAH development. Still, questions remain about the exact role of these blood flow characteristics in disease progression. PAH animal models are important for obtaining insight in new pathobiological processes and therapeutical targets. However, as for any preclinical model the pathophysiological mechanism and clinical course has to be comparable to the human disease that it mimics. This means that animal models mimicking human PAH ideally are characterized by: a hit recognized in human disease (e.g., altered pulmonary blood flow), specific vascular remodeling resembling human neointimal lesions, and disease progression that leads to right ventriclular dysfunction and death. A review that underlines the current knowledge of PAH due to disturbed flow is still lacking. In this review we will summarize the current knowledge obtained from PAH animal models associated with disturbed pulmonary blood flow and address questions for future treatment strategies for PAH.

  6. Risk and profitability of animal and crop production in Slovak farms

    Directory of Open Access Journals (Sweden)

    Marián Tóth

    2017-10-01

    Full Text Available The paper focuses on profitability and risk of crop and animal production based on an analysis of farms operating in Slovak Republic. The individual farm data used for the analysis are from the database of Ministry of Agriculture and Rural Development of the Slovak Republic. For our analysis, data were selected according to the farm production orientation to the subset of crop farms and animal farms. The selecting criterion for production orientation was the percentage share of revenues from crop production, or revenues from animal production from the overall revenues from own products and services. We analyse profitability of farms divided into groups based on the type of production into crop and animal farms (according to the share in sales from crop or animal production. Using descriptive statistics and portfolio theory we simulate the total farm profitability and volatility of animal and crop production in Slovakia. The modified Markowitz portfolio theory approach was used to estimate the total risk of portfolios of crop and animal farms. Based on the results we conclude that in the long run crop farms are profitable and profit from crop production is used to cover the losses from animal production in mixed farms. Farms focused on animal production only are efficient and profitable, but the profitability is lower in comparison with crop farms. Animal farms results are less volatile than crop farms. Large farms tend to production with lower value added and can generate enough profit for the owner.

  7. Role of Nano-Mineral as A Feed Additive to Enhance Animal Productivity and Quality of Animal Products

    Directory of Open Access Journals (Sweden)

    Frans Kurnia

    2012-12-01

    Full Text Available A development of nanotechnology today has penetrated almost all areas of life. Utilization in improving livestock production can be done by replacing commonly used conventional mineral by nanoparticles-mineral. Application of chromium (Cr, selenium (Se, silver (Ag and copper (Cu nanoparticles are reported to improve livestock production. However, the potential risk of the application such as mineral deposit in the body of animal itself and to people as consumers of livestock product has to be evaluated. Nanoparticle-minerals that have smaller size are easier to penetrate the cells and it is suspected that it may give more negative risk. Analysis evaluation of nanoparticle-minerals in the animal including people are still being developed.

  8. Antibiotics in Animal Products

    Science.gov (United States)

    Falcão, Amílcar C.

    The administration of antibiotics to animals to prevent or treat diseases led us to be concerned about the impact of these antibiotics on human health. In fact, animal products could be a potential vehicle to transfer drugs to humans. Using appropri ated mathematical and statistical models, one can predict the kinetic profile of drugs and their metabolites and, consequently, develop preventive procedures regarding drug transmission (i.e., determination of appropriate withdrawal periods). Nevertheless, in the present chapter the mathematical and statistical concepts for data interpretation are strictly given to allow understanding of some basic pharma-cokinetic principles and to illustrate the determination of withdrawal periods

  9. Methicillin-resistant Staphylococcus aureus in Danish production animals

    DEFF Research Database (Denmark)

    Hansen, Julie Elvekjær

    into naive animal productions. Focus was consequently turned to investigate the emergence of possible new animal reservoirs in Denmark. We investigated if Danish veal and dairy herds constitute a reservoir of MRSA CC398. Both production lines was found positive for MRSA CC398 in low prevalence, however veal...... with the bacterium most often found on the paws and in the pharynx, which poses a human health hazard to farmers, who risk getting bites and scratches when handling the animals. Based on results from phylogenetic analysis of isolates from both the cattle and mink production, we suggested a spillover from the pig...

  10. Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges.

    Directory of Open Access Journals (Sweden)

    Roland R Regoes

    2005-08-01

    Full Text Available Trials in macaque models play an essential role in the evaluation of biomedical interventions that aim to prevent HIV infection, such as vaccines, microbicides, and systemic chemoprophylaxis. These trials are usually conducted with very high virus challenge doses that result in infection with certainty. However, these high challenge doses do not realistically reflect the low probability of HIV transmission in humans, and thus may rule out preventive interventions that could protect against "real life" exposures. The belief that experiments involving realistically low challenge doses require large numbers of animals has so far prevented the development of alternatives to using high challenge doses.Using statistical power analysis, we investigate how many animals would be needed to conduct preclinical trials using low virus challenge doses. We show that experimental designs in which animals are repeatedly challenged with low doses do not require unfeasibly large numbers of animals to assess vaccine or microbicide success.Preclinical trials using repeated low-dose challenges represent a promising alternative approach to identify potential preventive interventions.

  11. Animal Models of Hemophilia

    Science.gov (United States)

    Sabatino, Denise E.; Nichols, Timothy C.; Merricks, Elizabeth; Bellinger, Dwight A.; Herzog, Roland W.; Monahan, Paul E.

    2013-01-01

    The X-linked bleeding disorder hemophilia is caused by mutations in coagulation factor VIII (hemophilia A) or factor IX (hemophilia B). Unless prophylactic treatment is provided, patients with severe disease (less than 1% clotting activity) typically experience frequent spontaneous bleeds. Current treatment is largely based on intravenous infusion of recombinant or plasma-derived coagulation factor concentrate. More effective factor products are being developed. Moreover, gene therapies for sustained correction of hemophilia are showing much promise in pre-clinical studies and in clinical trials. These advances in molecular medicine heavily depend on availability of well-characterized small and large animal models of hemophilia, primarily hemophilia mice and dogs. Experiments in these animals represent important early and intermediate steps of translational research aimed at development of better and safer treatments for hemophilia, such a protein and gene therapies or immune tolerance protocols. While murine models are excellent for studies of large groups of animals using genetically defined strains, canine models are important for testing scale-up and for longer-term follow-up as well as for studies that require larger blood volumes. PMID:22137432

  12. Animal production and health newsletter. No. 32

    International Nuclear Information System (INIS)

    2000-06-01

    Project reviews and research coordination meetings on milk production, rinderpest diagnosis, animal vaccinations, quality assurance in veterinary diagnostic laboratories and evaluation of animal feeds are the major highlights of this issue of the Newsletter

  13. Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice.

    Science.gov (United States)

    Willmann, Raffaella; De Luca, Annamaria; Benatar, Michael; Grounds, Miranda; Dubach, Judith; Raymackers, Jean-Marc; Nagaraju, Kanneboyina

    2012-01-01

    Duchenne Muscular Dystrophy is an X-linked disorder that affects boys and leads to muscle wasting and death due to cardiac involvement and respiratory complications. The cause is the absence of dystrophin, a large structural protein indispensable for muscle cell function and viability. The mdx mouse has become the standard animal model for pre-clinical evaluation of potential therapeutic treatments. Recent years have seen a rapid increase in the number of experimental compounds being evaluated in the mdx mouse. There is, however, much variability in the design of these pre-clinical experimental studies. This has made it difficult to interpret and compare published data from different laboratories and to evaluate the potential of a treatment for application to patients. The authors therefore propose the introduction of a standard study design for the mdx mouse model. Several aspects, including animal care, sampling times and choice of tissues, as well as recommended endpoints and methodologies are addressed and, for each aspect, a standard procedure is proposed. Testing of all new molecules/drugs using a widely accepted and agreed upon standard experimental protocol would greatly improve the power of pre-clinical experimentations and help identifying promising therapies for the translation into clinical trials for boys with Duchenne Muscular Dystrophy. Copyright © 2011 Elsevier B.V. All rights reserved.

  14. Monochromatic minibeam radiotherapy: theoretical and experimental dosimetry for preclinical treatment plans

    Energy Technology Data Exchange (ETDEWEB)

    Deman, P; Vautrin, M; Stupar, V; Barbier, E L; Elleaume, H; Esteve, F; Adam, J F, E-mail: adam@esrf.fr [INSERM, U836, BP 170, Grenoble Cedex 9, F-38042 (France)

    2011-07-21

    Monochromatic x-ray minibeam radiotherapy is a new radiosurgery approach based on arrays of submillimetric interlaced planar x-ray beams. The aim of this study was to characterize the dose distributions obtained with this new modality when being used for preclinical trials. Monte Carlo simulations were performed in water phantoms. Percentage depth-dose curves and dose profiles were computed for single incidences and interleaved incidences of 80 keV planar x-ray minibeam (0.6 x 5 mm) arrays. Peak to valley dose ratios were also computed at various depths for an increasing number of minibeams. 3D experimental polymer gel (nPAG) dosimetry measurements were performed using MRI devices designed for small animal imaging. These very high spatial resolution (50 {mu}m) dose maps were compared to the simulations. Preclinical minibeams dose distributions were fully characterized. Experimental dosimetry correlated well with Monte Carlo calculations (Student t-tests: p > 0.1). F98 tumor-bearing rats were also irradiated with interleaved minibeams (80 keV, prescribed dose: 25 Gy). This associated preclinical trial serves as a proof of principle of the technique. The mean survival time of irradiated glioma-bearing rats increased significantly, when compared to the untreated animals (59.6 {+-} 2.8 days versus 28.25 {+-} 0.75 days, p < 0.001).

  15. Animal production and health newsletter. No. 27

    International Nuclear Information System (INIS)

    1997-12-01

    The news letter reports workshops and training events in the areas of animal diseases and application of ELISA and radioimmunoassay techniques. It also describes existing and future coordinated research programs in animal production and health

  16. The role of the World Organisation for Animal Health (OIE) to facilitate the international trade in animals and animal products.

    Science.gov (United States)

    Brückner, G K

    2009-03-01

    The international trade in animals and animal products has become a sensitive issue for both developed and developing countries by posing an important risk for the international spread of animal and human pathogens whilst at the same time being an essential activity to ensure world-wide food security and food safety. The OIE has since its founding in 1924, applied a democratic and transparent decision-making process to continuously develop and review international standards for animal health and zoonoses to facilitate trade in animals and animal products. The role of the OIE is also mandated by the World Trade Organization (WTO) as international reference point for standards related to animal health. In support of its overall objective of promoting animal health world-wide, the OIE has also launched several other initiatives such as the improvement of the governance of veterinary services within its member countries and territories and to enhance the availability of diagnostic and scientific expertise on a more even global geographical distribution. Several trade facilitating concepts such as country, zonal and compartment freedom from disease as well the trade in disease free commodities has been introduced to enhance the trade in animals and animal products for all its members including those from developing and transitional countries who are still in the process of enhancing to full compliance with international sanitary standards.

  17. Animal models for evaluation of oral delivery of biopharmaceuticals

    DEFF Research Database (Denmark)

    Harloff-Helleberg, Stine; Nielsen, Line Hagner; Nielsen, Hanne Mørck

    2017-01-01

    of systems for oral delivery of biopharmaceuticals may result in new treatment modalities to increase the patient compliance and reduce product cost. In the preclinical development phase, use of experimental animal models is essential for evaluation of new formulation designs. In general, the limited oral...... bioavailability of biopharmaceuticals, of just a few percent, is expected, and therefore, the animal models and the experimental settings must be chosen with utmost care. More knowledge and focus on this topic is highly needed, despite experience from the numerous studies evaluating animal models for oral drug...... delivery of small molecule drugs. This review highlights and discusses pros and cons of the most currently used animal models and settings. Additionally, it also looks into the influence of anesthetics and sampling methods for evaluation of drug delivery systems for oral delivery of biopharmaceuticals...

  18. Inflammation: friend or foe for animal production?

    Science.gov (United States)

    Broom, Leon J; Kogut, Michael H

    2018-02-01

    Inflammation is an essential immune response that seeks to contain microbial infection and repair damaged tissue. Increased pro-inflammatory mediators have been associated with enhanced resistance to a range of important poultry and pig pathogens. However, inflammation may also have undesirable consequences, including potentially exacerbating tissue damage and diverting nutrients away from productive purposes. The negative effects of inflammation have led to the active pursuit of anti-inflammatory feed additives and/or strategies. These approaches may, however, impair the ability of an animal to respond appropriately and effectively to the array of pathogens that are likely to be encountered in commercial production, and specifically young animals who may be particularly reliant on innate immune responses. Thus, promoting an animal's capacity to mount a rapid, acute inflammatory response to control and contain the infection and the timely transition to anti-inflammatory, tissue repair processes, and a homeostatic state are suggested as the optimum scenario to maintain an animal's resistance to pathogens and minimize non-productive nutrient losses. Important future studies will help to unravel the trade-offs, and relevant metabolic pathways, between robust immune defense and optimum productive performance, and thus provide real insight into methods to appropriately influence this relationship. © 2017 Poultry Science Association Inc.

  19. Animal production and health newsletter. No. 22

    International Nuclear Information System (INIS)

    1995-07-01

    This newsletter contains brief reports on 9 workshops, research coordination meetings, consultant meetings and training courses held between January-June 1995, the status of 6 co-ordinated research programmes organized by the Animal Production and Health Section of the Joint FAO/IAEA Division, recent developments at the Animal Production Unit of the IAEA Laboratory Seibersdorf, a presentation of 4 forthcoming events (meetings, workshops, training courses) and 3 software programs in the field

  20. Animal Products and Handling: A Caution for Consumers and ...

    African Journals Online (AJOL)

    This study reviewed pertinent literature on edible animal products and handling with respect to contaminations and adulterations. Animal products include eggs, meat, milk, fish, skin/hide that are processed into other by products for human consumption. There is the need for awareness campaignsto consumers and ...

  1. Companion Animals as a Source of Viruses for Human Beings and Food Production Animals

    NARCIS (Netherlands)

    L.A. Reperant (Leslie); I.H. Brown (Ian); Haenen, O.L.; M.D. de Jong (Menno); A.D.M.E. Osterhaus (Albert); A. Papa (Anna); Rimstad, E.; Valarcher, J.-F.; T. Kuiken (Thijs)

    2016-01-01

    textabstractCompanion animals comprise a wide variety of species, including dogs, cats, horses, ferrets, guinea pigs, reptiles, birds and ornamental fish, as well as food production animal species, such as domestic pigs, kept as companion animals. Despite their prominent place in human society,

  2. 77 FR 71194 - Draft Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy...

    Science.gov (United States)

    2012-11-29

    ...] Draft Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy... Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products,'' dated November... Evaluation (CBER), Office of Cellular, Tissue, and Gene Therapies (OCTGT). The product areas covered by this...

  3. Preclinical imaging in animal models of radiation therapy; Praeklinische Bildgebung im Tiermodell bei Strahlentherapie

    Energy Technology Data Exchange (ETDEWEB)

    Nikolaou, K.; Cyran, C.C.; Reiser, M.F.; Clevert, D.-A. [Klinikum der Ludwig-Maximilians-Universitaet, Campus Grosshadern, Institut fuer Klinische Radiologie, Muenchen (Germany); Lauber, K. [Klinikum der Ludwig-Maximilians-Universitaet, Klinik und Poliklinik fuer Strahlentherapie, Muenchen (Germany)

    2012-03-15

    Modern radiotherapy benefits from precise and targeted diagnostic and pretherapeutic imaging. Standard imaging modalities, such as computed tomography (CT) offer high morphological detail but only limited functional information on tumors. Novel functional and molecular imaging modalities provide biological information about tumors in addition to detailed morphological information. Perfusion magnetic resonance imaging (MRI) CT or ultrasound-based perfusion imaging as well as hybrid modalities, such as positron emission tomography (PET) CT or MRI-PET have the potential to identify and precisely delineate viable and/or perfused tumor areas, enabling optimization of targeted radiotherapy. Functional information on tissue microcirculation and/or glucose metabolism allow a more precise definition and treatment of tumors while reducing the radiation dose and sparing the surrounding healthy tissue. In the development of new imaging methods for planning individualized radiotherapy, preclinical imaging and research plays a pivotal role, as the value of multimodality imaging can only be assessed, tested and adequately developed in a preclinical setting, i.e. in animal tumor models. New functional imaging modalities will play an increasing role for the surveillance of early treatment response during radiation therapy and in the assessment of the potential value of new combination therapies (e.g. combining anti-angiogenic drugs with radiotherapy). (orig.) [German] Die moderne Strahlentherapie profitiert massgeblich von einer detaillierten wie auch funktionellen praetherapeutischen Bildgebung. Die ueblicherweise praetherapeutisch eingesetzten radiologischen Standardverfahren wie die Computertomographie liefern zwar hochwertige morphologische Details, jedoch keine funktionelle Information. Es ist somit ein zunehmender Bedarf an funktionellen und molekularen Bildgebungsmodalitaeten feststellbar, mit denen ergaenzend zur morphologischen Bildgebung auch biologisch

  4. Animal models for bone tissue engineering and modelling disease

    Science.gov (United States)

    Griffin, Michelle

    2018-01-01

    ABSTRACT Tissue engineering and its clinical application, regenerative medicine, are instructing multiple approaches to aid in replacing bone loss after defects caused by trauma or cancer. In such cases, bone formation can be guided by engineered biodegradable and nonbiodegradable scaffolds with clearly defined architectural and mechanical properties informed by evidence-based research. With the ever-increasing expansion of bone tissue engineering and the pioneering research conducted to date, preclinical models are becoming a necessity to allow the engineered products to be translated to the clinic. In addition to creating smart bone scaffolds to mitigate bone loss, the field of tissue engineering and regenerative medicine is exploring methods to treat primary and secondary bone malignancies by creating models that mimic the clinical disease manifestation. This Review gives an overview of the preclinical testing in animal models used to evaluate bone regeneration concepts. Immunosuppressed rodent models have shown to be successful in mimicking bone malignancy via the implantation of human-derived cancer cells, whereas large animal models, including pigs, sheep and goats, are being used to provide an insight into bone formation and the effectiveness of scaffolds in induced tibial or femoral defects, providing clinically relevant similarity to human cases. Despite the recent progress, the successful translation of bone regeneration concepts from the bench to the bedside is rooted in the efforts of different research groups to standardise and validate the preclinical models for bone tissue engineering approaches. PMID:29685995

  5. Companion Animals as a Source of Viruses for Human Beings and Food Production Animals

    NARCIS (Netherlands)

    Reperant, L. A.; Brown, I. H.; Haenen, O. L.; de Jong, M. D.; Osterhaus, A. D. M. E.; Papa, A.; Rimstad, E.; Valarcher, J.-F.; Kuiken, T.

    2016-01-01

    Companion animals comprise a wide variety of species, including dogs, cats, horses, ferrets, guinea pigs, reptiles, birds and ornamental fish, as well as food production animal species, such as domestic pigs, kept as companion animals. Despite their prominent place in human society, little is known

  6. Animal production and health newsletter. No. 18

    International Nuclear Information System (INIS)

    1993-07-01

    This newsletter contains brief summaries of the final Research Co-ordination Meetings of Co-ordinated Research Programmes on ''Strengthening Animal Reproduction Research in Asia Through the Application of Immunoassay Techniques'' and ''Strengthening Animal Disease Diagnosis in Asia Through Application of Immunoassay Techniques'' and of the first Research Co-ordination Meeting on ''Development of Feed Supplementation Strategies for Milk-Producing Animals in Tropical and Subtropical Environments Through the Use of Nuclear and Related Techniques''. Developments at the IAEA's Animal Production Unit, Seibersdorf, are described

  7. Transmission of Salmonella between wildlife and meat-production animals in Denmark

    DEFF Research Database (Denmark)

    Skov, M. N.; Madsen, J. J.; Rahbek, C.

    2008-01-01

    Aims: To investigate the transmission of Salmonella spp. between production animals (pigs and cattle) and wildlife on production animal farms in Denmark. Methods and Results: In the winter and summer of 2001 and 2002, 3622 samples were collected from Salmonella-infected and noninfected herds...... of pigs and cattle and surrounding wildlife. Salmonella was detected in wildlife on farms carrying Salmonella-positive production animals and only during the periods when Salmonella was detected in the production animals. The presence of Salmonella Typhimurium in wild birds significantly correlated...... to their migration pattern and food preference. Conclusions: Salmonella was transmitted from infected herds of production animals (cattle and pigs) to wildlife that lived amongst or in close proximity to them. Significance and Impact of the Study: Salmonella in animal food products is associated with the occurrence...

  8. Nuclear techniques in animal production and health

    Energy Technology Data Exchange (ETDEWEB)

    Moustgaard, J [Institute of Physiology, Endocrinology and Bloodgrouping, The Royal Veterinary and Agricultural University, Copenhagen (Denmark)

    1976-07-01

    In the fight against animal diseases, especially parasitic infections, nuclear techniques have also proved to be of great value, namely in the production of irradiated vaccines against helminthic diseases. In this context it should be stressed that reduced productivity due to protein loss caused by intestinal parasites is a problem of paramount economic importance in developing as well as developed countries. Recently radioisotopes in the so-called radioimmunoassays have also been applied in determination of the hormonal status of farm animals and to elucidate its relation to the environment and to the physiological and nutritional condition of the animal. This rapidly developing technique may make it possible to control the reproductive performance of cattle and sheep more efficiently than has hitherto been the case. Production of animal protein of a high biological value for human nutrition is still a problem of great concern for the less developed countries. Without doubt the use of nuclear techniques, hand in hand with other research methods, will be of great help in overcoming this condition, always provided that the countries in question possess the necessary equipment and trained personnel.

  9. Nuclear techniques in animal production and health

    International Nuclear Information System (INIS)

    Moustgaard, J.

    1976-01-01

    In the fight against animal diseases, especially parasitic infections, nuclear techniques have also proved to be of great value, namely in the production of irradiated vaccines against helminthic diseases. In this context it should be stressed that reduced productivity due to protein loss caused by intestinal parasites is a problem of paramount economic importance in developing as well as developed countries. Recently radioisotopes in the so-called radioimmunoassays have also been applied in determination of the hormonal status of farm animals and to elucidate its relation to the environment and to the physiological and nutritional condition of the animal. This rapidly developing technique may make it possible to control the reproductive performance of cattle and sheep more efficiently than has hitherto been the case. Production of animal protein of a high biological value for human nutrition is still a problem of great concern for the less developed countries. Without doubt the use of nuclear techniques, hand in hand with other research methods, will be of great help in overcoming this condition, always provided that the countries in question possess the necessary equipment and trained personnel

  10. Bulletin of Animal Health and Production in Africa: Journal ...

    African Journals Online (AJOL)

    Bulletin of Animal Health and Production in Africa: Journal Sponsorship. Journal Home > About the Journal > Bulletin of Animal Health and Production in Africa: Journal Sponsorship. Log in or Register to get access to full text downloads.

  11. INTERCEPTION OF ANIMAL-ORIGIN PRODUCTS AT LAND BORDERS IN BRAZIL

    Directory of Open Access Journals (Sweden)

    Mirela Janice Eidt

    2015-07-01

    Full Text Available Infectious agents and veterinary diseases can be disseminated across borders and contribute to change the country sanitary status. The aim of this study was to identify the main animal products intercepted and seized by the agricultural surveillance units. This paper studied three Agricultural Surveillance Units located at land borders in the North region of Brazil: Assis Brasil and Epitaciolândia (Acre State and Pacaraima (Roraima State, respectively borders with Peru, Bolivia and Venezuela. The main animal products confiscated were dairy products, fish, meat, sausage, veterinary products (drugs, animal food (pet foods and apiculture products. Given the clandestine nature of animal transit and its products in these borders, the possibilities of introduction of infectious agents and diseases must be better evaluated, considering the type of products confiscated, as well as the sanitary status of the countries of origin.

  12. Animal production and health newsletter. No. 29

    International Nuclear Information System (INIS)

    1998-12-01

    This issue of the newsletter outlines activities and coordinated research programmes in the areas of animal production and animal health for the year 1999 by the Joint FAO/IAEA Division of Nuclear Techniques in food and agriculture and FAO/IAEA Agriculture and Biotechnology Laboratory, Seibersdorf

  13. The Economics of Reproducibility in Preclinical Research.

    Directory of Open Access Journals (Sweden)

    Leonard P Freedman

    2015-06-01

    Full Text Available Low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development. An analysis of past studies indicates that the cumulative (total prevalence of irreproducible preclinical research exceeds 50%, resulting in approximately US$28,000,000,000 (US$28B/year spent on preclinical research that is not reproducible-in the United States alone. We outline a framework for solutions and a plan for long-term improvements in reproducibility rates that will help to accelerate the discovery of life-saving therapies and cures.

  14. Animal production and health newsletter, No. 49, January 2009

    International Nuclear Information System (INIS)

    2009-01-01

    This issue of the Newsletter highlights the upcoming International Symposium on 'Sustainable Improvement of Animal Production and Health' from 8 to 11 June 2009 in Vienna, Austria. The Symposium will address: The early and rapid diagnosis and control methods for transboundary animal diseases including those of a zoonotic nature; Improved reproduction technologies and breeding strategies; The efficient and sustainable use of locally available resources for animal production

  15. Contribution of micro-scanner in the preclinical study of hepatic and pancreatic cancer treatments in rat

    International Nuclear Information System (INIS)

    Youssef Azer Akladios, Cherif

    2010-01-01

    Animal experimentation is an unavoidable step in preclinical studies and relies on small animals. In vivo imaging constitutes a precious tool giving information on anatomy, biochemistry, physiology, genetic, pharmacology, while saving cell and tissue integrities of investigated animals. It opens wide the scientific perspective in the field of biological development, physiopathology of diseases, as well as in oncology, from early diagnosis to cancer treatment. This thesis had demonstrated the relevance of micro-scanner in the longitudinal follow up and the management of ortho-topic models of hepatic and pancreatic carcinoma in the rat. For both of these cancers, known to be very poorly or even non curable, there is an urgent need of research on the bases of their onco-genesis as of investigation of the resulting new therapeutic routes. The results of our thesis suggest a role for micro-CT in the preclinical evaluation of their emerging therapies. As far as animal experiment is concerned, in vivo micro-scanner imaging permits, beside a reduction in the number of experimental animals, to establish new (imaging) end-points allowing experiment ending before any sign of animal suffering. It fulfils the main requirements of animal experiment. (author) [fr

  16. Animal production and health newsletter. No. 34

    International Nuclear Information System (INIS)

    2001-06-01

    This issue of the newsletter briefs on forthcoming events and on-going activities of the Joint Division. Active Co-ordinated Research Programmes, training workshops, expert meetings in the fields of animal feed supplementation, animal productivity and reproductive efficiency, and diagnostic methodologies in disease control are highlighted

  17. Blender production creating short animations from start to finish

    CERN Document Server

    Hess, Roland

    2012-01-01

    Blender has become one of the most popular 3D animation tools on the market because it is robust and absolutely free. Blender Production is the definitive resource for anyone who wants to create short animations from scratch. With this book, and Blender, you have the ideal platform to make it happen.  Blender expert and author Roland Hess walks you through the entire process of creating a short animation including: writing, storyboarding, blocking, character creation, animation, rendering, and production. The associated web site includes the full Blender software kit and a compl

  18. A global assessment of the Water Footprint of Farm Animal Products

    NARCIS (Netherlands)

    Mekonnen, Mesfin; Hoekstra, Arjen Ysbert

    2012-01-01

    The increase in the consumption of animal products is likely to put further pressure on the world’s freshwater resources. This paper provides a comprehensive account of the water footprint of animal products, considering different production systems and feed composition per animal type and country.

  19. Spinal Cord Tolerance in the Age of Spinal Radiosurgery: Lessons From Preclinical Studies

    International Nuclear Information System (INIS)

    Medin, Paul M.; Boike, Thomas P.

    2011-01-01

    Clinical implementation of spinal radiosurgery has increased rapidly in recent years, but little is known regarding human spinal cord tolerance to single-fraction irradiation. In contrast, preclinical studies in single-fraction spinal cord tolerance have been ongoing since the 1970s. The influences of field length, dose rate, inhomogeneous dose distributions, and reirradiation have all been investigated. This review summarizes literature regarding single-fraction spinal cord tolerance in preclinical models with an emphasis on practical clinical significance. The outcomes of studies that incorporate uniform irradiation are surprisingly consistent among multiple small- and large-animal models. Extensive investigation of inhomogeneous dose distributions in the rat has demonstrated a significant dose-volume effect while preliminary results from one pig study are contradictory. Preclinical spinal cord dose-volume studies indicate that dose distribution is more critical than the volume irradiated suggesting that neither dose-volume histogram analysis nor absolute volume constraints are effective in predicting complications. Reirradiation data are sparse, but results from guinea pig, rat, and pig studies are consistent with the hypothesis that the spinal cord possesses a large capacity for repair. The mechanisms behind the phenomena observed in spinal cord studies are not readily explained and the ability of dose response models to predict outcomes is variable underscoring the need for further investigation. Animal studies provide insight into the phenomena and mechanisms of radiosensitivity but the true significance of animal studies can only be discovered through clinical trials.

  20. Embodied crop calories in animal products

    International Nuclear Information System (INIS)

    Pradhan, Prajal; Lüdeke, Matthias K B; Reusser, Dominik E; Kropp, Jürgen P

    2013-01-01

    Increases in animal products consumption and the associated environmental consequences have been a matter of scientific debate for decades. Consequences of such increases include rises in greenhouse gas emissions, growth of consumptive water use, and perturbation of global nutrients cycles. These consequences vary spatially depending on livestock types, their densities and their production system. In this letter, we investigate the spatial distribution of embodied crop calories in animal products. On a global scale, about 40% of the global crop calories are used as livestock feed (we refer to this ratio as crop balance for livestock) and about 4 kcal of crop products are used to generate 1 kcal of animal products (embodied crop calories of around 4). However, these values vary greatly around the world. In some regions, more than 100% of the crops produced is required to feed livestock requiring national or international trade to meet the deficit in livestock feed. Embodied crop calories vary between less than 1 for 20% of the livestock raising areas worldwide and greater than 10 for another 20% of the regions. Low values of embodied crop calories are related to production systems for ruminants based on fodder and forage, while large values are usually associated with production systems for non-ruminants fed on crop products. Additionally, we project the future feed demand considering three scenarios: (a) population growth, (b) population growth and changes in human dietary patterns and (c) changes in population, dietary patterns and feed conversion efficiency. When considering dietary changes, we project the global feed demand to be almost doubled (1.8–2.3 times) by 2050 compared to 2000, which would force us to produce almost equal or even more crops to raise our livestock than to directly nourish ourselves in the future. Feed demand is expected to increase over proportionally in Africa, South-Eastern Asia and Southern Asia, putting additional stress on

  1. Effects of the thermal environment on animal production in the tropics

    International Nuclear Information System (INIS)

    Robertshaw, D.

    1986-01-01

    The problems of heat stress in animal production can be solved by an interdisciplinary approach whereby the engineer, animal scientist and animal physiologist can all interact. By understanding the principles associated with heat flow between an animal and its environment it is possible to predict the potential success of an animal production system. This review analyses the nature of the thermal environment and the way in which it can affect production. Methods for alleviating heat stress are also described. (author)

  2. Sex differences in the vulnerability to drug abuse: a review of preclinical studies.

    Science.gov (United States)

    Roth, Megan E; Cosgrove, Kelly P; Carroll, Marilyn E

    2004-10-01

    Clinical and preclinical findings indicate that males and females differ on several aspects of drug reinforcement. Females are more vulnerable than males during transition periods of drug use that are characteristic of drug addiction and relapse. Females are also more sensitive than males to the reinforcing effects of stimulants. It has been suggested that ovarian hormones contribute to the mechanisms of action underlying these sex differences. This review examines the preclinical literature on sex differences and ovarian hormonal influences on drug self-administration in animals. It summarizes the findings on the effects of these variables during different phases of drug addiction. Possible differences in the mechanisms of action of drugs of abuse due to interactions with sex differences or ovarian hormonal factors are considered. The animal literature on sex differences in drug abuse treatment effectiveness is also discussed.

  3. Activities of the Animal Production and Health Laboratory (Animal Production and Health Newsletter, No. 60, July 2014)

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2014-07-15

    This article provides information on: Genetic variation on the control of resistance to infectious diseases in small ruminants for improving animal productivity; Genetic characterization of indigenous livestock breeds; Testing irradiation technology for potential use in trypanosome vaccine development; Strengthening animal disease diagnostic capacities in veterinary laboratories in sub-Saharan Africa; Proficiency testing for Peste des Petits Ruminants (PPR) diagnosis by Nucleic Acid Amplification (RT-PCR). Information on Fellows is also provided.

  4. Activities of the Animal Production and Health Laboratory (Animal Production and Health Newsletter, No. 60, July 2014)

    International Nuclear Information System (INIS)

    2014-01-01

    This article provides information on: Genetic variation on the control of resistance to infectious diseases in small ruminants for improving animal productivity; Genetic characterization of indigenous livestock breeds; Testing irradiation technology for potential use in trypanosome vaccine development; Strengthening animal disease diagnostic capacities in veterinary laboratories in sub-Saharan Africa; Proficiency testing for Peste des Petits Ruminants (PPR) diagnosis by Nucleic Acid Amplification (RT-PCR). Information on Fellows is also provided

  5. Animal Production and Health Newsletter, No. 60, July 2014

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2014-07-15

    This year, the Animal Production and Health Section is 50 years old. The Animal Production and Health Section identifies new areas of interest based on the Member States' needs to improve efficiencies and to control threats to animal production and health. To this effect, several platforms, assays, diagnostic kits and technical procedures have been developed, adapted and transferred to Member States, supported by R&D, expert technical backstopping and guidance from our Animal Production and Health Laboratory. In addition, several nuclear based technologies (such as reproduction and disease related technologies (such as reproduction and disease related radioimmunoassay have been adapted to other types of chemistries (e.g. chemiluminescence instead of isotopes) to be used at the farm level. Stable isotopes and radioisotopes, however, still play an important and niche role to achieve the levels of sensitivity and specificity needed by the livestock community in ensuring secure and safe food, to follow and measure feed and nutritional conversion into usable energy in the animal, to improve animal breeding traits towards more and of better quality animals, to monitor migratory animals and their associated pathogens, to generate safe and protective animal vaccines through the irradiation of pathogens and to develop and transfer early and rapid diagnostic platforms. Looking back at the activities of the past six months, we had several workshops, training courses, research co-ordination meetings (RCMs) and consultants meetings. Activities scheduled for the next half-year include project review meetings, RCMs, inter-regional training courses and regional workshops. Both past and future activities are discussed in further detail in this newsletter and are also further accessible at our website.

  6. Animal Production and Health Newsletter, No. 60, July 2014

    International Nuclear Information System (INIS)

    2014-07-01

    This year, the Animal Production and Health Section is 50 years old. The Animal Production and Health Section identifies new areas of interest based on the Member States' needs to improve efficiencies and to control threats to animal production and health. To this effect, several platforms, assays, diagnostic kits and technical procedures have been developed, adapted and transferred to Member States, supported by R&D, expert technical backstopping and guidance from our Animal Production and Health Laboratory. In addition, several nuclear based technologies (such as reproduction and disease related technologies (such as reproduction and disease related radioimmunoassay have been adapted to other types of chemistries (e.g. chemiluminescence instead of isotopes) to be used at the farm level. Stable isotopes and radioisotopes, however, still play an important and niche role to achieve the levels of sensitivity and specificity needed by the livestock community in ensuring secure and safe food, to follow and measure feed and nutritional conversion into usable energy in the animal, to improve animal breeding traits towards more and of better quality animals, to monitor migratory animals and their associated pathogens, to generate safe and protective animal vaccines through the irradiation of pathogens and to develop and transfer early and rapid diagnostic platforms. Looking back at the activities of the past six months, we had several workshops, training courses, research co-ordination meetings (RCMs) and consultants meetings. Activities scheduled for the next half-year include project review meetings, RCMs, inter-regional training courses and regional workshops. Both past and future activities are discussed in further detail in this newsletter and are also further accessible at our website

  7. Standard Operating Procedures (SOPs) for Evaluating the Heart in Preclinical Studies of Duchenne Muscular Dystrophy.

    Science.gov (United States)

    Duan, Dongsheng; Rafael-Fortney, Jill A; Blain, Alison; Kass, David A; McNally, Elizabeth M; Metzger, Joseph M; Spurney, Christopher F; Kinnett, Kathi

    2016-02-01

    A recent working group meeting focused on contemporary cardiac issues in Duchenne muscular dystrophy (DMD) was hosted by the National Heart, Lung, and Blood Institute in collaboration with the Parent Project Muscular Dystrophy. An outcome of this meeting was to provide freely available detailed protocols for preclinical animal studies. The goal of these protocols is to improve the quality and reproducibility of cardiac preclinical studies aimed at developing new therapeutics for the prevention and treatment of DMD cardiomyopathy.

  8. Role of Biotechnology in Animal Production Systems in Hot Climates

    Directory of Open Access Journals (Sweden)

    P. J. Hansen

    1996-01-01

    Full Text Available Developments in the biological sciences in the last three decades have revolutionized mankind's ability to manipulate the genetics, cell biology and physiology of biological organisms. These techniques, collectively termed biotechnology, create the opportunity for modifying domestic animals in ways that markedly increase the efficiency of production. Among the procedures being developed for animal production systems are marker-assisted selection of specific alleles of a gene that are associated with high production, production of transgenic animals , super ovulation and embryo transfer, in vitro fertilization, embryo sexing and cloning, production of large amounts of previously-rare proteins through use of genetically -engineered bacteria or other cells, and identification of new biologically-active molecules as potential regulators of animal function. To date, most uses of biotechnology have concentrated on problems of general relevance to animal agriculture rather than specific problems related to livestock production in hot climates. However, it is likely that biotechnology will be used for this latter purpose also. Strategies to increase disease resistance using marker-assisted selection, production of transgenic animals expressing viral proteins, and recombinant cytokines to enhance immune function should prove useful to reducing the incidence and seventy of various tropical diseases. Additionally, there are methods to reduce effects of heat stress on oestrus detection and establishment of pregnancy. These include remote sensing of oestrus, ovulation synchronization systems and embryo transfer. More research regarding the physiological processes determining heat tolerance and of the pathways through which heat stress alters physiological function will be required before molecular biology techniques can be used to reduce the adverse effects of heat stress on animal production.

  9. Research in Organic Animals and Livestock Production

    DEFF Research Database (Denmark)

    Vaarst, Mette

    2009-01-01

    developed in Western Europe and USA, where they are primarily niche products for consumers who give priority to environmental and animal welfare concerns. In these countries organic livestock production offers the option of establishing a niche product that can be sold at a higher price, e.g. as for milk...

  10. Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys.

    Science.gov (United States)

    Choi, Woo Hyuck; Jo, Hye Ryun; Jeon, Eun-Jeong; Youm, So-Young; Jeon, Jang Su; Son, Yong-Gyu; You, Weon-Kyoo; Koh, Woo Suk; Lee, Sang Hoon; Kim, Sang Kyum

    2016-11-30

    Unwanted immunogenicity of protein therapeutics can result in severe side effects and should be assessed in animals before applying the treatment to humans. Monkeys are the most relevant choice for pre-clinical toxicity testing of antibody-based therapeutics. To assess the immunogenicity of HD105, a novel antibody therapeutic that targets both vascular endothelial growth factor and Delta-like-ligand 4, a bridging enzyme-linked immunosorbent assay was developed as an anti-drug antibody (ADA) assay and validated for use in pre-clinical studies using non-human primates. This method was found to have suitable assay sensitivity, intra- and inter-assay precision, confirmation, drug tolerance, recovery, and sample stability for measuring ADA in monkey serum samples. The results showed that ADA elevation occurred following repeated doses of HD105, and that ADA production was negatively associated with serum HD105 concentration. These results suggest that intravenous administration of HD105 induces production of ADA in monkeys and that the detection of ADA may be negatively influenced by free HD105 in serum. Copyright © 2016 Elsevier B.V. All rights reserved.

  11. A preclinical cognitive test battery to parallel the National Institute of Health Toolbox in humans: bridging the translational gap.

    Science.gov (United States)

    Snigdha, Shikha; Milgram, Norton W; Willis, Sherry L; Albert, Marylin; Weintraub, S; Fortin, Norbert J; Cotman, Carl W

    2013-07-01

    A major goal of animal research is to identify interventions that can promote successful aging and delay or reverse age-related cognitive decline in humans. Recent advances in standardizing cognitive assessment tools for humans have the potential to bring preclinical work closer to human research in aging and Alzheimer's disease. The National Institute of Health (NIH) has led an initiative to develop a comprehensive Toolbox for Neurologic Behavioral Function (NIH Toolbox) to evaluate cognitive, motor, sensory and emotional function for use in epidemiologic and clinical studies spanning 3 to 85 years of age. This paper aims to analyze the strengths and limitations of animal behavioral tests that can be used to parallel those in the NIH Toolbox. We conclude that there are several paradigms available to define a preclinical battery that parallels the NIH Toolbox. We also suggest areas in which new tests may benefit the development of a comprehensive preclinical test battery for assessment of cognitive function in animal models of aging and Alzheimer's disease. Copyright © 2013 Elsevier Inc. All rights reserved.

  12. Animal models of contraception: utility and limitations

    Directory of Open Access Journals (Sweden)

    Liechty ER

    2015-04-01

    Full Text Available Emma R Liechty,1 Ingrid L Bergin,1 Jason D Bell2 1Unit for Laboratory Animal Medicine, 2Program on Women's Health Care Effectiveness Research, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA Abstract: Appropriate animal modeling is vital for the successful development of novel contraceptive devices. Advances in reproductive biology have identified novel pathways for contraceptive intervention. Here we review species-specific anatomic and physiologic considerations impacting preclinical contraceptive testing, including efficacy testing, mechanistic studies, device design, and modeling off-target effects. Emphasis is placed on the use of nonhuman primate models in contraceptive device development. Keywords: nonhuman primate, preclinical, in vivo, contraceptive devices

  13. Towards a better preclinical model of PTSD: characterizing animals with weak extinction, maladaptive stress responses and low plasma corticosterone.

    Science.gov (United States)

    Reznikov, Roman; Diwan, Mustansir; Nobrega, José N; Hamani, Clement

    2015-02-01

    Most of the available preclinical models of PTSD have focused on isolated behavioural aspects and have not considered individual variations in response to stress. We employed behavioural criteria to identify and characterize a subpopulation of rats that present several features analogous to PTSD-like states after exposure to classical fear conditioning. Outbred Sprague-Dawley rats were segregated into weak- and strong-extinction groups on the basis of behavioural scores during extinction of conditioned fear responses. Animals were subsequently tested for anxiety-like behaviour in the open-field test (OFT), novelty suppressed feeding (NSF) and elevated plus maze (EPM). Baseline plasma corticosterone was measured prior to any behavioural manipulation. In a second experiment, rats underwent OFT, NSF and EPM prior to being subjected to fear conditioning to ascertain whether or not pre-stress levels of anxiety-like behaviours could predict extinction scores. We found that 25% of rats exhibit low extinction rates of conditioned fear, a feature that was associated with increased anxiety-like behaviour across multiple tests in comparison to rats showing strong extinction. In addition, weak-extinction animals showed low levels of corticosterone prior to fear conditioning, a variable that seemed to predict extinction recall scores. In a separate experiment, anxiety measures taken prior to fear conditioning were not predictive of a weak-extinction phenotype, suggesting that weak-extinction animals do not show detectable traits of anxiety in the absence of a stressful experience. These findings suggest that extinction impairment may be used to identify stress-vulnerable rats, thus providing a useful model for elucidating mechanisms and investigating potential treatments for PTSD. Copyright © 2014 Elsevier Ltd. All rights reserved.

  14. Animal production and health newsletter. No. 28

    International Nuclear Information System (INIS)

    1998-06-01

    As we move into the second half of 1998, it is appropriate to look forward to 1999 which will see the commencement of four new FAO/IAEA Co-ordinated Research Projects (CRP) and the initiation of new round of biennium support for the Agency's programme of Technical C-operation (TC). The technical direction of support through these two activities reflects the process that was begun with the external review of the animal production and heath Sub-programme in 1996. Thus in the animal health field this year we have started three new CRPs on rinderpest, contagious bovine pleuropneumonia (CBPP) and Newcastle Disease, and in 1999 we will start a new CRP on developing techniques for separating foot-and-mouth disease (FMD) vaccinated animals from those naturally infected. In the animal production field we will start new CRPs in 1999 on purine derivative analysis in urine, and on tannins whilst in veterinary drug residue analysis the first CRP will commence, again in 1999. Further information on these activities is contained in this Newsletter

  15. Animal production and health newsletter. No. 28

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-06-01

    As we move into the second half of 1998, it is appropriate to look forward to 1999 which will see the commencement of four new FAO/IAEA Co-ordinated Research Projects (CRP) and the initiation of new round of biennium support for the Agency`s programme of Technical C-operation (TC). The technical direction of support through these two activities reflects the process that was begun with the external review of the animal production and heath Sub-programme in 1996. Thus in the animal health field this year we have started three new CRPs on rinderpest, contagious bovine pleuropneumonia (CBPP) and Newcastle Disease, and in 1999 we will start a new CRP on developing techniques for separating foot-and-mouth disease (FMD) vaccinated animals from those naturally infected. In the animal production field we will start new CRPs in 1999 on purine derivative analysis in urine, and on tannins whilst in veterinary drug residue analysis the first CRP will commence, again in 1999. Further information on these activities is contained in this Newsletter

  16. Utilization and cost of log production from animal loging operations

    Science.gov (United States)

    Suraj P. Shrestha; Bobby L. Lanford; Robert B. Rummer; Mark Dubois

    2006-01-01

    Forest harvesting with animals is a labor-intensive operation. It is expensive to use machines on smaller woodlots, which require frequent moves if mechanically logged. So, small logging systems using animals may be more cost effective. In this study, work sampling was used for five animal logging operations in Alabama to measure productive and non-productive time...

  17. Archives: Bulletin of Animal Health and Production in Africa

    African Journals Online (AJOL)

    Items 1 - 50 of 60 ... Archives: Bulletin of Animal Health and Production in Africa. Journal Home > Archives: Bulletin of Animal Health and Production in Africa. Log in or Register to get access to full text downloads. Username, Password, Remember me, or Register · Journal Home · ABOUT THIS JOURNAL · Advanced Search ...

  18. Trends in recombinant protein use in animal production.

    Science.gov (United States)

    Gifre, Laia; Arís, Anna; Bach, Àlex; Garcia-Fruitós, Elena

    2017-03-04

    Recombinant technologies have made possible the production of a broad catalogue of proteins of interest, including those used for animal production. The most widely studied proteins for the animal sector are those with an important role in reproduction, feed efficiency, and health. Nowadays, mammalian cells and fungi are the preferred choice for recombinant production of hormones for reproductive purposes and fibrolytic enzymes to enhance animal performance, respectively. However, the development of low-cost products is a priority, particularly in livestock. The study of cell factories such as yeast and bacteria has notably increased in the last decades to make the new developed reproductive hormones and fibrolytic enzymes a real alternative to the marketed ones. Important efforts have also been invested to developing new recombinant strategies for prevention and therapy, including passive immunization and modulation of the immune system. This offers the possibility to reduce the use of antibiotics by controlling physiological processes and improve the efficacy of preventing infections. Thus, nowadays different recombinant fibrolytic enzymes, hormones, and therapeutic molecules with optimized properties have been successfully produced through cost-effective processes using microbial cell factories. However, despite the important achievements for reducing protein production expenses, alternative strategies to further reduce these costs are still required. In this context, it is necessary to make a giant leap towards the use of novel strategies, such as nanotechnology, that combined with recombinant technology would make recombinant molecules affordable for animal industry.

  19. Animal models in genomic research: Techniques, applications, and roles for nurses.

    Science.gov (United States)

    Osier, Nicole D; Pham, Lan; Savarese, Amanda; Sayles, Kendra; Alexander, Sheila A

    2016-11-01

    Animal research has been conducted by scientists for over two millennia resulting in a better understanding of human anatomy, physiology, and pathology, as well as testing of novel therapies. In the molecular genomic era, pre-clinical models represent a key tool for understanding the genomic underpinnings of health and disease and are relevant to precision medicine initiatives. Nurses contribute to improved health by collecting and translating evidence from clinically relevant pre-clinical models. Using animal models, nurses can ask questions that would not be feasible or ethical to address in humans, and establish the safety and efficacy of interventions before translating them to clinical trials. Two advantages of using pre-clinical models are reduced variability between test subjects and the opportunity for precisely controlled experimental exposures. Standardized care controls the effects of diet and environment, while the availability of inbred strains significantly reduces the confounding effects of genetic differences. Outside the laboratory, nurses can contribute to the approval and oversight of animal studies, as well as translation to clinical trials and, ultimately, patient care. This review is intended as a primer on the use of animal models to advance nursing science; specifically, the paper discusses the utility of preclinical models for studying the pathophysiologic and genomic contributors to health and disease, testing interventions, and evaluating effects of environmental exposures. Considerations specifically geared to nurse researchers are also introduced, including discussion of how to choose an appropriate model and controls, potential confounders, as well as legal and ethical concerns. Finally, roles for nurse clinicians in pre-clinical research are also highlighted. Copyright © 2016 Elsevier Inc. All rights reserved.

  20. Animal production and health newsletter, No. 50, July 2009

    International Nuclear Information System (INIS)

    2009-07-01

    The biggest event this year was undoubtedly, the successful International Symposium on Sustainable Improvement of Animal Production and Health that was held from 8 to 11 June 2009, here in Vienna. It was attended by more than 400 participants from about 100 Member States of the IAEA and FAO, including several international organizations, with oral and poster contributions. The most important aspects of the symposium were to renew old and form new acquaintances, to discuss common topics and strategies and to form networks and partnerships to address animal production and health problems. The symposium was indeed topical and designed to address issues of importance to our Member States. The new and emerging areas of interest such as One Heath, Food Security and Safety and our ability to produce more and healthier animals and animal products in an 'environmentally safe, clean and ethical' way were hotly discussed. Some of the conclusions and challenges that animal scientists face, whose primary concern have been improving livestock productivity, are more extensively reported on in this newsletter. In addition, we will publish full length papers of all the oral presentations, and some of the most imminent poster presentations, as symposium proceedings shortly. Both past and future activities are described in further detail in this newsletter

  1. Monitoring residue in animals and primary products of animal origin

    Directory of Open Access Journals (Sweden)

    Janković Saša

    2008-01-01

    Full Text Available The objective of control and systematic monitoring of residue is to secure, by the examination of a corresponding number of samples, the efficient monitoring of the residue level in tissues and organs of animals, as well as in primary products of animal origin. This creates possibilities for the timely taking of measures toward the securing of food hygiene of animal origin and the protection of public health. Residue can be a consequence of the inadequate use of medicines in veterinary medicine and pesticides in agriculture and veterinary medicine, as well as the polluting of the environment with toxic elements, dioxins, polychlorinated biphenyls, and others. Residue is being monitored in Serbia since 1972, and in 2004, national monitoring was brought to the level of EU countries through significant investments by the Ministry of Agriculture, Forestry and Water Management. This is also evident in the EU directives which permit exports of all kinds of meat and primary products of animal origin, covered by the Residue Monitoring Program. The program of systematic examinations of residue has been coordinated with the requirements of the European Union, both according to the type of examined substance, as well as according to the number of samples and the applied analytical techniques. In addition to the development of methods and the including of new harmful substances into the monitoring programme, it is also necessary to coordinate the national regulations that define the maximum permitted quantities of certain medicines and contaminants with the EU regulations, in order to protect the health of consumers as efficiently as possible, and for the country to take equal part in international trade.

  2. Improvement of animal production through research using radioisotopes and radiation

    International Nuclear Information System (INIS)

    1976-01-01

    High birth rates coupled with greater longevity continue to increase the.world's population, especially in the less developed countries. The prevention of undernutrition and ultimately starvation will only be averted by increased food production and more efficient use of that food. At the same time people who have largely subsisted upon plant food diets and whose standards of living are rising, want to increase the use of animal products in order to upgrade their diets. To provide this high quality food animal scientists must find ways of increasing the supply especially in the less developed countries. Since most of the available pasture lands are presently being fully utilized or overgrazed, improved efficiency of the present herds and use of agroindustrial wastes are the only methods left to increase production significantly. The use of radioisotopes and radiation in research are making major contributions to the understanding of the processes necessary to achieve better animal production. In order to provide a forum for exchange of information in this field, the FAO/IAEA Joint Division of Atomic Energy in Food and Agriculture organized an international symposium, held in Vienna, from 2?6 February, on the use of nuclear techniques in animal production. Among the topics discussed at the symposium were: Soil-plant-animal relations regarding minerals, Trace elements in animal nutrition, Calcium, phosphorus and magnesium metabolism, Protein (nitrogen) metabolism - ruminants Protein (nitrogen) metabolism - non-ruminants Nuclear techniques in the control of parasitic infections Animal endocrinology with special emphasis on radioimmunoassays

  3. Improvement of animal production through research using radioisotopes and radiation

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1976-07-01

    High birth rates coupled with greater longevity continue to increase the.world's population, especially in the less developed countries. The prevention of undernutrition and ultimately starvation will only be averted by increased food production and more efficient use of that food. At the same time people who have largely subsisted upon plant food diets and whose standards of living are rising, want to increase the use of animal products in order to upgrade their diets. To provide this high quality food animal scientists must find ways of increasing the supply especially in the less developed countries. Since most of the available pasture lands are presently being fully utilized or overgrazed, improved efficiency of the present herds and use of agroindustrial wastes are the only methods left to increase production significantly. The use of radioisotopes and radiation in research are making major contributions to the understanding of the processes necessary to achieve better animal production. In order to provide a forum for exchange of information in this field, the FAO/IAEA Joint Division of Atomic Energy in Food and Agriculture organized an international symposium, held in Vienna, from 2?6 February, on the use of nuclear techniques in animal production. Among the topics discussed at the symposium were: Soil-plant-animal relations regarding minerals, Trace elements in animal nutrition, Calcium, phosphorus and magnesium metabolism, Protein (nitrogen) metabolism - ruminants Protein (nitrogen) metabolism - non-ruminants Nuclear techniques in the control of parasitic infections Animal endocrinology with special emphasis on radioimmunoassays.

  4. Animal production and health newsletter. No. 20

    International Nuclear Information System (INIS)

    1994-07-01

    The activities of the Animal Production and Health Section of the Joint FAO/IAEA Division are carried out through the operation of Co-ordinated Research Programmes and Technical Co-operation projects, both of which aim to encourage and improve the capacity of national institutions in tropical and subtropical countries to identify and resolve problems connected with livestock development. This particular programme at the outset, it was envisaged that an inter-disciplinary approach would be adopted by each participating institute whereby studies on nutrition, reproduction and health would be integrated into a number of site specific projects. The one discussed in this newsletter covers animal production and focussing on animal reproduction and reproduction-nutrition interactions. This paper contains an outline for the program which encourages scientists from universities and research institutes to provide assistance and solutions to developing countries on the technical difficulties associated with artificial insemination

  5. ANIMAL PRODUCTS IN NUTRITION OF HUMAN POPULATION

    Directory of Open Access Journals (Sweden)

    Gordana Kralik

    2000-06-01

    Full Text Available In this paper, the significance of animal food (meat and milk in human nutrition and satisfaction of life needs with special look on health is reviewed. Meat is excelent source of proteins with high biological value.The proteins from meat are of high quality because they contain high share of essencial amino acids which are necessary for human organism. Polyunsaturated fatty acids, esspecialy those from ω3 group, became very importat to human nutritionists because they have significant role in prevention of stress induced deseases and of those induced by improper diets. New findings from western industrial countries point out the fact that longer intake of LA (ω-6 with relative “deficiency” of ω-3 is the main risk factor in occurence of cancer, coronary deseases (CHD, cerebrovascular deseases (CVD and alergic hyperactivity; not cholesterol as was considered till now. Therefore it is important to reduce the ω-6 / ω-3 acids ratio in meat and milk using some feedstufs in diets of animals. Dairy products contribute to health throughout life. Epidemiological researches as well as studies in animals and humans indicate that dairy food and/or their components have a protective effect against cancer. The potential anticancer agents identified so far in dairy foods include conjugated linoleic acid (CLA, calcium, vitamin D, sphingomyelin, butyric acid, ether lipids, protein and lactic acid bacteria. Milk is exclusive source of nutrients for the young and it also represents a high grade source of dietary nitrogen and indispensable amino acids for adults. Consumers are increasing looking for animal products, which could prevent disease or illness.Keywords: animal products, polyunsaturated fatty acids, meat, milk, nutrients.

  6. Radiation hygiene of animal production in normal and emergency situations

    International Nuclear Information System (INIS)

    Stajicj, J.; Petrovicj, B.; Draganovicj, B.

    1977-01-01

    Radiation hazards imposed by contemporary development and peaceful and military uses of nuclear energy have implied the introduction of radiational control in animal production, and radiation-hygienic expertize of animal products and animal foodstuffs. Various treatments in scientific research, education and uses of relevant equipment, undertaken in right time, enabled our Veterinary services to start successfully to solve problems of radiation control and protection of animal production in normal and emergency situations. An important role in this context has the Section of Radiation Hygiene Yugoslav Veterinary Association, as an initiator of many activities that are intended to affirme Radiation Hygiene in the domain of scientific research and in the field of national defence and self-protection

  7. Marketing Animal-Friendly Products: Addressing the Consumer Social Dilemma with Reinforcement Positioning Strategies

    Science.gov (United States)

    Ingenbleek, Paul T.M.; van Trijp, Hans C.M.; van der Veen, Gerrita

    2017-01-01

    Simple Summary Modern production systems aimed at improving animal welfare are more costly than traditional systems. Animal-friendly products are therefore typically more expensive than mainstream products, which presents one of the main barriers to consumer animal-friendly product choice. To overcome this barrier, marketing strategies that associate animal welfare with different types of value, such as taste, healthiness or good feeling, may be useful. This article presents a theoretical framework with marketing strategies using various types of value, suitable for animal-friendly products to encourage consumers to buy animal-friendly instead of mainstream products. We also explain why some consumers, such as those with a rational or an intuitive thinking style, may be more sensitive to some strategies over others, giving directions to marketing managers on how to approach different types of consumers. Because the credibility of animal welfare claims is a critical issue in marketing animal-friendly products, we address this issue as well. Specifically, we propose that, to gain consumer trust, companies selling animal-friendly products need to take into account the impact of their overall strategy on the effectiveness of marketing strategies for individual products and that they may need to collaborate with relevant stakeholders, such as media or animal-interest organizations. Abstract This article presents a conceptual framework that aims to encourage consumer animal-friendly product choice by introducing positioning strategies for animal-friendly products. These strategies reinforce the animal welfare with different types of consumption values and can therefore reduce consumers’ social dilemma, which is a major barrier to animal-friendly consumer choices. The article suggests how animal-friendly products can use various types of consumption values (functional, sensory, emotional, social, epistemic and situational) to create an attractive position relative to

  8. Bioactive Peptides in Animal Food Products

    Directory of Open Access Journals (Sweden)

    Marzia Albenzio

    2017-05-01

    Full Text Available Proteins of animal origin represent physiologically active components in the human diet; they exert a direct action or constitute a substrate for enzymatic hydrolysis upon food processing and consumption. Bioactive peptides may descend from the hydrolysis by digestive enzymes, enzymes endogenous to raw food materials, and enzymes from microorganisms added during food processing. Milk proteins have different polymorphisms for each dairy species that influence the amount and the biochemical characteristics (e.g., amino acid chain, phosphorylation, and glycosylation of the protein. Milk from other species alternative to cow has been exploited for their role in children with cow milk allergy and in some infant pathologies, such as epilepsy, by monitoring the immune status. Different mechanisms concur for bioactive peptides generation from meat and meat products, and their functionality and application as functional ingredients have proven effects on consumer health. Animal food proteins are currently the main source of a range of biologically-active peptides which have gained special interest because they may also influence numerous physiological responses in the organism. The addition of probiotics to animal food products represent a strategy for the increase of molecules with health and functional properties.

  9. ANIMAL PRODUCTION IN A GRAIN HUNGRY WORLD - or ...

    African Journals Online (AJOL)

    ted plant matter. animal products are not essen- tial in human ... the energy of plant matter is lost in converting it to animal .... to electricity or by harnessing wind and wave power. nu- ..... nomy. will also adapt to the changing cost structure by.

  10. Small animal radiotherapy research platforms

    Energy Technology Data Exchange (ETDEWEB)

    Verhaegen, Frank; Granton, Patrick [Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht 6201 BN (Netherlands); Tryggestad, Erik, E-mail: frank.verhaegen@maastro.nl [Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21231 (United States)

    2011-06-21

    Advances in conformal radiation therapy and advancements in pre-clinical radiotherapy research have recently stimulated the development of precise micro-irradiators for small animals such as mice and rats. These devices are often kilovolt x-ray radiation sources combined with high-resolution CT imaging equipment for image guidance, as the latter allows precise and accurate beam positioning. This is similar to modern human radiotherapy practice. These devices are considered a major step forward compared to the current standard of animal experimentation in cancer radiobiology research. The availability of this novel equipment enables a wide variety of pre-clinical experiments on the synergy of radiation with other therapies, complex radiation schemes, sub-target boost studies, hypofractionated radiotherapy, contrast-enhanced radiotherapy and studies of relative biological effectiveness, to name just a few examples. In this review we discuss the required irradiation and imaging capabilities of small animal radiation research platforms. We describe the need for improved small animal radiotherapy research and highlight pioneering efforts, some of which led recently to commercially available prototypes. From this, it will be clear that much further development is still needed, on both the irradiation side and imaging side. We discuss at length the need for improved treatment planning tools for small animal platforms, and the current lack of a standard therein. Finally, we mention some recent experimental work using the early animal radiation research platforms, and the potential they offer for advancing radiobiology research. (topical review)

  11. Small animal radiotherapy research platforms

    Science.gov (United States)

    Verhaegen, Frank; Granton, Patrick; Tryggestad, Erik

    2011-06-01

    Advances in conformal radiation therapy and advancements in pre-clinical radiotherapy research have recently stimulated the development of precise micro-irradiators for small animals such as mice and rats. These devices are often kilovolt x-ray radiation sources combined with high-resolution CT imaging equipment for image guidance, as the latter allows precise and accurate beam positioning. This is similar to modern human radiotherapy practice. These devices are considered a major step forward compared to the current standard of animal experimentation in cancer radiobiology research. The availability of this novel equipment enables a wide variety of pre-clinical experiments on the synergy of radiation with other therapies, complex radiation schemes, sub-target boost studies, hypofractionated radiotherapy, contrast-enhanced radiotherapy and studies of relative biological effectiveness, to name just a few examples. In this review we discuss the required irradiation and imaging capabilities of small animal radiation research platforms. We describe the need for improved small animal radiotherapy research and highlight pioneering efforts, some of which led recently to commercially available prototypes. From this, it will be clear that much further development is still needed, on both the irradiation side and imaging side. We discuss at length the need for improved treatment planning tools for small animal platforms, and the current lack of a standard therein. Finally, we mention some recent experimental work using the early animal radiation research platforms, and the potential they offer for advancing radiobiology research.

  12. Small animal radiotherapy research platforms

    International Nuclear Information System (INIS)

    Verhaegen, Frank; Granton, Patrick; Tryggestad, Erik

    2011-01-01

    Advances in conformal radiation therapy and advancements in pre-clinical radiotherapy research have recently stimulated the development of precise micro-irradiators for small animals such as mice and rats. These devices are often kilovolt x-ray radiation sources combined with high-resolution CT imaging equipment for image guidance, as the latter allows precise and accurate beam positioning. This is similar to modern human radiotherapy practice. These devices are considered a major step forward compared to the current standard of animal experimentation in cancer radiobiology research. The availability of this novel equipment enables a wide variety of pre-clinical experiments on the synergy of radiation with other therapies, complex radiation schemes, sub-target boost studies, hypofractionated radiotherapy, contrast-enhanced radiotherapy and studies of relative biological effectiveness, to name just a few examples. In this review we discuss the required irradiation and imaging capabilities of small animal radiation research platforms. We describe the need for improved small animal radiotherapy research and highlight pioneering efforts, some of which led recently to commercially available prototypes. From this, it will be clear that much further development is still needed, on both the irradiation side and imaging side. We discuss at length the need for improved treatment planning tools for small animal platforms, and the current lack of a standard therein. Finally, we mention some recent experimental work using the early animal radiation research platforms, and the potential they offer for advancing radiobiology research. (topical review)

  13. Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

    Directory of Open Access Journals (Sweden)

    Susanne Krasemann

    Full Text Available Prion diseases are transmissible fatal neurodegenerative disorders affecting humans and animals. A central step in disease progression is the accumulation of a misfolded form (PrP(Sc of the host encoded prion protein (PrP(C in neuronal and non-neuronal tissues. The involvement of peripheral tissues in preclinical states increases the risk of accidental transmission. On the other hand, detection of PrP(Sc in non-neuronal easy-accessible compartments such as muscle may offer a novel diagnostic tool. Primate models have proven invaluable to investigate prion diseases. We have studied the deposition of PrP(Sc in muscle and central nervous system of rhesus monkeys challenged with sporadic Creutzfeldt-Jakob disease (sCJD, variant CJD (vCJD and bovine spongiform encephalopathy (BSE in preclinical and clinical stage using biochemical and morphological methods. Here, we show the preclinical presence of PrP(Sc in muscle and central nervous system of rhesus monkeys experimentally infected with vCJD.

  14. 9.4 T small animal MRI using clinical components for direct translational studies.

    Science.gov (United States)

    Felder, Jörg; Celik, A Avdo; Choi, Chang-Hoon; Schwan, Stefan; Shah, N Jon

    2017-12-28

    Magnetic resonance is a major preclinical and clinical imaging modality ideally suited for longitudinal studies, e.g. in pharmacological developments. The lack of a proven platform that maintains an identical imaging protocol between preclinical and clinical platforms is solved with the construction of an animal scanner based on clinical hard- and software. A small animal magnet and gradient system were connected to a clinical MR system. Several hardware components were either modified or built in-house to achieve compatibility. The clinical software was modified to account for the different field-of-view of a preclinical MR system. The established scanner was evaluated using clinical QA protocols, and platform compatibility for translational research was verified against clinical scanners of different field strength. The constructed animal scanner operates with the majority of clinical imaging sequences. Translational research is greatly facilitated as protocols can be shared between preclinical and clinical platforms. Hence, when maintaining sequences parameters, maximum similarity between pulses played out on a human or an animal system is maintained. Coupling of a small animal magnet with a clinical MR system is a flexible, easy to use way to establish and advance translational imaging capability. It provides cost and labor efficient translational capability as no tedious sequence reprogramming between moieties is required and cross-platform compatibility of sequences facilitates multi-center studies.

  15. Recent Advances in Translational Magnetic Resonance Imaging in Animal Models of Stress and Depression.

    Science.gov (United States)

    McIntosh, Allison L; Gormley, Shane; Tozzi, Leonardo; Frodl, Thomas; Harkin, Andrew

    2017-01-01

    Magnetic resonance imaging (MRI) is a valuable translational tool that can be used to investigate alterations in brain structure and function in both patients and animal models of disease. Regional changes in brain structure, functional connectivity, and metabolite concentrations have been reported in depressed patients, giving insight into the networks and brain regions involved, however preclinical models are less well characterized. The development of more effective treatments depends upon animal models that best translate to the human condition and animal models may be exploited to assess the molecular and cellular alterations that accompany neuroimaging changes. Recent advances in preclinical imaging have facilitated significant developments within the field, particularly relating to high resolution structural imaging and resting-state functional imaging which are emerging techniques in clinical research. This review aims to bring together the current literature on preclinical neuroimaging in animal models of stress and depression, highlighting promising avenues of research toward understanding the pathological basis of this hugely prevalent disorder.

  16. Recent Advances in Translational Magnetic Resonance Imaging in Animal Models of Stress and Depression

    Directory of Open Access Journals (Sweden)

    Allison L. McIntosh

    2017-05-01

    Full Text Available Magnetic resonance imaging (MRI is a valuable translational tool that can be used to investigate alterations in brain structure and function in both patients and animal models of disease. Regional changes in brain structure, functional connectivity, and metabolite concentrations have been reported in depressed patients, giving insight into the networks and brain regions involved, however preclinical models are less well characterized. The development of more effective treatments depends upon animal models that best translate to the human condition and animal models may be exploited to assess the molecular and cellular alterations that accompany neuroimaging changes. Recent advances in preclinical imaging have facilitated significant developments within the field, particularly relating to high resolution structural imaging and resting-state functional imaging which are emerging techniques in clinical research. This review aims to bring together the current literature on preclinical neuroimaging in animal models of stress and depression, highlighting promising avenues of research toward understanding the pathological basis of this hugely prevalent disorder.

  17. Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.

    Science.gov (United States)

    Provencher, Steeve; Archer, Stephen L; Ramirez, F Daniel; Hibbert, Benjamin; Paulin, Roxane; Boucherat, Olivier; Lacasse, Yves; Bonnet, Sébastien

    2018-03-30

    Despite advances in our understanding of the pathophysiology and the management of pulmonary arterial hypertension (PAH), significant therapeutic gaps remain for this devastating disease. Yet, few innovative therapies beyond the traditional pathways of endothelial dysfunction have reached clinical trial phases in PAH. Although there are inherent limitations of the currently available models of PAH, the leaky pipeline of innovative therapies relates, in part, to flawed preclinical research methodology, including lack of rigour in trial design, incomplete invasive hemodynamic assessment, and lack of careful translational studies that replicate randomized controlled trials in humans with attention to adverse effects and benefits. Rigorous methodology should include the use of prespecified eligibility criteria, sample sizes that permit valid statistical analysis, randomization, blinded assessment of standardized outcomes, and transparent reporting of results. Better design and implementation of preclinical studies can minimize inherent flaws in the models of PAH, reduce the risk of bias, and enhance external validity and our ability to distinguish truly promising therapies form many false-positive or overstated leads. Ideally, preclinical studies should use advanced imaging, study several preclinical pulmonary hypertension models, or correlate rodent and human findings and consider the fate of the right ventricle, which is the major determinant of prognosis in human PAH. Although these principles are widely endorsed, empirical evidence suggests that such rigor is often lacking in pulmonary hypertension preclinical research. The present article discusses the pitfalls in the design of preclinical pulmonary hypertension trials and discusses opportunities to create preclinical trials with improved predictive value in guiding early-phase drug development in patients with PAH, which will need support not only from researchers, peer reviewers, and editors but also from

  18. Production, Usage, and Comprehension in Animal Vocalizations

    Science.gov (United States)

    Seyfarth, Robert M.; Cheney, Dorothy L.

    2010-01-01

    In this review, we place equal emphasis on production, usage, and comprehension because these components of communication may exhibit different developmental trajectories and be affected by different neural mechanisms. In the animal kingdom generally, learned, flexible vocal production is rare, appearing in only a few orders of birds and few…

  19. Transfer of radionuclides to animal products following ingestion or inhalation

    International Nuclear Information System (INIS)

    Coughtrey, P.J.

    1996-01-01

    Contamination of animal products forms an important pathway in the transfer of radionuclides from source to man. Simulation of radionuclide transfer via animal products requires an understanding of the processes and mechanisms involved in absorption, distribution, turnover and excretion of radionuclides and related elements in animals as well as knowledge of animal grazing habits and husbandry. This paper provides a summary of the metabolism of important radionuclides in typical domestic animals and of the mathematical approaches that have been used to simulate transfer from diet to animal product. The equilibrium transfer factor approach has been used widely but suffers a number of disadvantages when releases or intakes are variable with time or when intakes are short relative to the lifetime of the animal of interest. Dynamic models, especially those of the compartmental type, have been developed and used widely. Both approaches have benefited from experiences obtained after the Chernobyl accident but a number of uncertainties still exist. Whereas there is now extensive knowledge on the behaviour of radiocaesium in both domestic and wild animals, knowledge of the behaviour of other potentially important radionuclides remains limited. Further experimental and metabolic studies will be required to reduce uncertainties associated with the transfer of radionuclides other than radiocaesium and thereby produce a sound basis for radiological assessments. (author)

  20. Animal production off grassland. | J.E. | African Journal of Range ...

    African Journals Online (AJOL)

    Veld rehabilitation is considered an overwhelming priority in the sweetveld. The limiting factors in the sourveld are poor veld management and lack of economic motivation. Research in the sourveld should be appointed to promote improved grazing management and animal production. Keywords: animal production; current ...

  1. Animal welfare in multipurpose cattle production Systems and its ...

    African Journals Online (AJOL)

    Animal welfare and its influence on beef production are major considerations in many developed countries. In the developing world, where food insecurity and poverty are prevalent, the welfare of animals receives low priority due to factors such as traditional customs and beliefs, lack of knowledge in animal handling and ...

  2. Understanding in vivo modelling of depression in non-human animals: a systematic review protocol

    DEFF Research Database (Denmark)

    Bannach-Brown, Alexandra; Liao, Jing; Wegener, Gregers

    2016-01-01

    experimental model(s) to induce or mimic a depressive-like phenotype. Data that will be extracted include the model or method of induction; species and gender of the animals used; the behavioural, anatomical, electrophysiological, neurochemical or genetic outcome measure(s) used; risk of bias......The aim of this study is to systematically collect all published preclinical non-human animal literature on depression to provide an unbiased overview of existing knowledge. A systematic search will be carried out in PubMed and Embase. Studies will be included if they use non-human animal......-analysis of the preclinical studies modelling depression-like behaviours and phenotypes in animals....

  3. Preclinical efficacy and safety of herbal formulation for management ...

    African Journals Online (AJOL)

    Preclinical efficacy and safety of herbal formulation for management of wounds. ... The effects of the treatments on rate of wound closure, epithelialisation time ... inflammation and better tissue remodeling for rats treated with herbal product.

  4. Identification and preclinical testing of novel antiepileptic compounds.

    Science.gov (United States)

    Meldrum, B S

    1997-01-01

    Procedures for identifying novel antiepileptic drugs (AEDs) are changing and need to change more. Widespread reliance on two primary screens has led to the identification of novel compounds that resemble either phenytoin (suppressing high-frequency repetitive firing in cultured neurons and prolonging inactivation of voltage-dependent sodium channels identified by the maximal electroshock test) or benzodiazepines (potentiating the inhibitory effect of gamma-aminobutyric acid (GABA), identified by the threshold pentylenetetrazol test). Advances in molecular neurobiology have identified specific molecular targets (subunits of ion channels, neurotransmitter receptors, and transporters) and have made them available in a form permitting high-throughput screening. AEDs can be designed to interact with specific sites on the target molecules. Alternatively, the molecular screens can be used to identify active components in natural products, including folk remedies. Preclinical in vivo screens can be improved by using animals with genetic or acquired epilepsies that have similar modifications in the properties of the target molecules as do human epilepsy syndromes. Future work is likely to define molecular targets for AEDs that will block or reverse chronic epileptogenesis.

  5. Improving animal health and livestock productivity to reduce poverty.

    Science.gov (United States)

    Pradère, J-P

    2014-12-01

    This study is based on scientific publications, statistics and field observations. It shows the importance of livestock in the economy and in the risk management strategies implemented by poor farming households. A comparison of livestock performance trends with the evolution of rural poverty in developing countries indicates that growth in livestock production alone is not enough to reduce rural poverty. To help reduce poverty, sustainable production should be based on productivity gains. Prerequisites for improving productivity include better public policies, enhanced research and the reduction of animal disease risk. The study draws attention to the economic, social and environmental consequences of inadequate support for animal health and production in the least developed countries, especially those of sub-Saharan Africa.

  6. Animal production and health newsletter. No. 46, July 2007

    International Nuclear Information System (INIS)

    2007-07-01

    In response to many requests from our readers, I will continue to highlight a practical topic related to animal production and health in this section of the newsletter. Increasing the efficiency of animal reproduction is a critical component of a holistic approach to sustainably increase animal productivity in developing Member States. For example, the resources spent to formulate and obtain the ingredients for dairy rations are wasted when a significant proportion of the cows in the herd are dry due to delays in achieving pregnancy. Effective genetic selection to improve productivity is only possible if a regular supply of potential replacements is generated by the females already in the herd or flock. For this reason, improving reproductive efficiency is a key aspect of many of the APH projects

  7. Safety of Animal Fats for Biodiesel Production: A Critical Review of Literature

    Energy Technology Data Exchange (ETDEWEB)

    Greene, A; Dawson, P; Nixon, D; Atkins, J; Pearl, G [Clemson University, SC (United States)

    2007-05-15

    An in-depth review of available literature was conducted on the safety of using animal fats for biodiesel. The review indicated little or no known risk to human and animal health and to the environment relative to inherent microbial, organic or inorganic agents in animal fats destined for biodiesel production. Animal by-products are generated from the inedible tissues derived from meat, poultry and fish production. This material is thermally processed by the rendering industry to generate a number of industrial materials including use of the fat portion to produce biodiesel. As the biodiesel industry continues to develop, questions have emerged about the safety of animal versus vegetable fats for biodiesel production and utilization. The following report is the result of a detailed literature search into the potential microbial, organic, and inorganic contaminants that may be present in animal fats and the potential for human or environmental safety issues associated with each. The potential safety risks associated with prions are discussed in a separate report, 'Biodiesel from Specified Risk Material Tallow: An Appraisal of TSE Risks and their Reduction'. In certain instances, very little was reported about the potential contaminating moiety and its fate in biodiesel production and usage. Establishing an absolute zero risk assessment is impossible on any fat utilized for biodiesel production. Among the potential microbial contaminants, bacteria, viruses, fungi, yeast, parasites, and microbial toxins were considered. In each instance, the nature of the production process and usage of biodiesel via combustion reduce the possibility that microbial contaminants would be a cause for concern to humans, animals, or the environment. Potential organic moieties contaminating the fat should meet a similar fate. Current evidence suggests that metals and metalloids within animal fats will not cause significant safety issues in the production and use of rendered fat

  8. Safety of Animal Fats for Biodiesel Production: A Critical Review of Literature

    Energy Technology Data Exchange (ETDEWEB)

    Greene, A.; Dawson, P.; Nixon, D.; Atkins, J.; Pearl, G. [Clemson University, SC (United States)

    2007-05-15

    An in-depth review of available literature was conducted on the safety of using animal fats for biodiesel. The review indicated little or no known risk to human and animal health and to the environment relative to inherent microbial, organic or inorganic agents in animal fats destined for biodiesel production. Animal by-products are generated from the inedible tissues derived from meat, poultry and fish production. This material is thermally processed by the rendering industry to generate a number of industrial materials including use of the fat portion to produce biodiesel. As the biodiesel industry continues to develop, questions have emerged about the safety of animal versus vegetable fats for biodiesel production and utilization. The following report is the result of a detailed literature search into the potential microbial, organic, and inorganic contaminants that may be present in animal fats and the potential for human or environmental safety issues associated with each. The potential safety risks associated with prions are discussed in a separate report, 'Biodiesel from Specified Risk Material Tallow: An Appraisal of TSE Risks and their Reduction'. In certain instances, very little was reported about the potential contaminating moiety and its fate in biodiesel production and usage. Establishing an absolute zero risk assessment is impossible on any fat utilized for biodiesel production. Among the potential microbial contaminants, bacteria, viruses, fungi, yeast, parasites, and microbial toxins were considered. In each instance, the nature of the production process and usage of biodiesel via combustion reduce the possibility that microbial contaminants would be a cause for concern to humans, animals, or the environment. Potential organic moieties contaminating the fat should meet a similar fate. Current evidence suggests that metals and metalloids within animal fats will not cause significant safety issues in the production and use of rendered fat

  9. Industrial halal meat production and animal welfare: A review.

    Science.gov (United States)

    Farouk, M M; Pufpaff, K M; Amir, M

    2016-10-01

    Islam teaches zero-tolerance to all forms of animal abuse throughout the halal meat production supply chain and demands that when animals are slaughtered, they must be slaughtered in the mindful and attentive way espoused by the Prophet Muhammad. Why then are poor practices and animal welfare abuses still occurring during halal meat production, and how can they be reduced or eliminated? In this review we discuss how improvements might be achieved through: (1) training of staff regarding the religious and regulatory requirements of animal welfare from on-farm to slaughter; (2) empathy and compassion assessment of applicants prior to employment; (3) installation of CCTV cameras around lairage and slaughter sites; (4) regular employee follow-up training to minimise 'compassion fatigue'; (5) incorporating animal welfare requirements in halal certification; (6) using mosque-based sermons by Imams to increase awareness of animal welfare issues; and (7) making portable humane slaughter units available to small cottage operations and home/neighbourhood-kills through mosque-based organizations/structures. Copyright © 2016 Elsevier Ltd. All rights reserved.

  10. Animal derived products may conflict with religious patients' beliefs.

    Science.gov (United States)

    Eriksson, Axelina; Burcharth, Jakob; Rosenberg, Jacob

    2013-12-01

    Implants and drugs with animal and human derived content are widely used in medicine and surgery, but information regarding ingredients is rarely obtainable by health practitioners. A religious perspective concerning the use of animal and human derived drug ingredients has not thoroughly been investigated. The purpose of this study was to clarify which parts of the medical and surgical treatments offered in western world-hospitals that conflicts with believers of major religions. Religious and spiritual leaders of the six largest religions worldwide (18 branches) were contacted. A standardised questionnaire was sent out regarding their position on the use of human and animal derived products in medical and surgical treatments. Of the 18 contacted religious branches, 10 replied representing the 6 largest religions worldwide. Hindus and Sikhs did not approve of the use of bovine or porcine derived products, and Muslims did not accept the use of porcine derived drugs, dressings or implants. Christians (including Jehovah's Witnesses), Jews and Buddhists accepted the use of all animal and human derived products. However, all religions accepted the use of all these products in case of an emergency and only if alternatives were not available. The views here suggest that religious codes conflict with some treatment regimens. It is crucial to obtain informed consent from patients for the use of drugs and implants with animal or human derived content. However, information on the origin of ingredients in drugs is not always available to health practitioners.

  11. Brazilian Citizens' Opinions and Attitudes about Farm Animal Production Systems.

    Science.gov (United States)

    Yunes, Maria C; von Keyserlingk, Marina A G; Hötzel, Maria J

    2017-09-28

    The inclusion of societal input is needed for food animal production industries to retain their "social license to operate"; failure to engage with the public on this topic risks the long-term sustainability of these industries. The primary aim of this study was to explore the beliefs and attitudes of Brazilians citizens not associated with livestock production towards farm animal production. A related secondary aim was to identify the specific beliefs and attitudes towards systems that are associated with restriction of movement. Each participant was shown pictures representing two of five possible major food animal industries (laying hens, beef cattle, pregnant sows, lactating sows, and poultry meat). Participants were presented a six pages survey that included demographic questions plus two sets of two pictures and a series of questions pertaining to the pictures. Each set of pictures represented a particular industry where one picture represented a housing type that is associated with behavioural restrictions and the other picture represented a system that allowed for a greater degree of movement. Participants were asked their perceptions on the prevalence of each system in Brazil, then their preference of one picture vs. the other, and the reasons justifying their preference. Immediately following, the participant repeated the same exercise with the second set of two pictures representing another industry followed by the same series of questions as described above. Quantitative data were analysed with mixed effects logistic regression, and qualitative responses were coded into themes. The proportion of participants that believed animals are reared in confinement varied by animal production type: 23% (beef cattle), 82% (poultry), 81% (laying hens), and 60% (swine). A large majority (79%) stated that farm animals are not well-treated in Brazil. Overall, participants preferred systems that were not associated with behavioural restriction. The preference for free

  12. Animal production and health newsletter. No. 38

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2003-06-01

    This Issue outlines recent activities of the Animal Production and Health Section outstanding among them being the support it provides to the implementation of over 40 Technical Cooperation Projects and eight Coordinated Research Projects. Future activities will focus on the theme of 'Sustainable Intensification of Livestock Production Systems through Technologies (with emphasis on biotechnology) and Capacity Building.

  13. Animal production and health newsletter. No. 38

    International Nuclear Information System (INIS)

    2003-06-01

    This Issue outlines recent activities of the Animal Production and Health Section outstanding among them being the support it provides to the implementation of over 40 Technical Cooperation Projects and eight Coordinated Research Projects. Future activities will focus on the theme of 'Sustainable Intensification of Livestock Production Systems through Technologies (with emphasis on biotechnology) and Capacity Building

  14. Animal Production and Health Newsletter. No. 13

    International Nuclear Information System (INIS)

    1991-01-01

    This newsletter includes reports of FAO/IAEA-organized meetings held between 17 September 1990 and 23 November 1990, with emphasis on the development and application of radioimmunoassay and enzyme-linked immunosorbent assay techniques to study Foot and Mouth Disease, bluetongue vins and other diseases, and animal reproduction. The status of existing coordinated research programmes is summarized, and a new coordinated research programme on the development of supplementation strategies for milk-producing animals in tropical and subtropical environments is announced. Applications for contracts to participate in this programme are invited. The role of the Section's Animal Production Unit at Seibersdorf is reviewed, and a list of forthcoming events is given

  15. Animal production and health newsletter. No. 23

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-01-01

    The Newsletter presents the staffing, past and forthcoming workshops, status of the existing coordinated research programmes in the area of application of nuclear and biotechnology techniques in animal production and health.

  16. Animal production and health newsletter. No. 23

    International Nuclear Information System (INIS)

    1996-01-01

    The Newsletter presents the staffing, past and forthcoming workshops, status of the existing coordinated research programmes in the area of application of nuclear and biotechnology techniques in animal production and health

  17. Animal health and production

    International Nuclear Information System (INIS)

    Kallfelz, F.A.; Lengemann, F.W.

    1984-01-01

    An outline review is presented of the use of radioisotopes and radiation in animal health and production research. Techniques covered are the qualitative localization of a radioisotope (static and dynamic measurements, detection procedures involving locating concentration sites of labelled toxins, parasites, abnormal blood cells, etc.), quantitative measurement of isotopes (absorption and excretion, transfer across membranes) comparator studies (determination of mass, volume or flow), isotope dilution and related studies (in vivo and in vitro applications, determination of total body red cell or plasma volume), dynamic systems (single compartmental systems such as rumen studies and the suckling lamb or calf, multiple exits from a compartment and multiple doses), stable isotopes and mass spectrometry, activation analysis and nuclear magnetic resonance, and the use of internal irradiation (sterile male technique, control of insects and parasites, production of attenuated vaccines etc.). (U.K.)

  18. 75 FR 65565 - Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications...

    Science.gov (United States)

    2010-10-26

    ... 558 [Docket No. FDA-2010-N-0002] Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran AGENCY...) is amending the animal drug regulations by removing those portions that reflect approval of eight new...

  19. Traditional products: Base for the sustainable development of Serbian animal origin products

    Directory of Open Access Journals (Sweden)

    Stevanović Jasna Lj.

    2016-01-01

    Full Text Available Research results on the diversity of traditional products of animal origin from certain areas of the Republic of Serbia, provides an opportunity to become part of the sustainable quality development, which would be based on their promotion and protection of local resources. Traditional products of animal origin are different and inseparable from the local identity, typical for nation and its food culture. Through confidence-building, and protection from oblivion, the value of domestic products, had preserved trough centuries-old tradition. Nowadays, each domestic product has its own recognisable taste, representing climate of the Republic of Serbia, from which it comes. Universally accepted model of rural institutional structure does not exist. Instead it accommodates and develops in accordance to needs, possibilities and area specific characteristics. By the efficient protection rural models becomes an investment incentives and contribute to general economic and industrial prosperity of the society.

  20. 75 FR 24394 - Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of a New Animal Drug...

    Science.gov (United States)

    2010-05-05

    ... [Docket No. FDA-2010-N-0002] Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations by...

  1. Establishment approval in international trade of animal products

    NARCIS (Netherlands)

    Rau, M.L.; Ge, L.; Valeeva, N.I.; Wagenberg, van C.P.A.

    2012-01-01

    This report provides an overview of different approaches of establishment approval as well as its implementation and organisation in international agrifood trade. The focus is on animal products as establishment approval is particularly used for exporting these products. Based on trade data, 8

  2. Marketing Animal-Friendly Products: Addressing the Consumer Social Dilemma with Reinforcement Positioning Strategies.

    Science.gov (United States)

    van Riemsdijk, Lenka; Ingenbleek, Paul T M; van Trijp, Hans C M; van der Veen, Gerrita

    2017-12-14

    This article presents a conceptual framework that aims to encourage consumer animal-friendly product choice by introducing positioning strategies for animal-friendly products. These strategies reinforce the animal welfare with different types of consumption values and can therefore reduce consumers' social dilemma, which is a major barrier to animal-friendly consumer choices. The article suggests how animal-friendly products can use various types of consumption values (functional, sensory, emotional, social, epistemic and situational) to create an attractive position relative to their competitors. It also explains why some consumer segments, such as those with a specific thinking style, may experience a stronger effect of some strategies, giving directions on how to approach different types of consumers. Finally, building on research asserting that animal welfare is a credence product attribute, the article proposes moderating effects of two factors that help consumers to evaluate the credibility of animal welfare claims, namely corporate social responsibility strategy and the role of stakeholders. Here it concludes that companies selling animal-friendly products need to be aware of the impact of their overall strategy on the effectiveness of positioning strategies for individual products and that, to gain consumer trust, they may need to collaborate with relevant stakeholders, such as media or animal-interest organizations.

  3. Marketing Animal-Friendly Products: Addressing the Consumer Social Dilemma with Reinforcement Positioning Strategies

    Directory of Open Access Journals (Sweden)

    Lenka van Riemsdijk

    2017-12-01

    Full Text Available This article presents a conceptual framework that aims to encourage consumer animal-friendly product choice by introducing positioning strategies for animal-friendly products. These strategies reinforce the animal welfare with different types of consumption values and can therefore reduce consumers’ social dilemma, which is a major barrier to animal-friendly consumer choices. The article suggests how animal-friendly products can use various types of consumption values (functional, sensory, emotional, social, epistemic and situational to create an attractive position relative to their competitors. It also explains why some consumer segments, such as those with a specific thinking style, may experience a stronger effect of some strategies, giving directions on how to approach different types of consumers. Finally, building on research asserting that animal welfare is a credence product attribute, the article proposes moderating effects of two factors that help consumers to evaluate the credibility of animal welfare claims, namely corporate social responsibility strategy and the role of stakeholders. Here it concludes that companies selling animal-friendly products need to be aware of the impact of their overall strategy on the effectiveness of positioning strategies for individual products and that, to gain consumer trust, they may need to collaborate with relevant stakeholders, such as media or animal-interest organizations.

  4. Preclinical Science Regarding Cannabinoids as Analgesics: An Overview

    Directory of Open Access Journals (Sweden)

    ME Lynch

    2005-01-01

    Full Text Available Modern pharmacology of cannabinoids began in 1964 with the isolation and partial synthesis of delta-9-tetrahydrocannabinol, the main psychoactive agent in herbal cannabis. Since then, potent antinociceptive and antihyperalgesic effects of cannabinoid agonists in animal models of acute and chronic pain; the presence of cannabinoid receptors in pain-processing areas of the brain, spinal cord and periphery; and evidence supporting endogenous modulation of pain systems by cannabinoids has provided support that cannabinoids exhibit significant potential as analgesics. The present article presents an overview of the preclinical science.

  5. 9 CFR 355.42 - Marking of mule meat and animal food mule meat by-product.

    Science.gov (United States)

    2010-01-01

    ... mule meat by-product. 355.42 Section 355.42 Animals and Animal Products FOOD SAFETY AND INSPECTION... Meat and Animal Food, Mule Meat By-Product § 355.42 Marking of mule meat and animal food mule meat by-product. All mule meat and animal food mule meat by-product inspected under this part shall be marked and...

  6. Animal health in organic livestock production systems: a review

    NARCIS (Netherlands)

    Kijlstra, A.; Eijck, I.A.J.M.

    2006-01-01

    Organic livestock production is a means of food production with a large number of rules directed towards a high status of animal welfare, care for the environment, restricted use of medical drugs and the production of a healthy product without residues (pesticides or medical drugs). The intentions

  7. Drug Development Process

    Science.gov (United States)

    ... Preclinical Research Preclinical Research Drugs undergo laboratory and animal testing to answer basic questions about safety. More Information ... Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products

  8. The development of mixer machine for organic animal feed production: Proposed study

    Science.gov (United States)

    Leman, A. M.; Wahab, R. Abdul; Zakaria, Supaat; Feriyanto, Dafit; Nor, M. I. F. Che Mohd; Muzarpar, Syafiq

    2017-09-01

    Mixer machine plays a major role in producing homogenous composition of animal feed. Long time production, inhomogeneous and minor agglomeration has been observed by existing mixer. Therefore, this paper proposed continuous mixer to enhance mixing efficiency with shorter time of mixing process in order to abbreviate the whole process in animal feed production. Through calculation of torque, torsion, bending, power and energy consumption will perform in mixer machine process. Proposed mixer machine is designed by two layer buckets with purpose for continuity of mixing process. Mixing process was performed by 4 blades which consists of various arm length such as 50, 100,150 and 225 mm in 60 rpm velocity clockwise rotation. Therefore by using this machine will produce the homogenous composition of animal feed through nutrition analysis and short operation time of mixing process approximately of 5 minutes. Therefore, the production of animal feed will suitable for various animals including poultry and aquatic fish. This mixer will available for various organic material in animal feed production. Therefore, this paper will highlights some areas such as continues animal feed supply chain and bio-based animal feed.

  9. A novel semi-automatic snake robot for natural orifice transluminal endoscopic surgery: preclinical tests in animal and human cadaver models (with video).

    Science.gov (United States)

    Son, Jaebum; Cho, Chang Nho; Kim, Kwang Gi; Chang, Tae Young; Jung, Hyunchul; Kim, Sung Chun; Kim, Min-Tae; Yang, Nari; Kim, Tae-Yun; Sohn, Dae Kyung

    2015-06-01

    Natural orifice transluminal endoscopic surgery (NOTES) is an emerging surgical technique. We aimed to design, create, and evaluate a new semi-automatic snake robot for NOTES. The snake robot employs the characteristics of both a manual endoscope and a multi-segment snake robot. This robot is inserted and retracted manually, like a classical endoscope, while its shape is controlled using embedded robot technology. The feasibility of a prototype robot for NOTES was evaluated in animals and human cadavers. The transverse stiffness and maneuverability of the snake robot appeared satisfactory. It could be advanced through the anus as far as the peritoneal cavity without any injury to adjacent organs. Preclinical tests showed that the device could navigate the peritoneal cavity. The snake robot has advantages of high transverse force and intuitive control. This new robot may be clinically superior to conventional tools for transanal NOTES.

  10. Coupling movement and landscape ecology for animal conservation in production landscapes.

    Science.gov (United States)

    Doherty, Tim S; Driscoll, Don A

    2018-01-10

    Habitat conversion in production landscapes is among the greatest threats to biodiversity, not least because it can disrupt animal movement. Using the movement ecology framework, we review animal movement in production landscapes, including areas managed for agriculture and forestry. We consider internal and external drivers of altered animal movement and how this affects navigation and motion capacities and population dynamics. Conventional management approaches in fragmented landscapes focus on promoting connectivity using structural changes in the landscape. However, a movement ecology perspective emphasizes that manipulating the internal motivations or navigation capacity of animals represents untapped opportunities to improve movement and the effectiveness of structural connectivity investments. Integrating movement and landscape ecology opens new opportunities for conservation management in production landscapes. © 2018 The Authors.

  11. Environmental Sustainability Analysis and Nutritional Strategies of Animal Production in China.

    Science.gov (United States)

    Tan, Bie; Yin, Yulong

    2017-02-08

    Animal production in China has achieved considerable progress and contributes to 46% of the total agriculture output value of the country. However, this fast expansion of animal production has led to environmental pollution. In this article, we review the status of soil, water, and air pollution associated with animal production in China and analyze the main sources of the pollutants. The government has promulgated regulations and standards, and effective models and technologies have been developed to control pollution during the last 10 years. Because nutrition and feed strategies represent the most effective method of controlling environmental pollution at the source, this review focuses on nutritional technologies, including accurate feed formulation, rational use of additives, and proper processing of feeds. The advances of modern biotechnology and big data systems also provide more modern approaches to decreasing wastage release. These nutritional strategies are expected to promote sustainable development of animal production.

  12. Animal production and health newsletter. No. 39

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2004-01-01

    In addition to highlights of research coordination meetings, training events and announcements of upcoming events, this issue of the Newsletter carries editorial note regarding the potential of biotechnology in animal health and production for developing countries.

  13. Animal production and health newsletter. No. 39

    International Nuclear Information System (INIS)

    2004-01-01

    In addition to highlights of research coordination meetings, training events and announcements of upcoming events, this issue of the Newsletter carries editorial note regarding the potential of biotechnology in animal health and production for developing countries

  14. The use of tritiated water in evaluating animal production parameters

    International Nuclear Information System (INIS)

    Robertshaw, D.

    1988-01-01

    Tritiated water (TOH) provides a means of measuring a number of parameters of importance not only to the applied animal physiologist but to those involved in assessing animal productivity. For the examination of animal-environment interactions, TOH is an invaluable tool for assessing total body water, water turnover rate and hence water requirements of different types of animals kept under a variety of climatic and other conditions. It can also be useful for measuring water losses, e.g. through evaporation, and hence is a tool for assessing thermal stress. For animal productivity studies, TOH is useful for assessing such parameters as carcass composition, the intake of forages, supplements and milk. Each of these aspects is described as are the assumptions which have to be made when using TOH for the measurements concerned. (author). 11 refs, 1 tab

  15. Animal behaviour and animal nutrition science working together to support livestock production

    NARCIS (Netherlands)

    Edwards, S.A.; Spoolder, H.A.M.

    2016-01-01

    Within livestock production and welfare science, many of the interesting and important questions lie at the interface of traditional fields of study and benefit from an interdisciplinary approach. The effects of nutrition on the behaviour of animals have been widely studied. They range from the

  16. Sustainability of animal production systems: an ecological perspective.

    Science.gov (United States)

    Vavra, M

    1996-06-01

    The question of sustainability of agricultural production and the use of natural resources has become a popular topic. Most scientists agree that current systems are generally non-sustainable. Current rates of resource extraction will lead us to a depleted earth in the future. Sustainability is defined in many ways. For this paper sustainability should be considered the overlap of what is wanted and what is ecologically possible. Attempts have been made to place a quantitative measure on sustainability. However, it should be considered a trajectory or goal, a direction that guides constructive change, rather than a single quantitative measure. Research and extension personnel may have to take a broader look at their efforts and expand their knowledge base in order to address the issue of sustainable production systems. Both natural events and those caused by humans bring about changes in production potential that require shifts in management. Uncertainty and change should be incorporated into adaptive management strategies. Interdisciplinary efforts are needed to confront these issues. Animal scientists need to formulate management systems that are environmentally compatible or face restrictive legislation that will force change. Members of the American Society of Animal Science seem to agree: efficient and sustainable use of natural resources appears in the draft of the Strategic Plan of the Society, and a poll of members revealed that environmental concerns about animal agriculture was a primary issue facing animal scientists.

  17. Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies.

    Science.gov (United States)

    Versteegden, Luuk R M; de Jonge, Paul K J D; IntHout, Joanna; van Kuppevelt, Toin H; Oosterwijk, Egbert; Feitz, Wout F J; de Vries, Rob B M; Daamen, Willeke F

    2017-10-01

    Urethra repair by tissue engineering has been extensively studied in laboratory animals and patients, but is not routinely used in clinical practice. To systematically investigate preclinical and clinical evidence of the efficacy of tissue engineering for urethra repair in order to stimulate translation of preclinical studies to the clinic. A systematic search strategy was applied in PubMed and EMBASE. Studies were independently screened for relevance by two reviewers, resulting in 80 preclinical and 23 clinical studies of which 63 and 13 were selected for meta-analysis to assess side effects, functionality, and study completion. Analyses for preclinical and clinical studies were performed separately. Full circumferential and inlay procedures were assessed independently. Evaluated parameters included seeding of cells and type of biomaterial. Meta-analysis revealed that cell seeding significantly reduced the probability of encountering side effects in preclinical studies. Remarkably though, cells were only sparsely used in the clinic (4/23 studies) and showed no significant reduction of side effects. ln 21 out of 23 clinical studies, decellularized templates were used, while in preclinical studies other biomaterials showed promising outcomes as well. No direct comparison to current clinical practice could be made due to the limited number of randomized controlled studies. Due to a lack of controlled (pre)clinical studies, the efficacy of tissue engineering for urethra repair could not be determined. Meta-analysis outcome measures were similar to current treatment options described in literature. Surprisingly, it appeared that favorable preclinical results, that is inclusion of cells, were not translated to the clinic. Improved (pre)clinical study designs may enhance clinical translation. We reviewed all available literature on urethral tissue engineering to assess the efficacy in preclinical and clinical studies. We show that improvements to (pre)clinical study

  18. A Flexible, Preclinical, Medical School Curriculum Increases Student Academic Productivity and the Desire to Conduct Future Research

    Science.gov (United States)

    Peacock, Justin G.; Grande, Joseph P.

    2015-01-01

    In 2006, small blocks of flexible curriculum time, termed selectives, were implemented in the Mayo Medical School preclinical curriculum. Selectives permitted students to pursue professional endeavors, such as research, service, and career exploration, in the preclinical years. The purpose of this study was to survey current and former Mayo…

  19. Animal Production and Health Newsletter, No. 56, July 2012

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2012-07-15

    The first six months of this year have been a busy time for all personnel in the sub-programme. Apart from our regular Co-ordinated Research Project (CRP) activities and our technical support given to on-going national and regional Technical Co-operation (TC) projects, we were also involved in the initiation (together with TC country officers) of the 2014/15 biennial TC project cycle. In addition to this, when carrying out our 2010/11 end of cycle programmatic performance evaluations, we could identify the areas where good performance was achieved as well as areas where further improvements are needed. It is hoped that our inputs will serve the best interests of our Member States for the present programme cycle 2012-2013. In response to many requests from our readers, I have decided to give a brief overview of our Subprogramme as background to the upcoming 'Scientific Forum' (Food for the Future: Meeting the Challenges with Nuclear Applications) that will take place during he IAEA General Conference in September 2012. The focus of the Animal production and Health Subprogramme activities is on enhancing food security by supporting sustainable livestock production systems in developing countries. This is to be achieved by strategic and applied research, technology transfer and capacity building. The three principal components of the sub-programme are animal nutrition, animal reproduction and breeding and animal health. Problems are identified and solutions developed through the use of strategically applied nuclear-based tools, in conjunction with conventional technologies to: - Characterize and optimally utilize locally available feed and feed resources to enhance maximum energy conversion, whilst minimizing methane and CO2 emissions; - Increase animal production through the characterization of livestock genetic make-up to drive the integration of locally adapted animal breeds with trait selected exotic breeds to satisfy the increasing demand for 'more and of better

  20. Animal Production and Health Newsletter, No. 56, July 2012

    International Nuclear Information System (INIS)

    2012-07-01

    The first six months of this year have been a busy time for all personnel in the sub-programme. Apart from our regular Co-ordinated Research Project (CRP) activities and our technical support given to on-going national and regional Technical Co-operation (TC) projects, we were also involved in the initiation (together with TC country officers) of the 2014/15 biennial TC project cycle. In addition to this, when carrying out our 2010/11 end of cycle programmatic performance evaluations, we could identify the areas where good performance was achieved as well as areas where further improvements are needed. It is hoped that our inputs will serve the best interests of our Member States for the present programme cycle 2012-2013. In response to many requests from our readers, I have decided to give a brief overview of our Subprogramme as background to the upcoming 'Scientific Forum' (Food for the Future: Meeting the Challenges with Nuclear Applications) that will take place during he IAEA General Conference in September 2012. The focus of the Animal production and Health Subprogramme activities is on enhancing food security by supporting sustainable livestock production systems in developing countries. This is to be achieved by strategic and applied research, technology transfer and capacity building. The three principal components of the sub-programme are animal nutrition, animal reproduction and breeding and animal health. Problems are identified and solutions developed through the use of strategically applied nuclear-based tools, in conjunction with conventional technologies to: - Characterize and optimally utilize locally available feed and feed resources to enhance maximum energy conversion, whilst minimizing methane and CO2 emissions; - Increase animal production through the characterization of livestock genetic make-up to drive the integration of locally adapted animal breeds with trait selected exotic breeds to satisfy the increasing demand for 'more and of better

  1. ECONOMIC UNITY OF PRODUCTION AND TRADE OF SLAUGHTER ANIMALS AND MEAT (PATHS OF INITIATION OF LONG TERM SOLUTIONS IN CROATIAN ANIMAL BREEDING

    Directory of Open Access Journals (Sweden)

    Krsto Benčević

    2000-06-01

    Full Text Available For starting a long term programmes in Croatian animal production, formation of "economic unities" is necessary. Presentation and explanation of production and trade unity for animal production and marketing with subjects and phases is given here. It is pointed out that production of slaughter animals and meat is key interest of market and economic policy as well as of development of agricultural country. It seems that production and trade of meat in Croatia is not organized enough in overall market competition and in meat processing. Creating the economic unity of production and trade of slaughter animals can help in relative fast and efficient solving of problems accumulated in agriculture, especialy in meat production (PIK Vrbovec, Danica, Bejle etc. For initiating and getting in function the phases of production and trade of slaughter animals and meat, proper legislation should be introduced. This legislation should comprehencively define the idea of agricultural economy as a subject of legislative and normisation acts for overall, process and market oriented functioning of multidisciplinary agricultural systems. Additionaly, law on trade of slaughter animals, meat and agricultural products should be introduced in order to form a market and determine the share and obligations of certain participants in structure of such market.

  2. The basics of preclinical drug development for neurodegenerative disease indications.

    Science.gov (United States)

    Steinmetz, Karen L; Spack, Edward G

    2009-06-12

    Preclinical development encompasses the activities that link drug discovery in the laboratory to initiation of human clinical trials. Preclinical studies can be designed to identify a lead candidate from several hits; develop the best procedure for new drug scale-up; select the best formulation; determine the route, frequency, and duration of exposure; and ultimately support the intended clinical trial design. The details of each preclinical development package can vary, but all have some common features. Rodent and nonrodent mammalian models are used to delineate the pharmacokinetic profile and general safety, as well as to identify toxicity patterns. One or more species may be used to determine the drug's mean residence time in the body, which depends on inherent absorption, distribution, metabolism, and excretion properties. For drugs intended to treat Alzheimer's disease or other brain-targeted diseases, the ability of a drug to cross the blood brain barrier may be a key issue. Toxicology and safety studies identify potential target organs for adverse effects and define the Therapeutic Index to set the initial starting doses in clinical trials. Pivotal preclinical safety studies generally require regulatory oversight as defined by US Food and Drug Administration (FDA) Good Laboratory Practices and international guidelines, including the International Conference on Harmonization. Concurrent preclinical development activities include developing the Clinical Plan and preparing the new drug product, including the associated documentation to meet stringent FDA Good Manufacturing Practices regulatory guidelines. A wide range of commercial and government contract options are available for investigators seeking to advance their candidate(s). Government programs such as the Small Business Innovative Research and Small Business Technology Transfer grants and the National Institutes of Health Rapid Access to Interventional Development Pilot Program provide funding and

  3. Prudent Use of Veterinary Drugs: Impact on Safe Animal Products ...

    African Journals Online (AJOL)

    Like any other therapeutic compounds, veterinary drugs are used to alleviate diseases in animals as either therapeutic or prophylactic compounds for specific disease entities. They can also be used as production aids in food producing animals to increase market sale of these animals whereby the producers save on the ...

  4. Effects of Amendment of Agricultural Bye Products with Animal ...

    African Journals Online (AJOL)

    Effects of Amendment of Agricultural Bye Products with Animal Manures on Soil ... Discovery and Innovation ... Open Access DOWNLOAD FULL TEXT ... into the effectiveness of locally available agricultural by-products as source of nutrient.

  5. Brazilian Citizens’ Opinions and Attitudes about Farm Animal Production Systems

    Directory of Open Access Journals (Sweden)

    Maria C. Yunes

    2017-09-01

    Full Text Available The inclusion of societal input is needed for food animal production industries to retain their “social license to operate”; failure to engage with the public on this topic risks the long-term sustainability of these industries. The primary aim of this study was to explore the beliefs and attitudes of Brazilians citizens not associated with livestock production towards farm animal production. A related secondary aim was to identify the specific beliefs and attitudes towards systems that are associated with restriction of movement. Each participant was shown pictures representing two of five possible major food animal industries (laying hens, beef cattle, pregnant sows, lactating sows, and poultry meat. Participants were presented a six pages survey that included demographic questions plus two sets of two pictures and a series of questions pertaining to the pictures. Each set of pictures represented a particular industry where one picture represented a housing type that is associated with behavioural restrictions and the other picture represented a system that allowed for a greater degree of movement. Participants were asked their perceptions on the prevalence of each system in Brazil, then their preference of one picture vs. the other, and the reasons justifying their preference. Immediately following, the participant repeated the same exercise with the second set of two pictures representing another industry followed by the same series of questions as described above. Quantitative data were analysed with mixed effects logistic regression, and qualitative responses were coded into themes. The proportion of participants that believed animals are reared in confinement varied by animal production type: 23% (beef cattle, 82% (poultry, 81% (laying hens, and 60% (swine. A large majority (79% stated that farm animals are not well-treated in Brazil. Overall, participants preferred systems that were not associated with behavioural restriction. The

  6. Biological basis of sex differences in drug abuse: preclinical and clinical studies.

    Science.gov (United States)

    Lynch, Wendy J; Roth, Megan E; Carroll, Marilyn E

    2002-11-01

    The recent focus on drug abuse in women has brought attention to numerous differences between women and men. In this review, we discuss both preclinical and clinical findings of sex differences in drug abuse as well as mechanisms that may underlie these differences. Recent evidence suggests that the progression to dependence and abuse may differ between women and men; thus, different prevention and treatment strategies may be required. Similar sex differences in drug sensitivity and self-administration have been reported in laboratory animal studies. Females appear to be more vulnerable than males to the reinforcing effects of psychostimulants, opiates, and nicotine during many phases of the addiction process (e.g. acquisition, maintenance, dysregulation-escalation, relapse). Male and female animals differ in their behavioral, neurological, and pharmacological responses to drugs. Although the role of sex in the mechanisms of drug action remains unclear, preclinical and clinical studies indicate that ovarian hormones, particularly estrogen, play a role in producing sex differences in drug abuse. Future research is necessary to provide information on how to design more effective drug abuse treatment programs and resources that are sex specific.

  7. Precise image-guided irradiation of small animals: a flexible non-profit platform

    International Nuclear Information System (INIS)

    Tillner, Falk; Thute, Prasad; Löck, Steffen; Dietrich, Antje; Fursov, Andriy; Haase, Robert; Lukas, Mathias; Krause, Mechthild; Baumann, Michael; Bütof, Rebecca; Enghardt, Wolfgang; Rimarzig, Bernd; Sobiella, Manfred

    2016-01-01

    Preclinical in vivo studies using small animals are essential to develop new therapeutic options in radiation oncology. Of particular interest are orthotopic tumour models, which better reflect the clinical situation in terms of growth patterns and microenvironmental parameters of the tumour as well as the interplay of tumours with the surrounding normal tissues. Such orthotopic models increase the technical demands and the complexity of preclinical studies as local irradiation with therapeutically relevant doses requires image-guided target localisation and accurate beam application. Moreover, advanced imaging techniques are needed for monitoring treatment outcome. We present a novel small animal image-guided radiation therapy (SAIGRT) system, which allows for precise and accurate, conformal irradiation and x-ray imaging of small animals. High accuracy is achieved by its robust construction, the precise movement of its components and a fast high-resolution flat-panel detector. Field forming and x-ray imaging is accomplished close to the animal resulting in a small penumbra and a high image quality. Feasibility for irradiating orthotopic models has been proven using lung tumour and glioblastoma models in mice. The SAIGRT system provides a flexible, non-profit academic research platform which can be adapted to specific experimental needs and therefore enables systematic preclinical trials in multicentre research networks. (paper)

  8. Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach.

    Science.gov (United States)

    Lekic, Tim; Klebe, Damon; Pichon, Pilar; Brankov, Katarina; Sultan, Sally; McBride, Devin; Casel, Darlene; Al-Bayati, Alhamza; Ding, Yan; Tang, Jiping; Zhang, John H

    2017-01-01

    Germinal matrix hemorrhage is a leading cause of mortality and morbidity from prematurity. This brain region is vulnerable to bleeding and re-bleeding within the first 72 hours of preterm life. Cerebroventricular expansion of blood products contributes to the mechanisms of brain injury. Consequences include lifelong hydrocephalus, cerebral palsy, and intellectual disability. Unfortunately little is known about the therapeutic needs of this patient population. This review discusses the mechanisms of germinal matrix hemorrhage, the animal models utilized, and the potential therapeutic targets. Potential therapeutic approaches identified in pre-clinical investigations include corticosteroid therapy, iron chelator administration, and transforming growth factor-β pathway modulation, which all warrant further investigation. Thus, effective preclinical modeling is essential for elucidating and evaluating novel therapeutic approaches, ahead of clinical consideration. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

  9. Impacts of prenatal nutrition on animal production and performance

    DEFF Research Database (Denmark)

    Khanal, Prabhat; Nielsen, Mette Olaf

    2017-01-01

    The concept of foetal programming (FP) originated from human epidemiological studies, where foetal life nutrition was linked to health and disease status later in life. Since the proposal of this phenomenon, it has been evaluated in various animal models to gain further insights into the mechanisms...... programming in animals born precocial, such as sheep. Appropriate attention to the nutrition of the late pregnant dam should therefore be a priority in animal production systems....

  10. Affective Biases in Humans and Animals.

    Science.gov (United States)

    Robinson, E S J; Roiser, J P

    Depression is one of the most common but poorly understood psychiatric conditions. Although drug treatments and psychological therapies are effective in some patients, many do not achieve full remission and some patients receive no apparent benefit. Developing new improved treatments requires a better understanding of the aetiology of symptoms and evaluation of novel therapeutic targets in pre-clinical studies. Recent developments in our understanding of the basic cognitive processes that may contribute to the development of depression and its treatment offer new opportunities for both clinical and pre-clinical research. This chapter discusses the clinical evidence supporting a cognitive neuropsychological model of depression and antidepressant efficacy, and how this information may be usefully translated to pre-clinical investigation. Studies using neuropsychological tests in depressed patients and at risk populations have revealed basic negative emotional biases and disrupted reward and punishment processing, which may also impact on non-affective cognition. These affective biases are sensitive to antidepressant treatments with early onset effects observed, suggesting an important role in recovery. This clinical work into affective biases has also facilitated back-translation to animals and the development of assays to study affective biases in rodents. These animal studies suggest that, similar to humans, rodents in putative negative affective states exhibit negative affective biases on decision-making and memory tasks. Antidepressant treatments also induce positive biases in these rodent tasks, supporting the translational validity of this approach. Although still in the early stages of development and validation, affective biases in depression have the potential to offer new insights into the clinical condition, as well as facilitating the development of more translational approaches for pre-clinical studies.

  11. Tissue Engineering of the Urethra: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies

    NARCIS (Netherlands)

    Versteegden, L.R.; Jonge, P. de; Hout, J. in't; Kuppevelt, T.H. van; Oosterwijk, E.; Feitz, W.F.J.; Vries, R.B.M. de; Daamen, W.F.

    2017-01-01

    CONTEXT: Urethra repair by tissue engineering has been extensively studied in laboratory animals and patients, but is not routinely used in clinical practice. OBJECTIVE: To systematically investigate preclinical and clinical evidence of the efficacy of tissue engineering for urethra repair in order

  12. A metabolic derivation of tritium transfer factors in animal products

    International Nuclear Information System (INIS)

    Galeriu, D.; Melintescu, A.; Crout, N. M. J.; Bersford, N. A.; Peterson, S. R.; Hess, M. van

    2001-01-01

    Tritium is a potentially important environmental contaminant arising from the nuclear industry. Because tritium is an isotope of hydrogen, its behaviour in the environment is controlled by the behaviour of hydrogen. Chronic releases of tritium to the atmosphere, in particular, will result in tritium-to-hydrogen (T/H) ratios in plants and animals that are more or less in equilibrium with T/H ratios in the air moisture. Tritium is thus a potentially important contaminant of plant and animal food products. The transfer of tritium from air moisture to plants is quite well understood. In contrast, although a number of regulatory agencies have published transfer coefficient values for diet tritium transfer for a limited number of animal products, a fresh evaluation of these transfers needs to be made In this paper we present an approach for the derivation of tritium transfer coefficients which is based on the metabolism of hydrogen in animals in conjunction with experimental data on tritium transfer. The derived transfer coefficients separately account for transfer to and from free (i.e. water) and organically bound tritium. The predicted transfer coefficients are compared to available data independent of model development. Agreement is good, with the exception of the transfer coefficient for transfer from tritiated water to organically bound tritium in ruminants, which may be attributable to the particular characteristics of ruminant digestion. We show that transfer coefficients will vary in response to the metabolic status of an animal (e.g. stage of lactation, digestibility of diet, etc.) and that the use of a single transfer coefficient from diet to animal product is not appropriate for tritium. It is possible to derive concentration ratio values which relate the concentration of tritiated water and organically bound tritium in an animal product to the corresponding concentrations in the animals diet. These concentration ratios are shown to be less subject to

  13. Animal Production and Health Newsletter, No. 63, January 2016

    International Nuclear Information System (INIS)

    2016-01-01

    This past year went particularly fast with many unexpected and emergency food security challenges and it was indeed an asking period for the Animal Production and Health Subprogramme. We have some remarkable achievements but also some gaps, such as improved communication and collaboration, where we need to improve our support to Member States. Both past and future activities are described in detail in this newsletter. The Animal Production and Health Subprogramme will continue to move progressively forward and in pace with developments within the livestock field to optimally serve our Member States

  14. [Animal experimentation in the discovery and production of veterinary vaccines].

    Science.gov (United States)

    Audonnet, J Ch; Lechenet, J; Verschuere, B

    2007-08-01

    Veterinary vaccine research, development and production facilities must aim to improve animal welfare, respond to public concerns and meet regulatory requirements, while at the same time fulfilling their objective of producing evermore effective and safer vaccines. The use of animal experimentation for the development of new veterinary vaccines is inevitable, as no in vitro model can predict a candidate vaccine's ability to induce protection in the target species. Against the backdrop of ethical and regulatory constraints, constant progress is being made in creating the best possible conditions for animal experimentation. Keeping up to date with the constant changes in the field of animal ethics requires a particular effort on the part of the pharmaceutical industry, which must make careful changes to product registration documentation in accordance with each new development.

  15. 78 FR 70307 - Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy...

    Science.gov (United States)

    2013-11-25

    ...] Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products... Assessment of Investigational Cellular and Gene Therapy Products'' dated November 2013. The guidance document... products reviewed by the Office of Cellular, Tissue and Gene Therapies (OCTGT). The product areas covered...

  16. Gas transport during in vitro and in vivo preclinical testing of inert gas therapies

    Directory of Open Access Journals (Sweden)

    Ira Katz

    2016-01-01

    Full Text Available New gas therapies using inert gases such as xenon and argon are being studied, which require in vitro and in vivo preclinical experiments. Examples of the kinetics of gas transport during such experiments are analyzed in this paper. Using analytical and numerical models, we analyze an in vitro experiment for gas transport to a 96 cell well plate and an in vivo delivery to a small animal chamber, where the key processes considered are the wash-in of test gas into an apparatus dead volume, the diffusion of test gas through the liquid media in a well of a cell test plate, and the pharmacokinetics in a rat. In the case of small animals in a chamber, the key variable controlling the kinetics is the chamber wash-in time constant that is a function of the chamber volume and the gas flow rate. For cells covered by a liquid media the diffusion of gas through the liquid media is the dominant mechanism, such that liquid depth and the gas diffusion constant are the key parameters. The key message from these analyses is that the transport of gas during preclinical experiments can be important in determining the true dose as experienced at the site of action in an animal or to a cell.

  17. Principles of optimizing animal production from rangeland

    International Nuclear Information System (INIS)

    Stubbendieck, J.; Waller, S.S.

    1983-01-01

    Increasing world population is one of the dominant factors escalating demands for the world's natural resources. Range and forage resources, which are used primarily for food and fibre, could be more efficiently used if management techniques were improved. The principles of managing forage resources are directly associated with both the growth and development of plants and the actions and needs of the grazing animal. An understanding of the effects of environmental factors and herbage removal (frequency, intensity and season of defoliation) on growth and regrowth of plants is the first step towards optimizing animal productivity from rangelands. Most potential changes will fit into three categories: (1) increase the quantity of forage, (2) improve the quality of forage, and (3) improve use of forage. The principles of grazing management can be separated into four intricately related categories: (1) proper degree of grazing, (2) proper season of grazing, (3) proper kind of livestock, and (4) proper distribution of grazing. Grazing management is affected by the manner in which both improvements and manipulation of vegetation affect forage yield and quality. The adaptation and application of existing knowledge to individual locations will be one step towards optimizing animal production from rangeland. Some of the problems may be solved through better dissemination of present knowledge through existing educational programmes, while others will require expanded programmes of information dissemination. A third group of problems may also be solved with present technology, but the solutions are not currently economical. Some of the problems will be solved only through expanded research. These research efforts need to be directed towards grazing or browsing animals, plant resources and the interaction between plants and animals. Application of nuclear techniques will be an integral part of this research. (author)

  18. Review of SPECT collimator selection, optimization, and fabrication for clinical and preclinical imaging

    Energy Technology Data Exchange (ETDEWEB)

    Van Audenhaege, Karen, E-mail: karen.vanaudenhaege@ugent.be; Van Holen, Roel; Vandenberghe, Stefaan; Vanhove, Christian [Department of Electronics and Information Systems, MEDISIP-IBiTech, Ghent University–iMinds Medical IT, De Pintelaan 185 block B/5, Ghent B-9000 (Belgium); Metzler, Scott D. [Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 (United States); Moore, Stephen C. [Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115 (United States)

    2015-08-15

    In single photon emission computed tomography, the choice of the collimator has a major impact on the sensitivity and resolution of the system. Traditional parallel-hole and fan-beam collimators used in clinical practice, for example, have a relatively poor sensitivity and subcentimeter spatial resolution, while in small-animal imaging, pinhole collimators are used to obtain submillimeter resolution and multiple pinholes are often combined to increase sensitivity. This paper reviews methods for production, sensitivity maximization, and task-based optimization of collimation for both clinical and preclinical imaging applications. New opportunities for improved collimation are now arising primarily because of (i) new collimator-production techniques and (ii) detectors with improved intrinsic spatial resolution that have recently become available. These new technologies are expected to impact the design of collimators in the future. The authors also discuss concepts like septal penetration, high-resolution applications, multiplexing, sampling completeness, and adaptive systems, and the authors conclude with an example of an optimization study for a parallel-hole, fan-beam, cone-beam, and multiple-pinhole collimator for different applications.

  19. New Breed of Mice May Improve Accuracy for Preclinical Testing of Cancer Drugs | Poster

    Science.gov (United States)

    A new breed of lab animals, dubbed “glowing head mice,” may do a better job than conventional mice in predicting the success of experimental cancer drugs—while also helping to meet an urgent need for more realistic preclinical animal models. The mice were developed to tolerate often-used light-emitting molecules, such as luciferase from fireflies and green fluorescent protein (GFP) from jellyfish. These “optical reporters” are useful for monitoring the effect of experimental therapies in live animals over time because they emit an immediate and easily detected light signal showing whether a tumor inside the animal’s body is shrinking as desired.

  20. Alcohol, psychomotor-stimulants and behaviour: methodological considerations in preclinical models of early-life stress.

    Science.gov (United States)

    McDonnell-Dowling, Kate; Miczek, Klaus A

    2018-04-01

    In order to assess the risk associated with early-life stress, there has been an increase in the amount of preclinical studies investigating early-life stress. There are many challenges associated with investigating early-life stress in animal models and ensuring that such models are appropriate and clinically relevant. The purpose of this review is to highlight the methodological considerations in the design of preclinical studies investigating the effects of early-life stress on alcohol and psychomotor-stimulant intake and behaviour. The protocols employed for exploring early-life stress were investigated and summarised. Experimental variables include animals, stress models, and endpoints employed. The findings in this paper suggest that there is little consistency among these studies and so the interpretation of these results may not be as clinically relevant as previously thought. The standardisation of these simple stress procedures means that results will be more comparable between studies and that results generated will give us a more robust understanding of what can and may be happening in the human and veterinary clinic.

  1. FAO/IAEA international symposium on sustainable improvement of animal production and health. Synopses

    International Nuclear Information System (INIS)

    2009-01-01

    The on-going 'Livestock Revolution', a demand-driven increase in livestock production, especially in developing countries, presents both opportunities and risks. The shift in the human diet from plant-based protein sources to animal-based protein sources, consumer demand for safe and quality animal products, and expanding markets for livestock products have raised several challenges such as; cost-effective production of safe and quality animal products, control of emerging and zoonotic diseases, and efficient management of impact of livestock on the environment. However, these changes have also provided many opportunities to benefit the local economy and producers, and reduce poverty. New challenges and opportunities demand innovative ideas and approaches, and mechanisms to take this knowledge to potential users. Many of the approaches will be multidisciplinary in nature and require collaboration with specialists in areas other than animal scientists. Livestock production in developing countries is constrained by low genetic potential of animals, poor nutrition, poor husbandry and infectious diseases. Nuclear techniques, when applied in conjunction with conventional methods, can identify critical points in these areas that can be targeted for cost-effective improvements and interventions. Thus the challenge is to use such technologies to enhance food security and alleviate poverty by supporting sustainable livestock production systems in developing countries through strategic and applied research, technology transfer and capacity building. Topics addressed at the symposium: - Interactions among nutrition, reproduction and genotype; - Livestock-environment interaction / productivity/ climate (water/ land/ plants/heat/ altitude); - Detection and control of transboundary animal diseases, including zoonoses; - Animal product safety and food quality. Each of the papers published in this book of synopses has been indexed separately

  2. Animal research ethics in Africa: is Tanzania making progress?

    Science.gov (United States)

    Seth, Misago; Saguti, Fredy

    2013-12-01

    The significance of animals in research cannot be over-emphasized. The use of animals for research and training in research centres, hospitals and schools is progressively increasing. Advances in biotechnology to improve animal productivity require animal research. Drugs being developed and new interventions or therapies being invented for cure and palliation of all sorts of animal diseases and conditions need to be tested in animals for their safety and efficacy at some stages of their development. Drugs and interventions for human use pass through a similar development process and must be tested pre-clinically in laboratory animals before clinical trials in humans can be conducted. Therefore, animals are important players in research processes which directly and indirectly benefit animals and humans. However, questions remain as to whether these uses of animals consider the best interests of animals themselves. Various research and training institutions in Tanzania have established some guidelines on animal use, including establishing animal ethics committees. However, most institutions have not established oversight committees. In institutions where there may be guidelines and policies, there are no responsible committees or units to directly oversee if and how these guidelines and policies are enforced; thus, implementation becomes difficult or impossible. This paper endeavours to raise some issues associated with the responsible use of animals in research and training in Tanzania and highlights suggestions for improvement of deficiencies that exist in order to bridge the gap between what ought to be practised and what is practised. © 2012 John Wiley & Sons Ltd.

  3. Agency perspectives on food safety for the products of animal biotechnology.

    Science.gov (United States)

    Howard, H J; Jones, K M; Rudenko, L

    2012-08-01

    Animal biotechnology represents one subset of tools among a larger set of technologies for potential use to meet increasing world demands for food. Assisted reproductive technologies (ART) such as artificial insemination and embryo transfer continue to make positive contributions in food animal production. The US Food and Drug Administration (FDA) performed a comprehensive risk assessment to identify potential food consumption or animal health risks associated with animal cloning, an emerging ART. At that time, FDA concluded that animal cloning posed no unique risks either to animal health or to food consumption, and food from animal clones and their sexually reproduced offspring required no additional federal regulation beyond that applicable to conventionally bred animals of the species examined. At this time, no new information has arisen that would necessitate a change in FDA's conclusions on food from animal clones or their sexually reproduced offspring. Use of recombinant DNA technologies to produce genetically engineered (GE) animals represents another emerging technology with potential to impact food animal production. In its regulation of GE animals, FDA follows a cumulative, risk-based approach to address scientific questions related to the GE animals. FDA evaluates data and information on the safety, effectiveness and stability of the GE event. FDA carries out its review at several levels (e.g. molecular biology, animal safety, food safety, environmental safety and claim validation). GE animal sponsors provide data to address risk questions for each level. This manuscript discusses FDA's role in evaluation of animal cloning and GE animals. © 2012 Blackwell Verlag GmbH.

  4. EGFR-targeted anti-cancer drugs in radiotherapy: Preclinical evaluation of mechanisms

    International Nuclear Information System (INIS)

    Baumann, Michael; Krause, Mechthild; Dikomey, Ekkehard; Dittmann, Klaus; Doerr, Wolfgang; Kasten-Pisula, Ulla; Rodemann, H. Peter

    2007-01-01

    Preclinical and clinical results indicate that the EGFR can mediate radioresistance in different solid human tumours. Combination of radiotherapy and EGFR inhibitors can improve local tumour control compared to irradiation alone and has been introduced into clinical radiotherapy practice. So far several mechanisms have been identified in preclinical studies to contribute to improved local tumour control after radiation combined with EGFR inhibitors. These include direct kill of cancer stem cells by EGFR inhibitors, cellular radiosensitization through modified signal transduction, inhibition of repair of DNA damage, reduced repopulation and improved reoxygenation during fractionated radiotherapy. Effects and mechanisms may differ for different classes of EGFR inhibitors, for different tumours and for normal tissues. The mechanisms underlying this heterogeneity are currently poorly understood, and predictive assays are not available yet. Importantly, mechanisms and predictors for the combined effects of radiation with EGFR inhibitors appear to be considerably different to those for application of EGFR inhibitors alone or in combination with chemotherapy. Therefore to further evaluate the efficacy and mechanisms of EGFR-inhibition in combined treatments, radiotherapy-specific preclinical research strategies, which include in vivo experiments using local tumour control as an endpoint, as well as animal studies on normal tissue toxicity are needed

  5. Reducing the number of laboratory animals used in tissue engineering research by restricting the variety of animal models. Articular cartilage tissue engineering as a case study.

    Science.gov (United States)

    de Vries, Rob B M; Buma, Pieter; Leenaars, Marlies; Ritskes-Hoitinga, Merel; Gordijn, Bert

    2012-12-01

    The use of laboratory animals in tissue engineering research is an important underexposed ethical issue. Several ethical questions may be raised about this use of animals. This article focuses on the possibilities of reducing the number of animals used. Given that there is considerable debate about the adequacy of the current animal models in tissue engineering research, we investigate whether it is possible to reduce the number of laboratory animals by selecting and using only those models that have greatest predictive value for future clinical application of the tissue engineered product. The field of articular cartilage tissue engineering is used as a case study. Based on a study of the scientific literature and interviews with leading experts in the field, an overview is provided of the animal models used and the advantages and disadvantages of each model, particularly in terms of extrapolation to the human situation. Starting from this overview, it is shown that, by skipping the small models and using only one large preclinical model, it is indeed possible to restrict the number of animal models, thereby reducing the number of laboratory animals used. Moreover, it is argued that the selection of animal models should become more evidence based and that researchers should seize more opportunities to choose or create characteristics in the animal models that increase their predictive value.

  6. 78 FR 75570 - Guidance for Industry on New Animal Drugs and New Animal Drug Combination Products Administered...

    Science.gov (United States)

    2013-12-12

    ... Guidance for Industry (GFI) 209, ``The Judicious Use of Medically Important Antimicrobial Drugs in Food... of certain antimicrobial new animal drug products who are interested in revising conditions of use... Medically Important Antimicrobial Drugs in Food-Producing Animals,'' and to set timelines for stakeholders...

  7. A systematic review of methodology applied during preclinical anesthetic neurotoxicity studies: important issues and lessons relevant to the design of future clinical research.

    Science.gov (United States)

    Disma, Nicola; Mondardini, Maria C; Terrando, Niccolò; Absalom, Anthony R; Bilotta, Federico

    2016-01-01

    Preclinical evidence suggests that anesthetic agents harm the developing brain thereby causing long-term neurocognitive impairments. It is not clear if these findings apply to humans, and retrospective epidemiological studies thus far have failed to show definitive evidence that anesthetic agents are harmful to the developing human brain. The aim of this systematic review was to summarize the preclinical studies published over the past decade, with a focus on methodological issues, to facilitate the comparison between different preclinical studies and inform better design of future trials. The literature search identified 941 articles related to the topic of neurotoxicity. As the primary aim of this systematic review was to compare methodologies applied in animal studies to inform future trials, we excluded a priori all articles focused on putative mechanism of neurotoxicity and the neuroprotective agents. Forty-seven preclinical studies were finally included in this review. Methods used in these studies were highly heterogeneous-animals were exposed to anesthetic agents at different developmental stages, in various doses and in various combinations with other drugs, and overall showed diverse toxicity profiles. Physiological monitoring and maintenance of physiological homeostasis was variable and the use of cognitive tests was generally limited to assessment of specific brain areas, with restricted translational relevance to humans. Comparison between studies is thus complicated by this heterogeneous methodology and the relevance of the combined body of literature to humans remains uncertain. Future preclinical studies should use better standardized methodologies to facilitate transferability of findings from preclinical into clinical science. © 2015 John Wiley & Sons Ltd.

  8. Applications of gene-based technologies for improving animal production and health in developing countries

    International Nuclear Information System (INIS)

    Makkar, H.P.S.; Viljoen, G.J.

    2005-01-01

    This book provides a compilation of peer-reviewed scientific contributions from authoritative researchers attending an international symposium convened by the Animal Production and Health Sub-programme of the Animal Production and Health (APH), Joint FAO/IAEA Programme in cooperation with the Animal Production and Health Division of the FAO. These Proceedings contain invaluable information on the role and future potential of gene-based technologies for improving animal production and health, possible applications and constraints in the use of this technology in developing countries and their specific research needs

  9. The basics of preclinical drug development for neurodegenerative disease indications

    Directory of Open Access Journals (Sweden)

    Spack Edward G

    2009-06-01

    Full Text Available Abstract Preclinical development encompasses the activities that link drug discovery in the laboratory to initiation of human clinical trials. Preclinical studies can be designed to identify a lead candidate from several hits; develop the best procedure for new drug scale-up; select the best formulation; determine the route, frequency, and duration of exposure; and ultimately support the intended clinical trial design. The details of each preclinical development package can vary, but all have some common features. Rodent and nonrodent mammalian models are used to delineate the pharmacokinetic profile and general safety, as well as to identify toxicity patterns. One or more species may be used to determine the drug's mean residence time in the body, which depends on inherent absorption, distribution, metabolism, and excretion properties. For drugs intended to treat Alzheimer's disease or other brain-targeted diseases, the ability of a drug to cross the blood brain barrier may be a key issue. Toxicology and safety studies identify potential target organs for adverse effects and define the Therapeutic Index to set the initial starting doses in clinical trials. Pivotal preclinical safety studies generally require regulatory oversight as defined by US Food and Drug Administration (FDA Good Laboratory Practices and international guidelines, including the International Conference on Harmonisation. Concurrent preclinical development activities include developing the Clinical Plan and preparing the new drug product, including the associated documentation to meet stringent FDA Good Manufacturing Practices regulatory guidelines. A wide range of commercial and government contract options are available for investigators seeking to advance their candidate(s. Government programs such as the Small Business Innovative Research and Small Business Technology Transfer grants and the National Institutes of Health Rapid Access to Interventional Development Pilot

  10. Antibiotic resistance--consequences for animal health, welfare, and food production.

    Science.gov (United States)

    Bengtsson, Björn; Greko, Christina

    2014-05-01

    Most of the literature on the consequences of emergence and spread of bacteria resistant to antibiotics among animals relate to the potential impact on public health. But antibiotics are used to treat sick animals, and resistance in animal pathogens may lead to therapy failure. This has received little scientific attention, and therefore, in this article, we discuss examples that illustrate the possible impact of resistance on animal health and consequences thereof. For all animals, there may be a negative effect on health and welfare when diseases cannot be treated. Other consequences will vary depending on why and how different animal species are kept. Animals kept as companions or for sports often receive advanced care, and antibiotic resistance can lead to negative social and economic consequences for the owners. Further, spread of hospital-acquired infections can have an economic impact on the affected premises. As to animals kept for food production, antibiotics are not needed to promote growth, but, if infectious diseases cannot be treated when they occur, this can have a negative effect on the productivity and economy of affected businesses. Antibiotic resistance in animal bacteria can also have positive consequences by creating incentives for adoption of alternative regimes for treatment and prevention. It is probable that new antibiotic classes placed on the market in the future will not reach veterinary medicine, which further emphasizes the need to preserve the efficacy of currently available antibiotics through antibiotic stewardship. A cornerstone in this work is prevention, as healthy animals do not need antibiotics.

  11. Animal production and health newsletter. No 16

    International Nuclear Information System (INIS)

    1992-07-01

    This Newsletter contains reports on the meetings and training courses held between January and April 1992, including a detailed summary of the final FAO/IAEA Research Coordination Meeting on ''Development of Feeding Strategies for Improving Ruminant Productivity in Areas of Fluctuating Nutrient Supply through the Use of Nuclear and Related Techniques'', held in Vienna from 30 March to 3 April. Status reports are presented for the existing nine coordinated research programs, and developments at the Animal Production Unit, Seibersdorf are described

  12. Bioluminescent imaging: a critical tool in pre-clinical oncology research.

    LENUS (Irish Health Repository)

    O'Neill, Karen

    2010-02-01

    Bioluminescent imaging (BLI) is a non-invasive imaging modality widely used in the field of pre-clinical oncology research. Imaging of small animal tumour models using BLI involves the generation of light by luciferase-expressing cells in the animal following administration of substrate. This light may be imaged using an external detector. The technique allows a variety of tumour-associated properties to be visualized dynamically in living models. The increasing use of BLI as a small-animal imaging modality has led to advances in the development of xenogeneic, orthotopic, and genetically engineered animal models expressing luciferase genes. This review aims to provide insight into the principles of BLI and its applications in cancer research. Many studies to assess tumour growth and development, as well as efficacy of candidate therapeutics, have been performed using BLI. More recently, advances have also been made using bioluminescent imaging in studies of protein-protein interactions, genetic screening, cell-cycle regulators, and spontaneous cancer development. Such novel studies highlight the versatility and potential of bioluminescent imaging in future oncological research.

  13. Developmental origins of metabolic disorders: The need for biomarker candidates and therapeutic targets from adequate preclinical models

    Directory of Open Access Journals (Sweden)

    Antonio Gonzalez-Bulnes

    2016-03-01

    Full Text Available The investigation on obesity and associated disorders have changed from an scenario in which genome drove the phenotype to a dynamic setup in which prenatal and early-postnatal conditions are determinant. However, research in human beings is difficult due to confounding factors (lifestyle and socioeconomic heterogeneity plus ethical issues. Hence, there is currently an intensive effort for developing adequate preclinical models, aiming for an adequate combination of basic studies in rodent models and specific preclinical studies in large animals. The results of these research strategies may increase the identification and development of contrasted biomarkers and therapeutic targets.

  14. Health risk from veterinary antimicrobial use in China's food animal production and its reduction.

    Science.gov (United States)

    Hu, Yuanan; Cheng, Hefa

    2016-12-01

    The overuse and misuse of veterinary drugs, particularly antimicrobials, in food animal production in China cause environmental pollution and wide food safety concerns, and pose public health risk with the selection of antimicrobial resistance (AMR) that can spread from animal populations to humans. Elevated abundance and diversity of antimicrobial resistance genes (ARGs) and resistant bacteria (including multi-drug resistant strains) in food-producing animals, food products of animal origin, microbiota of human gut, and environmental media impacted by intensive animal farming have been reported. To rein in drug use in food animal production and protect public health, the government made a total of 227 veterinary drugs, including 150 antimicrobial products, available only by prescription from licensed veterinarians for curing, controlling, and preventing animal diseases in March 2014. So far the regulatory ban on non-therapeutic use has failed to bring major changes to the long-standing practice of drug overuse and misuse in animal husbandry and aquaculture, and significant improvement in its implementation and enforcement is necessary. A range of measures, including improving access to veterinary services, strengthening supervision on veterinary drug production and distribution, increasing research and development efforts, and enhancing animal health management, are recommended to facilitate transition toward rational use of veterinary drugs, particularly antimicrobials, and to reduce the public health risk arising from AMR development in animal agriculture. Copyright © 2016 Elsevier Ltd. All rights reserved.

  15. Sex Reporting in Preclinical Microbiological and Immunological Research.

    Science.gov (United States)

    Potluri, Tanvi; Engle, Kyrra; Fink, Ashley L; Vom Steeg, Landon G; Klein, Sabra L

    2017-11-14

    Both sex (i.e., biological construct of male and female) and gender (i.e., social construct of masculine and feminine) impact the pathogenesis of diseases, including those caused by microbial infections. Following the 2015 NIH policy for consideration of sex as a biological variable in preclinical research, in 2018, authors of papers published in primary-research American Society for Microbiology (ASM) journals will be asked to report the sex of the research subjects and animals and of materials derived directly from them. To address the need for sex reporting in ASM journals, we systematically reviewed 2,928 primary-research articles published in six primary-research ASM journals ( Antimicrobial Agents and Chemotherapy , Clinical and Vaccine Immunology , Infection and Immunity , Journal of Bacteriology , Journal of Virology , and mBio ) in 2016. Approximately 37% of animal studies and 9% of primary cell culture papers published in 2016 would have been affected by the new sex-reporting policy. For animal studies (i.e., studies with any nonhuman vertebrate hosts), most published papers either did not report the sex of the animals or used only female animals, and a minority used only males or both sexes. For published studies using primary cells from diverse animal species (i.e., humans and nonhuman vertebrates), almost all studies failed to report the sex of donors from which the cells were isolated. We believe that reporting the sex of animals and even of the donors of derived cells could improve the rigor and reproducibility of research conducted in microbiology and immunology and published in ASM journals. Copyright © 2017 Potluri et al.

  16. Design and production of a short 2D animated film

    OpenAIRE

    Prusnik, Petra

    2014-01-01

    Design and production of a short 2D animated film The thesis aims at analysing animation, the process of creating an ani- mated film with its technical and compositional details as well as show the process of making a short 2D animated movie with Toon Boom Studio. It is composed of theoretical and practical part. The theoretical part of this thesis consists of the definition of the term "animation", a quick overview of its history and evolution, and an in-depth look into var...

  17. ANIMAL PRODUCTS IN NUTRITION OF HUMAN POPULATION

    Directory of Open Access Journals (Sweden)

    Gordana Kralik

    2000-06-01

    Full Text Available In this paper, the significance of animal food (meat and milk in human nutrition and satisfaction of life needs with special look on health is reviewed. Meat is excelent source of proteins with high biological value.The proteins from meat are of high quality because they contain high share of essencial amino acids which are necessary for human organism. Polyunsaturated fatty acids, esspecialy those from 3 group, became very importat to human nutritionists because they have significant role in prevention of stress induced deseases and of those induced by improper diets. New findings from western industrial countries point out the fact that longer intake of LA (-6 with relative “deficiency” of -3 is the main risk factor in occurence of cancer, coronary deseases (CHD, cerebrovascular deseases (CVD and alergic hyperactivity; not cholesterol as was considered till now. Therefore it is important to reduce the -6 / -3 acids ratio in meat and milk using some feedstufs in diets of animals. Dairy products contribute to health throughout life. Epidemiological researches as well as studies in animals and humans indicate that dairy food and/or their components have a protective effect against cancer. The potential anticancer agents identified so far in dairy foods include conjugated linoleic acid (CLA, calcium, vitamin D, sphingomyelin, butyric acid, ether lipids, protein and lactic acid bacteria. Milk is exclusive source of nutrients for the young and it also represents a high grade source of dietary nitrogen and indispensable amino acids for adults. Consumers are increasing looking for animal products, which could prevent disease or illness.

  18. Global Farm Animal Production and Global Warming: Impacting and Mitigating Climate Change

    OpenAIRE

    Koneswaran, Gowri; Nierenberg, Danielle

    2008-01-01

    Background The farm animal sector is the single largest anthropogenic user of land, contributing to many environmental problems, including global warming and climate change. Objectives The aim of this study was to synthesize and expand upon existing data on the contribution of farm animal production to climate change. Methods We analyzed the scientific literature on farm animal production and documented greenhouse gas (GHG) emissions, as well as various mitigation strategies. Discussions An a...

  19. Consumer decision-making for animal-friendly products: synthesis and implications

    NARCIS (Netherlands)

    Ingenbleek, P.T.M.; Immink, V.M.

    2011-01-01

    Understanding how consumers’ concerns affect the consumer decision-making process is important for developing a market for animal-friendly products. This paper presents a synthesis of research on the role of animal welfare in consumer decision-making. Drawing on basic models and concepts from

  20. Study on the Problems and Countermeasure in the Animal Products Quality and Safety

    Institute of Scientific and Technical Information of China (English)

    Shishan; WANG

    2013-01-01

    As the supply chain of animal products is long,there are many factors which would influence the quality safety of animal production.Therefore,by focusing on the present and having a vision for future,Jiaozuo government promulgated Ten Polices on the Food Safety in Jiaozuo City,which pushed forward the technological development,intensified measures to monitor the quality of animal products,set up a series of mechanism,and provided reference for the food quality and safety monitoring.

  1. The transfer of radionuclides into domestic animals and their products

    International Nuclear Information System (INIS)

    Miyamoto, Susumu

    1979-01-01

    The contamination of animal products, especially milk, with radionuclides, are regarded as the important problem in the food chain, and has been one of the remarkable public concerns in Japan since the nuclear tests in 1954. The transfer of several radionuclides into domestic animals and their products is described. 131 I, 90 Sr and 137 Cs are very important as the radionuclides that transfer into domestic animals and their products. The data of the transfer of several orally administered radionuclides into milk from the references are summarized as follows: (1) 131 I transfered into milk was 5 -- 30% of dose (cow), 10 -- 40% (goat). (2) 90 Sr( 89 Sr) transfered into milk was 0.6 -- 1.9% (cow), 0.5 -- 0.6% (goat). (3) 137 Cs( 134 Cs) transfered into milk was 10 -- 13% (cow), 7.0% (goat). (4) 140 Ba- 140 La transfered into milk was 0.6% (cow), 0.1 -- 0.2% (goat). (5) 181 W transfered into milk was 0.06% (goat). (author)

  2. Experimental psychiatric illness and drug abuse models: from human to animal, an overview.

    Science.gov (United States)

    Edwards, Scott; Koob, George F

    2012-01-01

    Preclinical animal models have supported much of the recent rapid expansion of neuroscience research and have facilitated critical discoveries that undoubtedly benefit patients suffering from psychiatric disorders. This overview serves as an introduction for the following chapters describing both in vivo and in vitro preclinical models of psychiatric disease components and briefly describes models related to drug dependence and affective disorders. Although there are no perfect animal models of any psychiatric disorder, models do exist for many elements of each disease state or stage. In many cases, the development of certain models is essentially restricted to the human clinical laboratory domain for the purpose of maximizing validity, whereas the use of in vitro models may best represent an adjunctive, well-controlled means to model specific signaling mechanisms associated with psychiatric disease states. The data generated by preclinical models are only as valid as the model itself, and the development and refinement of animal models for human psychiatric disorders continues to be an important challenge. Collaborative relationships between basic neuroscience and clinical modeling could greatly benefit the development of new and better models, in addition to facilitating medications development.

  3. Co-ordinated Interdisciplinary Efforts on Research in Animal Production and Health

    Directory of Open Access Journals (Sweden)

    Houe Hans

    2003-03-01

    Full Text Available The objectives are to review results and experiences from interdisciplinary research projects in Research Centre for the Management of Animal Production and Health (CEPROS concerning scientific content, organisation, and collaboration. The Centre has been founded as a result of an agreement between four institutions: the Danish Institute of Agricultural Sciences (DIAS, the Danish Veterinary Laboratory (DVL, the Danish Veterinary Institute for Virus Research (DVIV and The Royal Veterinary and Agricultural University (KVL. CEPROS is a "research centre without walls" and is physically located as an integrated part of the four institutions named above. The Centre has close collaboration with the industry. The superior goals of the Centre are to co-ordinate fundamental and applied research and simultaneously integrate the veterinary and the production oriented livestock research within animal health and welfare, taking into consideration the production economics and reduced use of medication. The assignment of the Centre is to initiate and carry out research, aiming to investigate the influence of breeding and production systems on animal health and welfare as well as on production and product quality. The Centre has since 1997 established 16 interdisciplinary research projects dealing with cattle, pigs, poultry, or mink. The scientific content can be divided into three research clusters: A. Management of animal production and health in production systems, B: Pathogenesis of production diseases, and C. Animal health economics. In Cluster A, the physical environments of production systems have been investigated, broader definitions of the concept health have been established and used in identification of risk factors. Cluster B has investigated physiological, immunological and genetic mechanisms behind development of production diseases and how to apply this knowledge in disease prevention. The cluster in animal health economics has developed decision

  4. Activities of the Animal Production and Health Laboratory (Animal Production and Health Newsletter, No. 61, January 2015)

    International Nuclear Information System (INIS)

    2015-01-01

    This article provides information on: Genetic variation on the control of resistance to internal parasites in small ruminants for improving animal productivity; Genetic characterization of indigenous livestock breeds; Genetic relationship of domestic sheep breeds with primitive Asian wild Urial sheep; Using irradiation technology to develop a potential trypanosome vaccine; Peste des petits ruminants (PPR); Technical visit to the Central Veterinary Laboratory, Kinshasa, Democratic Republic of Congo; Fellows/interns/consultants

  5. Stem Cells for Cartilage Repair: Preclinical Studies and Insights in Translational Animal Models and Outcome Measures

    OpenAIRE

    Lo Monaco, Melissa; Merckx, Greet; Ratajczak, Jessica; Gervois, Pascal; Hilkens, Petra; Clegg, Peter; Bronckaers, Annelies; Vandeweerd, Jean-Michel; Lambrichts, Ivo

    2018-01-01

    Due to the restricted intrinsic capacity of resident chondrocytes to regenerate the lost cartilage postinjury, stem cell-based therapies have been proposed as a novel therapeutic approach for cartilage repair. Moreover, stem cell-based therapies using mesenchymal stem cells (MSCs) or induced pluripotent stem cells (iPSCs) have been used successfully in preclinical and clinical settings. Despite these promising reports, the exact mechanisms underlying stem cell-mediated cartilage repair remain...

  6. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.

    Science.gov (United States)

    Indran, Inthrani Raja; Lee, Bao Hui; Yong, Eu-Leong

    2016-11-01

    Basic science studies have advanced our understanding of the role of key enzymes in the steroidogenesis pathway and those that affect the pathophysiology of PCOS. Studies with ovarian theca cells taken from women with PCOS have demonstrated increased androgen production due to increased CYP17A1 and HSD3B2 enzyme activities. Furthermore, overexpression of DENND1A variant 2 in normal theca cells resulted in a PCOS phenotype with increased androgen production. Notably, cellular steroidogenesis models have facilitated the understanding of the mechanistic effects of pharmacotherapies, including insulin sensitizers (e.g., pioglitazone and metformin) used for the treatment of insulin resistance in PCOS, on androgen production. In addition, animal models of PCOS have provided a critical platform to study the effects of therapeutic agents in a manner closer to the physiological state. Indeed, recent breakthroughs have demonstrated that natural derivatives such as the dietary medium-chain fatty acid decanoic acid (DA) can restore estrous cyclicity and lower androgen levels in an animal model of PCOS, thus laying the platform for novel therapeutic developments in PCOS. This chapter reviews the current understanding on the pathways modulating androgen biosynthesis, and the cellular and animal models that form the basis for preclinical research in PCOS, and sets the stage for clinical research. Copyright © 2016. Published by Elsevier Ltd.

  7. SIMULATED ANIMAL EXPERIMENTS IN TEACHING AND RESEARCH

    Directory of Open Access Journals (Sweden)

    Chirag B. Mistry, Shreya M. Shah, Jagatkumar D. Bhatt

    2015-07-01

    Full Text Available Animal experiments are of paramount importance in the pre-clinical screening of new chemical entity. On the other hand, various regulatory guidelines for animal experiments are becoming more stringent in the face of worldwide protests by animal rights activists. Moreover, simulated animal experiments’ softwares are being developed and they can be implemented in the postgraduate and graduate students’ curriculum for demonstration of standard physiological and pharmacological principles compared to real time animal experiments. In fact, implementation of virtual experiment will decrease hand on experience of animal experiments among medical students, but after medical graduation, animal experiment is lest utilized during their day to day clinical practice. Similarly, in case of postgraduate pharmacology curriculum, computer based virtual animal experiments can facilitate teaching and learning in a short span of time with various protocols, without sacrificing any animal for already established experimental outcomes.

  8. Post-SSRI Sexual Dysfunction: Preclinical to Clinical. Is It Fact or Fiction?

    Science.gov (United States)

    Coskuner, Enis Rauf; Culha, Mehmet Gokhan; Ozkan, Burak; Kaleagasi, Elcin Orhan

    2018-04-01

    Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drug for various psychiatric disorders during the lifespan, including pregnancy, lactation, childhood, and adolescence. Deterioration in sexual functioning is a major and serious adverse effect of SSRIs. There is emerging evidence that SSRIs can have long-lasting effects on sexuality. To summarize the long-lasting effects of SSRIs on sexuality, starting with animal models and continuing with the clinical experience of different investigators. A literature review of relevant publications in PubMed. To assess the long-lasting effects of SSRIs on sexuality. Although the persistent effects of SSRIs on sexuality have been little studied in humans, animal studies suggest that SSRIs might cause permanent sexual dysfunction after ending SSRI exposure at a young age but not in adulthood in rats. There are no prospective randomized controlled trials in humans and the present evidence is derived from case reports, incidental research findings, and experiences of some internet communities. There is some preclinical evidence from animal studies for enduring SSRI-induced sexual dysfunction, but the available clinical information could prevent a clear decision about the existence of post-SSRI sexual dysfunction, its pathophysiology, and its management. We need more research to fill in the gaps in our knowledge. Coskuner ER, Culha MG, Ozkan B, Kaleagasi EO. Post-SSRI Sexual Dysfunction: Preclinical to Clinical. Is It Fact or Fiction? Sex Med Rev 2018;6:217-223. Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

  9. WE-E-BRE-04: Dual Focal Spot Dose Painting for Precision Preclinical Radiobiological Investigations

    Energy Technology Data Exchange (ETDEWEB)

    Stewart, J; Lindsay, P [Princess Margaret Cancer Centre, Toronto (Canada); University of Toronto, Toronto (Canada); Jaffray, D [Princess Margaret Cancer Centre, Toronto (Canada); The Techna Institute for the Advancement of Technology for Health, Toronto (Canada)

    2014-06-15

    Purpose: Recent progress in small animal radiotherapy systems has provided the foundation for delivering the heterogeneous, millimeter scale dose distributions demanded by preclinical radiobiology investigations. Despite advances in preclinical dose planning, delivery of highly heterogeneous dose distributions is constrained by the fixed collimation systems and large x-ray focal spot common in small animal radiotherapy systems. This work proposes a dual focal spot dose optimization and delivery method with a large x-ray focal spot used to deliver homogeneous dose regions and a small focal spot to paint spatially heterogeneous dose regions. Methods: Two-dimensional dose kernels were measured for a 1 mm circular collimator with radiochromic film at 10 mm depth in a solid water phantom for the small and large x-ray focal spots on a recently developed small animal microirradiator. These kernels were used in an optimization framework which segmented a desired dose distribution into low- and high-spatial frequency regions for delivery by the large and small focal spot, respectively. For each region, the method determined an optimal set of stage positions and beam-on times. The method was demonstrated by optimizing a bullseye pattern consisting of 0.75 mm radius circular target and 0.5 and 1.0 mm wide rings alternating between 0 and 2 Gy. Results: Compared to a large focal spot technique, the dual focal spot technique improved the optimized dose distribution: 69.2% of the optimized dose was within 0.5 Gy of the intended dose for the large focal spot, compared to 80.6% for the dual focal spot method. The dual focal spot design required 14.0 minutes of optimization, and will require 178.3 minutes for automated delivery. Conclusion: The dual focal spot optimization and delivery framework is a novel option for delivering conformal and heterogeneous dose distributions at the preclinical level and provides a new experimental option for unique radiobiological investigations

  10. WE-E-BRE-04: Dual Focal Spot Dose Painting for Precision Preclinical Radiobiological Investigations

    International Nuclear Information System (INIS)

    Stewart, J; Lindsay, P; Jaffray, D

    2014-01-01

    Purpose: Recent progress in small animal radiotherapy systems has provided the foundation for delivering the heterogeneous, millimeter scale dose distributions demanded by preclinical radiobiology investigations. Despite advances in preclinical dose planning, delivery of highly heterogeneous dose distributions is constrained by the fixed collimation systems and large x-ray focal spot common in small animal radiotherapy systems. This work proposes a dual focal spot dose optimization and delivery method with a large x-ray focal spot used to deliver homogeneous dose regions and a small focal spot to paint spatially heterogeneous dose regions. Methods: Two-dimensional dose kernels were measured for a 1 mm circular collimator with radiochromic film at 10 mm depth in a solid water phantom for the small and large x-ray focal spots on a recently developed small animal microirradiator. These kernels were used in an optimization framework which segmented a desired dose distribution into low- and high-spatial frequency regions for delivery by the large and small focal spot, respectively. For each region, the method determined an optimal set of stage positions and beam-on times. The method was demonstrated by optimizing a bullseye pattern consisting of 0.75 mm radius circular target and 0.5 and 1.0 mm wide rings alternating between 0 and 2 Gy. Results: Compared to a large focal spot technique, the dual focal spot technique improved the optimized dose distribution: 69.2% of the optimized dose was within 0.5 Gy of the intended dose for the large focal spot, compared to 80.6% for the dual focal spot method. The dual focal spot design required 14.0 minutes of optimization, and will require 178.3 minutes for automated delivery. Conclusion: The dual focal spot optimization and delivery framework is a novel option for delivering conformal and heterogeneous dose distributions at the preclinical level and provides a new experimental option for unique radiobiological investigations

  11. Hungry for success: Urban consumer demand for wild animal products in Vietnam

    OpenAIRE

    Rebecca Drury

    2011-01-01

    Rising urban prosperity is escalating demand for wild animal products in Vietnam. Conservation interventions seek to influence consumer demand, but are based on a limited understanding of consumers and consumption behaviour. This report presents key findings of a structured survey (n=915) and semi-structured interviews (n=78) to investigate the social context of consumption of wild animal-derived products among the population of central Hanoi. Wildmeat is the product most commonly reported co...

  12. Animal production and health newsletter. No. 36

    International Nuclear Information System (INIS)

    2002-07-01

    This issue of the Newsletter highlights the importance of Information and Communication technologies (ICTs) in improving all aspects of human social, economic and cultural life and the role played by the IAEA's Animal Production and Health Sub-programme, in using these technologies to undertake training programmes in Africa. Coordinated research programmes, training and other events are also announced

  13. Animal production and health newsletter. No. 36

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2002-07-01

    This issue of the Newsletter highlights the importance of Information and Communication technologies (ICTs) in improving all aspects of human social, economic and cultural life and the role played by the IAEA's Animal Production and Health Sub-programme, in using these technologies to undertake training programmes in Africa. Coordinated research programmes, training and other events are also announced.

  14. Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization.

    Science.gov (United States)

    Tuzun, Erdem; Berrih-Aknin, Sonia; Brenner, Talma; Kusner, Linda L; Le Panse, Rozen; Yang, Huan; Tzartos, Socrates; Christadoss, Premkumar

    2015-08-01

    Myasthenia gravis (MG) is an autoimmune disorder characterized by generalized muscle weakness due to neuromuscular junction (NMJ) dysfunction brought by acetylcholine receptor (AChR) antibodies in most cases. Although steroids and other immunosuppressants are effectively used for treatment of MG, these medications often cause severe side effects and a complete remission cannot be obtained in many cases. For pre-clinical evaluation of more effective and less toxic treatment methods for MG, the experimental autoimmune myasthenia gravis (EAMG) induced by Torpedo AChR immunization has become one of the standard animal models. Although numerous compounds have been recently proposed for MG mostly by using the active immunization EAMG model, only a few have been proven to be effective in MG patients. The variability in the experimental design, immunization methods and outcome measurements of pre-clinical EAMG studies make it difficult to interpret the published reports and assess the potential for application to MG patients. In an effort to standardize the active immunization EAMG model, we propose standard procedures for animal care conditions, sampling and randomization of mice, experimental design and outcome measures. Utilization of these standard procedures might improve the power of pre-clinical EAMG experiments and increase the chances for identifying promising novel treatment methods that can be effectively translated into clinical trials for MG. Copyright © 2015 Elsevier Inc. All rights reserved.

  15. Evaluation of methane-utilising bacteria products as feed ingredients for monogastric animals

    DEFF Research Database (Denmark)

    Øverland, Margareth; Tauson, Anne-Helene; Shearer, Karl

    2010-01-01

    ingredients for animals. We present results from earlier work and recent findings concerning bacterial protein, including the production process, chemical composition, effects on nutrient digestibility, metabolism, and growth performance in several monogastric species, including pigs, broiler chickens, mink......Bacterial proteins represent a potential future nutrient source for monogastric animal production because they can be grown rapidly on substrates with minimum dependence on soil, water, and climate conditions. This review summarises the current knowledge on methane-utilising bacteria as feed...... Methylococcus capsulatus (Bath), is a promising source of protein based on criteria such as amino acid composition, digestibility, and animal performance and health. Future research challenges include modified downstream processing to produce value-added products, and improved understanding of factors...

  16. Detection of Different DNA Animal Species in Commercial Candy Products.

    Science.gov (United States)

    Muñoz-Colmenero, Marta; Martínez, Jose Luis; Roca, Agustín; Garcia-Vazquez, Eva

    2016-03-01

    Candy products are consumed all across the world, but there is not much information about their composition. In this study we have used a DNA-based approach for determining the animal species occurring in 40 commercial candies of different types. We extracted DNA and performed PCR amplification, cloning and sequencing for obtaining species-informative DNA sequences. Eight species were identified including fish (hake and anchovy) in 22% of the products analyzed. Bovine and porcine were the most abundant appearing in 27 samples each one. Most products contained a mixture of species. Marshmallows (7), jelly-types, and gummies (20) contained a significantly higher number of species than hard candies (9). We demonstrated the presence of DNA animal species in candy product which allow consumers to make choices and prevent allergic reaction. © 2016 Institute of Food Technologists®

  17. Prospects from agroecology and industrial ecology for animal production in the 21st century.

    Science.gov (United States)

    Dumont, B; Fortun-Lamothe, L; Jouven, M; Thomas, M; Tichit, M

    2013-06-01

    Agroecology and industrial ecology can be viewed as complementary means for reducing the environmental footprint of animal farming systems: agroecology mainly by stimulating natural processes to reduce inputs, and industrial ecology by closing system loops, thereby reducing demand for raw materials, lowering pollution and saving on waste treatment. Surprisingly, animal farming systems have so far been ignored in most agroecological thinking. On the basis of a study by Altieri, who identified the key ecological processes to be optimized, we propose five principles for the design of sustainable animal production systems: (i) adopting management practices aiming to improve animal health, (ii) decreasing the inputs needed for production, (iii) decreasing pollution by optimizing the metabolic functioning of farming systems, (iv) enhancing diversity within animal production systems to strengthen their resilience and (v) preserving biological diversity in agroecosystems by adapting management practices. We then discuss how these different principles combine to generate environmental, social and economic performance in six animal production systems (ruminants, pigs, rabbits and aquaculture) covering a long gradient of intensification. The two principles concerning economy of inputs and reduction of pollution emerged in nearly all the case studies, a finding that can be explained by the economic and regulatory constraints affecting animal production. Integrated management of animal health was seldom mobilized, as alternatives to chemical drugs have only recently been investigated, and the results are not yet transferable to farming practices. A number of ecological functions and ecosystem services (recycling of nutrients, forage yield, pollination, resistance to weed invasion, etc.) are closely linked to biodiversity, and their persistence depends largely on maintaining biological diversity in agroecosystems. We conclude that the development of such ecology

  18. Animal welfare: an animal science approach.

    Science.gov (United States)

    Koknaroglu, H; Akunal, T

    2013-12-01

    Increasing world population and demand for animal-derived protein puts pressure on animal production to meet this demand. For this purpose animal breeding efforts were conducted to obtain the maximum yield that the genetic makeup of the animals permits. Under the influence of economics which is the driving force behind animal production, animal farming became more concentrated and controlled which resulted in rearing animals under confinement. Since more attention was given on economics and yield per animal, animal welfare and behavior were neglected. Animal welfare which can be defined as providing environmental conditions in which animals can display all their natural behaviors in nature started gaining importance in recent years. This does not necessarily mean that animals provided with good management practices would have better welfare conditions as some animals may be distressed even though they are in good environmental conditions. Consumers are willing to pay more for welfare-friendly products (e.g.: free range vs caged egg) and this will change the animal production practices in the future. Thus animal scientists will have to adapt themselves for the changing animal welfare rules and regulations that differ for farm animal species and countries. In this review paper, animal welfare is discussed from an animal science standpoint. Crown Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

  19. Techno-economic feasibility of animal feed production from empty fruit bunches

    International Nuclear Information System (INIS)

    Muhamad Lebai Juri; Mat Rasol Awang; Hassan Hamdani Mutaat; Yusri Atan; Tamikazu Kume; Shinpei Matsuhashi

    1998-01-01

    It has been shown in our laboratory that EFB has the potential to be converted into animal feeds through the process of fermentation; and also use as media for mushroom growing (1). Irradiation of EFB at doses above 10 kGy followed by fermentation can reduce crude fibre (CF) content to almost 20-30% and crude protein (CP) content elevated to 10-15% from 50% and 2% respectively (2)(3). The end-product of fermentation displayed all the characteristics of animal feed, and at these levels of CF and CP can be utilised for feeding ruminants. Further reduction of CF and raising of CP can result in the products suitable for feeding non-ruminants such as poultry and pigs. Following the successful conversion of raw EFB into foodstuff for ruminant in the laboratory, there is an urgent need to evaluate whether such products could be mass-produced economically at larger scale for further feeding-trials. Pilot plant has to be set up to simulate the actual commercial production process before any technology transfer can be undertaken. The main objective of this paper is to report firstly, the economic and financial feasibility of the production process at pilot level. Secondly, preliminary evaluation on the cost of production of animal feed from EFB

  20. Animal DNA identification in food products and animal feed by real time polymerase chain reaction method

    Directory of Open Access Journals (Sweden)

    Людмила Мар’янівна Іщенко

    2016-11-01

    Full Text Available Approbation of diagnostic tests for species identification of beef, pork and chicken by real time polymerase chain reaction method was done. Meat food, including heat treated and animal feed, was used for research. The fact of inconsistencies was revealed for product composition of some meat products that is marked by manufacturer 

  1. Forms and Factors of Animal Products Marketing in the early post-Meiji Years

    OpenAIRE

    Ono, Seishi

    1982-01-01

    As far as the period after the Meiji era is concerned, at its begining marketing of animal products was formed in conlpliance with the properties of products as a public commodity and the amount of investment needed. The former factor depends basically on the divisibility and the preservation possibilities of the products. The latter is the capital needed for marketing and production. 1) Eggs are the most divisible and preservable of all the animal products. Also, hens can be kept with sm...

  2. Nuclear and related techniques in animal production and health

    International Nuclear Information System (INIS)

    1986-01-01

    The international symposium was attended by about 130 participants from 45 countries and included 83 scientific presentations of which 42 were posters. This volume covers four principal and interrelated topics: adaptation of animals to the environment, and animal reproduction, health and nutrition. Within each topic, consideration is given to those nuclear and related techniques currently employed in investigative research and their usefulness in studying animal production systems. Progress towards new areas of application and new techniques is also covered, particularly the development and practicability of immunoassay and related biotechnological methods for the diagnosis of livestock diseases. A separate abstract was prepared for each of the papers in this volume

  3. Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

    Directory of Open Access Journals (Sweden)

    Sam Illingworth

    2017-06-01

    Full Text Available Enadenotucirev is an oncolytic group B adenovirus identified by a process of bio-selection for the ability to selectively propagate in and rapidly kill carcinoma cells. It is resistant to inactivation by human blood components, potentially enabling intravenous dosing in patients with metastatic cancer. However, there are no known permissive animal models described for group B adenoviruses that could facilitate a conventional approach to preclinical safety studies. In this manuscript, we describe our tailored preclinical strategy designed to evaluate the key biological properties of enadenotucirev. As enadenotucirev does not replicate in animal cells, a panel of primary human cells was used to evaluate enadenotucirev replication selectivity in vitro, demonstrating that virus genome levels were >100-fold lower in normal cells relative to tumor cells. Acute intravenous tolerability in mice was used to assess virus particle-mediated toxicology and effects on innate immunity. These studies showed that particle toxicity could be ameliorated by dose fractionation, using an initial dose of virus to condition the host such that cytokine responses to subsequent doses were significantly attenuated. This, in turn, supported the initiation of a phase I intravenous clinical trial with a starting dose of 1 × 1010 virus particles given on days 1, 3, and 5.

  4. Bioengineered Temporomandibular Joint Disk Implants: Study Protocol for a Two-Phase Exploratory Randomized Preclinical Pilot Trial in 18 Black Merino Sheep (TEMPOJIMS)

    Science.gov (United States)

    Monje, Florencio Gil; González-García, Raúl; Little, Christopher B; Mónico, Lisete; Pinho, Mário; Santos, Fábio Abade; Carrapiço, Belmira; Gonçalves, Sandra Cavaco; Morouço, Pedro; Alves, Nuno; Moura, Carla; Wang, Yadong; Jeffries, Eric; Gao, Jin; Sousa, Rita; Neto, Lia Lucas; Caldeira, Daniel; Salvado, Francisco

    2017-01-01

    Background Preclinical trials are essential to test efficacious options to substitute the temporomandibular joint (TMJ) disk. The contemporary absence of an ideal treatment for patients with severe TMJ disorders can be related to difficulties concerning the appropriate study design to conduct preclinical trials in the TMJ field. These difficulties can be associated with the use of heterogeneous animal models, the use of the contralateral TMJ as control, the absence of rigorous randomized controlled preclinical trials with blinded outcomes assessors, and difficulties involving multidisciplinary teams. Objective This study aims to develop a new, reproducible, and effective study design for preclinical research in the TMJ domain, obtaining rigorous data related to (1) identify the impact of bilateral discectomy in black Merino sheep, (2) identify the impact of bilateral discopexy in black Merino sheep, and (3) identify the impact of three different bioengineering TMJ discs in black Merino sheep. Methods A two-phase exploratory randomized controlled preclinical trial with blinded outcomes is proposed. In the first phase, nine sheep are randomized into three different surgical bilateral procedures: bilateral discectomy, bilateral discopexy, and sham surgery. In the second phase, nine sheep are randomized to bilaterally test three different TMJ bioengineering disk implants. The primary outcome is the histological gradation of TMJ. Secondary outcomes are imaging changes, absolute masticatory time, ruminant time per cycle, ruminant kinetics, ruminant area, and sheep weight. Results Previous preclinical studies in this field have used the contralateral unoperated side as a control, different animal models ranging from mice to a canine model, with nonrandomized, nonblinded and uncontrolled study designs and limited outcomes measures. The main goal of this exploratory preclinical protocol is to set a new standard for future preclinical trials in oromaxillofacial surgery

  5. Attitudes towards genetically modified animals in food production

    NARCIS (Netherlands)

    Frewer, L.J.; Coles, D.; Houdebine, L.M.; Kleter, G.A.

    2014-01-01

    Purpose – Food products developed using genetically modified (GM) animals may soon be introduced in Europe and beyond. Their successful commercialisation depends on consumer acceptance, and so it is timely to review the existing literature in this respect. The paper aims to discuss these issues.

  6. Greenhouse gas mitigation in animal production: towards an integrated life cycle sustainability assessment.

    NARCIS (Netherlands)

    Boer, de I.J.M.; Cederberg, C.; Eady, S.; Gollnow, S.; Kristensen, T.; Macleod, M.; Meul, M.; Nemecek, T.; Phong, L.T.; Thoma, G.; Werf, H.M.G.; Williams, A.G.; Zonderland-Thomassen, M.A.

    2011-01-01

    The animal food chain contributes significantly to emission of greenhouse gases (GHGs). We explored studies that addressed options to mitigate GHG emissions in the animal production chain and concluded that most studies focused on production systems in developed countries and on a single GHG. They

  7. Principles and limitations of stable isotopes in differentiating organic and conventional foodstuffs: 2. Animal products.

    Science.gov (United States)

    Inácio, Caio T; Chalk, Phillip M

    2017-01-02

    In this review, we examine the variation in stable isotope signatures of the lighter elements (δ 2 H, δ 13 C, δ 15 N, δ 18 O, and δ 34 S) of tissues and excreta of domesticated animals, the factors affecting the isotopic composition of animal tissues, and whether stable isotopes may be used to differentiate organic and conventional modes of animal husbandry. The main factors affecting the δ 13 C signatures of livestock are the C3/C4 composition of the diet, the relative digestibility of the diet components, metabolic turnover, tissue and compound specificity, growth rate, and animal age. δ 15 N signatures of sheep and cattle products have been related mainly to diet signatures, which are quite variable among farms and between years. Although few data exist, a minor influence in δ 15 N signatures of animal products was attributed to N losses at the farm level, whereas stocking rate showed divergent findings. Correlations between mode of production and δ 2 H and δ 18 O have not been established, and only in one case of an animal product was δ 34 S a satisfactory marker for mode of production. While many data exist on diet-tissue isotopic discrimination values among domesticated animals, there is a paucity of data that allow a direct and statistically verifiable comparison of the differences in the isotopic signatures of organically and conventionally grown animal products. The few comparisons are confined to beef, milk, and egg yolk, with no data for swine or lamb products. δ 13 C appears to be the most promising isotopic marker to differentiate organic and conventional production systems when maize (C4) is present in the conventional animal diet. However, δ 13 C may be unsuitable under tropical conditions, where C4 grasses are abundant, and where grass-based husbandry is predominant in both conventional and organic systems. Presently, there is no universal analytical method that can be applied to differentiate organic and conventional animal products.

  8. Efficacy and Safety of Pomegranate Medicinal Products for Cancer

    OpenAIRE

    Vlachojannis, Christian; Zimmermann, Benno F.; Chrubasik-Hausmann, Sigrun

    2015-01-01

    Preclinical in vitro and in vivo studies demonstrate potent effects of pomegranate preparations in cancer cell lines and animal models with chemically induced cancers. We have carried out one systematic review of the effectiveness of pomegranate products in the treatment of cancer and another on their safety. The PubMed search provided 162 references for pomegranate and cancer and 122 references for pomegranate and safety/toxicity. We identified 4 clinical studies investigating 3 pomegranate ...

  9. Restrictions on antimicrobial use in food animal production: an international regulatory and economic survey

    Science.gov (United States)

    2013-01-01

    Background The administration of antimicrobial drugs to food animals at low doses for extended durations for growth promotion and disease prevention has been linked to the global health crisis of antimicrobial resistance. Internationally, multiple jurisdictions have responded by restricting antimicrobial use for these purposes, and by requiring a veterinary prescription to use these drugs in food animals. Opponents of these policies have argued that restrictions have been detrimental to food animal production where they have been adopted. Methods We surveyed the antimicrobial use policies of 17 political jurisdictions outside of the United States with respect to growth promotion, disease prevention, and veterinary oversight, and reviewed the available evidence regarding their production impacts, including measures of animal health. Jurisdictions were included if they were a top-five importer of a major U.S. food animal product in 2011, as differences between the policies of the U.S. and other jurisdictions may lead to trade barriers to U.S. food animal product exports. Jurisdictions were also included if information on their policies was publicly available in English. We searched the peer-reviewed and grey literatures and corresponded with jurisdictions’ U.S. embassies, regulators, and local experts. Results Jurisdictions were categorized by whether they prohibit use of antimicrobials for growth promotion and/or use of antimicrobials without a veterinary prescription. Of the 17 jurisdictions surveyed, six jurisdictions have prohibited both types of use, five jurisdictions have prohibited one use but not the other use, and five jurisdictions have not prohibited either use, while information was not available for one jurisdiction. Data on the production impacts of these prohibitions were limited, although available data, especially from Denmark and Sweden, suggest that restrictions on growth promotion use can be implemented with minimal production consequences

  10. Restrictions on antimicrobial use in food animal production: an international regulatory and economic survey.

    Science.gov (United States)

    Maron, Dina Fine; Smith, Tyler J S; Nachman, Keeve E

    2013-10-16

    The administration of antimicrobial drugs to food animals at low doses for extended durations for growth promotion and disease prevention has been linked to the global health crisis of antimicrobial resistance. Internationally, multiple jurisdictions have responded by restricting antimicrobial use for these purposes, and by requiring a veterinary prescription to use these drugs in food animals. Opponents of these policies have argued that restrictions have been detrimental to food animal production where they have been adopted. We surveyed the antimicrobial use policies of 17 political jurisdictions outside of the United States with respect to growth promotion, disease prevention, and veterinary oversight, and reviewed the available evidence regarding their production impacts, including measures of animal health. Jurisdictions were included if they were a top-five importer of a major U.S. food animal product in 2011, as differences between the policies of the U.S. and other jurisdictions may lead to trade barriers to U.S. food animal product exports. Jurisdictions were also included if information on their policies was publicly available in English. We searched the peer-reviewed and grey literatures and corresponded with jurisdictions' U.S. embassies, regulators, and local experts. Jurisdictions were categorized by whether they prohibit use of antimicrobials for growth promotion and/or use of antimicrobials without a veterinary prescription. Of the 17 jurisdictions surveyed, six jurisdictions have prohibited both types of use, five jurisdictions have prohibited one use but not the other use, and five jurisdictions have not prohibited either use, while information was not available for one jurisdiction. Data on the production impacts of these prohibitions were limited, although available data, especially from Denmark and Sweden, suggest that restrictions on growth promotion use can be implemented with minimal production consequences. A majority of leading U.S. trade

  11. Physical properties, fuel characteristics and P-fertilizer production related to animal slurry and products from separation of animal slurry

    DEFF Research Database (Denmark)

    Thygesen, Ole; Johnsen, Tina; Triolo, Jin Mi

    The purpose of this study was twofold: firstly to examine the relationship between dry matter content (DM) and specific gravity (SG) and viscosity in slurry and the liquid fraction from slurry separation, and secondly to investigate the potential of energy production from combustion of manure fibre...... from slurry separation and phosphorus (P) fertilizer production from recycling of the ash. Manure fibre has a positive calorific value and may be used as a CO2-neutral fuel for combustion. The ashes from combustion are rich in P, an essential fertilizer compound. The study is based on samples of animal...

  12. Alternatives to animal testing in basic and preclinical research of atopic dermatitis.

    Science.gov (United States)

    Löwa, Anna; Jevtić, Marijana; Gorreja, Frida; Hedtrich, Sarah

    2018-01-22

    Atopic dermatitis (AD) is a chronic inflammatory skin disease of increasing prevalence, especially in industrialized countries. Roughly 25% of the children and 1%-3% of adults are affected. Although significant progress has been made in the understanding of the pathogenesis of AD, many aspects remain poorly understood. Moreover, there is a pressing need for improved therapeutic options. Studies to elucidate the pathophysiological pathways of AD and to identify novel therapeutic targets over the last few decades have been conducted almost exclusively in animal models. However, in vitro approaches such as 3D skin disease models have recently emerged due to an increasing awareness of distinct interspecies-related differences that hamper the effective translation of results from animal models to humans. In addition, there is growing political and social pressure to develop alternatives to animal models according to the 3Rs principle (reduction, refinement and replacement of animal models). © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  13. Synchrotron radiation microimaging in rabbit models of cancer for preclinical testing

    Energy Technology Data Exchange (ETDEWEB)

    Umetani, Keiji [Japan Synchrotron Radiation Research Institute, SPring-8, Sayo-cho, Sayo-gun, Hyogo 679-5198 (Japan)], E-mail: umetani@spring8.or.jp; Uesugi, Kentaro [Japan Synchrotron Radiation Research Institute, SPring-8, Sayo-cho, Sayo-gun, Hyogo 679-5198 (Japan); Kobatake, Makito; Yamamoto, Akira; Yamashita, Takenori; Imai, Shigeki [Kawasaki Medical School, Matsushima, Kurashiki-shi, Okayama 701-0192 (Japan)

    2009-10-01

    Preclinical laboratory animal imaging modalities such as microangiography and micro-computed tomography (micro-CT) have been developed at the SPring-8 BL20B2 bending magnet beamline. The objective of this paper is to demonstrate the usefulness of microangiography systems for physiological examinations of live animals and micro-CT systems for postmortem morphological examinations. Synchrotron radiation microangiography and micro-CT with contrast agents present the main advantageous capability of depicting the anatomy of small blood vessels with tens of micrometers' diameter. This paper reports two imaging instrument types and their respective applications to preclinical imaging of tumor angiogenic blood vessels in tumor-bearing rabbits, where tumor angiogenesis is characterized morphologically by an increased number of blood vessels. A microangiography system with spatial resolution around 10 {mu}m has been used for therapeutically evaluating angiogenic vessels in a rabbit model of cancer for evaluating embolization materials in transcatheter arterial embolization and for radiation therapy. After an iodine contrast agent was injected into an artery, in vivo imaging was carried out using a high-resolution real-time detector incorporating an X-ray direct-conversion-type SATICON pickup tube. On the other hand, a micro-CT system capably performed three-dimensional visualization of tumor angiogenic blood vessels using tumor-transplanted rabbit specimens with a barium sulfate contrast agent injected into the blood vessels. For specimen imaging, a large-field high-resolution micro-CT system based on a 10-megapixel CCD camera was developed to study tumor-associated alterations in angioarchitecture. Evidence of increased vascularity by tumor angiogenesis and decreased vascularity by tumor treatments was achieved by physiological evaluation of angiogenic small blood vessels in microangiographic imaging and by morphological assessment in micro-CT imaging. These results

  14. Synchrotron radiation microimaging in rabbit models of cancer for preclinical testing

    International Nuclear Information System (INIS)

    Umetani, Keiji; Uesugi, Kentaro; Kobatake, Makito; Yamamoto, Akira; Yamashita, Takenori; Imai, Shigeki

    2009-01-01

    Preclinical laboratory animal imaging modalities such as microangiography and micro-computed tomography (micro-CT) have been developed at the SPring-8 BL20B2 bending magnet beamline. The objective of this paper is to demonstrate the usefulness of microangiography systems for physiological examinations of live animals and micro-CT systems for postmortem morphological examinations. Synchrotron radiation microangiography and micro-CT with contrast agents present the main advantageous capability of depicting the anatomy of small blood vessels with tens of micrometers' diameter. This paper reports two imaging instrument types and their respective applications to preclinical imaging of tumor angiogenic blood vessels in tumor-bearing rabbits, where tumor angiogenesis is characterized morphologically by an increased number of blood vessels. A microangiography system with spatial resolution around 10 μm has been used for therapeutically evaluating angiogenic vessels in a rabbit model of cancer for evaluating embolization materials in transcatheter arterial embolization and for radiation therapy. After an iodine contrast agent was injected into an artery, in vivo imaging was carried out using a high-resolution real-time detector incorporating an X-ray direct-conversion-type SATICON pickup tube. On the other hand, a micro-CT system capably performed three-dimensional visualization of tumor angiogenic blood vessels using tumor-transplanted rabbit specimens with a barium sulfate contrast agent injected into the blood vessels. For specimen imaging, a large-field high-resolution micro-CT system based on a 10-megapixel CCD camera was developed to study tumor-associated alterations in angioarchitecture. Evidence of increased vascularity by tumor angiogenesis and decreased vascularity by tumor treatments was achieved by physiological evaluation of angiogenic small blood vessels in microangiographic imaging and by morphological assessment in micro-CT imaging. These results

  15. Stability, resilience and animal production in continuously grazed ...

    African Journals Online (AJOL)

    The Jones-Sandland model, popularly used in southern Africa, may be criticised because it ignores firstly the long-term effects of grazing intensity on the acceptability and productivity of pasture or veld, and secondly possible discontinuities in the animal performance - stocking rate relationship. A mathematical model is ...

  16. Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies

    Directory of Open Access Journals (Sweden)

    A.G.M. Mostofa

    2017-06-01

    Full Text Available Thymoquinone (TQ, the main bioactive component of Nigella sativa, has been found to exhibit anticancer effects in numerous preclinical studies. Due to its multitargeting nature, TQ interferes in a wide range of tumorigenic processes and counteracts carcinogenesis, malignant growth, invasion, migration, and angiogenesis. Moreover, TQ can specifically sensitize tumor cells toward conventional cancer treatments (e.g., radiotherapy, chemotherapy, and immunotherapy and simultaneously minimize therapy-associated toxic effects in normal cells. In this review, we summarized the adjuvant potential of TQ as observed in various in vitro and in vivo animal models and discussed the pharmacological properties of TQ to rationalize its supplementary role in potentiating the efficacy of standard therapeutic modalities namely surgery, radiotherapy, chemotherapy, and immunotherapy. Altogether, we suggest further comprehensive evaluation of TQ in preclinical and clinical levels to delineate its implied utility as a novel complementary adjuvant therapy for cancer treatment.

  17. Tendinopathies and platelet-rich plasma (PRP: from pre-clinical experiments to therapeutic use

    Directory of Open Access Journals (Sweden)

    Kaux JF

    2015-05-01

    Full Text Available Objectives: The restorative properties of platelets, through the local release of growth factors, are used in various medical areas. This article reviews fundamental and clinical research relating to platelet-rich plasma applied to tendinous lesions. Materials and method: Articles in French and English, published between 1 January 2012 and 31 December 2014. dealing with PRP and tendons were searched for using the Medline and Scopus data bases. Results: Forty-seven articles were identified which addressed pre-clinical and clinical studies: 27 relating to in vitro and in vivo animal studies and 20 relating to human studies. Of these, five addressed lateral epicondylitis, two addressed rotator cuff tendinopathies, ten dealt with patellar tendinopathies and three looked at Achilles tendinopathies. Conclusions: The majority of pre-clinical studies show that PRP stimulates the tendon's healing process. However, clinical series remain more controversial and level 1, controlled, randomised studies are still needed.

  18. Animal Meal: Production and Determination in Feedstuffs and the Origin of Bovine Spongiform Encephalopathy

    Science.gov (United States)

    Hahn, Heinz

    This contribution examines what animal meal is, how it is produced in rendering plants, and means of investigating feedstuff constituents. In addition to animal meal, numerous other products of animal origin are also on the market (e.g., blood meal, bone meal, feather meal, gelatin). Constituents of animal origin can be detected in feedstuffs by microscopy, but determining the animal species from which the constituents are derived, as required by law in Germany, requires methods such as enzyme-linked immunosorbent assay and polymerase chain reaction. We consider the problem of trace contamination being introduced accidentally during the production of ruminants' feedstuffs containing constituents of animal origin. The future of animal meal is discussed together with alternatives for disposing of animal carcasses and slaughtery offal, i.e., composting and incineration.

  19. Chilean consumers' perception about animal welfare in dairy production systems

    DEFF Research Database (Denmark)

    Vargas-Bello-Pérez, Einar; Riveros, José Luis; Köbrich, Claus

    2017-01-01

    production systems and animal welfare, and the main aspects they considered when buying dairy products. A face-to-face interview was conducted on a sample of 501 persons from the Province of Santiago, Chile. The survey was conducted in major supermarkets from 15 different municipalities of Santiago...

  20. Nitrogen in global animal production and management options for improving nitrogen use efficiency

    NARCIS (Netherlands)

    Oenema, O.; Tamminga, S.

    2005-01-01

    Animal production systems convert plant protein into animal protein. Depending on animal species, ration and management, between 5% and 45 % of the nitrogen (N) in plant protein is converted to and deposited in animal protein. The other 55%-95% is excreted via urine and feces, and can be used as

  1. Review on Sources and Handling Method of Pesticide Residues in Animal Products

    Directory of Open Access Journals (Sweden)

    Indraningsih

    2006-06-01

    Full Text Available Field studies and literature search showed that some pesticide residues either organochlorines (OC or organophosphates (OP were detected in animal products (meat and milk . Pesticide residues in meat collected from West Java were detected at the level of 0 .8 ppb lindane and 62 ppb diazinon . While in meat from Lampung was detected at the level of 7 ppb lindane . 2 .7 heptachlor, 0 .8 endosulfan and 0 .5 ppb aldrin . Furthermore, pesticide residues were also detected in the milk collected from West, Central and East Java . The levels of lindane were 2,3 ; 15,9 ; 0,2 ppb ; heptachlor 8 ; 0 .4 and 0,05 ppb; diazinon 8 ; 0 and 1,8 ppb; CPM 0,4 ; 0,8 and 0 ppb ; endosulfan 0,1 ; 0,04 and 0,05 ppb for West, Central and East Java, respectively . The source of pesticide contamination in animal products is generally originated from feed materials, fodders . contaminated soils and water around the farm areas . Minimalization approach of pesticide residues in animal products could be conducted integratedly, such as through chemical process, biodegradation using microorganisms . Organic farming system is recognised as an alternative that may be applied to minimise contamination on agricultural land, eventually reducing pesticide residues in the agricultural products . Feeding with organic agricultural by-products with low pesticide residues appears to reduce pesticide residues in animal products . In order to eliminate pesticide contamination in soil, it has to be conducted progressively by implementing sustainable organic farming .

  2. Properties of various plants and animals feedstocks for biodiesel production.

    Science.gov (United States)

    Karmakar, Aninidita; Karmakar, Subrata; Mukherjee, Souti

    2010-10-01

    As an alternative fuel biodiesel is becoming increasingly important due to diminishing petroleum reserves and adverse environmental consequences of exhaust gases from petroleum-fuelled engines. Biodiesel, the non-toxic fuel, is mono alkyl esters of long chain fatty acids derived from renewable feedstock like vegetable oils, animal fats and residual oils. Choice of feedstocks depends on process chemistry, physical and chemical characteristics of virgin or used oils and economy of the process. Extensive research information is available on transesterification, the production technology and process optimization for various biomaterials. Consistent supply of feedstocks is being faced as a major challenge by the biodiesel production industry. This paper reviews physico-chemical properties of the plant and animal resources that are being used as feedstocks for biodiesel production. Efforts have also been made to review the potential resources that can be transformed into biodiesel successfully for meeting the ever increasing demand of biodiesel production. Copyright 2010 Elsevier Ltd. All rights reserved.

  3. Bridging the gap between basic and applied biology: towards preclinical translation

    Directory of Open Access Journals (Sweden)

    Ross L. Cagan

    2013-05-01

    To better translate basic research findings into the clinic, we are moving away from the traditional one-gene–one-phenotype model towards the discovery of complex mechanisms. In this Editorial, the new Editor-in-Chief and Senior Editors of Disease Models & Mechanisms (DMM discuss the role that the journal will play in this transition. DMM will continue to provide a platform for studies that bridge basic and applied science, and, by demanding the rigorous assessment of animal models of disease, will help drive the establishment of robust standards of preclinical testing for drug development.

  4. Animal husbandry and food production in China and Europe: A shared moral problem?

    NARCIS (Netherlands)

    Meijboom, F.L.B.; Li, Jianjun

    2015-01-01

    In China and Europe many millions of animals are used for food production. For both regions animal food production is considered to be important for both the internal market, but also for export. In spite of these similarities there are many differences. First, while in Europe there currently is a

  5. Lichen ranges, animal densities and production in Finnish reindeer management

    Directory of Open Access Journals (Sweden)

    T. Helle

    1990-09-01

    Full Text Available In the 1970s, mean lichen biomass ranged by the earmark districts (comprising of 2-9 adjacent herding associations between 54 kg and 380 kg DM per ha correlating negatively with animal density per lichen ranges (range 1.5 - 14.3 ind. per km2. Biomasses were far below economic carrying capacity of lichen ranges (900 kg DM per ha. The condition of lichen ranges was poorest in the southern half of the area where alternative food to reindeer lichens (Deschampsia flexuosa, arboreal lichens and supplementary feeding was available. In 1980-86, recruitment (calves per 100 females was 33% higher than in the 1970's, on an average (65 vs. 49, despite a 90% increase in animal numbers between 1970 and 1986; recruitment has not been dependent on the condition of lichen ranges. The increase in production has been some higher than expected on the basis of animal numbers. The reasons for the increasing trends in animal numbers, recruitment and production remains some unclear, but they may include favorable winter conditions, supplementary feeding, medical treatment against parasites and proper harvesting policy.

  6. Nuclear techniques in animal production and health and food irradiation

    International Nuclear Information System (INIS)

    Cetinkaya, N.

    2002-01-01

    Nuclear techniques applied to animal production and health are concentrated in three main fields: Animal nutrition, reproduction and animal health. Isotopic markers, both radioactive (''1''4C, ''5 1 Cr, 32 P and 35 S) and stable ( 15 N), have been used in the development of feeding strategies by understanding the rumen fermentation process, and how protein and other nutrients are utilized to determine a balanced diet for meeting animal requirements for growth, pregnancy and lactation. The simple and easily applicable technology was developed for the preparation of a urea mineral multi nutrient block as a supplement and animal cake for the replacement of concentrate feed used by dairy cattle holders. The model was developed in Yerli Kara Cattle and its cross-breeds to estimate protein requirements of animals. Progesterone immunoassays (RIA/EIA) make it possible to control the reproductive performance of cattle, sheep and goats. A milk progesterone enzyme immunoassay kit known as Reprokon was developed at our Center. The kit has licensed by the Ministry of Agriculture and Rural Affairs. As for animal diseases, especially parasitic infections, nuclear techniques have proved to be of great value, namely in the production of irradiated vaccines against helminitic diseases. The Enzyme Linked Immunosorbent assay (ELISA) diagnostic techniques were used on the diagnosis of babesiosis, a disease which cause great economic loss in livestock in Turkey. Food irradiation is the treatment of raw, semi-processed or processed food or food ingredients with ionizing radiation to achieve a reduction of losses due to insect infestation, germination of root crops, spoilage and deterioration of perishable produce, and/or the control of microorganisms and other organisms that cause food borne diseases

  7. Designing foods: animal product options in the marketplace

    National Research Council Canada - National Science Library

    1988-01-01

    ... of Animal Products Board on Agriculture National Research Council NATIONAL ACADEMY PRESS Washington, D.C. 1988 i Copyrighttrue Please breaks inserted. are Page files. accidentally typesetting been have may original from the errors not typographic original retained, and from the created cannot be files XML from however, formatting, recomposed typesetti...

  8. Alternatives to antibiotics: a symposium on the challenges and solutions for animal production.

    Science.gov (United States)

    Seal, Bruce S; Lillehoj, Hyun S; Donovan, David M; Gay, Cyril G

    2013-06-01

    Antibiotics are one of the most important medical discoveries of the 20th century and will remain an essential tool for treating animal and human diseases in the 21st century. However, antibiotic resistance among bacterial pathogens and concerns over their extensive use in food animals has garnered global interest in limiting antibiotic use in animal agriculture. Yet, limiting the availability of medical interventions to prevent and control animal diseases on the farm will directly impact global food security and safety as well as animal and human health. Insufficient attention has been given to the scientific breakthroughs and novel technologies that provide alternatives to antibiotics. The objectives of the symposium 'Alternatives to Antibiotics' were to highlight promising research results and novel technologies that could potentially lead to alternatives to conventional antibiotics, and assess challenges associated with their commercialization, and provide actionable strategies to support development of alternative antimicrobials. The symposium focused on the latest scientific breakthroughs and technologies that could provide new options and alternative strategies for preventing and treating diseases of animals. Some of these new technologies have direct applications as medical interventions for human health, but the focus of the symposium was animal production, animal health and food safety during food-animal production. Five subject areas were explored in detail through scientific presentations and expert panel discussions, including: (1) alternatives to antibiotics, lessons from nature; (2) immune modulation approaches to enhance disease resistance and to treat animal diseases; (3) gut microbiome and immune development, health and diseases; (4) alternatives to antibiotics for animal production; and (5) regulatory pathways to enable the licensure of alternatives to antibiotics.

  9. The impact of animal source food products on human nutrition and ...

    African Journals Online (AJOL)

    FBDG

    Associates of the Institute of Food, Nutrition and Well-being, University of ... nutrition), the role of animal source foods as part of a healthy diet requires continuous investment ... Keywords: Animal source foods, livestock products, nutrition, health ..... sensation of fullness that persists after eating until hunger returns (Benelam, ...

  10. Enabling Passive Immunization as an Alternative to Antibiotics for Controlling Enteric Infections in Production Animals

    DEFF Research Database (Denmark)

    Heegaard, Peter M. H.; Hald, Birthe; Madsen, M.

    Enteric infections cause major problems in most intensive animal production sectors, including poultry, pigs and cattle, leading to disease, reduced production and compromised welfare. In addition some of these infections are zoonotic, and they are to a large extent responsible for the continued ...... as a viable strategy for control of infectious diseases in the intensive animal production, with the potential to significantly reduce antibiotics consumption.......Enteric infections cause major problems in most intensive animal production sectors, including poultry, pigs and cattle, leading to disease, reduced production and compromised welfare. In addition some of these infections are zoonotic, and they are to a large extent responsible for the continued...... massive use of antibiotics in food animals. Thus there is a pressing need for economically feasible, efficient, non-antibiotics based means for controlling the problem. Passive immunization has been known for decades as an efficient way of endowing humans or animals with short-term (weeks) immunity...

  11. The anxious mouse: implications for preclinical research and animal welfare

    NARCIS (Netherlands)

    Salomons, A.R.

    2011-01-01

    Anxiety is an essential emotion that is highly conserved during evolution and is present in animals and humans. Although anxiety is a biological adaptive response, anxiety disorders in humans are common and affect about 10-17% of the world population. To gain more insight in the underlying

  12. Animal-derived natural products of Sowa Rigpa medicine: Their pharmacopoeial description, current utilization and zoological identification.

    Science.gov (United States)

    Yeshi, Karma; Morisco, Paolo; Wangchuk, Phurpa

    2017-07-31

    The Bhutanese Sowa Rigpa medicine (BSM) uses animal parts in the preparation of numerous polyingredient traditional remedies. Our study reports the taxonomical identification of medicinal animals and the description of traditional uses in English medical terminologies. To taxonomically identify the medicinal animals and their derived natural products used as a zootherapeutic agents in BSM. First, the traditional textbooks were reviewed to generate a list of animal products described as ingredients. Second, animal parts that are currently used in Bhutan were identified. Third, the ethnopharmacological uses of each animal ingredients were translated into English medical terminologies by consulting Traditional Physicians, clinical assistants, pharmacognosists, and pharmacists in Bhutan. Fourth, the animal parts were taxonomically identified and their Latin names were confirmed by crosschecking them with online animal databases and relevant scientific literature. The study found 73 natural products belonging to 29 categories derived from 45 medicinal animals (36 vertebrates and 9 invertebrates), comprising of 9 taxonomic categories and 30 zoological families. Out of 116 formulations currently produced, 87 of them contain one or more extracts and products obtained from 13 medicinal animals to treat more than 124 traditionally classified illnesses. Only five animal ingredients were found available in Bhutan and rest of the animal parts are being imported from India. Out of 73 natural products described in the traditional textbooks, only 13 of them (some omitted and few substituted by plants) are currently included in 87 formulations of BSM. Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

  13. Analysis of integrated animal-fish production system under subtropical hill agro ecosystem in India: growth performance of animals, total biomass production and monetary benefit.

    Science.gov (United States)

    Kumaresan, A; Pathak, K A; Bujarbaruah, K M; Vinod, K

    2009-03-01

    The present study assessed the benefits of integration of animals with fish production in optimizing the bio mass production from unit land in subtropical hill agro ecosystem. Hampshire pigs and Khaki Campbell ducks were integrated with composite fish culture. The pig and duck excreta were directly allowed into the pond and no supplementary feed was given to fish during the period of study. The average levels of N, P and K in dried pig and duck manure were 0.9, 0.7 and 0.6 per cent and 1.3, 0.6 and 0.5 per cent, respectively. The average body weight of pig and duck at 11 months age was 90 and 1.74 kg with an average daily weight gain of 333.33 and 6.44 g, respectively. The fish production in pig-fish and duck-fish systems were 2209 and 2964 kg/ha, respectively while the fish productivity in control pond was only 820 kg/ha. The total biomass (animal and fish) production was higher (pfeeding system compared to the traditional system, however the input/output ratio was 1:1.2 and 1:1.55 for commercial and traditional systems, respectively. It was inferred that the total biomass production per unit land was high (pfish were integrated together.

  14. Commoditizing Nonhuman Animals and Their Consumers: Industrial Livestock Production, Animal Welfare, and Ecological Justice

    Science.gov (United States)

    McLeod-Kilmurray, Heather

    2012-01-01

    There is increasing research on the effects of industrial livestock production on the environment and human health, but less on the effects this has on animal welfare and ecological justice. The concept of ecological justice as a tool for achieving sustainability is gaining traction in the legal world. Klaus Bosselman defines ecological justice as…

  15. Pollution by animal production in The Netherlands: solutions.

    Science.gov (United States)

    Voorburg, J H

    1991-09-01

    Provided that the application rates of manure do not exceed the crop uptake of nutrients, pollution by animal production is mainly caused by nitrogenous substances. Applying manure outside the growing season causes pollution of groundwater and surface water due to leaching and runoff. In regions with a high livestock density, the evaporation of ammonia has a serious impact on the environment. It contributes to acidification and causes a nutrient imbalance in natural vegetation. The prevention of nutrient losses from manure is unprofitable. The environmental impact is not caused by the individual farmer but is a result of the sum of activities in a region. This means that legislation is necessary to impose limits in order to arrive at production without pollution. Within this framework, the farmer should optimise the utilisation of minerals from manure by more efficient animal nutrition and better handling of the manure. One of the most difficult problems is the prevention of ammonia evaporation. A reduction of these losses generally also has a favourable effect on odour emissions. A new development is the processing of manure surpluses into a dried manure of sufficient quality to compete on the fertiliser market. As is usually the case with pollution control, these measures raise the costs of livestock production.

  16. Application of nuclear techniques in animal health and production

    Energy Technology Data Exchange (ETDEWEB)

    1974-01-01

    Under United Nations Development Programme in collaboration with the International Atomic Energy Agency, Vienna, a beginning was made in the use of nuclear techniques in animal health and production at the Indian Veterinary Research Institute, Izatnagar. Radioisotopes are being used as tracers for investigations in rumen digestion, metabolism, physiology and endocrinology of animals. Irradiated vaccines against parasitic infestation are being developed. Various facilities available, salient research findings of the studies carried so far and research work under progress and future development plans are described.

  17. Application of nuclear techniques in animal health and production

    International Nuclear Information System (INIS)

    1974-01-01

    Under United Nations Development Programme in collaboration with the International Atomic Energy Agency, Vienna, a beginning was made in the use of nuclear techniques in animal health and production at the Indian Veterinary Research Institute, Izatnagar. Radioisotopes are being used as tracers for investigations in rumen digestion, metabolism, physiology and endocrinology of animals. Irradiated vaccines against parasitic infestation are being developed. Various facilities available, salient research findings of the studies carried so far and research work under progress and future development plans are described. (M.G.B.)

  18. Stroke Lesions in a Large Upper Limb Rehabilitation Trial Cohort Rarely Match Lesions in Common Preclinical Models

    Science.gov (United States)

    Edwardson, Matthew A.; Wang, Ximing; Liu, Brent; Ding, Li; Lane, Christianne J.; Park, Caron; Nelsen, Monica A.; Jones, Theresa A; Wolf, Steven L; Winstein, Carolee J; Dromerick, Alexander W.

    2017-01-01

    Background Stroke patients with mild-moderate upper extremity (UE) motor impairments and minimal sensory and cognitive deficits provide a useful model to study recovery and improve rehabilitation. Laboratory-based investigators use lesioning techniques for similar goals. Objective Determine whether stroke lesions in an UE rehabilitation trial cohort match lesions from the preclinical stroke recovery models used to drive translational research. Methods Clinical neuroimages from 297 participants enrolled in the Interdisciplinary Comprehensive Arm Rehabilitation Evaluation (ICARE) study were reviewed. Images were characterized based on lesion type (ischemic or hemorrhagic), volume, vascular territory, depth (cortical gray matter, cortical white matter, subcortical), old strokes, and leukoaraiosis. Lesions were compared with those of preclinical stroke models commonly used to study upper limb recovery. Results Among the ischemic stroke participants, median infarct volume was 1.8 mL, with most lesions confined to subcortical structures (61%) including the anterior choroidal artery territory (30%) and the pons (23%). Of ICARE participants, stroke patients, but they represent a clinically and scientifically important subgroup. Compared to lesions in general stroke populations and widely-studied animal models of recovery, ICARE participants had smaller, more subcortically-based strokes. Improved preclinical-clinical translational efforts may require better alignment of lesions between preclinical and human stroke recovery models. PMID:28337932

  19. Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.

    Science.gov (United States)

    Siegler, Elizabeth Louise; Wang, Pin

    2018-05-01

    Cancer immunotherapy has enormous potential in inducing long-term remission in cancer patients, and chimeric antigen receptor (CAR)-engineered T cells have been largely successful in treating hematological malignancies in the clinic. CAR-T therapy has not been as effective in treating solid tumors, in part due to the immunosuppressive tumor microenvironment. Additionally, CAR-T therapy can cause dangerous side effects, including off-tumor toxicity, cytokine release syndrome, and neurotoxicity. Animal models of CAR-T therapy often fail to predict such adverse events and frequently overestimate the efficacy of the treatment. Nearly all preclinical CAR-T studies have been performed in mice, including syngeneic, xenograft, transgenic, and humanized mouse models. Recently, a few studies have used primate models to mimic clinical side effects better. To date, no single model perfectly recapitulates the human immune system and tumor microenvironment, and some models have revealed CAR-T limitations that were contradicted or missed entirely in other models. Careful model selection based on the primary goals of the study is a crucial step in evaluating CAR-T treatment. Advancements are being made in preclinical models, with the ultimate objective of providing safer, more effective CAR-T therapy to patients.

  20. The Role of Three-Dimensional Scaffolds in Treating Long Bone Defects: Evidence from Preclinical and Clinical Literature-A Systematic Review.

    Science.gov (United States)

    Roffi, Alice; Krishnakumar, Gopal Shankar; Gostynska, Natalia; Kon, Elizaveta; Candrian, Christian; Filardo, Giuseppe

    2017-01-01

    Long bone defects represent a clinical challenge. Bone tissue engineering (BTE) has been developed to overcome problems associated with conventional methods. The aim of this study was to assess the BTE strategies available in preclinical and clinical settings and the current evidence supporting this approach. A systematic literature screening was performed on PubMed database, searching for both preclinical (only on large animals) and clinical studies. The following string was used: "(Scaffold OR Implant) AND (Long bone defect OR segmental bone defect OR large bone defect OR bone loss defect)." The search retrieved a total of 1573 articles: 51 preclinical and 4 clinical studies were included. The great amount of preclinical papers published over the past few years showed promising findings in terms of radiological and histological evidence. Unfortunately, this in vivo situation is not reflected by a corresponding clinical impact, with few published papers, highly heterogeneous and with small patient populations. Several aspects should be further investigated to translate positive preclinical findings into clinical protocols: the identification of the best biomaterial, with both biological and biomechanical suitable properties, and the selection of the best choice between cells, GFs, or their combination through standardized models to be validated by randomized trials.

  1. Dietary sources and their effects on animal production and environmental sustainability

    Directory of Open Access Journals (Sweden)

    Metha Wanapat

    2015-09-01

    Full Text Available Animal agriculture has been an important component in the integrated farming systems in developing countries. It serves in a paramount diversified role in producing animal protein food, draft power, farm manure as well as ensuring social status-quo and enriching livelihood. Ruminants are importantly contributable to the well-being and the livelihood of the global population. Ruminant production systems can vary from subsistence to intensive type of farming depending on locality, resource availability, infrastructure accessibility, food demand and market potentials. The growing demand for sustainable animal production is compelling to researchers exploring the potential approaches to reduce greenhouse gases (GHG emissions from livestock. Global warming has been an issue of concern and importance for all especially those engaged in animal agriculture. Methane (CH4 is one of the major GHG accounted for at least 14% of the total GHG with a global warming potential 25-fold of carbon dioxide and a 12-year atmospheric lifetime. Agricultural sector has a contribution of 50 to 60% methane emission and ruminants are the major source of methane contribution (15 to 33%. Methane emission by enteric fermentation of ruminants represents a loss of energy intake (5 to 15% of total and is produced by methanogens (archae as a result of fermentation end-products. Ruminants׳ digestive fermentation results in fermentation end-products of volatile fatty acids (VFA, microbial protein and methane production in the rumen. Rumen microorganisms including bacteria, protozoa and fungal zoospores are closely associated with the rumen fermentation efficiency. Besides using feed formulation and feeding management, local feed resources have been used as alternative feed additives for manipulation of rumen ecology with promising results for replacement in ruminant feeding. Those potential feed additive practices are as follows: 1 the use of plant extracts or plants containing

  2. Method and apparatus for treatment of animal waste products

    Energy Technology Data Exchange (ETDEWEB)

    Davidson, R R

    1977-12-15

    Animal wastes (fresh manure and urine) are converted to products useful on farmland or in animal feed by treating them with alkali metal hydroxides or carbonates and/or alkaline earth hydroxides to give slurries with pH 9.0 to 12.0, thus deactivating urease. Thus, a slurry of swine manure and urine adjusted with CaO to pH 11 has urea content 27.0 and 26.5 mg/L after 0 and 10 days, respectively, at 20/sup 0/, compared with 22.0 and 0, respectively, in the absence of base.

  3. Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.

    Science.gov (United States)

    Dos Santos, Rafael G; Hallak, Jaime E C

    2017-01-01

    Harmine is a natural β-carboline alkaloid found in several botanical species, such as the Banisteriopsis caapi vine used in the preparation of the hallucinogenic beverage ayahuasca and the seeds of Syrian rue (Peganum harmala). Preclinical studies suggest that harmine may have neuroprotective and cognitive-enhancing effects, and retrospective/observational investigations of the mental health of long-term ayahuasca users suggest that prolonged use of this harmine-rich hallucinogen is associated with better neuropsychological functioning. Thus, in order to better investigate these possibilities, we performed a systematic literature review of preclinical studies analyzing the effects of harmine on hippocampal neurons and in memory-related behavioral tasks in animal models. We found two studies involving hippocampal cell cultures and nine studies using animal models. Harmine administration was associated with neuroprotective effects such as reduced excitotoxicity, inflammation, and oxidative stress, and increased brain-derived neurotrophic factor (BDNF) levels. Harmine also improved memory/learning in several animal models. These effects seem be mediated by monoamine oxidase or acetylcholinesterase inhibition, upregulation of glutamate transporters, decreases in reactive oxygen species, increases in neurotrophic factors, and anti-inflammatory effects. The neuroprotective and cognitive-enhancing effects of harmine should be further investigated in both preclinical and human studies.

  4. The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulator

    Energy Technology Data Exchange (ETDEWEB)

    Grant, Claire, E-mail: claire.grant@astrazeneca.com [Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield SK10 4TG (United Kingdom); Ewart, Lorna [Drug Safety and Metabolism, AstraZeneca, Da Vinci Building, Melbourn Science Park, Cambridge Road, Melbourn, Royston SG8 6HB (United Kingdom); Muthas, Daniel [Respiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal (Sweden); Deavall, Damian [Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield SK10 4TG (United Kingdom); Smith, Simon A. [Oncology Translational Medicine Unit, Early Clinical Development, AstraZeneca, Da Vinci Building, Melbourn Science Park, Melbourn, Royston SG8 6HB (United Kingdom); Clack, Glen [Translational Medicine Unit, Early Clinical Development, AstraZeneca, Alderley Park, Macclesfield SK10 4TG (United Kingdom); Newham, Pete [Drug Safety and Metabolism, AstraZeneca, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG (United Kingdom)

    2016-04-01

    Nausea and vomiting are components of a complex mechanism that signals food avoidance and protection of the body against the absorption of ingested toxins. This response can also be triggered by pharmaceuticals. Predicting clinical nausea and vomiting liability for pharmaceutical agents based on pre-clinical data can be problematic as no single animal model is a universal predictor. Moreover, efforts to improve models are hampered by the lack of translational animal and human data in the public domain. AZD3514 is a novel, orally-administered compound that inhibits androgen receptor signaling and down-regulates androgen receptor expression. Here we have explored the utility of integrating data from several pre-clinical models to predict nausea and vomiting in the clinic. Single and repeat doses of AZD3514 resulted in emesis, salivation and gastrointestinal disturbances in the dog, and inhibited gastric emptying in rats after a single dose. AZD3514, at clinically relevant exposures, induced dose-responsive “pica” behaviour in rats after single and multiple daily doses, and induced retching and vomiting behaviour in ferrets after a single dose. We compare these data with the clinical manifestation of nausea and vomiting encountered in patients with castration-resistant prostate cancer receiving AZD3514. Our data reveal a striking relationship between the pre-clinical observations described and the experience of nausea and vomiting in the clinic. In conclusion, the emetic nature of AZD3514 was predicted across a range of pre-clinical models, and the approach presented provides a valuable framework for predicition of clinical nausea and vomiting. - Highlights: • Integrated pre-clinical data can be used to predict clinical nausea and vomiting. • Data integrated from standard toxicology studies is sufficient to make a prediction. • The use of the nausea algorithm developed by Parkinson (2012) aids the prediction. • Additional pre-clinical studies can be used

  5. Salmonella contamination: a significant challenge to the global marketing of animal food products.

    Science.gov (United States)

    L Plym, Forshell; Wierup, M

    2006-08-01

    Salmonellosis is the most common food-borne bacterial disease in the world. Salmonella is a significant pathogen for food-producing animals and these animals are the primary source of salmonellosis. It is estimated that herd prevalence varies between 0% and 90%, depending on the animal species and region. The pathogen is spread by trade in animals and non-heated animal food products. The emergence of strains that are resistant to antimicrobials, often as a result of antimicrobial usage in animals, is a public health hazard of great concern. It is increasingly accepted that the prevalence of Salmonella in animal production must be decreased and, in the European Union, plans to achieve this are currently being implemented. In this paper, the authors propose various risk mitigation strategies. Successful control must focus on a range of preventive actions because there is no simple 'silver bullet' solution to reduce Salmonella contamination. The authors conclude that the key to controlling Salmonella is to follow the general rules that have been successfully applied to other infectious diseases.

  6. Closer to Nature: the Ethics of ‘Green’ Representations in Animal Product Marketing

    DEFF Research Database (Denmark)

    Borkfelt, Sune; Kondrup, Sara Vincentzen; Gjerris, Mickey

    2013-01-01

    – thus attempting to display a green, eco-, climate-, and animal friendly production. The tension between marketing and the idea of ethical consumerism is apparent as the need for independent information to make value-based choices is challenged by the liberal rules of the market and more specifically......Empirical cases from the Danish food market are examined in order to critically discuss the respective modes of communication in light of the premises of socially responsible consumer marketing. This analysis suggests that specific marketing instruments are used to sell animal products by blurring...... by the lack of a restrictive food labelling policy. The relationship between the ways in which animal welfare is communicated and emphasized through food marketing, and commonly held perceptions of acceptable standards for animal welfare, is discussed and the need for transparency in the area of animal...

  7. Animals

    Energy Technology Data Exchange (ETDEWEB)

    Skuterud, L.; Strand, P. [Norwegian Radiation Protection Authority (Norway); Howard, B.J. [Inst. of Terrestrial Ecology (United Kingdom)

    1997-10-01

    The radionuclides of most concern with respect to contamination of animals after a nuclear accident are radioiodine, radiocaesium and radiostrontium (ICRP 30, 1979). Of the other significant anthropogenic radionuclides likely to be released in most accidents, only small proportions of that ingested will be absorbed in an animals gut, and the main animal products, milk and meat, will not normally be contaminated to a significant extent. Animal products will mostly be contaminated as a result of ingestion of contaminated feed and possibly, but to a much lesser extent, from inhalation (for radioiodine only). Direct external contamination of animals is of little or no consequence in human food production. Radioiodine and radiostrontium are important with respect to contamination of milk; radiocaesium contaminates both milk and meat. The physical and chemical form of a radionuclide can influence its absorption in the animal gut. For example, following the Chernobyl accident radiocaesium incorporated into vegetation by root uptake was more readily absorbed than that associated with the original deposit. The transfer of radiocaesium and radiostrontium to animals will be presented both as transfer coefficients and aggregated transfer coefficients. For most animal meat products, only radiocaesium is important as other radionuclides do not significantly contaminate muscle. Farm animal products are the most important foodstuff determining radiocaesium intake by the average consumer in the Nordic countries. The major potential source of radioiodine and radiostrontium to humans is milk and milk products. Of the different species, the smaller animals have the highest transfer of radiocaesium from fodder to meat and milk. (EG). 68 refs.

  8. Animals

    International Nuclear Information System (INIS)

    Skuterud, L.; Strand, P.; Howard, B.J.

    1997-01-01

    The radionuclides of most concern with respect to contamination of animals after a nuclear accident are radioiodine, radiocaesium and radiostrontium (ICRP 30, 1979). Of the other significant anthropogenic radionuclides likely to be released in most accidents, only small proportions of that ingested will be absorbed in an animals gut, and the main animal products, milk and meat, will not normally be contaminated to a significant extent. Animal products will mostly be contaminated as a result of ingestion of contaminated feed and possibly, but to a much lesser extent, from inhalation (for radioiodine only). Direct external contamination of animals is of little or no consequence in human food production. Radioiodine and radiostrontium are important with respect to contamination of milk; radiocaesium contaminates both milk and meat. The physical and chemical form of a radionuclide can influence its absorption in the animal gut. For example, following the Chernobyl accident radiocaesium incorporated into vegetation by root uptake was more readily absorbed than that associated with the original deposit. The transfer of radiocaesium and radiostrontium to animals will be presented both as transfer coefficients and aggregated transfer coefficients. For most animal meat products, only radiocaesium is important as other radionuclides do not significantly contaminate muscle. Farm animal products are the most important foodstuff determining radiocaesium intake by the average consumer in the Nordic countries. The major potential source of radioiodine and radiostrontium to humans is milk and milk products. Of the different species, the smaller animals have the highest transfer of radiocaesium from fodder to meat and milk. (EG)

  9. The water footprint of animal products : The meat crisis: Developing more sustainable and ethical production and consumption

    NARCIS (Netherlands)

    Hoekstra, Arjen Y.; D'Silva, Joyce; Webster, John

    2017-01-01

    Meat and dairy production and consumption are in crisis. Globally, 70 billion farm animals are used for food production every year. It is well accepted that livestock production is a major contributor to greenhouse gas emissions. The Food and Agriculture Organization of the United Nations (FAO)

  10. Animal production and health newsletter. No. 33

    International Nuclear Information System (INIS)

    2000-12-01

    A full report on the final research coordination meeting on the long running Coordinated Research Project supporting rinderpest eradication is contained in this Newsletter. It is reported that all the national rinderpest vaccination campaigns have been terminated and except for a very few isolated areas where vaccination continues, the effort is now on disease surveillance to demonstrate freedom from rinderpest. Other research coordination meetings on animal diseases and productivity as well as new projects are highlighted in this issue

  11. Animal production and health newsletter. No. 33

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2000-12-01

    A full report on the final research coordination meeting on the long running Coordinated Research Project supporting rinderpest eradication is contained in this Newsletter. It is reported that all the national rinderpest vaccination campaigns have been terminated and except for a very few isolated areas where vaccination continues, the effort is now on disease surveillance to demonstrate freedom from rinderpest. Other research coordination meetings on animal diseases and productivity as well as new projects are highlighted in this issue.

  12. Animal Production Performance and Herd Management in Suckling Farms on Réunion Island

    Directory of Open Access Journals (Sweden)

    J.P. Choisis

    2008-02-01

    Full Text Available In Réunion, because of the insularity and the small size of farms, improving cattle farm productivity involves increas­ing technical management aspects. To analyze relationships between herd management practices and animal perform­ances, a survey was conducted in ten suckling farms, located in the Highlands, from 1999 to 2002. Three sets of 4, 8 and 3 variables, respectively, were thus extracted from the moni­toring database: animal performances (calving interval, fertil­ity rate, body weight at standard age, live meat production, farmers’ practices (grazing time per hectare and paddock, time interval between two passages, paddock size, stocking rate, feed complementation of weaned animals and lactating cows, culling rate, and environment (rainfall, herbage production, body condition score of cows. An analysis of co-inertia was carried out on the first two tables to analyze relationships between animal production performances and practices. A significant correlation was observed between the two tables. The results of the co-inertia analysis were interpreted for each farm. Beyond specific constraints, they revealed proximities between farms and herd management based on various strat­egies, which were relevant with the observed performances. A STATICO analysis was performed to assess relationships between performance parameters and environment parameters for the four studied years. It revealed that there was a stable costructure between the environment and performance tables. This suggests that practices had a highly structuring effect on animal production and that some system adjustments miti­gated the climate effects.

  13. Estimating animal movement contacts between holdings of different production types.

    Science.gov (United States)

    Lindström, Tom; Sisson, Scott A; Lewerin, Susanna Stenberg; Wennergren, Uno

    2010-06-01

    Animal movement poses a great risk for disease transmission between holdings. Heterogeneous contact patterns are known to influence the dynamics of disease transmission and should be included in modeling. Using pig movement data from Sweden as an example, we present a method for quantification of between holding contact probabilities based on different production types. The data contained seven production types: Sow pool center, Sow pool satellite, Farrow-to-finish, Nucleus herd, Piglet producer, Multiplying herd and Fattening herd. The method also estimates how much different production types will determine the contact pattern of holdings that have more than one type. The method is based on Bayesian analysis and uses data from central databases of animal movement. Holdings with different production types are estimated to vary in the frequency of contacts as well as in what type of holding they have contact with, and the direction of the contacts. Movements from Multiplying herds to Sow pool centers, Nucleus herds to other Nucleus herds, Sow pool centers to Sow pool satellites, Sow pool satellites to Sow pool centers and Nucleus herds to Multiplying herds were estimated to be most common relative to the abundance of the production types. We show with a simulation study that these contact patterns may also be expected to result in substantial differences in disease transmission via animal movements, depending on the index holding. Simulating transmission for a 1 year period showed that the median number of infected holdings was 1 (i.e. only the index holding infected) if the infection started at a Fattening herd and 2161 if the infection started on a Nucleus herd. We conclude that it is valuable to include production types in models of disease transmission and the method presented in this paper may be used for such models when appropriate data is available. We also argue that keeping records of production types is of great value since it may be helpful in risk

  14. Polyhydroxyalkanoates production with Ralstonia eutropha from low quality waste animal fats.

    Science.gov (United States)

    Riedel, Sebastian L; Jahns, Stefan; Koenig, Steven; Bock, Martina C E; Brigham, Christopher J; Bader, Johannes; Stahl, Ulf

    2015-11-20

    Polyhydroxyalkanoates (PHAs) are biodegradable and biocompatible polyesters considered as alternatives to petroleum-based plastics. Ralstonia eutropha is a model organism for PHA production. Utilizing industrially rendered waste animal fats as inexpensive carbon feedstocks for PHA production is demonstrated here. An emulsification strategy, without any mechanical or chemical pre-treatment, was developed to increase the bioavailability of solid, poorly-consumable fats. Wild type R. eutropha strain H16 produced 79-82% (w/w) polyhydroxybutyrate (PHB) per cell dry weight (CDW) when cultivated on various fats. A productivity of 0.3g PHB/(L × h) with a total PHB production of 24 g/L was achieved using tallow as carbon source. Using a recombinant strain of R. eutropha that produces poly(hydroxybutyrate-co-hydroxyhexanoate) [P(HB-co-HHx)], 49-72% (w/w) of PHA per CDW with a HHx content of 16-27 mol% were produced in shaking flask experiments. The recombinant strain was grown on waste animal fat of the lowest quality available at lab fermenter scale, resulting in 45 g/L CDW with 60% (w/w) PHA per CDW and a productivity of 0.4 g PHA/(L × h). The final HHx content of the polymer was 19 mol%. The use of low quality waste animal fats as an inexpensive carbon feedstock exhibits a high potential to accelerate the commercialization of PHAs. Copyright © 2015 Elsevier B.V. All rights reserved.

  15. Nigerian Journal of Animal Production - Vol 25, No 1 (1998)

    African Journals Online (AJOL)

    Nigerian Journal of Animal Production. ... Growth And Some Carcass Characteristics Of Growing Pigs Fed Full-Fat Soybean-Based Diets ... On Carcass Yield And Meat Quality Of Indigenous Guineafowl (Numida mefeagris galeata Pallas).

  16. Animal production and health newsletter. No. 37

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2002-12-01

    This issue focuses on the specific biotechnological methods that have the greatest potential for livestock production and health in developing countries, and which of these require nuclear and related techniques? The consultants' meeting that we held during 2001 (http://www.iaea.org/programmes/nafa/d3/public/ gene-technologies.pdf) provided us with the answers. We have subsequently discussed these concepts further with FAO, ILRI and other partners, and have planned a series of activities over the next two years to facilitate the transition of our Sub-programme. The first is an FAO/IAEA International Symposium on 'Applications of Gene Based Technologies for Improving Animal Production and Health in Developing Countries' which will be held here in Vienna from 6 to 10 October 2003. The official announcement is included in this Newsletter. This will be followed by three inter-regional training courses, to be held during 2004 and 2005, to train scientists in developing countries on the molecular techniques currently being used in the fields of animal nutrition, genetics and disease diagnosis. Subsequently, four new CRPs will be initiated during 2005-2006, dealing with (a) rumen molecular techniques for predicting and enhancing productivity; (b) manipulation of nutrition in utero to alter gene expression; (c) characterization of small ruminant genetic resources aimed at selection for parasite resistance; and (d) improvement of diagnostic tests for African Swine Fever to assist in molecular epidemiology. The announcements for the first two have already appeared in previous Newsletters and that for the third will be in the next issue. The projects that have been approved for implementation during the next biennium (2003-2004) are listed in this Newsletter.

  17. Animal production and health newsletter. No. 37

    International Nuclear Information System (INIS)

    2002-12-01

    This issue focuses on the specific biotechnological methods that have the greatest potential for livestock production and health in developing countries, and which of these require nuclear and related techniques? The consultants' meeting that we held during 2001 (http://www.iaea.org/programmes/nafa/d3/public/ gene-technologies.pdf) provided us with the answers. We have subsequently discussed these concepts further with FAO, ILRI and other partners, and have planned a series of activities over the next two years to facilitate the transition of our Sub-programme. The first is an FAO/IAEA International Symposium on 'Applications of Gene Based Technologies for Improving Animal Production and Health in Developing Countries' which will be held here in Vienna from 6 to 10 October 2003. The official announcement is included in this Newsletter. This will be followed by three inter-regional training courses, to be held during 2004 and 2005, to train scientists in developing countries on the molecular techniques currently being used in the fields of animal nutrition, genetics and disease diagnosis. Subsequently, four new CRPs will be initiated during 2005-2006, dealing with (a) rumen molecular techniques for predicting and enhancing productivity; (b) manipulation of nutrition in utero to alter gene expression; (c) characterization of small ruminant genetic resources aimed at selection for parasite resistance; and (d) improvement of diagnostic tests for African Swine Fever to assist in molecular epidemiology. The announcements for the first two have already appeared in previous Newsletters and that for the third will be in the next issue. The projects that have been approved for implementation during the next biennium (2003-2004) are listed in this Newsletter

  18. Preclinical models in radiation oncology

    Directory of Open Access Journals (Sweden)

    Kahn Jenna

    2012-12-01

    Full Text Available Abstract As the incidence of cancer continues to rise, the use of radiotherapy has emerged as a leading treatment modality. Preclinical models in radiation oncology are essential tools for cancer research and therapeutics. Various model systems have been used to test radiation therapy, including in vitro cell culture assays as well as in vivo ectopic and orthotopic xenograft models. This review aims to describe such models, their advantages and disadvantages, particularly as they have been employed in the discovery of molecular targets for tumor radiosensitization. Ultimately, any model system must be judged by its utility in developing more effective cancer therapies, which is in turn dependent on its ability to simulate the biology of tumors as they exist in situ. Although every model has its limitations, each has played a significant role in preclinical testing. Continued advances in preclinical models will allow for the identification and application of targets for radiation in the clinic.

  19. Comparing environmental impacts from insects for feed and food as an alternative to animal production

    DEFF Research Database (Denmark)

    Halloran, Afton Marina Szasz; Hansen, Hanne Helene; Jensen, Lars Stoumann

    2018-01-01

    This chapter systematically compares and contrasts the known environmental impacts of traditional vertebrate animal production with insect production intended for both food and animal feed. There are major physiological and biological differences between traditional livestock species and insects,...

  20. Hungry for success: Urban consumer demand for wild animal products in Vietnam

    Directory of Open Access Journals (Sweden)

    Rebecca Drury

    2011-01-01

    Full Text Available Rising urban prosperity is escalating demand for wild animal products in Vietnam. Conservation interventions seek to influence consumer demand, but are based on a limited understanding of consumers and consumption behaviour. This report presents key findings of a structured survey (n=915 and semi-structured interviews (n=78 to investigate the social context of consumption of wild animal-derived products among the population of central Hanoi. Wildmeat is the product most commonly reported consumed-predominantly by successful, high-income, high-status males of all ages and educational levels-and is used as a medium to communicate prestige and obtain social leverage. As Vietnam′s economy grows and its population ages, demand for wildmeat and medicinal products is likely to rise. Given the difficulties of acting on personal rather than collective interests and the symbolic role of wildmeat in an extremely status-conscious society, reducing demand is challenging. Influencing consumer behaviour over the long term requires social marketing expertise and has to be informed by an in-depth understanding, achieved using appropriate methods, of the social drivers of consumer demand for wild animal products. In the meantime, strengthened enforcement is needed to prevent the demand being met from consumers prepared to pay the rising costs of finding the last individuals of a species.

  1. Evaluation of biochemical factors from mixed animal wastes feedstock in biogas production

    Science.gov (United States)

    Animal wastes can serve as the feedstock for biogas production (mainly methane) that could be used as alternative energy source. The green energy derived from animal wastes is considered to be carbon neutral and offsetting those generated from fossil fuels. In this study, an evaluation of methane ...

  2. Effect of biochemical factors from mixed animal wastes feedstock in biogas production

    Science.gov (United States)

    Animal wastes can serve as the feedstock for biogas production (mainly methane) that could be used as alternative energy source. The green energy derived from animal wastes is considered to be carbon neutral and offsetting those generated from fossil fuels. In this study, an evaluation of methane...

  3. Cost-efficiency of animal welfare in broiler production systems

    NARCIS (Netherlands)

    Gocsik, Éva; Brooshooft, Suzanne D.; Jong, de Ingrid C.; Saatkamp, Helmut W.

    2016-01-01

    Broiler producers operate in a highly competitive and cost-price driven environment. In addition, in recent years the societal pressure to improve animal welfare (AW) in broiler production systems is increasing. Hence, from an economic and decision making point of view, the cost-efficiency of

  4. Animal production and health newsletter. No. 40

    International Nuclear Information System (INIS)

    2004-06-01

    This issue of the Newsletter highlights the activities of the Animal Production and Health Section and the Sub-programme. Apart from the regular Coordinated Research Project (CRP) activities and the customary technical support given to national and regional Technical Cooperation (TC) projects, the personnel were involved in the technical evaluation of applications for new TC projects by Member States for the 2005/2006 biennial project cycle. The Section also was also occupied with preparing the IAEA's 2006/2007 Work and Budget Programme

  5. A Grading System To Evaluate Objectively the Strength of Pre-Clinical Data of Acute Neuroprotective Therapies for Clinical Translation in Spinal Cord Injury

    Science.gov (United States)

    Okon, Elena B.; Tsai, Eve; Beattie, Michael S.; Bresnahan, Jacqueline C.; Magnuson, David K.; Reier, Paul J.; McTigue, Dana M.; Popovich, Phillip G.; Blight, Andrew R.; Oudega, Martin; Guest, James D.; Weaver, Lynne C.; Fehlings, Michael G.; Tetzlaff, Wolfram

    2011-01-01

    Abstract The past three decades have seen an explosion of research interest in spinal cord injury (SCI) and the development of hundreds of potential therapies that have demonstrated some promise in pre-clinical experimental animal models. A growing number of these treatments are seeking to be translated into human clinical trials. Conducting such a clinical trial, however, is extremely costly, not only for the time and money required to execute it, but also for the limited resources that will then no longer be available to evaluate other promising therapies. The decision about what therapies have sufficient pre-clinical evidence of efficacy to justify testing in humans is therefore of utmost importance. Here, we have developed a scoring system for objectively grading the body of pre-clinical literature on neuroprotective treatments for acute SCI. The components of the system include an evaluation of a number of factors that are thought to be important in considering the “robustness” of a therapy's efficacy, including the animal species and injury models that have been used to test it, the time window of efficacy, the types of functional improvements effected by it, and whether efficacy has been independently replicated. The selection of these factors was based on the results of a questionnaire that was performed within the SCI research community. A modified Delphi consensus-building exercise was then conducted with experts in pre-clinical SCI research to refine the criteria and decide upon how to score them. Finally, the grading system was applied to a series of potential neuroprotective treatments for acute SCI. This represents a systematic approach to developing an objective method of evaluating the extent to which the pre-clinical literature supports the translation of a particular experimental treatment into human trials. PMID:20507235

  6. Pre-clinical studies of toxin-specific Nanobodies: Evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming

    International Nuclear Information System (INIS)

    Hmila, Issam; Cosyns, Bernard; Tounsi, Hayfa; Roosens, Bram; Caveliers, Vicky; Abderrazek, Rahma Ben; Boubaker, Samir; Muyldermans, Serge; El Ayeb, Mohamed; Bouhaouala-Zahar, Balkiss; Lahoutte, Tony

    2012-01-01

    Scorpions represent a significant threat to humans and animals in various countries throughout the world. Recently, we introduced Nanobodies (Nbs) to combat more efficiently scorpion envenoming and demonstrated the performance of NbAahIF12 and NbAahII10 to neutralize scorpion toxins of Androctonus australis hector venom. A bispecific Nb construct (NbF12-10) comprising these two Nbs is far more protective than the classic Fab′ 2 based therapy and is the most efficient antivenom therapy against scorpion sting in preclinical studies. Now we investigate the biodistribution and pharmacokinetics of 99m Tc labeled Nbs by in vivo imaging in rodents and compared these data with those of the Fab′ 2 product (PAS). The pharmacodynamics of the Nbs was investigated in rats by in vivo echocardiography and it is shown that NbF12-10 prevents effectively the hemodynamic disturbances induced by a lethal dose of venom. Moreover, even a late injection of NbF12-10 restores the heart rate and brings the blood pressure to baseline values. Histology confirms that NbF12-10 prevents lung and heart lesions of treated mice after envenoming. In conjunction, in this preclinical study, we provide proof of concept that NbF12-10 prevents effectively the fatal disturbances induced by Androctonus venom, and that the Nanobody based therapeutic has a potential to substitute the classic Fab′ 2 based product as immunotherapeutic in scorpion envenoming. Further clinical study using larger cohorts of animals should be considered to confirm the full protecting potential of our NbF12-10. -- Highlights: ► Nanobody therapy prevents the hemodynamic disturbances induced by a lethal dose. ► Late injection of Nanobody restores hemodynamic parameters to baseline values. ► Nanobody therapy prevents lung and heart lesions of treated mice after envenoming. ► Labeled Nanobody and Fab’2 pharmacokinetics curves reach plateau in favour of Nanobody.

  7. Pre-clinical studies of toxin-specific Nanobodies: Evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming

    Energy Technology Data Exchange (ETDEWEB)

    Hmila, Issam [Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis (Tunisia); Cosyns, Bernard [Laboratory of In Vivo Cellular and Molecular Imaging, Vrije Universiteit Brussel (Belgium); Tounsi, Hayfa [Service d' Anatomo-Pathologie, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis (Tunisia); Roosens, Bram; Caveliers, Vicky [Laboratory of In Vivo Cellular and Molecular Imaging, Vrije Universiteit Brussel (Belgium); Abderrazek, Rahma Ben [Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis (Tunisia); Boubaker, Samir [Service d' Anatomo-Pathologie, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis (Tunisia); Muyldermans, Serge [Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussel (Belgium); Department of Structural Biology, VIB, Brussels (Belgium); El Ayeb, Mohamed [Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis (Tunisia); Bouhaouala-Zahar, Balkiss, E-mail: balkiss.bouhaouala@pasteur.rns.tn [Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, 13 Place Pasteur, BP-74, 1002 Tunis (Tunisia); Faculté de Médecine de Tunis, Université de Tunis-El Manar (Tunisia); Lahoutte, Tony [Laboratory of In Vivo Cellular and Molecular Imaging, Vrije Universiteit Brussel (Belgium)

    2012-10-15

    Scorpions represent a significant threat to humans and animals in various countries throughout the world. Recently, we introduced Nanobodies (Nbs) to combat more efficiently scorpion envenoming and demonstrated the performance of NbAahIF12 and NbAahII10 to neutralize scorpion toxins of Androctonus australis hector venom. A bispecific Nb construct (NbF12-10) comprising these two Nbs is far more protective than the classic Fab′{sub 2} based therapy and is the most efficient antivenom therapy against scorpion sting in preclinical studies. Now we investigate the biodistribution and pharmacokinetics of {sup 99m}Tc labeled Nbs by in vivo imaging in rodents and compared these data with those of the Fab′{sub 2} product (PAS). The pharmacodynamics of the Nbs was investigated in rats by in vivo echocardiography and it is shown that NbF12-10 prevents effectively the hemodynamic disturbances induced by a lethal dose of venom. Moreover, even a late injection of NbF12-10 restores the heart rate and brings the blood pressure to baseline values. Histology confirms that NbF12-10 prevents lung and heart lesions of treated mice after envenoming. In conjunction, in this preclinical study, we provide proof of concept that NbF12-10 prevents effectively the fatal disturbances induced by Androctonus venom, and that the Nanobody based therapeutic has a potential to substitute the classic Fab′{sub 2} based product as immunotherapeutic in scorpion envenoming. Further clinical study using larger cohorts of animals should be considered to confirm the full protecting potential of our NbF12-10. -- Highlights: ► Nanobody therapy prevents the hemodynamic disturbances induced by a lethal dose. ► Late injection of Nanobody restores hemodynamic parameters to baseline values. ► Nanobody therapy prevents lung and heart lesions of treated mice after envenoming. ► Labeled Nanobody and Fab’2 pharmacokinetics curves reach plateau in favour of Nanobody.

  8. Animal Models of Schizophrenia with a Focus on Models Targeting NMDA Receptors

    Czech Academy of Sciences Publication Activity Database

    Svojanovská, Markéta; Stuchlík, Aleš

    2015-01-01

    Roč. 4, č. 1 (2015), s. 3-18 ISSN 1805-7225 R&D Projects: GA MZd(CZ) NT13386 Institutional support: RVO:67985823 Keywords : schizophrenia * animal models * pharmacological models * genetic models * neurodevelopmental models * preclinical studies Subject RIV: FH - Neurology

  9. The future trends for research on quality and safety of animal products

    Directory of Open Access Journals (Sweden)

    Nigel D. Scollan

    2010-01-01

    Full Text Available Quality must now be considered as a convergence between consumers' wishes and needs and the intrinsic and extrinsic quality attributes of food products. The increasing number of quality attributes which must be considered, increasing globalisation and the heterogeneity in consumption habits between countries are making this convergence progressively more difficult. In parallel, science is rapidly evolving (with the advent of genomics for instance, and a growing number of applications is thus expected for the improvement of food safety and quality. Among the meat and fish quality attributes, colour is very important because it determines, at least in part, consumer choice. The key targets to ensure a satisfactory colour are animal nutrition and management for fish, processing and product conditioning for meat. Tenderness and flavour continue to be important issues for the consumer because eating remains a pleasure. They both determine quality experience which itself influences repetitive purchase. Meat tenderness is a very complex problem which can be solved only by a holistic approach involving all the factors from conception, animal breeding and production, muscle biology and slaughter practice to carcass processing and meat preparation at the consumer end. Today, safety and healthiness are among the most important issues. Unfortunately, animal products can potentially be a source of biological and chemical contamination for consumers. The introduction of both control strategies along the food chain and the development of a food safety management system, from primary production to the domestic environment, are key issues that must be achieved. Despite a high dietary supply of saturated fats by dairy and meat products, it is imperative that professionals involved in animal research and in the associated industry convey the positive nutritional contributions of animal products to both consumers and health professionals. The latter include protein

  10. Epigenetics and developmental programming of welfare and production traits in farm animals.

    Science.gov (United States)

    Sinclair, K D; Rutherford, K M D; Wallace, J M; Brameld, J M; Stöger, R; Alberio, R; Sweetman, D; Gardner, D S; Perry, V E A; Adam, C L; Ashworth, C J; Robinson, J E; Dwyer, C M

    2016-07-21

    The concept that postnatal health and development can be influenced by events that occur in utero originated from epidemiological studies in humans supported by numerous mechanistic (including epigenetic) studies in a variety of model species. Referred to as the 'developmental origins of health and disease' or 'DOHaD' hypothesis, the primary focus of large-animal studies until quite recently had been biomedical. Attention has since turned towards traits of commercial importance in farm animals. Herein we review the evidence that prenatal risk factors, including suboptimal parental nutrition, gestational stress, exposure to environmental chemicals and advanced breeding technologies, can determine traits such as postnatal growth, feed efficiency, milk yield, carcass composition, animal welfare and reproductive potential. We consider the role of epigenetic and cytoplasmic mechanisms of inheritance, and discuss implications for livestock production and future research endeavours. We conclude that although the concept is proven for several traits, issues relating to effect size, and hence commercial importance, remain. Studies have also invariably been conducted under controlled experimental conditions, frequently assessing single risk factors, thereby limiting their translational value for livestock production. We propose concerted international research efforts that consider multiple, concurrent stressors to better represent effects of contemporary animal production systems.

  11. Recommendations for Benchmarking Preclinical Studies of Nanomedicines.

    Science.gov (United States)

    Dawidczyk, Charlene M; Russell, Luisa M; Searson, Peter C

    2015-10-01

    Nanoparticle-based delivery systems provide new opportunities to overcome the limitations associated with traditional small-molecule drug therapy for cancer and to achieve both therapeutic and diagnostic functions in the same platform. Preclinical trials are generally designed to assess therapeutic potential and not to optimize the design of the delivery platform. Consequently, progress in developing design rules for cancer nanomedicines has been slow, hindering progress in the field. Despite the large number of preclinical trials, several factors restrict comparison and benchmarking of different platforms, including variability in experimental design, reporting of results, and the lack of quantitative data. To solve this problem, we review the variables involved in the design of preclinical trials and propose a protocol for benchmarking that we recommend be included in in vivo preclinical studies of drug-delivery platforms for cancer therapy. This strategy will contribute to building the scientific knowledge base that enables development of design rules and accelerates the translation of new technologies. ©2015 American Association for Cancer Research.

  12. Biogas production from animal manure and agri-organic by-products. An analysis of the environment

    International Nuclear Information System (INIS)

    De Boo, W.

    1997-12-01

    Growing interest in sustainable energy has been directed to the production of biogas from organic matter in animal manure and agri-organic by-products. The technology of biogas production by anaerobic digestion of organic materials is used in several parts of the world. Based on this experience and on positive results in a Novem study for the Netherlands situation in 1995, an actor survey has been carried out. The introduction of combined digestion of animal manure and agri-organic by-products has been discussed with companies, business associations and governmental organisations in the energy, agricultural and waste sectors. The survey has revealed that commercial exploitation of biogas plants with a capacity of 100 kton per year is possible under the following conditions: (1) costs of investment should not be higher than 100 Dutch Guilders (45 ECU) per ton processing capacity; (2) yield demands on investment capital, both equity and debt, should not be higher than 8%; (3) selling price for biogas should be around 0,30 Dutch Guilders (0,135 ECU) per m o 3 natural gas equivalents; (4) supply for processing of agri-organic by-products with a received minimum fee of 35 Dutch Guilders (15,7 ECU) per ton should be guaranteed; (5) dairy, pig and arable farmers involved in the biogas plant should have both financial and quality incentives to participation; (6) environmental legislation on the level of heavy metals in animal manure mixed with agri-organic byproducts should not be different from the accepted levels in 'normal' animal manure; and finally (7) the site of the biogas plant accepted by local authorities should be suitable by logistic standards for the transports of animal manure, agri-organic by-products, the digested mixture and biogas. It has been concluded that these conditions are not unrealistic, although there is no absolute certainty that they will be fulfilled. However, circumstances for the implementation of biogas plants have improved in recent years

  13. Use of a clinical PET/MR scanner for preclinical research with first results

    International Nuclear Information System (INIS)

    Chary, Karthik; Teuho, Jarmo; Virta, Jenni; Sipilä, Hannu; Saunavaara, Virva; Roivainen, Anne; Teräs, Mika

    2014-01-01

    This study was performed to evaluate the feasibility of preclinical imaging in a clinical PET/MR system. Preliminary sequences were evaluated for establishing preclinical protocols for rat brain and rabbit knee. Rats were placed in a stereotactic holder, allowing a 30 minute scan time before re-administration of anesthesia. In-house developed warm-water heating system was used to maintain the body temperature at 37.5°C, monitored using an MR-compatible rectal probe. Brain imaging was performed with a dedicated 4 channel phased array receive coil (RAPID Biomedical GmbH, Germany). High resolution coronal images were acquired using conventional T1-SE (0.30x0.30x1.2mm) and T2-TSE (0.23x0.23x0.7mm) with a total scan time of 30 min. PET/MR imaging was performed on two white rabbits. The rabbits were imaged in a custom wooden holder. PET/MR protocol had a total duration of 45 minutes. No external heating was used. MR protocol consisted of anatomical T1, T2 and PDW of the knees, using a SENSE Flex-S coil. MR attenuation correction (MRAC) was acquired with 3D T1-FFE using three-class segmentation. A dynamic 30 minute PET acquisition was started on injection of 33.8MBq of Ga-68. Animal coils enabled high resolution images to be acquired in reasonable acquisition time with regards to animal handling and anesthesia. T1 and T2 images provided good differentiation of anatomy in the rat brain with high contrast. T1, T2 and PDW images of the rabbit knee had high resolution and differentiation of anatomical structures. MRAC was able to distinguish the knees and the body contour. Image fusion of PET and MR was able to localize the infection, which was confirmed by a physician. Pre-clinical imaging with the Ingenuity TF was deemed feasible, although PET imaging is limited by the resolution of the scanner. The preliminary sequences were successfully implemented for future studies on the Ingenuity TF.

  14. Use of a clinical PET/MR scanner for preclinical research with first results

    Energy Technology Data Exchange (ETDEWEB)

    Chary, Karthik; Teuho, Jarmo; Virta, Jenni; Sipilä, Hannu; Saunavaara, Virva; Roivainen, Anne; Teräs, Mika [Turku PET Centre, Turku University Hospital, Turku (Finland)

    2014-07-29

    This study was performed to evaluate the feasibility of preclinical imaging in a clinical PET/MR system. Preliminary sequences were evaluated for establishing preclinical protocols for rat brain and rabbit knee. Rats were placed in a stereotactic holder, allowing a 30 minute scan time before re-administration of anesthesia. In-house developed warm-water heating system was used to maintain the body temperature at 37.5°C, monitored using an MR-compatible rectal probe. Brain imaging was performed with a dedicated 4 channel phased array receive coil (RAPID Biomedical GmbH, Germany). High resolution coronal images were acquired using conventional T1-SE (0.30x0.30x1.2mm) and T2-TSE (0.23x0.23x0.7mm) with a total scan time of 30 min. PET/MR imaging was performed on two white rabbits. The rabbits were imaged in a custom wooden holder. PET/MR protocol had a total duration of 45 minutes. No external heating was used. MR protocol consisted of anatomical T1, T2 and PDW of the knees, using a SENSE Flex-S coil. MR attenuation correction (MRAC) was acquired with 3D T1-FFE using three-class segmentation. A dynamic 30 minute PET acquisition was started on injection of 33.8MBq of Ga-68. Animal coils enabled high resolution images to be acquired in reasonable acquisition time with regards to animal handling and anesthesia. T1 and T2 images provided good differentiation of anatomy in the rat brain with high contrast. T1, T2 and PDW images of the rabbit knee had high resolution and differentiation of anatomical structures. MRAC was able to distinguish the knees and the body contour. Image fusion of PET and MR was able to localize the infection, which was confirmed by a physician. Pre-clinical imaging with the Ingenuity TF was deemed feasible, although PET imaging is limited by the resolution of the scanner. The preliminary sequences were successfully implemented for future studies on the Ingenuity TF.

  15. Challenges for Preclinical Investigations of Human Biofield Modalities

    Science.gov (United States)

    Gronowicz, Gloria; Bengston, William

    2015-01-01

    Preclinical models for studying the effects of the human biofield have great potential to advance our understanding of human biofield modalities, which include external qigong, Johrei, Reiki, therapeutic touch, healing touch, polarity therapy, pranic healing, and other practices. A short history of Western biofield studies using preclinical models is presented and demonstrates numerous and consistent examples of human biofields significantly affecting biological systems both in vitro and in vivo. Methodological issues arising from these studies and practical solutions in experimental design are presented. Important questions still left unanswered with preclinical models include variable reproducibility, dosing, intentionality of the practitioner, best preclinical systems, and mechanisms. Input from the biofield practitioners in the experimental design is critical to improving experimental outcomes; however, the development of standard criteria for uniformity of practice and for inclusion of multiple practitioners is needed. Research in human biofield studies involving preclinical models promises a better understanding of the mechanisms underlying the efficacy of biofield therapies and will be important in guiding clinical protocols and integrating treatments with conventional medical therapies. PMID:26665042

  16. Experimental protocols for behavioral imaging: seeing animal models of drug abuse in a new light.

    Science.gov (United States)

    Aarons, Alexandra R; Talan, Amanda; Schiffer, Wynne K

    2012-01-01

    Behavioral neuroimaging is a rapidly evolving discipline that represents a marriage between the fields of behavioral neuroscience and preclinical molecular imaging. This union highlights the changing role of imaging in translational research. Techniques developed for humans are now widely applied in the study of animal models of brain disorders such as drug addiction. Small animal or preclinical imaging allows us to interrogate core features of addiction from both behavioral and biological endpoints. Snapshots of brain activity allow us to better understand changes in brain function and behavior associated with initial drug exposure, the emergence of drug escalation, and repeated bouts of drug withdrawal and relapse. Here we review the development and validation of new behavioral imaging paradigms and several clinically relevant radiotracers used to capture dynamic molecular events in behaving animals. We will discuss ways in which behavioral imaging protocols can be optimized to increase throughput and quantitative methods. Finally, we discuss our experience with the practical aspects of behavioral neuroimaging, so investigators can utilize effective animal models to better understand the addicted brain and behavior.

  17. Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugs.

    Science.gov (United States)

    Köster, Ursula; Nolte, Ingo; Michel, Martin C

    2016-02-01

    Having observed a large variation in the number and type of original preclinical publications for newly registered drugs, we have explored whether longitudinal trends and/or factors specific for certain drugs or their manufacturers may explain such variation. Our analysis is based on 1954 articles related to 170 newly approved drugs. The number of preclinical publications per compound declined from a median of 10.5 in 1991 to 3 in 2011. A similar trend was observed for the number of in vivo studies in general, but not in the subset of in vivo studies in animal models of disease. The percentage of compounds with studies using isolated human cells or cell lines almost doubled over time from 37 to 72%. Number of publications did not exhibit major differences between compounds intended for human versus veterinary use, therapeutic areas, small molecules versus biologicals, or innovator versus follow-up compounds; however, some companies may publish fewer studies per compound than others. However, there were qualitative differences in the types of models being used depending on the therapeutic area; specifically, compounds for use in oncology very often used isolated cells and cell lines, often from human origin. We conclude that the large variation in number and type of reported preclinical data is not easily explained. We propose that pharmaceutical companies should consistently provide a comprehensive documentation of the preclinical data they generate as part of their development programs in the public domain to enable a better understanding of the drugs they intend to market.

  18. Common data elements for preclinical epilepsy research: Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE.

    Science.gov (United States)

    Harte-Hargrove, Lauren C; French, Jacqueline A; Pitkänen, Asla; Galanopoulou, Aristea S; Whittemore, Vicky; Scharfman, Helen E

    2017-11-01

    The major objective of preclinical translational epilepsy research is to advance laboratory findings toward clinical application by testing potential treatments in animal models of seizures and epilepsy. Recently there has been a focus on the failure of preclinical discoveries to translate reliably, or even to be reproduced in different laboratories. One potential cause is a lack of standardization in preclinical data collection. The resulting difficulties in comparing data across studies have led to high cost and missed opportunity, which in turn impede clinical trials and advances in medical care. Preclinical epilepsy research has successfully brought numerous antiseizure treatments into the clinical practice, yet the unmet clinical needs have prompted the reconsideration of research strategies to optimize epilepsy therapy development. In the field of clinical epilepsy there have been successful steps to improve such problems, such as generation of common data elements (CDEs) and case report forms (CRFs and standards of data collection and reporting) by a team of leaders in the field. Therefore, the Translational Task Force was appointed by the International League Against Epilepsy (ILAE) and the American Epilepsy Society (AES), in partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) to define CDEs for animal epilepsy research studies and prepare guidelines for data collection and experimental procedures. If adopted, the preclinical CDEs could facilitate collaborative epilepsy research, comparisons of data across different laboratories, and promote rigor, transparency, and impact, particularly in therapy development. Wiley Periodicals, Inc. © 2017 International League Against Epilepsy.

  19. Impressions of animal production in South Africa with particular ...

    African Journals Online (AJOL)

    Impressions of animal production in South Africa with particular reference to biological research. I.W. McDonald. Abstract. No Abstract. Full Text: EMAIL FREE FULL TEXT EMAIL FREE FULL TEXT · DOWNLOAD FULL TEXT DOWNLOAD FULL TEXT · AJOL African Journals Online. HOW TO USE AJOL... for Researchers · for ...

  20. Preclinical quantitative MicroPET imaging in evaluation of neuroprotective drug candidates

    International Nuclear Information System (INIS)

    Son, Ji Yeon; Kim, Yu Kyeong; Kim, Ji Sun; Lee, Byung Chul; Kim, Kyeong Min; Choi, Tae Hyun; Cheon, Gi Jeong; Lee, Won Woo; Kim, Sang Eun

    2007-01-01

    Using in vivo molecular imaging with microPET/SPECT has been expected to facilitate drug discovery and development. In this study, we applied quantitative microPET to the preclinical evaluation of the effects of two neuroprotective drug candidates to the nigrostriatal dopaminergic neuronal damage. Fifteen SD rats were divided into three groups. The rats of each group were orally administrated one of neuroprotective candidate; NeuProtec (100mg/kg bid) and SureCero (10mg/kg, qd) or normal saline (0.1ml, qd) for 3 weeks. 6-OHDA was sterotactically placed to the right striatum on eighth day after starting while continuing the medication for additional 14 days. [ 124 I]FP-ClT PET scans were obtained using microPET R4 scanner. The behavioral test by amphetamine-induced rotation and the histological examination after thyrosine hydroxylase (TH) immunohistochemical staining were performed. Different uptake in the lesioned striatum among the groups were demonstrated on [ 124 I]FP-CIT PET images. The rats with NeuProtec showed higher binding in the lesion than controls. No differences were observed in SureCere groups. The FP-CIT uptake in the lesioned striatum was well correlated with the % reduction of TH(+) cells (rho =0.73, p=0.025), and also correlated with rotation test (rho =0.79, p=0.001) [ 124 I]FP-CIT animal PET depicted the neuroprotective effects of NeuProtec to the 6-OHDA neurotoxicity in the rat striatum. No demonstrable effect of SureCero might indicate that inadequate dosage was used in this study. MicroPET imaging with small animal could be a great tool in preclinical evaluation of drug efficacy

  1. Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice.

    Science.gov (United States)

    Gándara, Carolina; Affleck, Valerie; Stoll, Elizabeth Ann

    2018-02-01

    Lentiviral vectors are used in laboratories around the world for in vivo and ex vivo delivery of gene therapies, and increasingly clinical investigation as well as preclinical applications. The third-generation lentiviral vector system has many advantages, including high packaging capacity, stable gene expression in both dividing and post-mitotic cells, and low immunogenicity in the recipient organism. Yet, the manufacture of these vectors is challenging, especially at high titers required for direct use in vivo, and further challenges are presented by the process of translating preclinical gene therapies toward manufacture of products for clinical investigation. The goals of this paper are to report the protocol for manufacturing high-titer third-generation lentivirus for preclinical testing and to provide detailed information on considerations for translating preclinical viral vector manufacture toward scaled-up platforms and processes in order to make gene therapies under Good Manufacturing Practice that are suitable for clinical trials.

  2. Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.

    Science.gov (United States)

    Grassi, Giacomo; Micheli, Laura; Di Cesare Mannelli, Lorenzo; Compagno, Elisa; Righi, Lorenzo; Ghelardini, Carla; Pallanti, Stefano

    2016-12-01

    Despite several studies suggested that inattention and impulsivity-compulsivity could represent two core dimensions of hoarding disorder (HD), only a small case series study investigated the effectiveness of attention-deficit-hyperactivity-disorder (ADHD) medications in HD. The aim of the present study was to target attentional and inhibitory control networks in HD patients through the ADHD medication atomoxetine, moving from a preclinical investigation on an animal model of compulsive-like behavior (marble burying test) to a clinical investigation on both medicated and unmedicated patients with a primary diagnosis of HD without ADHD. Our preclinical investigation showed that acute administration of atomoxetine significantly reduced the compulsive-like behaviours of mice in the marble burying test without affecting neither locomotor activity and coordination nor exploration behaviours. When compared, atomoxetine and fluoxetine showed similar effects on the marble burying test. However, fluoxetine impaired both locomotor and exploratory activity. In our clinical investigation 12 patients were enrolled and 11 patients completed an open trial with atomoxetine at flexible dose (40-80 mg) for 12 weeks. At the endpoint the mean UCLA Hoarding Severity Scale score decreased by 41.3% for the whole group (p = 0003). Six patients were classified as full responders (mean symptom reduction of 57.2%) and three patients as partial responders (mean symptom reduction of 27.3%). Inattentive and impulsivity symptoms showed a significant mean score reduction of 18.5% from baseline to the endpoint (F (1,9) = 20.9, p = 0.0013). Hoarding symptoms improvement was correlated to reduction of patients' disability and increased in their global functioning. These preclinical and clinical data suggest that atomoxetine may be effective for HD and therefore should be considered for future controlled trials. Copyright © 2016 Elsevier Ltd. All rights reserved.

  3. A study on current risk assessments and guidelines on the use of food animal products derived from cloned animals.

    Science.gov (United States)

    Hur, Sun Jin

    2017-10-01

    The author widely surveyed and analyzed the food safety issues, ethical issues, permits, and approval of animal products from animals cloned by somatic cell nuclear transfer worldwide. As a result of a 2-year survey, the author found that there is no evidence that meat and milk derived from cloned animals or their progeny pose a risk to food safety in terms of genotoxicity, adverse reproductive effects, or allergic reactions. Most countries have not approved meat and milk derived from cloned animals, and their progeny are entering the food supply. To establish the guidelines, the author suggests four principles of safety assessment for meat and milk derived from cloned animals. The four main principles for safety assessment are similarities of chemical composition, adverse reproductive effects, genotoxicity, and allergic reactions under the influence of meat and milk from cloned animals and noncloned counterparts. This principle means that meat and milk derived from a cloned animal are safe if there are no differences in the four safety assessments of meat and milk between cloned animal's progeny and noncloned counterparts. Copyright © 2017 Elsevier Ltd. All rights reserved.

  4. Usage of Farm Animal Waste for Biogas Production

    Science.gov (United States)

    Sankina, O. V.; Chernysh, A. P.; Sankin, A. S.

    2017-05-01

    The article considers problems connecting with the development of cattle breeding in Russia, especially the utilization of animals and poultry waste products. Basing on the foreign scientists’ experience, it has been proposed different solutions to this problem in terms of the Russian Federation, conducted the study, and presented the results of the undertaken experiments. Recommendations on the use of substances, that speed up fermentation processes at certain temperatures, has been developed.

  5. Animal Board Invited Review: Comparing conventional and organic livestock production systems on different aspects of sustainability.

    Science.gov (United States)

    van Wagenberg, C P A; de Haas, Y; Hogeveen, H; van Krimpen, M M; Meuwissen, M P M; van Middelaar, C E; Rodenburg, T B

    2017-10-01

    To sustainably contribute to food security of a growing and richer world population, livestock production systems are challenged to increase production levels while reducing environmental impact, being economically viable, and socially responsible. Knowledge about the sustainability performance of current livestock production systems may help to formulate strategies for future systems. Our study provides a systematic overview of differences between conventional and organic livestock production systems on a broad range of sustainability aspects and animal species available in peer-reviewed literature. Systems were compared on economy, productivity, environmental impact, animal welfare and public health. The review was limited to dairy cattle, beef cattle, pigs, broilers and laying hens, and to Europe, North America and New Zealand. Results per indicators are presented as in the articles without performing additional calculations. Out of 4171 initial search hits, 179 articles were analysed. Studies varied widely in indicators, research design, sample size and location and context. Quite some studies used small samples. No study analysed all aspects of sustainability simultaneously. Conventional systems had lower labour requirements per unit product, lower income risk per animal, higher production per animal per time unit, higher reproduction numbers, lower feed conversion ratio, lower land use, generally lower acidification and eutrophication potential per unit product, equal or better udder health for cows and equal or lower microbiological contamination. Organic systems had higher income per animal or full time employee, lower impact on biodiversity, lower eutrophication and acidification potential per unit land, equal or lower likelihood of antibiotic resistance in bacteria and higher beneficial fatty acid levels in cow milk. For most sustainability aspects, sometimes conventional and sometimes organic systems performed better, except for productivity, which was

  6. Gene and protein patterns of potential prion-related markers in the central nervous system of clinical and preclinical infected sheep

    Science.gov (United States)

    2013-01-01

    The molecular pathogenic mechanisms of prion diseases are far from clear. Genomic analyses have revealed genetic biomarkers potentially involved in prion neuropathology in naturally scrapie-infected sheep, a good animal model of infectious prionopathies. However, these biomarkers must be validated in independent studies at different stages of the disease. The gene and protein expression profiles and protein distribution of six potential genetic biomarkers (i.e., CAPN6, COL1A2, COL3A1, GALA1, MT2A and MTNR1B) are presented here for both the early and terminal stages of scrapie in five different brain regions. Gene transcription changes were confirmed in the medulla oblongata, and the expression profiles were generally similar in other central nervous system regions. The changes were more substantial in clinical animals compared to preclinical animals. The expression of the CAPN6 protein increased in the spinal cord and cerebellum of the clinical and preclinical brains. The distribution of the GALA1 was identified in glial cells from the cerebellum of scrapie-infected animals, GALA1 protein expression was increased in clinical animals in the majority of regions, and the increase of MT2A was in agreement with previous reports. The downregulation of MTNR1B was especially marked in the Purkinje cells. Finally, although collagen genes were downregulated the protein immunostaining did not reveal significant changes between the scrapie-infected and control animals. In conclusion, this study of gene transcription and protein expression and distribution confirm CAPN6, GALA1, MTNR1B and MT2A as potential targets for further prion disease research. PMID:23497022

  7. Rapid production of antigen-specific monoclonal antibodies from a variety of animals

    Directory of Open Access Journals (Sweden)

    Kurosawa Nobuyuki

    2012-09-01

    Full Text Available Abstract Background Although a variety of animals have been used to produce polyclonal antibodies against antigens, the production of antigen-specific monoclonal antibodies from animals remains challenging. Results We propose a simple and rapid strategy to produce monoclonal antibodies from a variety of animals. By staining lymph node cells with an antibody against immunoglobulin and a fluorescent dye specific for the endoplasmic reticulum, plasma/plasmablast cells were identified without using a series of antibodies against lineage markers. By using a fluorescently labeled antigen as a tag for a complementary cell surface immunoglobulin, antigen-specific plasma/plasmablast cells were sorted from the rest of the cell population by fluorescence-activated cell sorting. Amplification of cognate pairs of immunoglobulin heavy and light chain genes followed by DNA transfection into 293FT cells resulted in the highly efficient production of antigen-specific monoclonal antibodies from a variety of immunized animals. Conclusions Our technology eliminates the need for both cell propagation and screening processes, offering a significant advantage over hybridoma and display strategies.

  8. The detection, diagnosis, therapy, and pre-clinical biology of breast cancer

    International Nuclear Information System (INIS)

    1978-01-01

    The Cancergram covers clinical aspects of cancers of the mammary glands, the fat pads and the supporting tissues. Abstracts included concern certain specific types of neoplasms which occur in the breast, and in ancillary tissues related to the breast (axillary lymph nodes, etc.). Also included are selected studies on receptors and the physiological aspects of lactation, pregnancy, and ontogeny related to cancer of the breast. The topic includes clinically relevant aspects of the prevention, detection, diagnosis, evaluation, and therapy of breast cancer. With certain exceptions, pre-clinical studies of tissue culture systems or animal model studies which are not directly related to primary human disease are excluded

  9. Animation of Antimicrobial Resistance

    Medline Plus

    Full Text Available ... Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Animal & Veterinary Home Animal & Veterinary Safety & Health ... Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products

  10. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals.

    Science.gov (United States)

    Butler, Michael

    2005-08-01

    There has been a rapid increase in the number and demand for approved biopharmaceuticals produced from animal cell culture processes over the last few years. In part, this has been due to the efficacy of several humanized monoclonal antibodies that are required at large doses for therapeutic use. There have also been several identifiable advances in animal cell technology that has enabled efficient biomanufacture of these products. Gene vector systems allow high specific protein expression and some minimize the undesirable process of gene silencing that may occur in prolonged culture. Characterization of cellular metabolism and physiology has enabled the design of fed-batch and perfusion bioreactor processes that has allowed a significant improvement in product yield, some of which are now approaching 5 g/L. Many of these processes are now being designed in serum-free and animal-component-free media to ensure that products are not contaminated with the adventitious agents found in bovine serum. There are several areas that can be identified that could lead to further improvement in cell culture systems. This includes the down-regulation of apoptosis to enable prolonged cell survival under potentially adverse conditions. The characterization of the critical parameters of glycosylation should enable process control to reduce the heterogeneity of glycoforms so that production processes are consistent. Further improvement may also be made by the identification of glycoforms with enhanced biological activity to enhance clinical efficacy. The ability to produce the ever-increasing number of biopharmaceuticals by animal cell culture is dependent on sufficient bioreactor capacity in the industry. A recent shortfall in available worldwide culture capacity has encouraged commercial activity in contract manufacturing operations. However, some analysts indicate that this still may not be enough and that future manufacturing demand may exceed production capacity as the number

  11. Animation of Antimicrobial Resistance

    Medline Plus

    Full Text Available ... Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Animal & Veterinary Home Animal & Veterinary Safety & ... Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products

  12. Characterization of the animal by-product meal industry in Costa Rica: Manufacturing practices through the production chain and food safety.

    Science.gov (United States)

    Leiva, A; Granados-Chinchilla, F; Redondo-Solano, M; Arrieta-González, M; Pineda-Salazar, E; Molina, A

    2018-06-01

    Animal by-product rendering establishments are still relevant industries worldwide. Animal by-product meal safety is paramount to protect feed, animals, and the rest of the food chain from unwanted contamination. As microbiological contamination may arise from inadequate processing of slaughterhouse waste and deficiencies in good manufacturing practices within the rendering facilities, we conducted an overall establishment's inspection, including the product in several parts of the process.An evaluation of the Good Manufacturing Practices (GMP) was carried out, which included the location and access (i.e., admission) to the facilities, integrated pest management programs, physical condition of the facilities (e.g., infrastructure), equipments, vehicles and transportation, as well as critical control points (i.e., particle size and temperature set at 50 mm, 133°C at atmospheric pressure for 20 min, respectively) recommended by the OIE and the European Commission. The most sensitive points according to the evaluation are physical structure of the facilities (avg 42.2%), access to the facilities (avg 48.6%), and cleaning procedures (avg 51.4%).Also, indicator microorganisms (Salmonella spp., Clostridium spp., total coliforms, E. coli, E. coli O157:H7) were used to evaluate the safety in different parts of the animal meal production process. There was a prevalence of Salmonella spp. of 12.9, 14.3, and 33.3% in Meat and Bone Meal (MBM), poultry by-products, and fish meal, respectively. However, there were no significant differences (P = 0.73) in the prevalence between the different animal meals, according to the data collected.It was also observed that renderings associated with the poultry industry (i.e., 92.0%) obtained the best ratings overall, which reflects a satisfactory development of this sector and the integration of its production system as a whole.

  13. Animal Production and Health Newsletter, No. 57, January 2013

    International Nuclear Information System (INIS)

    2013-01-01

    The 2012 Scientific Forum examined the challenges related to the improvement of food production, food protection and food safety through the use of nuclear applications. In the first session on 'Increasing Food Production' it was noted that the world will need to produce 70% more food between now and 2050 to satisfy the demand of a population in excess of 9 billion people. In this regard, the intensification and diversification of more and higher quality food in a climate-smart and sustainable manner whilst protecting the environment is therefore critical to smallholder farmers and is the key to poverty reduction and increased food security. The Forum noted that the increasing global population faces the challenge of substantially increasing food production under conditions of severe land degradation that has led to a significant reduction in the productive capacity of agricultural lands. Sustainable soil management, plant mutation breeding and animal nutrition and production are therefore critical to the improvement of agricultural productivity. The second session on 'Ensuring Food Protection' noted that global food insecurity is inherently linked to pests and diseases that harm or kill livestock and crops, as well as people working in rural agricultural areas. The losses caused by diseases and pests at both the pre- and post-harvest levels average 30-40% of agricultural outputs, making returns on agricultural investments in land, seeds, water, fertilizer, animal feed, labour and other inputs correspondingly inefficient. In addition, the world is currently facing an unprecedented increase of invasive animal and plant diseases and pests that threaten food security by causing serious losses in production and by necessitating costly control measures, including the escalating use of increasingly expensive pesticides. Outbreaks of secondary pests, the development of resistance of pests to pesticides and the increasing threat of zoonotic diseases to public health cause

  14. SU-E-T-606: Performance of MR-Based 3D FXG Dosimetry for Preclinical Irradiation

    Energy Technology Data Exchange (ETDEWEB)

    Welch, M [Department of Medical Biophysics, University of Toronto, Toronto, ON (Canada); Jaffray, D [Department of Medical Biophysics, University of Toronto, Toronto, ON (Canada); Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON (Canada); Department of Radiation Oncology, University of Toronto, Toronto, ON (Canada); TECHNA Institute for the Advancement of Technology for Health, Toronto, ON (Canada)

    2015-06-15

    Purpose: Technological advances have revolutionized preclinical radiation research to enable precise radiation delivery in preclinical models. Kilovoltage x-rays and complex geometries in preclinical radiation studies challenge conventional dosimetry methods. Previously developed gel-based dosimetry provides a viable means of accommodating complex geometries and accurately reporting dose at kV energies. This paper will describe the development and evaluation of gel-based ferrous xylenol-orange (FXG) dosimetry using a 7T preclinical imaging system. Methods: To confirm water equivalence, Zeff values were calculated for the FXG material, water and ICRU defined soft tissue. Proton T1 relaxivity response in FXG was measured using a preclinical 7T MR and a small animal irradiator for a dose range of 1–22 Gy. FXG was contained in 50 ml centrifuge tubes and irradiated with a 225 kVp x-ray beam at a nominal dose rate of 2.3 Gy/min. Pre and post irradiation maps of the T1 relaxivity were collected using variable TR spin-echo imaging (TE 6.65 ms; TR 500, 750, 1000, 1500, 2000, 3000 and 5000 ms) with 2 mm thick slices, 0.325 mm/pixel, 3 averages and an acquisition time of 26 minutes. A linear fit to the change in relaxation rate (1/T1) for the delivered doses reported the gel sensitivity in units of ms{sup -1}Gy{sup -1}. Irradiation and imaging studies were repeated using three batches of gel over 72 hrs. Results: FXG has a Zeff of 3.8 for the 225 kVp spectrum used; differing from water and ICRU defined soft tissue by 0.5% and 2.5%, respectively. The average sensitivity for the FXG dosimeter was 31.5 ± 0.7 ms{sup -1}Gy{sup -1} (R{sup 2} = 0.9957) with a y-intercept of −29.4 ± 9.0 ms{sup -1}. Conclusion: Preliminary results for the FXG dosimeter properties, sensitivity, and dose linearity at preclinical energies is promising. Future work will explore anatomically relevant tissue inclusions to test MR performance. Student funding provided by The Terry Fox Foundation

  15. Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence

    Czech Academy of Sciences Publication Activity Database

    Stuchlík, Aleš; Sumiyoshi, T.

    2014-01-01

    Roč. 8, - (2014), s. 444 ISSN 1662-5153 R&D Projects: GA ČR(CZ) GA14-03627S; GA ČR(CZ) GBP304/12/G069; GA MZd(CZ) NT13386; GA MŠk(CZ) LH14053 Grant - others:Rada Programu interní podpory projektů mezinárodní spolupráce AV ČR(CZ) M200111204 Institutional support: RVO:67985823 Keywords : cognition * neuropsychiatric disorders * animal models * clinical studies * preclinical studies Subject RIV: FH - Neurology Impact factor: 3.270, year: 2014

  16. SU-E-I-83: Error Analysis of Multi-Modality Image-Based Volumes of Rodent Solid Tumors Using a Preclinical Multi-Modality QA Phantom

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Y [University of Kansas Hospital, Kansas City, KS (United States); Fullerton, G; Goins, B [University of Texas Health Science Center at San Antonio, San Antonio, TX (United States)

    2015-06-15

    Purpose: In our previous study a preclinical multi-modality quality assurance (QA) phantom that contains five tumor-simulating test objects with 2, 4, 7, 10 and 14 mm diameters was developed for accurate tumor size measurement by researchers during cancer drug development and testing. This study analyzed the errors during tumor volume measurement from preclinical magnetic resonance (MR), micro-computed tomography (micro- CT) and ultrasound (US) images acquired in a rodent tumor model using the preclinical multi-modality QA phantom. Methods: Using preclinical 7-Tesla MR, US and micro-CT scanners, images were acquired of subcutaneous SCC4 tumor xenografts in nude rats (3–4 rats per group; 5 groups) along with the QA phantom using the same imaging protocols. After tumors were excised, in-air micro-CT imaging was performed to determine reference tumor volume. Volumes measured for the rat tumors and phantom test objects were calculated using formula V = (π/6)*a*b*c where a, b and c are the maximum diameters in three perpendicular dimensions determined by the three imaging modalities. Then linear regression analysis was performed to compare image-based tumor volumes with the reference tumor volume and known test object volume for the rats and the phantom respectively. Results: The slopes of regression lines for in-vivo tumor volumes measured by three imaging modalities were 1.021, 1.101 and 0.862 for MRI, micro-CT and US respectively. For phantom, the slopes were 0.9485, 0.9971 and 0.9734 for MRI, micro-CT and US respectively. Conclusion: For both animal and phantom studies, random and systematic errors were observed. Random errors were observer-dependent and systematic errors were mainly due to selected imaging protocols and/or measurement method. In the animal study, there were additional systematic errors attributed to ellipsoidal assumption for tumor shape. The systematic errors measured using the QA phantom need to be taken into account to reduce measurement

  17. Cytogenetics in animal production

    Directory of Open Access Journals (Sweden)

    L. Iannuzzi

    2010-04-01

    Full Text Available Cytogenetics applied to domestic animals is a useful biotechnology to be applied in the genetic improvement of livestock. Indeed, it can be used to select reproducers free chromosome abnormalities which are responsible for abnormal body conformation (aneuploidy, lower fertility (balanced chromosome abnormalities or sterility (sex chromosome abnormalities. Cytogenetics may also be applied to assess environmental pollution by studying animals living in hazardous areas and using them as biological indicators (sentinels. Chromosomes also represent optimal biological structures to study the evolution among related (bovids and unrelated (bovidshumans species, especially using comparative FISH-mapping which is one of the most powerful tools to establish the correct order of loci along chromosomes. These comparisons allow us to transfer useful information from richer genomes (human to those of domestic animals. Moreover, the use of specific molecular markers and the FISH-technique on both mitotic and extended (fiber-FISH chromosomes, has heralded a new era of cytogenetics, allowing swift extension of genetic physical maps, better anchoring of both linkage and RH-maps to specific chromosome regions, and use in a variety of applications (clinical cases, embryo and sperm analyses, evolution. In this study a brief review of these fields of the animal cytogenetics is presented.

  18. Actual problems of protecting highly productive animals farms in the Lipetsk region

    Directory of Open Access Journals (Sweden)

    A. A. Ushkova

    2016-01-01

    Full Text Available Due to more efficient use of feed, many farms, ensuring high productivity, has reached the profitability of milk production 40 % or more. No wonder milk has recently been called "white gold" because it provides the highest profitability among livestock products. However, higher producing cows have higher requirements for balanced feeding. Such cows are more intense metabolism: compared to cows of average productivity, the gas exchange is increased in 1,5-2 times, also increases blood pressure, pulse rate and respiration. This means that the wear and tear of the body is faster. And the consequences of inadequate feeding due to unbalanced diets on nutritional and biological active substances lead to profound metabolic disorders, which leads to disruption of the function of reproduction, diseases, shortening productive use of animals to one or two lactations. Without a system of introduction of achievements of zoo technical and veterinary Sciences, the proper organization of feeding, housing and care, application of progressive forms of work organization - cannot be opened, laid in the animals genetic potential. The main direction in the development of dairy cattle breeding is its intensification. The effectiveness of intensification is the implementation of the following development paths: full implementation and improvement of the genetic potential of dairy cattle; rich, biologically full feeding of animals; preparation of sufficient high-quality feed; implementation of efficient technologies.

  19. an assessment of the hygiene level in animal product processing

    African Journals Online (AJOL)

    cistvr

    Keywords: Hygiene, animal product processing plants, checklists ... Changing lifestyles have brought new demands on the food industry; the ... Inspection is an aspect that needs to be revamped to ensure hygienic ... processing can affect a large number of people. .... trolled and equipment well designed; basic system.

  20. Quetiapine: recent developments in preclinical research

    Directory of Open Access Journals (Sweden)

    Marco Orsetti

    2010-03-01

    Full Text Available Quetiapine (QTP is an atypical antipsychotic labelled for the treatment of patients with schizophrenia, bipolar mania and bipolar depression. Nevertheless, QTP has been tried across multiple diagnosis categories and seems to be used, among other atypical antipsychotics, in clinical practice for an expanding range of disorders such as major depression, substance abuse disorders, anxiety disorders, and borderline personality disorders. The present review focuses on papers which investigated the molecular mechanism(s of QTP antidepressant effect. In particular, preclinical studies performed by coupling the chronic mild stress, an animal model of human depression with Affymetrix microarray technology, revealed that chronic QTP administration prevented the stress-induced up- or down-regulation of 42 genes involved in the central nervous system development or having a crucial role for viability of neural cells, like regulation of signal transduction, inorganic ion transport, membrane organisation, and neurite morphogenesis. Among these, Ptgs2, Hes5, Plcb1, Senp2, Gad1, and Marcks are presumably the effectors of the QTP clinical efficacy.

  1. Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models

    Directory of Open Access Journals (Sweden)

    Nabeela Nathoo

    2014-01-01

    Full Text Available There are exciting new advances in multiple sclerosis (MS resulting in a growing understanding of both the complexity of the disorder and the relative involvement of grey matter, white matter and inflammation. Increasing need for preclinical imaging is anticipated, as animal models provide insights into the pathophysiology of the disease. Magnetic resonance (MR is the key imaging tool used to diagnose and to monitor disease progression in MS, and thus will be a cornerstone for future research. Although gadolinium-enhancing and T2 lesions on MRI have been useful for detecting MS pathology, they are not correlative of disability. Therefore, new MRI methods are needed. Such methods require validation in animal models. The increasing necessity for MRI of animal models makes it critical and timely to understand what research has been conducted in this area and what potential there is for use of MRI in preclinical models of MS. Here, we provide a review of MRI and magnetic resonance spectroscopy (MRS studies that have been carried out in animal models of MS that focus on pathology. We compare the MRI phenotypes of animals and patients and provide advice on how best to use animal MR studies to increase our understanding of the linkages between MR and pathology in patients. This review describes how MRI studies of animal models have been, and will continue to be, used in the ongoing effort to understand MS.

  2. Animal Models of Hemophilia and Related Bleeding Disorders

    Science.gov (United States)

    Lozier, Jay N.; Nichols, Timothy C.

    2013-01-01

    Animal models of hemophilia and related diseases are important for development of novel treatments and to understand the pathophysiology of bleeding disorders in humans. Testing in animals with the equivalent human disorder provides informed estimates of doses and measures of efficacy, which aids in design of human trials. Many models of hemophilia A, hemophilia B, and von Willebrand disease have been developed from animals with spontaneous mutations (hemophilia A dogs, rats, sheep; hemophilia B dogs; and von Willebrand disease pigs and dogs), or by targeted gene disruption in mice to create hemophilia A, B, or VWD models. Animal models have been used to generate new insights into the pathophysiology of each bleeding disorder and also to perform pre-clinical assessments of standard protein replacement therapies as well as novel gene transfer technology. Both the differences between species and differences in underlying causative mutations must be considered in choosing the best animal for a specific scientific study PMID:23956467

  3. Dose-on-demand production of diverse 18F-radiotracers for preclinical applications using a continuous flow microfluidic system.

    Science.gov (United States)

    Matesic, Lidia; Kallinen, Annukka; Greguric, Ivan; Pascali, Giancarlo

    2017-09-01

    The production of 18 F-radiotracers using continuous flow microfluidics is under-utilized due to perceived equipment limitations. We describe the dose-on-demand principle, whereby the back-to-back production of multiple, diverse 18 F-radiotracers can be prepared on the same day, on the same microfluidic system using the same batch of [ 18 F]fluoride, the same microreactor, the same HPLC column and SPE cartridge to obtain a useful production yield. [ 18 F]MEL050, [ 18 F]Fallypride and [ 18 F]PBR111 were radiolabeled with [ 18 F]fluoride using the Advion NanoTek Microfluidic Synthesis System. The outlet of the microreactor was connected to an automated HPLC injector and following the collection of the product, SPE reformulation produced the 18 F-radiotracer in productions for [ 18 F]MEL050 and [ 18 F]Fallypride were performed at total flow rates of 20μL/min, resulting in 40±13% and 25±13% RCY respectively. [ 18 F]PBR111 was performed at 200μL/min to obtain 27±8% RCY. Molar activities for each 18 F-radiotracer were >100GBq/μmol and radiochemical purities were >97%, implying that the cleaning procedure was effective. Using the same initial solution of [ 18 F]fluoride, microreactor, HPLC column and SPE cartridge, three diverse 18 F-radiotracers could be produced in yields sufficient for preclinical studies in a back-to-back fashion using a microfluidic system with no detectable cross-contamination. Crown Copyright © 2017. Published by Elsevier Inc. All rights reserved.

  4. The impact of animal source food products on human nutrition and ...

    African Journals Online (AJOL)

    The impact of animal source food products on human nutrition and health. ... the widest array of complex scientific, economic, environmental and political issues. ... investment in research and extrapolation of information towards appropriate ...

  5. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.

    Directory of Open Access Journals (Sweden)

    Kuo-Chen Wei

    Full Text Available The purpose of this study is to assess the preclinical therapeutic efficacy of magnetic resonance imaging (MRI-monitored focused ultrasound (FUS-induced blood-brain barrier (BBB disruption to enhance Temozolomide (TMZ delivery for improving Glioblastoma Multiforme (GBM treatment. MRI-monitored FUS with microbubbles was used to transcranially disrupt the BBB in brains of Fisher rats implanted with 9L glioma cells. FUS-BBB opening was spectrophotometrically determined by leakage of dyes into the brain, and TMZ was quantitated in cerebrospinal fluid (CSF and plasma by LC-MS\\MS. The effects of treatment on tumor progression (by MRI, animal survival and brain tissue histology were investigated. Results demonstrated that FUS-BBB opening increased the local accumulation of dyes in brain parenchyma by 3.8-/2.1-fold in normal/tumor tissues. Compared to TMZ alone, combined FUS treatment increased the TMZ CSF/plasma ratio from 22.7% to 38.6%, reduced the 7-day tumor progression ratio from 24.03 to 5.06, and extended the median survival from 20 to 23 days. In conclusion, this study provided preclinical evidence that FUS BBB-opening increased the local concentration of TMZ to improve the control of tumor progression and animal survival, suggesting its clinical potential for improving current brain tumor treatment.

  6. Preclinical electrogastrography in experimental pigs

    Science.gov (United States)

    Květina, Jaroslav; Varayil, Jithinraj Edakkanambeth; Ali, Shahzad Marghoob; Kuneš, Martin; Bureš, Jan; Tachecí, Ilja; Rejchrt, Stanislav; Kopáčová, Marcela

    2010-01-01

    Surface electrogastrography (EGG) is a non-invasive means of recording gastric myoelectric activity or slow waves from cutaneous leads placed over the stomach. This paper provides a comprehensive review of preclinical EGG. Our group recently set up and worked out the methods for EGG in experimental pigs. We gained our initial experience in the use of EGG in assessment of porcine gastric myoelectric activity after volume challenge and after intragastric administration of itopride and erythromycin. The mean dominant frequency in pigs is comparable with that found in humans. EGG in experimental pigs is feasible. Experimental EGG is an important basis for further preclinical projects in pharmacology and toxicology. PMID:21217873

  7. The Usefulness of Systematic Reviews of Animal Experiments for the Design of Preclinical and Clinical Studies

    Science.gov (United States)

    de Vries, Rob B. M.; Wever, Kimberley E.; Avey, Marc T.; Stephens, Martin L.; Sena, Emily S.; Leenaars, Marlies

    2014-01-01

    The question of how animal studies should be designed, conducted, and analyzed remains underexposed in societal debates on animal experimentation. This is not only a scientific but also a moral question. After all, if animal experiments are not appropriately designed, conducted, and analyzed, the results produced are unlikely to be reliable and the animals have in effect been wasted. In this article, we focus on one particular method to address this moral question, namely systematic reviews of previously performed animal experiments. We discuss how the design, conduct, and analysis of future (animal and human) experiments may be optimized through such systematic reviews. In particular, we illustrate how these reviews can help improve the methodological quality of animal experiments, make the choice of an animal model and the translation of animal data to the clinic more evidence-based, and implement the 3Rs. Moreover, we discuss which measures are being taken and which need to be taken in the future to ensure that systematic reviews will actually contribute to optimizing experimental design and thereby to meeting a necessary condition for making the use of animals in these experiments justified. PMID:25541545

  8. Molecular Imaging with Small Animal PET/CT

    DEFF Research Database (Denmark)

    Binderup, T.; El-Ali, H.H.; Skovgaard, D.

    2011-01-01

    is also described. In addition, the non-invasive nature of molecular imaging and the targets of these promising new tracers are attractive for other research areas as well, although these fields are much less explored. We present an example of an interesting research field with the application of small......Small animal positron emission tomography (PET) and computer tomography (CT) is an emerging field in pre-clinical imaging. High quality, state-of-the-art instruments are required for full optimization of the translational value of the small animal studies with PET and CT. However...... in this field of small animal molecular imaging with special emphasis on the targets for tissue characterization in tumor biology such as hypoxia, proliferation and cancer specific over-expression of receptors. The added value of applying CT imaging for anatomical localization and tumor volume measurements...

  9. International trade standards for commodities and products derived from animals: the need for a system that integrates food safety and animal disease risk management.

    Science.gov (United States)

    Thomson, G R; Penrith, M-L; Atkinson, M W; Thalwitzer, S; Mancuso, A; Atkinson, S J; Osofsky, S A

    2013-12-01

    A case is made for greater emphasis to be placed on value chain management as an alternative to geographically based disease risk mitigation for trade in commodities and products derived from animals. The geographic approach is dependent upon achievement of freedom in countries or zones from infectious agents that cause so-called transboundary animal diseases, while value chain-based risk management depends upon mitigation of animal disease hazards potentially associated with specific commodities or products irrespective of the locality of production. This commodity-specific approach is founded on the same principles upon which international food safety standards are based, viz. hazard analysis critical control points (HACCP). Broader acceptance of a value chain approach enables animal disease risk management to be combined with food safety management by the integration of commodity-based trade and HACCP methodologies and thereby facilitates 'farm to fork' quality assurance. The latter is increasingly recognized as indispensable to food safety assurance and is therefore a pre-condition to safe trade. The biological principles upon which HACCP and commodity-based trade are based are essentially identical, potentially simplifying sanitary control in contrast to current separate international sanitary standards for food safety and animal disease risks that are difficult to reconcile. A value chain approach would not only enable more effective integration of food safety and animal disease risk management of foodstuffs derived from animals but would also ameliorate adverse environmental and associated socio-economic consequences of current sanitary standards based on the geographic distribution of animal infections. This is especially the case where vast veterinary cordon fencing systems are relied upon to separate livestock and wildlife as is the case in much of southern Africa. A value chain approach would thus be particularly beneficial to under-developed regions of

  10. Pluripotent cells in farm animals: state of the art and future perspectives.

    Science.gov (United States)

    Nowak-Imialek, Monika; Niemann, Heiner

    2012-01-01

    Pluripotent cells, such as embryonic stem (ES) cells, embryonic germ cells and embryonic carcinoma cells are a unique type of cell because they remain undifferentiated indefinitely in in vitro culture, show self-renewal and possess the ability to differentiate into derivatives of the three germ layers. These capabilities make them a unique in vitro model for studying development, differentiation and for targeted modification of the genome. True pluripotent ESCs have only been described in the laboratory mouse and rat. However, rodent physiology and anatomy differ substantially from that of humans, detracting from the value of the rodent model for studies of human diseases and the development of cellular therapies in regenerative medicine. Recently, progress in the isolation of pluripotent cells in farm animals has been made and new technologies for reprogramming of somatic cells into a pluripotent state have been developed. Prior to clinical application of therapeutic cells differentiated from pluripotent stem cells in human patients, their survival and the absence of tumourigenic potential must be assessed in suitable preclinical large animal models. The establishment of pluripotent cell lines in farm animals may provide new opportunities for the production of transgenic animals, would facilitate development and validation of large animal models for evaluating ESC-based therapies and would thus contribute to the improvement of human and animal health. This review summarises the recent progress in the derivation of pluripotent and reprogrammed cells from farm animals. We refer to our recent review on this area, to which this article is complementary.

  11. S1P prophylaxis mitigates acute hypobaric hypoxia-induced molecular, biochemical, and metabolic disturbances: A preclinical report.

    Science.gov (United States)

    Chawla, Sonam; Rahar, Babita; Saxena, Shweta

    2016-05-01

    Sphingosine-1-phosphate (S1P) is emerging to have hypoxic preconditioning potential in various preclinical studies. The study aims to evaluate the preclinical preconditioning efficacy of exogenously administered S1P against acute hypobaric hypoxia (HH)-induced pathological disturbances. Male Sprague Dawley rats (200 ± 20 g) were preconditioned with 1, 10, and 100 μg/kg body weight (b.w.) S1P (i.v.) for three consecutive days. On the third day, S1P preconditioned animals, along with hypoxia control animals, were exposed to HH equivalent to 7,620 m (280 mm Hg) for 6 h. Postexposure status of cardiac energy production, circulatory vasoactive mediators, pulmonary and cerebral oxidative damage, and inflammation were assessed. HH exposure led to cardiac energy deficit indicated by low ATP levels and pronounced AMPK activation levels, raised circulatory levels of brain natriuretic peptide and endothelin-1 with respect to total nitrate (NOx), redox imbalance, inflammation, and alterations in NOx levels in the pulmonary and cerebral tissues. These pathological precursors have been routinely reported to be coincident with high-altitude diseases. Preconditioning with S1P, especially 1 µg/kg b.w. dose, was seen to reverse the manifestation of these pathological disturbances. The protective efficacy could be attributed, at least in part, to enhanced activity of cardioprotective protein kinase C and activation of small GTPase Rac1, which led to further induction of hypoxia-adaptive molecular mediators: hypoxia-inducible factor (HIF)-1α and Hsp70. This is a first such report, to the best of our knowledge, elucidating the mechanism of exogenous S1P-mediated HIF-1α/Hsp70 induction. Conclusively, systemic preconditioning with 1 μg/kg b.w. S1P in rats protects against acute HH-induced pathological disturbances. © 2016 IUBMB Life 68(5):365-375, 2016. © 2016 International Union of Biochemistry and Molecular Biology.

  12. Preclinical and clinical safety studies on DNA vaccines.

    NARCIS (Netherlands)

    Schalk, Johanna A C; Mooi, Frits R; Berbers, Guy A M; Aerts, Leon A G J M van; Ovelgönne, Hans; Kimman, Tjeerd G

    2007-01-01

    DNA vaccines are based on the transfer of genetic material, encoding an antigen, to the cells of the vaccine recipient. Despite high expectations of DNA vaccines as a result of promising preclinical data their clinical utility remains unproven. However, much data is gathered in preclinical and

  13. Critical overview of all available animal models for abdominal wall hernia research

    NARCIS (Netherlands)

    Vogels, R.R.M.; R. Kaufmann (Ruth); L.C.L. van den Hil (Leontine); van Steensel, S.; M.H.F. Schreinemacher (Marc H.F.); J.F. Lange (Johan); N.D. Kannekens-Bouvy (Nicole)

    2017-01-01

    textabstractPurpose: Since the introduction of the first prosthetic mesh for abdominal hernia repair, there has been a search for the “ideal mesh.” The use of preclinical or animal models for assessment of necessary characteristics of new and existing meshes is an indispensable part of hernia

  14. Animal use in the chemical and product manufacturing sectors - can the downtrend continue?

    Science.gov (United States)

    Curren, Rodger

    2009-12-01

    During the 1990s and early 2000s, a number of manufacturing companies in the cosmetic, personal care and household product industries were able to substantially reduce their use of animals for testing (or to not use animals in the first place). These reductions were almost always the result of significant financial contributions to either direct, in-house alternatives research, or to support personnel whose duties were to understand and apply the current state-of-the-art for in vitro testing. They occurred almost exclusively in non-regulatory areas, and primarily involved acute topical toxicities. Over the last few years, the reduction in animal use has been much less dramatic, because some companies are still reluctant to change from the traditional animal studies, because systemic, repeat-dose toxicity is more difficult to model in vitro, and because many products still require animal testing for regulatory approval. Encouragingly, we are now observing an increased acceptance of non-animal methods by regulatory agencies. This is due to mounting scientific evidence from larger databases, agreement by companies to share data and testing strategies with regulatory agencies, and a focus on smaller domains of applicability. These changes, along with new emphasis and financial support for addressing systemic toxicities, promise to provide additional possibilities for industry to replace animals with in vitro methods, alone or in combination with in silico methods. However, the largest advance will not occur until more companies commit to using the non-animal test strategies that are currently available. 2009 FRAME.

  15. The Sheep as a Model of Preclinical Safety and Pharmacokinetic Evaluations of Candidate Microbicides

    OpenAIRE

    Holt, Jonathon D. S.; Cameron, David; Dias, Nicola; Holding, Jeremy; Muntendam, Alex; Oostebring, Freddy; Dreier, Peter; Rohan, Lisa; Nuttall, Jeremy

    2015-01-01

    When developing novel microbicide products for the prevention of HIV infection, the preclinical safety program must evaluate not only the active pharmaceutical ingredient but also the product itself. To that end, we applied several relatively standard toxicology study methodologies to female sheep, incorporating an assessment of the pharmacokinetics, safety, tolerability, and local toxicity of a dapivirine-containing human vaginal ring formulation (Dapivirine Vaginal Ring-004). We performed a...

  16. Seeing the animal

    DEFF Research Database (Denmark)

    Harfeld, Jes Lynning; Cornou, Cecile; Kornum, Anna

    2016-01-01

    This article discusses the notion that the invisibility of the animalness of the animal constitutes a fundamental obstacle to change within current production systems. It is discussed whether housing animals in environments that resemble natural habitats could lead to a re-animalization...... of the animals, a higher appreciation of their moral significance, and thereby higher standards of animal welfare. The basic claim is that experiencing the animals in their evolutionary and environmental context would make it harder to objectify animals as mere bioreactors and production systems. It is argued...... that the historic objectification of animals within intensive animal production can only be reversed if animals are given the chance to express themselves as they are and not as we see them through the tunnel visions of economy and quantifiable welfare assessment parameters....

  17. Breeding for genetic improvement of forage plants in relation to increasing animal production with reduced environmental footprint.

    Science.gov (United States)

    Kingston-Smith, A H; Marshall, A H; Moorby, J M

    2013-03-01

    Animal production is a fundamental component of the food supply chain, and with an increasing global population production levels are set to increase. Ruminant animals in particular are valuable in their ability to convert a fibre-rich forage diet into a high-quality protein product for human consumption, although this benefit is offset by inefficiencies in rumen fermentation that contribute to emission of significant quantities of methane and nitrogenous waste. Through co-operation between plant and animal sciences, we can identify how the nutritional requirements of ruminants can be satisfied by high-quality forages for the future. Selective forage plant breeding has supported crop improvement for nearly a century. Early plant breeding programmes were successful in terms of yield gains (4% to 5% per decade), with quality traits becoming increasingly important breeding targets (e.g. enhanced disease resistance and digestibility). Recently, demands for more sustainable production systems have required high yielding, high-quality forages that enable efficient animal production with minimal environmental impact. Achieving this involves considering the entire farm system and identifying opportunities for maximising nutrient use efficiency in both forage and animal components. Forage crops of the future must be able to utilise limited resources (water and nutrients) to maximise production on a limited land area and this may require us to consider alternative plant species to those currently in use. Furthermore, new breeding targets will be identified as the interactions between plants and the animals that consume them become better understood. This will ensure that available resources are targeted at delivering maximum benefits to the animal through enhanced transformation efficiency.

  18. The relevance of preclinical research models for the development of antimigraine drugs: Focus on 5-HT1B/1D and CGRP receptors

    DEFF Research Database (Denmark)

    Gupta, S.; Villalon, C.M.

    2010-01-01

    to the relief of migraineurs. Pathophysiological factors culminating into migraine headaches have not yet been completely deciphered and, thus, pose an additional challenge for preclinical research in the absence of any direct experimental marker. Migraine provocation experiments in humans use a head......-score to evaluate migraine, as articulated by the volunteer, which cannot be applied to laboratory animals. Therefore, basic research focuses on different symptoms and putative mechanisms, one at a time or in combination, to validate the hypotheses. Studies in several species, utilizing different preclinical...... incorporating the newer ideas/techniques in order to get better insights into migraine pathophysiology. (C) 2010 Elsevier Inc. All rights reserved...

  19. Nigerian Journal of Animal Production - Vol 19, No 1 (1992)

    African Journals Online (AJOL)

    Nigerian Journal of Animal Production. ... Application of a real-time linear array ultrasound system to the evaluation of live cattle · EMAIL FULL TEXT EMAIL FULL TEXT DOWNLOAD FULL TEXT ... Prediction of carcass lean content in live pigs using scanoprobe ultrasonic machine · EMAIL FULL TEXT EMAIL FULL TEXT

  20. Transmission of methicillin-resistant Staphylococcus aureus from food production animals to humans: a review

    NARCIS (Netherlands)

    Broens, E.M.; Cleef, van B.A.G.L.; Graat, E.A.M.; Kluytmans, J.A.J.W.

    2008-01-01

    International surveillance of antimicrobial use in food animal production shows that methicillinresistant Staphylococcus aureus (MRSA), traditionally a human pathogen associated with hospitals, has emerged in the community and animals. Since 1961, MRSA has been causing human infections in hospitals

  1. Countermeasures for reduction of radioactive contamination of farm animals and animal products in agricultural ecosystems

    International Nuclear Information System (INIS)

    Poeschl, M.

    2006-01-01

    Contamination of food products reaching the consumer may be a serious problem following radioactive contamination deposited in the agricultural environment. A wide variety of measures is available to reduce or prevent the transfer of radionuclides through the food-chain and hence reduce the radiation dose to the consumer. This paper reviews both literature sources and practice of applying agricultural countermeasures: Interventions at the soil-plant step, at the plant-animal step, and at the foodstuff-man step. In practice, the most effective countermeasures which can be used to reduce radionuclide contamination of animals in agricultural ecosystems will be obtained by a combination of both management changes and the use of chemical binders to prevent gut absorption. Social, economic, and practical considerations of the countermeasures such as availability, technical feasibility, acceptability and side-effects need to be also taken into account. (authors)

  2. Growth/differentiation factor-5: a candidate therapeutic agent for periodontal regeneration? A review of pre-clinical data.

    Science.gov (United States)

    Moore, Yolanda R; Dickinson, Douglas P; Wikesjö, Ulf M E

    2010-03-01

    Therapeutic concepts involving the application of matrix, growth and differentiation factors have been advocated in support of periodontal wound healing/regeneration. Growth/differentiation factor-5 (GDF-5), a member of the bone morphogenetic protein family, represents one such factor. The purpose of this review is to provide a background of the therapeutic effects of GDF-5 expressed in various musculoskeletal settings using small and large animal platforms. A comprehensive literature search was conducted to identify all reports in the English language evaluating GDF-5 using the PubMed and Google search engines, and a manual search of the reference lists from the electronically retrieved reports. Two reviewers independently screened the titles and abstracts from a total of 69 reports, 22 of which were identified as pre-clinical (in vivo) evaluations of GDF-5. The full-length article of the 22 pre-clinical reports was then reviewed. Various applications including cranial and craniofacial bone formation, spine fusion, long bone fracture healing, cartilage, and tendon/ligament repair using a variety of small and large animal platforms evaluating GDF-5 as a therapeutic agent were identified. A majority of studies, using biomechanical, radiographic, and histological analysis, demonstrated significant dose-dependent effects of GDF-5. These include increased/enhanced local bone formation, fracture healing/repair, and cartilage and tendon/ligament formation. GDF-5 frequently was shown to accelerate wound maturation. Several studies demonstrated GDF-5 to be a realistic alternative to autograft bone. Studies using pre-clinical models and human histology suggest GDF-5 may also increase/enhance periodontal wound healing/regeneration. GDF-5 appears a promising therapeutic agent for periodontal wound healing/regeneration as GDF-5 supports/accelerates bone and tendon/ligament formation in several musculoskeletal settings including periodontal tissues.

  3. Animal production and health newsletter. No. 42

    International Nuclear Information System (INIS)

    2005-07-01

    Apart from regular Coordinated Research Project (CRP) activities and our technical support given to ongoing national and regional Technical Cooperation projects (TC), we were also involved in the initiation (together with TC Country Officers) of the 2005/6 biennial TC project cycle. In addition to this, when carrying out our 2004/5 midterm performance evaluations, we could identify the areas where good performance was achieved as well as areas where further improvements are needed. It is hoped that our inputs will serve the best interests of our Member States. 1. The characterization of locally available feed and animal genetic resources and the identification and alleviation of constraints in the management of feeding, breeding and reproduction so as to improve the efficiency of livestock production while conserving the environment. This is done through the transfer of the following technologies: Radioimmunoassays (RIA) for measuring hormones: for identifying and mitigating constraints to efficient livestock production and improving the delivery of national artificial insemination services and providing diagnostic services to farmers

  4. Animal production and health newsletter. No. 42

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2005-07-01

    Apart from regular Coordinated Research Project (CRP) activities and our technical support given to ongoing national and regional Technical Cooperation projects (TC), we were also involved in the initiation (together with TC Country Officers) of the 2005/6 biennial TC project cycle. In addition to this, when carrying out our 2004/5 midterm performance evaluations, we could identify the areas where good performance was achieved as well as areas where further improvements are needed. It is hoped that our inputs will serve the best interests of our Member States. 1. The characterization of locally available feed and animal genetic resources and the identification and alleviation of constraints in the management of feeding, breeding and reproduction so as to improve the efficiency of livestock production while conserving the environment. This is done through the transfer of the following technologies: Radioimmunoassays (RIA) for measuring hormones: for identifying and mitigating constraints to efficient livestock production and improving the delivery of national artificial insemination services and providing diagnostic services to farmers.

  5. MANAGEMENT OF QUALITY AND SAFETY OF FOOD PRODUCTS OF ANIMAL ORIGIN

    Directory of Open Access Journals (Sweden)

    Goryana Yonkova

    2016-12-01

    Full Text Available Bulgaria is famous not only in Europe but throughout the world, except for its rich natural and cultural heritage, but also traditional dairy products (yogurt and cheese - cow, sheep, buffalo and goats; yellow cheese, honey and bee products, rose oil. To be competitive on national and international markets, food production must meet the requirements for quality assurance and food safety. The article presents the key economic indicators and threats related to quality management and safety of food products of animal origin in relation to the conservation of components of the environment and human health.

  6. A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies

    Directory of Open Access Journals (Sweden)

    Jody E. Hooper

    2015-01-01

    Full Text Available Embryonal rhabdomyosarcoma (eRMS is one of the most common soft tissue sarcomas in children and adolescents. Parameningeal eRMS is a variant that is often more difficult to treat than eRMS occurring at other sites. A 14-year-old female with persistent headaches and rapid weight loss was diagnosed with parameningeal eRMS. She progressed and died despite chemotherapy with vincristine, actinomycin-D, and cyclophosphamide plus 50.4 Gy radiation therapy to the primary tumor site. Tumor specimens were acquired by rapid autopsy and tumor tissue was transplanted into immunodeficient mice to create a patient-derived xenograft (PDX animal model. As autopsy specimens had an ALK R1181C mutation, PDX tumor bearing animals were treated with the pan-kinase inhibitor lestaurtinib but demonstrated no decrease in tumor growth, suggesting that single agent kinase inhibitor therapy may be insufficient in similar cases. This unique parameningeal eRMS PDX model is publicly available for preclinical study.

  7. Growth promoting antibiotics in food animal production: an economic analysis.

    Science.gov (United States)

    Graham, Jay P; Boland, John J; Silbergeld, Ellen

    2007-01-01

    Considerable controversy persists regarding the use of human antibiotics to promote growth in animals raised for food. The authors examined the economic effect of removing antibiotics used for growth promotion in commercial broiler chickens. The authors utilized data published by the Perdue company, the fourth largest poultry producer in the United States, in which a non-randomized controlled trial of growth-promoting antibiotic (GPA) use was conducted with seven million broiler chickens to evaluate the impact of removing GPAs on production. Positive production changes were associated with GPA use, but were insufficient to offset the cost of the antibiotics. The net effect of using GPAs was a lost value of 0.0093 dollars per chicken (about 0.45% of total cost). Based upon these data, the authors found no basis for the claim that the use of GPAs lowers the cost of production. Note that this study does not include veterinary cost changes or changes in performance variability associated with the removal of GPAs. This economic analysis is the first study to the authors' knowledge utilizing large-scale empirical data collected by U.S. industry, in which it is demonstrated that the use of GPAs in poultry production is associated with economic losses to the producers. These data are of considerable importance in the ongoing national debate concerning the continued use of antibiotics for growth promotion of food animals. Based on the industry study and the resulting economic impact, the use of GPAs in U.S. poultry production should be reconsidered.

  8. Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.

    Science.gov (United States)

    Ng, Kok Pin; Pascoal, Tharick A; Mathotaarachchi, Sulantha; Chung, Chang-Oh; Benedet, Andréa L; Shin, Monica; Kang, Min Su; Li, Xiaofeng; Ba, Maowen; Kandiah, Nagaendran; Rosa-Neto, Pedro; Gauthier, Serge

    2017-05-09

    To identify regional brain metabolic dysfunctions associated with neuropsychiatric symptoms (NPS) in preclinical Alzheimer disease (AD). We stratified 115 cognitively normal individuals into preclinical AD (both amyloid and tau pathologies present), asymptomatic at risk for AD (either amyloid or tau pathology present), or healthy controls (no amyloid or tau pathology present) using [ 18 F]florbetapir PET and CSF phosphorylated tau biomarkers. Regression and voxel-based regression models evaluated the relationships between baseline NPS measured by the Neuropsychiatric Inventory (NPI) and baseline and 2-year change in metabolism measured by [ 18 F]fluorodeoxyglucose (FDG) PET. Individuals with preclinical AD with higher NPI scores had higher [ 18 F]FDG uptake in the posterior cingulate cortex (PCC), ventromedial prefrontal cortex, and right anterior insula at baseline. High NPI scores predicted subsequent hypometabolism in the PCC over 2 years only in individuals with preclinical AD. Sleep/nighttime behavior disorders and irritability and lability were the components of the NPI that drove this metabolic dysfunction. The magnitude of NPS in preclinical cases, driven by sleep behavior and irritability domains, is linked to transitory metabolic dysfunctions within limbic networks vulnerable to the AD process and predicts subsequent PCC hypometabolism. These findings support an emerging conceptual framework in which NPS constitute an early clinical manifestation of AD pathophysiology. Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

  9. What We Know about the Public’s Level of Concern for Farm Animal Welfare in Food Production in Developed Countries

    Science.gov (United States)

    Cornish, Amelia; Raubenheimer, David; McGreevy, Paul

    2016-01-01

    Simple Summary The production of food from animals poses many ethical challenges. This review explores what we know about different levels of concern for animal welfare in food production by such stakeholders as veterinarians, farmers, and the general public. Despite the general public’s level of concern for animal welfare in food production being high, their understanding and knowledge is poor. Thus, it is suggested that through widespread consciousness raising we can encourage the public to accurately translate their concerns into market drivers, in turn improving the welfare of billions of animals. Abstract Population growth and rising consumption of meat, dairy, eggs and fish are forcing the world to face the intersecting challenges of how to sustainably feed a population expected to exceed 9 billion by 2050, while also controlling the impact of food production on the planet, on people and on animals. This review acknowledges the absence of a globally accepted definition of animal welfare and then explores the literature regarding different levels of concern for animal welfare in food production by such stakeholders as veterinarians, farmers, and the general public. It focuses on the evidence that the general public’s level of concern for animal welfare is linked to various demographic and personal characteristics, such as age, gender, religion, location, meat eating, and knowledge of animal welfare. Certain animals have characteristics that influence concern for their welfare, with those species that are considered more intelligent being afforded more concern. There is compelling evidence that the general public’s understanding of animal welfare in food production is poor. Acknowledging that public concern can be a driving force to change current production methods, the authors suggest widespread consciousness raising to redefine socially acceptable methods of food production from animals and to ensure that it remains in step with societal concerns. PMID

  10. Preclinical incorporation dosimetry of (+)-[18F) flubatine in piglets

    International Nuclear Information System (INIS)

    Sattler, B.; Patt, M.; Sabri, O.; Kranz, M.; Donat, C.K.; Deuther-Conrad, W.; Fischer, S.; Brust, P.; Sattler, T.; Smits, R.; Hoepping, A.; Steinbach, J.

    2015-01-01

    Full text of publication follows. Aim: (+)-[ 18 F] flubatine is the mirror image isomer of (-)-[ 18 F] flubatine, which is successfully used for neuroimaging of alpha4beta2 nAChRs with PET. To assess the radiation risk by this new radiotracer, biodistribution, organ doses (OD) and the effective dose (ED) were investigated in a preclinical trials using piglets. Method: whole body dosimetry of (+)-[ 18 F] flubatine was performed in 3 female piglets (age: 43 ± 1.2 days, weight: 14 ± 1.0 kg). The animals were narcotized using 20 mg/kg Ketamine, 2 mg/kg Azaperone; 1.5% Isoflurane in 70% N 2 O/30% O 2 and sequentially PET-imaged up to 5 hours post i.v. injection of 183.5 ± 9.0 MBq on a SIEMENS Biograph16 PET/CT-system on 7 bed positions (BP) per frame, 1.5 to 6 min/BP, CT-attenuation correction (AC) and iterative reconstruction. All relevant organs were defined by volumes of interest. Exponential curves were fitted to the time-activity-data (%ID/g, and %ID/organ). Time- and mass-scales were adapted to the human order of magnitude. The ODs were calculated using the adult male model with OLINDA. The ED was calculated using tissue weighting factors as published in the ICRP103. Results: The highest OD was received by the urinary bladder (71.7 ± 26.3 μSv/MBq), the kidneys (45.1 ± 6.5 μSv/MBq) and the brain (32.3 ± 3.24 μSv/MBq). The highest contribution to the ED was by the urinary bladder (2.9 ± 1.1 μSv/MBq), the lungs (1.7 ± 0.02 μSv/MBq) and the red marrow (1.4 ± 0.1μSv/MBq). According to this data, the ED to humans is 14.3 ± 0.3 μSv/MBq. Conclusion: considering 40% underestimation of the ED to humans by preclinical dosimetry [1] the expected ED to humans after 300 MBq i.v. is 7.2 mSv, which is about the ED by (-)-[ 18 F]flubatine (6.8 mSv/300 MBq) and well within the range of what other 18 F-labeled compounds cause to humans. This risk assessment encourages to transfer (+)-[F 18 ] flubatine from preclinical to clinical study phases and to further develop

  11. Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations

    OpenAIRE

    Islam, Dilara; Ruamsap, Nattaya; Khantapura, Patchariya; Aksomboon, Ajchara; Srijan, Apichai; Wongstitwilairoong, Boonchai; Bodhidatta, Ladaporn; Gettayacamin, Montip; Venkatesan, Malabi M; Mason, Carl J

    2013-01-01

    Shigellosis is a worldwide disease, characterized by abdominal pain, fever, vomiting, and the passage of blood- and mucus-streaked stools. Rhesus monkeys and other primates are the only animals that are naturally susceptible to shigellosis. A suitable animal model is required for the pre-clinical evaluation of vaccines candidates. In this study, the minimal dose of Shigella dysenteriae1 1617 strain required to produce dysentery in four of five (80% attack rate) monkeys using an escalating dos...

  12. Animal models.

    Science.gov (United States)

    Walker, Ellen A

    2010-01-01

    As clinical studies reveal that chemotherapeutic agents may impair several different cognitive domains in humans, the development of preclinical animal models is critical to assess the degree of chemotherapy-induced learning and memory deficits and to understand the underlying neural mechanisms. In this chapter, the effects of various cancer chemotherapeutic agents in rodents on sensory processing, conditioned taste aversion, conditioned emotional response, passive avoidance, spatial learning, cued memory, discrimination learning, delayed-matching-to-sample, novel-object recognition, electrophysiological recordings and autoshaping is reviewed. It appears at first glance that the effects of the cancer chemotherapy agents in these many different models are inconsistent. However, a literature is emerging that reveals subtle or unique changes in sensory processing, acquisition, consolidation and retrieval that are dose- and time-dependent. As more studies examine cancer chemotherapeutic agents alone and in combination during repeated treatment regimens, the animal models will become more predictive tools for the assessment of these impairments and the underlying neural mechanisms. The eventual goal is to collect enough data to enable physicians to make informed choices about therapeutic regimens for their patients and discover new avenues of alternative or complementary therapies that reduce or eliminate chemotherapy-induced cognitive deficits.

  13. Animation of Antimicrobial Resistance

    Medline Plus

    Full Text Available ... Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Animal & ... back Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products

  14. Juvenile Animal Testing: Assessing Need and Use in the Drug Product Label.

    Science.gov (United States)

    Baldrick, Paul

    2018-01-01

    Juvenile animal testing has become an established part of drug development to support safe clinical use in the human pediatric population and for eventual drug product label use. A review of European Paediatric Investigation Plan decisions showed that from 2007 to mid-2017, 229 drugs had juvenile animal work requested, almost exclusively incorporating general toxicology study designs, in rat (57.5%), dog (8%), mouse (4.5%), monkey (4%), pig (2%), sheep (1%), rabbit (1%), hamster (0.5%), and species not specified (21.5%). A range of therapeutic areas were found, but the most common areas were infectious diseases (15%), endocrinology (13.5%), oncology (13%), neurology (11%), and cardiovascular diseases (10%). Examination of major clinical indications within these therapeutic areas showed some level of consistency in the species of choice for testing and the pediatric age that required support. Examination of juvenile animal study findings presented in product labels raises questions around how useful the data are to allow prescribing the drug to a child. It is hopeful that the new ICH S11 guideline "Nonclinical Safety Testing in Support of Development of Pediatric Medicines" currently in preparation will aid drug developers in clarifying the need for juvenile animal studies as well as in promoting a move away from toxicology studies with a conventional design. This would permit more focused testing to examine identified areas of toxicity or safety concerns and clarify the presentation/interpretation of juvenile animal study findings for proper risk assessment by a drug prescriber.

  15. Potential contamination issues arising from the use of biofuel and food industry by-products in animal feed

    DEFF Research Database (Denmark)

    Granby, Kit; Mortensen, Alicja; Broesboel-Jensen, B.

    2012-01-01

    By-products are secondary or discarded products from manufacturing. Contamination of by-products used for feed may result in carryover to animal food products and hence have impact on either animal health or food safety. Feed by-products from bioethanol production include, for example, 'dried...... distillers grain' (DDG) and 'dried distillers grain with solubles' (DDGS) from generation bioethanol production, C5-molasses from generation bioethanol production and glycerol from biodiesel production. By-products from food industry may comprise discarded or downgraded food and food surplus or secondary...... products such as peels, pulpettes, molasses, whey, mask, oil cakes, etc. Contamination of by-products and possible impacts are presented....

  16. 9 CFR 94.11 - Restrictions on importation of meat and other animal products from specified regions.

    Science.gov (United States)

    2010-01-01

    ... animal products, and ship stores, airplane meals, and baggage containing such meat or animal products... carcass of any ruminant or swine, other than meat and articles regulated under part 95 or 96 of this... conveyance that will bring the article to the United States in a manner to preclude its being commingled or...

  17. Proteomics and the search for welfare and stress biomarkers in animal production in the one-health context.

    Science.gov (United States)

    Marco-Ramell, A; de Almeida, A M; Cristobal, S; Rodrigues, P; Roncada, P; Bassols, A

    2016-06-21

    Stress and welfare are important factors in animal production in the context of growing production optimization and scrutiny by the general public. In a context in which animal and human health are intertwined aspects of the one-health concept it is of utmost importance to define the markers of stress and welfare. These are important tools for producers, retailers, regulatory agents and ultimately consumers to effectively monitor and assess the welfare state of production animals. Proteomics is the science that studies the proteins existing in a given tissue or fluid. In this review we address this topic by showing clear examples where proteomics has been used to study stress-induced changes at various levels. We adopt a multi-species (cattle, swine, small ruminants, poultry, fish and shellfish) approach under the effect of various stress inducers (handling, transport, management, nutritional, thermal and exposure to pollutants) clearly demonstrating how proteomics and systems biology are key elements to the study of stress and welfare in farm animals and powerful tools for animal welfare, health and productivity.

  18. Quantitative modeling of the Water Footprint and Energy Content of Crop and Animal Products Consumption in Tanzania

    Directory of Open Access Journals (Sweden)

    felichesmi Selestine lyakurwa

    2014-05-01

    Full Text Available A comprehensive understanding of the link between water footprint and energy content of crop and animal products is vitally important for the sound management of water resources. In this study, we developed a mathematical relationship between water content, and energy content of many crops and animal products by using an improved LCA approach (water footprint. The standard values of the water and energy contents of crops and animal products were obtained from the databases of Agricultural Research Service, UNESCO Institute for water education and Food, and Agriculture Organization of the United Nations. The water footprint approach was applied to analyze the relationship between water requirement and energy of content of crop and animal products, in which the uncertainty and sensitivity was evaluated by Monte Carlo simulation technique that is contained in the Oracle Crystal Ball Fusion Edition v11.1.1.3.00. The results revealed significant water saving due to changes in food consumption pattern i.e. from consumption of more meat to vegetables. The production of 1kcal of crop and animal products requires about 98% of green, 4.8% blue water and 0.4% of gray water. In which changes in consumption pattern gave annual blue water saving of about 1605 Mm3 that is equivalent to 41.30m3/capita, extremely greater than the standard drinking water requirement for the whole population. Moreover, the projected results indicated, triple increase of dietary water requirement from 30.9 Mm3 in 2005 to 108 Mm3 by 2050. It was also inferred that, Tanzania has a positive virtual water balance of crop and animal products consumption with net virtual water import of 9.1 Mm3 that is the contribution margin to the water scarcity alleviation strategy. Therefore, developed relationship of water footprint and energy content of crops and animal products can be used by water resource experts for sustainable freshwater and food supply.

  19. Growth and Productivity of Response of Hybrid Rice to Application of Animal Manures, Plant Residues and Phosphorus

    Directory of Open Access Journals (Sweden)

    Dr. Amanullah

    2016-10-01

    Full Text Available The objective of this research was to evaluate the impact of organic sources (animal manures vs. plant residues at the rate of 10 t ha-1 each on the productivity profitability of small land rice (Oryza sativa L. grower under different levels of phosphorus (0, 30, 60 and 90 kg P ha-1 fertilization. Two separate field experiments were conducted. In experiment (1, impact of three animal manures sources (cattle, sheep & poultry manures and P levels was studied along with one control plot (no animal manure and P applied as check was investigated. In experiment (2, three plant residues sources (peach leaves, garlic residues & wheat straw and P levels was studied along with one control plot (no plant residues and P applied as check. Both the experiments were carried out on small land farmer field at District Swabi, Khyber Pakhtunkhwa Province (Northwest Pakistan during summer 2015. The results revealed that in both experiments the control plot had significantly (p≤0.05 less productivity than the average of all treated plots with organic sources and P level. The increase in P levels in both experiments (animal manure vs. plant residues had resulted in higher rice productivity (90 = 60 > 30 > 0 kg P ha-1. In the experiment under animal manures, application of poultry manure increased rice productivity as compared with sheep and cattle manures (poultry > sheep > cattle manures. In the experiment under plant residues, application of peach leaves or garlic resides had higher rice productivity over wheat straw (peach leaves = garlic residues > wheat straw. On the average, the rice grown under animal manures produced about 20% higher grain yield than the rice grown under crop residues. We concluded from this study that application of 90 kg P ha-1 along with combined application of animal manures especially poultry manure could increase rice productivity. We conclude from this study that application of 90 kg P ha-1 along with combined application of animal

  20. Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery

    Directory of Open Access Journals (Sweden)

    Chiang Po-Chang

    2009-01-01

    Full Text Available Abstract Asthma and chronic obstructive pulmonary disease (COPD are pulmonary diseases that are characterized by inflammatory cell infiltration, cytokine production, and airway hyper-reactivity. Most of the effector cells responsible for these pathologies reside in the lungs. One of the most direct ways to deliver drugs to the target cells is via the trachea. In a pre-clinical setting, this can be achieved via intratracheal (IT, intranasal (IN, or aerosol delivery in the desired animal model. In this study, we pioneered the aerosol delivery of a nanosuspension formulation in a rodent model. The efficiency of different dosing techniques and formulations to target the lungs were compared, and fluticasone was used as the model compound. For the aerosol particle size determination, a ten-stage cascade impactor was used. The mass median aerodynamic diameter (MMAD was calculated based on the percent cumulative accumulation at each stage. Formulations with different particle size of fluticasone were made for evaluation. The compatibility of regular fluticasone suspension and nanosuspension for aerosol delivery was also investigated. The in vivo studies were conducted on mice with optimized setting. It was found that the aerosol delivery of fluticasone with nanosuspension was as efficient as intranasal (IN dosing, and was able to achieve dose dependent lung deposition.

  1. Open-source, small-animal magnetic resonance-guided focused ultrasound system.

    Science.gov (United States)

    Poorman, Megan E; Chaplin, Vandiver L; Wilkens, Ken; Dockery, Mary D; Giorgio, Todd D; Grissom, William A; Caskey, Charles F

    2016-01-01

    MR-guided focused ultrasound or high-intensity focused ultrasound (MRgFUS/MRgHIFU) is a non-invasive therapeutic modality with many potential applications in areas such as cancer therapy, drug delivery, and blood-brain barrier opening. However, the large financial costs involved in developing preclinical MRgFUS systems represent a barrier to research groups interested in developing new techniques and applications. We aim to mitigate these challenges by detailing a validated, open-source preclinical MRgFUS system capable of delivering thermal and mechanical FUS in a quantifiable and repeatable manner under real-time MRI guidance. A hardware and software package was developed that includes closed-loop feedback controlled thermometry code and CAD drawings for a therapy table designed for a preclinical MRI scanner. For thermal treatments, the modular software uses a proportional integral derivative controller to maintain a precise focal temperature rise in the target given input from MR phase images obtained concurrently. The software computes the required voltage output and transmits it to a FUS transducer that is embedded in the delivery table within the magnet bore. The delivery table holds the FUS transducer, a small animal and its monitoring equipment, and a transmit/receive RF coil. The transducer is coupled to the animal via a water bath and is translatable in two dimensions from outside the magnet. The transducer is driven by a waveform generator and amplifier controlled by real-time software in Matlab. MR acoustic radiation force imaging is also implemented to confirm the position of the focus for mechanical and thermal treatments. The system was validated in tissue-mimicking phantoms and in vivo during murine tumor hyperthermia treatments. Sonications were successfully controlled over a range of temperatures and thermal doses for up to 20 min with minimal temperature overshoot. MR thermometry was validated with an optical temperature probe, and focus

  2. Characterization of co-products of the pilot digesters to animal ...

    African Journals Online (AJOL)

    This work consists in evaluating the Co-products of the biomethanisation applied to the animal biomass on the level of various types of digesters (experimental I, II, III and IV, rural and industrial). This work made it possible to arise certain number of observations: The energy performances are more interesting in the case of ...

  3. Quantitative spectral K-edge imaging in preclinical photon-counting x-ray computed tomography.

    Science.gov (United States)

    de Vries, Anke; Roessl, Ewald; Kneepkens, Esther; Thran, Axel; Brendel, Bernhard; Martens, Gerhard; Proska, Roland; Nicolay, Klaas; Grüll, Holger

    2015-04-01

    The objective of this study was to investigate the feasibility and the accuracy of spectral computed tomography (spectral CT) to determine the tissue concentrations and localization of high-attenuation, iodine-based contrast agents in mice. Iodine tissue concentrations determined with spectral CT are compared with concentrations measured with single-photon emission computed tomography (SPECT) and inductively coupled plasma mass spectrometry (ICP-MS). All animal procedures were performed according to the US National Institutes of Health principles of laboratory animal care and were approved by the ethical review committee of Maastricht, The Netherlands. Healthy Swiss mice (n = 4) were injected with an iodinated emulsion radiolabeled with indium as multimodal contrast agent for CT and SPECT. The CT and SPECT scans were acquired using a dedicated small-animal SPECT/CT system. Subsequently, scans were performed with a preclinical spectral CT scanner equipped with a photon-counting detector and 6 energy threshold levels. Quantitative data analysis of SPECT and spectral CT scans were obtained using 3-dimensional volumes-of-interest drawing methods. The ICP-MS on dissected organs was performed to determine iodine uptake per organ and was compared with the amounts determined from spectral CT and SPECT. Iodine concentrations obtained with image-processed spectral CT data correlated well with data obtained either with noninvasive SPECT imaging (slope = 0.96, r = 0.75) or with ICP-MS (slope = 0.99, r = 0.89) in tissue samples. This preclinical proof-of-concept study shows the in vivo quantification of iodine concentrations in tissues using spectral CT. Our multimodal imaging approach with spectral CT and SPECT using radiolabeled iodinated emulsions together with ICP-based quantification allows a direct comparison of all methods. Benchmarked against ICP-MS data, spectral CT in the present implementation shows a slight underestimation of organ iodine concentrations compared

  4. Utility of Small Animal Models of Developmental Programming.

    Science.gov (United States)

    Reynolds, Clare M; Vickers, Mark H

    2018-01-01

    Any effective strategy to tackle the global obesity and rising noncommunicable disease epidemic requires an in-depth understanding of the mechanisms that underlie these conditions that manifest as a consequence of complex gene-environment interactions. In this context, it is now well established that alterations in the early life environment, including suboptimal nutrition, can result in an increased risk for a range of metabolic, cardiovascular, and behavioral disorders in later life, a process preferentially termed developmental programming. To date, most of the mechanistic knowledge around the processes underpinning development programming has been derived from preclinical research performed mostly, but not exclusively, in laboratory mouse and rat strains. This review will cover the utility of small animal models in developmental programming, the limitations of such models, and potential future directions that are required to fully maximize information derived from preclinical models in order to effectively translate to clinical use.

  5. 9 CFR 51.6 - Destruction of animals; time limit for destruction of animals.

    Science.gov (United States)

    2010-01-01

    ... 9 Animals and Animal Products 1 2010-01-01 2010-01-01 false Destruction of animals; time limit for destruction of animals. 51.6 Section 51.6 Animals and Animal Products ANIMAL AND PLANT HEALTH INSPECTION... ANIMALS DESTROYED BECAUSE OF BRUCELLOSIS Indemnity for Cattle, Bison, and Swine § 51.6 Destruction of...

  6. Enhancing Fatty Acid Production of Saccharomyces cerevisiae as an Animal Feed Supplement.

    Science.gov (United States)

    You, Seung Kyou; Joo, Young-Chul; Kang, Dae Hee; Shin, Sang Kyu; Hyeon, Jeong Eun; Woo, Han Min; Um, Youngsoon; Park, Chulhwan; Han, Sung Ok

    2017-12-20

    Saccharomyces cerevisiae is used for edible purposes, such as human food or as an animal feed supplement. Fatty acids are also beneficial as feed supplements, but S. cerevisiae produces small amounts of fatty acids. In this study, we enhanced fatty acid production of S. cerevisiae by overexpressing acetyl-CoA carboxylase, thioesterase, and malic enzyme associated with fatty acid metabolism. The enhanced strain pAMT showed 2.4-fold higher fatty acids than the wild-type strain. To further increase the fatty acids, various nitrogen sources were analyzed and calcium nitrate was selected as an optimal nitrogen source for fatty acid production. By concentration optimization, 672 mg/L of fatty acids was produced, which was 4.7-fold higher than wild-type strain. These results complement the low level fatty acid production and make it possible to obtain the benefits of fatty acids as an animal feed supplement while, simultaneously, maintaining the advantages of S. cerevisiae.

  7. 75 FR 75482 - Draft Guidance for Industry on Residual Solvents in Animal Drug Products; Questions and Answers...

    Science.gov (United States)

    2010-12-03

    ...] Draft Guidance for Industry on Residual Solvents in Animal Drug Products; Questions and Answers... Solvents in Animal Drug Products; Questions and Answers.'' The draft questions and answers (Q&A) guidance addresses the United States Pharmacopeia (USP) General Chapter Residual Solvents that applies to both human...

  8. Cost-effectiveness analysis: adding value to assessment of animal health welfare and production.

    Science.gov (United States)

    Babo Martins, S; Rushton, J

    2014-12-01

    Cost-effectiveness analysis (CEA) has been extensively used in economic assessments in fields related to animal health, namely in human health where it provides a decision-making framework for choices about the allocation of healthcare resources. Conversely, in animal health, cost-benefit analysis has been the preferred tool for economic analysis. In this paper, the use of CEA in related areas and the role of this technique in assessments of animal health, welfare and production are reviewed. Cost-effectiveness analysis can add further value to these assessments, particularly in programmes targeting animal welfare or animal diseases with an impact on human health, where outcomes are best valued in natural effects rather than in monetary units. Importantly, CEA can be performed during programme implementation stages to assess alternative courses of action in real time.

  9. USE OF ELECTROLYZED WATER IN ANIMAL PRODUCTION

    Directory of Open Access Journals (Sweden)

    Dana Jirotková

    2012-10-01

    Full Text Available The paper deals with the possibility to use the properties of electrolyzed water to disinfect breeding halls and to water animals. The aim of the research was to find out whether elektrolyzed water used for desinfication of breedings hall and watering of animals influences selected indicators of the meat quality. Electrolyzed water is produced in a patent-protected device Envirolyte that produces biocide solution using potable water with added NaCl. The technology of production guarantees the product is entirely ecological, biologically fully degradable, non-toxic that can replace traditional chemical agents. Possibilities of disinfection using this solution have been verified directly in stables at the interval of 20, 40, 60 min. after application. Staphylococci and streptococci and enterococci were inactive always after 60 minutes of effect. There was significant decrease in the number of total number of microorganisms. Further, the solution of electrolyzed water was used to water poultry; and the affect on some of the properties of poultry meat, changes in pH, colour and loss of water (dripping in particular, was observed. Testing was carried out under working conditions in two breeding halls at a time and the technology of electrolyzed water to disinfect premises and to water chickens was used in one of the halls. When the chickens were slaughter mature, the poultry was slaughtered at the standard slaughterhouse and samples (127 pieces were taken in order to measure pH, colour and loss of water (dripping. The values of pH, colour and loss of water (dripping ascertained, processed by the T-test did not confirm the hypothesis of the assumed possible differences in occurrence of critical values of these indicators in both groups observed.

  10. NCI Pediatric Preclinical Testing Consortium

    Science.gov (United States)

    NCI has awarded grants to five research teams to participate in its Pediatric Preclinical Testing Consortium, which is intended to help to prioritize which agents to pursue in pediatric clinical trials.

  11. Linking live animals and products: traceability.

    Science.gov (United States)

    Britt, A G; Bell, C M; Evers, K; Paskin, R

    2013-08-01

    It is rarely possible to successfully contain an outbreak of an infectious animal disease, or to respond effectively to a chemical residue incident, without the use of a system for identifying and tracking animals. The linking of animals at the time they are slaughtered--through the use of identification devices or marks and accompanying movement documentation--with the meat produced from their carcasses, adds further value from the perspective of consumer safety. Over the past decade, animal identification technology has become more sophisticated and affordable. The development of the Internet and mobile communication tools, complemented bythe expanded capacity of computers and associated data management applications, has added a new dimension to the ability of Competent Authorities and industry to track animals and the food they produce for disease control, food safety and commercial purposes.

  12. Animal models of pancreatic cancer for drug research.

    Science.gov (United States)

    Kapischke, Matthias; Pries, Alexandra

    2008-10-01

    The operative and conservative results of therapy in pancreatic ductal adenocarcinoma remain appallingly poor. This underlines the demand for further research for effective anticancer drugs. The various animal models remain the essential method for the determination of efficacy of substances during preclinical phase. Unfortunately, most of these tested substances showed a good efficacy in pancreatic carcinoma in the animal model but were not confirmed during the clinical phase. The available literature in PubMed, Medline, Ovid and secondary literature was searched regarding the available animal models for drug testing against pancreatic cancer. The models were analyzed regarding their pros and cons in anticancer drug testing. The different modifications of the orthotopic model (especially in mice) seem at present to be the best model for anticancer testing in pancreatic carcinoma. The value of genetically engineered animal model (GEM) and syngeneic models is on debate. A good selection of the model concerning the questions supposed to be clarified may improve the comparability of the results of animal experiments compared to clinical trials.

  13. Neurotoxicity in Preclinical Models of Occupational Exposure to Organophosphorus Compounds

    Science.gov (United States)

    Voorhees, Jaymie R.; Rohlman, Diane S.; Lein, Pamela J.; Pieper, Andrew A.

    2017-01-01

    Organophosphorus (OPs) compounds are widely used as insecticides, plasticizers, and fuel additives. These compounds potently inhibit acetylcholinesterase (AChE), the enzyme that inactivates acetylcholine at neuronal synapses, and acute exposure to high OP levels can cause cholinergic crisis in humans and animals. Evidence further suggests that repeated exposure to lower OP levels insufficient to cause cholinergic crisis, frequently encountered in the occupational setting, also pose serious risks to people. For example, multiple epidemiological studies have identified associations between occupational OP exposure and neurodegenerative disease, psychiatric illness, and sensorimotor deficits. Rigorous scientific investigation of the basic science mechanisms underlying these epidemiological findings requires valid preclinical models in which tightly-regulated exposure paradigms can be correlated with neurotoxicity. Here, we review the experimental models of occupational OP exposure currently used in the field. We found that animal studies simulating occupational OP exposures do indeed show evidence of neurotoxicity, and that utilization of these models is helping illuminate the mechanisms underlying OP-induced neurological sequelae. Still, further work is necessary to evaluate exposure levels, protection methods, and treatment strategies, which taken together could serve to modify guidelines for improving workplace conditions globally. PMID:28149268

  14. SUSTAINABLE DEVELOPMENT AND THE PROBLEM OF A NATIONAL STRATEGY FOR SUSTAINABLE DEVELOPMENT OF ANIMAL PRODUCTION

    Directory of Open Access Journals (Sweden)

    Condrea DRAGANESCU

    2013-12-01

    Full Text Available The paper aimed to approach the topic of a new strategy for the sustainable and competitive development of Romanian agriculture and especially for animal husbandry. In this purpose, a large variety of studies was investigated and the opinions of well-known personalities were used to present in a critical manner the history of sustainable development concept, principles, causes, reasons, moments, events, institutions involved at international, European and national level, achievements. The study is focused on Romania, starting from the actual situation of animal husbandry and learning from the country own and others experience. During the last centuries, the scientific studies noticed that the growth trends of the world population and resources utilization which could determine complications for survival of human society. The first Report of The Club of Rome (1972 concluded mathematically that " if the present growth trends in world population, industrialization, pollution, food production, and resources depletion continue to remain unchanged, the limits to growth on this planet will be reached sometime in the next hundred years",..that is in the 21 century. As a reply, the international and national bodies adopted recommendations for a sustainable development. This study analyzed the problems of sustainable development of animal production in Romania, taking into consideration that the conversion rate of energy provided by plants to animal products is about 20%, and this decrease of the number of population is supported by agricultural food production. Two production systems are proposed: (1. Intensive production systems, with high forage conversion, in favorable agricultural country area; (2. extensive (free-ranging, transhumance, pendulation, sustainable, biological production in not or less favorable agricultural area (mountain area, etc.

  15. Verification of photon attenuation characteristics for 3D printer based small animal lung model

    International Nuclear Information System (INIS)

    Lee, Se Ho; Lee, Seung Wook; Han, Su Chul; Park, Seung Woo

    2016-01-01

    Since it is difficult to measure absorbed dose to mice in vivo, replica mice are mostly used as alternative. In this study, realistic mouse phantom was fabricated by using 3D printer (object500 connex3, Stratasys, USA). Elemental inks as material of 3D printer were selected corresponding to mouse tissue. To represent lung, selected material was partially used with air layer. In order to verify material equivalent, super-flex bolus was simply compared to verify photon attenuation characteristics. In the case of lung, Hounsfield unit (HU) of the phantom were compared with a live mouse. In this study, we fabricated mouse phantom by using 3D printer, and practically verified photon attenuation characteristics. The fabricated phantom shows tissue equivalence as well as similar geometry with live mouse. As more and more growing of 3D printer technique, 3D printer based small preclinical animal phantom would increase reliability of verification of absorbed dose in small animal for preclinical study

  16. Verification of photon attenuation characteristics for 3D printer based small animal lung model

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Se Ho; Lee, Seung Wook [Pusan National University, Busan (Korea, Republic of); Han, Su Chul; Park, Seung Woo [Korea Institute of Radiological and Medical Sciences, Seoul (Korea, Republic of)

    2016-05-15

    Since it is difficult to measure absorbed dose to mice in vivo, replica mice are mostly used as alternative. In this study, realistic mouse phantom was fabricated by using 3D printer (object500 connex3, Stratasys, USA). Elemental inks as material of 3D printer were selected corresponding to mouse tissue. To represent lung, selected material was partially used with air layer. In order to verify material equivalent, super-flex bolus was simply compared to verify photon attenuation characteristics. In the case of lung, Hounsfield unit (HU) of the phantom were compared with a live mouse. In this study, we fabricated mouse phantom by using 3D printer, and practically verified photon attenuation characteristics. The fabricated phantom shows tissue equivalence as well as similar geometry with live mouse. As more and more growing of 3D printer technique, 3D printer based small preclinical animal phantom would increase reliability of verification of absorbed dose in small animal for preclinical study.

  17. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11

    DEFF Research Database (Denmark)

    Horn, Michael P; Zuercher, Adrian W; Imboden, Martin A

    2010-01-01

    with P. aeruginosa at doses as low as 5 microg/animal. Furthermore, a high efficacy of KBPA101 in protection from local respiratory infections in an acute lung infection model in mice was demonstrated. Preclinical toxicology evaluation on human tissue, in rabbits, and in mice did not indicate any...

  18. Mid-term financial impact of animal welfare improvements in Dutch broiler production.

    Science.gov (United States)

    Gocsik, E; Lansink, A G J M Oude; Saatkamp, H W

    2013-12-01

    This study used a stochastic bioeconomic simulation model to simulate the business and financial risk of different broiler production systems over a 5-yr period. Simulation analysis was conducted using the @Risk add-in in MS Excel. To compare the impact of different production systems on economic feasibility, 2 cases were considered. The first case focused on the economic feasibility of a completely new system, whereas the second examined economic feasibilities when a farm switches from a conventional to an animal welfare-improving production system. A sensitivity analysis was conducted to assess the key drivers of economic feasibility and to reveal systematic differences across production systems. The study shows that economic feasibility of systems with improved animal welfare predominantly depends on the price that farmers receive. Moreover, the study demonstrates the importance of the level and variation of the price premium for improved welfare, particularly in the first 5 yr after conversion. The economic feasibility of the production system increases with the level of welfare improvements for a sufficiently high price level for broiler meat and low volatility in producer prices. If this is not the case, however, risk attitudes of farmers become important as well as the use of potential risk management instruments.

  19. Small Animal Models for Evaluating Filovirus Countermeasures.

    Science.gov (United States)

    Banadyga, Logan; Wong, Gary; Qiu, Xiangguo

    2018-05-11

    The development of novel therapeutics and vaccines to treat or prevent disease caused by filoviruses, such as Ebola and Marburg viruses, depends on the availability of animal models that faithfully recapitulate clinical hallmarks of disease as it is observed in humans. In particular, small animal models (such as mice and guinea pigs) are historically and frequently used for the primary evaluation of antiviral countermeasures, prior to testing in nonhuman primates, which represent the gold-standard filovirus animal model. In the past several years, however, the filovirus field has witnessed the continued refinement of the mouse and guinea pig models of disease, as well as the introduction of the hamster and ferret models. We now have small animal models for most human-pathogenic filoviruses, many of which are susceptible to wild type virus and demonstrate key features of disease, including robust virus replication, coagulopathy, and immune system dysfunction. Although none of these small animal model systems perfectly recapitulates Ebola virus disease or Marburg virus disease on its own, collectively they offer a nearly complete set of tools in which to carry out the preclinical development of novel antiviral drugs.

  20. Genomics to benefit livestock production: improving animal health

    Directory of Open Access Journals (Sweden)

    Graham Stuart Plastow

    2016-06-01

    Full Text Available ABSTRACT The primary principle underlying the application of genomics is that it has the most value for difficult and expensive to measure traits. These traits will differ between species and probably also between markets. Maintenance of health will be one of the biggest challenges for efficient livestock production in the next few decades. This challenge will only increase in the face of demand for animal protein, resistance to existing drugs, and the pressure to reduce the use of antibiotics in agriculture. There is probably genetic variation in susceptibility for all diseases but little has been done to make use of this variation to date. In part this is because it is very difficult as well as expensive to measure this variation. This suggests that genomics should provide one of the ways of tackling the challenge of improving animal health. This paper will discuss the concepts of resistance, variation in susceptibility, and resilience; provide examples and present some recent results in cattle and pigs; and briefly discuss the application of gene editing in relation to disease resistance.

  1. Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery.

    Science.gov (United States)

    Mead, Andy N

    2014-11-01

    Drug abuse is an increasing social and public health issue, putting the onus on drug developers and regulatory agencies to ensure that the abuse potential of novel drugs is adequately assessed prior to product launch. This review summarizes the core preclinical data that frequently contribute to building an understanding of abuse potential for a new molecular entity, in addition to highlighting models that can provide increased resolution regarding the level of risk. Second, an important distinction between abuse potential and addiction potential is drawn, with comments on how preclinical models can inform on each. While the currently adopted preclinical models possess strong predictive validity, there are areas for future refinement and research. These areas include a more refined use of self-administration models to assess relative reinforcement; and the need for open innovation in pursuing improvements. There is also the need for careful scientifically driven application of models rather than a standardization of methodologies, and the need to explore the opportunities that may exist for enhancing the value of physical dependence and withdrawal studies by focusing on withdrawal-induced drug seeking, rather than broad symptomology.

  2. Promoting evidence based medicine in preclinical medical students via a federated literature search tool.

    Science.gov (United States)

    Keim, Samuel Mark; Howse, David; Bracke, Paul; Mendoza, Kathryn

    2008-01-01

    Medical educators are increasingly faced with directives to teach Evidence Based Medicine (EBM) skills. Because of its nature, integrating fundamental EBM educational content is a challenge in the preclinical years. To analyse preclinical medical student user satisfaction and feedback regarding a clinical EBM search strategy. The authors introduced a custom EBM search option with a self-contained education structure to first-year medical students. The implementation took advantage of a major curricular change towards case-based instruction. Medical student views and experiences were studied regarding the tool's convenience, problems and the degree to which they used it to answer questions raised by case-based instruction. Surveys were completed by 70% of the available first-year students. Student satisfaction and experiences were strongly positive towards the EBM strategy, especially of the tool's convenience and utility for answering issues raised during case-based learning sessions. About 90% of the students responded that the tool was easy to use, productive and accessed for half or more of their search needs. This study provides evidence that the integration of an educational EBM search tool can be positively received by preclinical medical students.

  3. Perspective: Recommendations for benchmarking pre-clinical studies of nanomedicines

    Science.gov (United States)

    Dawidczyk, Charlene M.; Russell, Luisa M.; Searson, Peter C.

    2015-01-01

    Nanoparticle-based delivery systems provide new opportunities to overcome the limitations associated with traditional small molecule drug therapy for cancer, and to achieve both therapeutic and diagnostic functions in the same platform. Pre-clinical trials are generally designed to assess therapeutic potential and not to optimize the design of the delivery platform. Consequently, progress in developing design rules for cancer nanomedicines has been slow, hindering progress in the field. Despite the large number of pre-clinical trials, several factors restrict comparison and benchmarking of different platforms, including variability in experimental design, reporting of results, and the lack of quantitative data. To solve this problem, we review the variables involved in the design of pre-clinical trials and propose a protocol for benchmarking that we recommend be included in in vivo pre-clinical studies of drug delivery platforms for cancer therapy. This strategy will contribute to building the scientific knowledge base that enables development of design rules and accelerates the translation of new technologies. PMID:26249177

  4. Animal Production and Health Newsletter, No. 55, January 2012

    International Nuclear Information System (INIS)

    2012-01-01

    The biggest event in 2011 was the declaration of global freedom from rinderpest by the Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health (OIE). The IAEA celebrated this momentous occasion on the 20th of September 2011, during the IAEA 55th General Conference. The commitment, dedication and hard work of past and present IAEA staff were commended by all participants as the contribution of the IAEA was a critical and essential component of the eradication success. Building on the success of the rinderpest campaign, technology transfer in the field of animal health continued to be a top priority of the Subprogramme during 2011 and this will continue for the future since our next target disease for eradication is peste des petits ruminants (PPR). Member States received support through Technical Cooperation Projects. In most of the tropics, climatic variation, rainfall patterns and droughts reduce plant growth and feed availability and quality leading to extensive livestock losses and reduced productivity. With the assistance of the IAEA, tremendous improvement has been achieved in terms of quantity and quality of the available feed resource base, particularly, in terms of nutritive value, palatability and/or cold and drought tolerance - vital benefits whose effectiveness can be monitored using nuclear technology. Both past and future activities are described in detail in this newsletter and are also accessible at our website (http://www-naweb.iaea.org/nafa/aph/index.html); I thus need not mention them in this section. Please contact us if you have any further ideas, comments, concerns or questions. As discussed in previous newsletters, the Animal Production and Health Subprogramme will continue to move progressively forward and in pace with developments within the livestock field, to optimally serve our Member States.

  5. 9 CFR 95.20 - Animal manure.

    Science.gov (United States)

    2010-01-01

    ... 9 Animals and Animal Products 1 2010-01-01 2010-01-01 false Animal manure. 95.20 Section 95.20 Animals and Animal Products ANIMAL AND PLANT HEALTH INSPECTION SERVICE, DEPARTMENT OF AGRICULTURE EXPORTATION AND IMPORTATION OF ANIMALS (INCLUDING POULTRY) AND ANIMAL PRODUCTS SANITARY CONTROL OF ANIMAL...

  6. Potential application of thermography (IRT in animal production and for animal welfare. A case report of working dogs

    Directory of Open Access Journals (Sweden)

    Veronica Redaelli

    2014-06-01

    Full Text Available INTRODUCTION. The authors describe the thermography technique in animal production and in veterinary medicine applications. The thermographic technique lends itself to countless applications in biology, thanks to its characteristics of versatility, lack of invasiveness and high sensitivity. Probably the major limitation to most important aspects for its application in the animal lies in the ease of use and in its extreme sensitivity. Materials and methods. This review provides an overview of the possible applications of the technique of thermo visual inspection, but it is clear that every phenomenon connected to temperature variations can be identified with this technique. Then the operator has to identify the best experimental context to obtain as much information as possible, concerning the physiopathological problems considered. Furthermore, we reported an experimental study about the thermography (IRT as a noninvasive technique to assess the state of wellbeing in working dogs. RESULTS. The first results showed the relationship between superficial temperatures and scores obtained by the animal during the behavioral test. This result suggests an interesting application of infrared thermography (IRT to measure the state of wellbeing of animals in a noninvasive way.

  7. For the sake of production. How agricultural colleges shape students' view on animal welfare

    DEFF Research Database (Denmark)

    Lassen, Jesper; Sandøe, Peter; Anneberg, Inger

    2016-01-01

    that there are only minor differences between the groups in the way good animal welfare is justified as both groups mainly view good animal welfare as a means of obtaining profitable production. In contrast, views which justify good animal welfare on the basis of the animals’ wellbeing or their right to have......The aim of this paper is to document and discuss the way future farmers’ views on animal welfare are formed and shaped during their studies at agricultural colleges. The paper is based on qualitative interviews with first year students and more advanced students in Denmark. It is shown...

  8. Some bibliometric indexes for members of the Scientific Association of Animal Production (ASPA

    Directory of Open Access Journals (Sweden)

    Giuseppe Pulina

    2010-01-01

    Full Text Available This study calculated several bibliometric indexes to analyze the scientific output of 363 members of the Scientific Association of Animal Production (ASPA in Italy, based on their publications listed by ISIThompson, Web of Science database (search period from 1989 until 2006. Five main research areas were considered: AGR/17 (Animal genetics and breeding, AGR/18 (Animal nutrition and feeding, AGR/19 (Animal husbandry, AGR/20 (Poultry, rabbits and fish production and External researcher (Ere. Position groups were: FP (Full Professor, AP (Associate Professor, Re (Researcher, EReUni (scientists working temporarily at the University or professors of an area different from AGR/17-20, and EReInst (scientists working at other institutions. Each institution was classified according to three geographical areas of Italy: North, Centre and South. Main calculated bibliometric indexes were: Ni = total number of papers published by member i over yi years; yi = number of years publishing of member i; Ci. = total number of citations of member i; IFpersonal. = Ci./Ni, Personal Impact factor of member i; Total IFjournal. = Sum of impact factor reported by the ISI-Thompson database of the journal in which a paper of member i was published (Journal Citation Reports Science Edition, 2004; Mean IFjournal. = Mean impact factor of all papers published in journals having a recognized IFjournal. by the ISI-Thompson database for member i; h = number of papers with at least h citations; m = h/y, i.e. average increase of h over the yi years publishing; and a = Ci./h2. Among the studied bibliometric indexes, Ni, Ci., Total IFjournal. and h are reliable, while IFpersonal. and Mean IFjournal. are not, to evaluate the scientific career of Animal Scientists in Italy. FP and members of AGR/17 tend to show the highest values of bibliometric indexes. Most ASPA members work in the North of Italy, which shows the highest median and highest percentage of scientists with maximum values

  9. Sustainable, efficient livestock production with high biodiversity and good welfare for animals.

    Science.gov (United States)

    Broom, D M; Galindo, F A; Murgueitio, E

    2013-11-22

    What is the future for livestock agriculture in the world? Consumers have concerns about sustainability but many widely used livestock production methods do not satisfy consumers' requirements for a sustainable system. However, production can be sustainable, occurring in environments that: supply the needs of the animals resulting in good welfare, allow coexistence with a wide diversity of organisms native to the area, minimize carbon footprint and provide a fair lifestyle for the people working there. Conservation need not just involve tiny islands of natural vegetation in a barren world of agriculture, as there can be great increases in biodiversity in farmed areas. Herbivores, especially ruminants that consume materials inedible by humans, are important for human food in the future. However, their diet should not be just ground-level plants. Silvopastoral systems, pastures with shrubs and trees as well as herbage, are described which are normally more productive than pasture alone. When compared with widely used livestock production systems, silvopastoral systems can provide efficient feed conversion, higher biodiversity, enhanced connectivity between habitat patches and better animal welfare, so they can replace existing systems in many parts of the world and should be further developed.

  10. Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models

    Directory of Open Access Journals (Sweden)

    Caridad Ivette Fernandez

    2017-12-01

    Full Text Available In 2016, 19.8% of the Cuban population was aged 60 or over. As a result, age-associated degenerative diseases and other diseases have become priority targets from a prophylactic, diagnostic and therapeutic perspective. As a result, the Cuban biomedical scientific community has addressed its basic, preclinical and epidemiological research in order to rise up to the challenge. A firm step in this direction has been the international congress “State of the art in non-clinical models for neurodegenerative diseases” which has brought together preclinical and clinical researchers, technicians and regulatory staff members from different countries to review the state of the art in neurodegenerations, find unifying ideas, objectives and collaborations or partnership. The objective is to expose the perspectives of new biotechnological products from Cuba and other countries from the diagnostic, therapeutic and neuroprotective point of view. It is crucial, therefore, that the irreplaceable role of laboratory animals in achieving these objectives is understood but they must be used in rational, adequate and ethical manner. We expose the current development trends in this field, being of common interest to the work directed to the search for potential drugs, diagnostic tools and the promotion of changes in lifestyle as a preventive projection.

  11. Feasibility of spatial frequency domain imaging (SFDI) for optically characterizing a preclinical oncology model.

    Science.gov (United States)

    Tabassum, Syeda; Zhao, Yanyu; Istfan, Raeef; Wu, Junjie; Waxman, David J; Roblyer, Darren

    2016-10-01

    Determination of chemotherapy efficacy early during treatment would provide more opportunities for physicians to alter and adapt treatment plans. Diffuse optical technologies may be ideally suited to track early biological events following chemotherapy administration due to low cost and high information content. We evaluated the use of spatial frequency domain imaging (SFDI) to characterize a small animal tumor model in order to move towards the goal of endogenous optical monitoring of cancer therapy in a controlled preclinical setting. The effects of key measurement parameters including the choice of imaging spatial frequency and the repeatability of measurements were evaluated. The precision of SFDI optical property extractions over repeat mouse measurements was determined to be within 3.52% for move and replace experiments. Baseline optical properties and chromophore values as well as intratumor heterogeneity were evaluated over 25 tumors. Additionally, tumor growth and chemotherapy response were monitored over a 45 day longitudinal study in a small number of mice to demonstrate the ability of SFDI to track treatment effects. Optical scattering and oxygen saturation increased as much as 70% and 25% respectively in treated tumors, suggesting SFDI may be useful for preclinical tracking of cancer therapies.

  12. Two-dimensional inverse planning and delivery with a preclinical image guided microirradiator

    International Nuclear Information System (INIS)

    Stewart, James M. P.; Lindsay, Patricia E.; Jaffray, David A.

    2013-01-01

    Purpose: Recent advances in preclinical radiotherapy systems have provided the foundation for scaling many of the elements of clinical radiation therapy practice to the dimensions and energy demanded in small animal studies. Such systems support the technical capabilities to accurately deliver highly complex dose distributions, but methods to optimize and deliver such distributions remain in their infancy. This study developed an optimization method based on empirically measured two-dimensional dose kernel measurements to deliver arbitrary planar dose distributions on a recently developed small animal radiotherapy platform.Methods: A two-dimensional dose kernel was measured with repeated radiochromic film measurements for the circular 1 mm diameter fixed collimator of the small animal radiotherapy system at 1 cm depth in a solid water phantom. This kernel was utilized in a sequential quadratic programming optimization framework to determine optimal beam positions and weights to deliver an arbitrary desired dose distribution. The positions and weights were then translated to a set of stage motions to automatically deliver the optimized dose distribution. End-to-end efficacy of the framework was quantified through five repeated deliveries of two dosimetric challenges: (1) a 5 mm radius bullseye distribution, and (2) a “sock” distribution contained within a 9 × 13 mm bounding box incorporating rectangular, semicircular, and exponentially decaying geometric constructs and a rectangular linear dose gradient region. These two challenges were designed to gauge targeting, geometric, and dosimetric fidelity.Results: Optimization of the bullseye and sock distributions required 2.1 and 5.9 min and utilized 50 and 77 individual beams for delivery, respectively. Automated delivery of the resulting optimized distributions, validated using radiochromic film measurements, revealed an average targeting accuracy of 0.32 mm, and a dosimetric delivery error along four line

  13. Animal Production and Health Newsletter, No. 59, January 2014

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2014-01-15

    As 2013 draws to a close, we are completing our activities and contributions to the 2012-2013 IAEA and FAO programmes of work and budget, and finalizing our tasks and products and services for the next biennium. We hope that our programme will satisfy Member State needs maximally. I want to mention two events regarding the activities of the Animal Production and Health Subprogramme. First, I have the pleasure to inform you that the Animal Production and Health Subprogramme was part of a 'One-House' IAEA team that was awarded an IAEA Superior Achievement Award for its response to Member States requests regarding the H7N9 avian influenza outbreak in several provinces of China. The aggravating factor with this new avian influenza disease was that it was asymptomatic in poultry (i.e. poultry showed no clinical disease), but symptomatic in humans (i.e. humans showed flu like symptoms) causing about 30% mortality in infected humans. This epidemiological character of the disease made it very difficult to trace and search for its origin in poultry, towards protecting human lives. The Chinese authorities, in particular the Beijing Genetics Institute, reacted appropriately to the outbreaks and characterized the virus, isolated from human patients, as an avian influenza H7N9 subtype. Knowing the panzootic potential of avian influenza viruses, the international community has immediately developed response plans on the eventual spread of the Chinese H7N9 strain and called for emergency preparedness. Upon requests of Member States from Europe and the Asia and Pacific Region, the Animal Production and Health Subprogramme of the Joint FAO/IAEA Division and the IAEA Technical Cooperation Department immediately reacted by taking advantage of the responsiveness of the TC Programme to unforeseen needs of Member States. In addition to the evaluation and validation of diagnostic and surveillance procedures and the transfer of technologies and the diagnostic support, two unplanned

  14. Animal Production and Health Newsletter, No. 59, January 2014

    International Nuclear Information System (INIS)

    2014-01-01

    As 2013 draws to a close, we are completing our activities and contributions to the 2012-2013 IAEA and FAO programmes of work and budget, and finalizing our tasks and products and services for the next biennium. We hope that our programme will satisfy Member State needs maximally. I want to mention two events regarding the activities of the Animal Production and Health Subprogramme. First, I have the pleasure to inform you that the Animal Production and Health Subprogramme was part of a 'One-House' IAEA team that was awarded an IAEA Superior Achievement Award for its response to Member States requests regarding the H7N9 avian influenza outbreak in several provinces of China. The aggravating factor with this new avian influenza disease was that it was asymptomatic in poultry (i.e. poultry showed no clinical disease), but symptomatic in humans (i.e. humans showed flu like symptoms) causing about 30% mortality in infected humans. This epidemiological character of the disease made it very difficult to trace and search for its origin in poultry, towards protecting human lives. The Chinese authorities, in particular the Beijing Genetics Institute, reacted appropriately to the outbreaks and characterized the virus, isolated from human patients, as an avian influenza H7N9 subtype. Knowing the panzootic potential of avian influenza viruses, the international community has immediately developed response plans on the eventual spread of the Chinese H7N9 strain and called for emergency preparedness. Upon requests of Member States from Europe and the Asia and Pacific Region, the Animal Production and Health Subprogramme of the Joint FAO/IAEA Division and the IAEA Technical Cooperation Department immediately reacted by taking advantage of the responsiveness of the TC Programme to unforeseen needs of Member States. In addition to the evaluation and validation of diagnostic and surveillance procedures and the transfer of technologies and the diagnostic support, two unplanned

  15. Utilization of tropical crop residues and agroindustrial by-products in animal nutrition. Constraints and perspectives

    International Nuclear Information System (INIS)

    Preston, T.R.; Parra, R.

    1983-01-01

    The importance of by-products and crop residues as animal feeds is increasing steadily. This is a consequence of the increasing demand for cereal grains as both human and animal (chiefly poultry) food, and the increasing demand for energy coupled with decreasing availability of fossil fuels. The effects of these two trends are that primary use of land for livestock production (usually grazing systems) will steadily diminish; at the same time, sources of biomass will increase in importance as renewable energy sources, and greater emphasis will be placed on draught animal power. Most by-products and crop residues are fibrous and therefore of only low to moderate nutritive value, or have special physical and chemical characteristics making them difficult to incorporate in conventional ''balanced'' rations. Such feed raw materials may need special processing and/or special forms of supplementation if they are to be used efficiently. It is hypothesized that industrial by-products and crop residues will be more efficiently utilized if they are incorporated in diversified and integrated production systems, i.e. (a) livestock production is integrated with production of cash crops both for food and fuel; (b) different livestock species are utilized in the same enterprise in a complementary way; (c) livestock feeding is based on crop residues (energy) supplemented with protein-rich forages and aquatic plants; and (d) animal wastes are recycled and used for food, fertilizer and fuel. This strategy is particularly suitable for the conditions in (i) tropical countries, whose climate favours high crop/biomass yields per unit area and ease of fermentation of organic wastes, and (ii) family farms, for which diversification means greater opportunity for self-sufficiency and increased possibilities for use of family resources. (author)

  16. What We Know about the Public’s Level of Concern for Farm Animal Welfare in Food Production in Developed Countries

    Directory of Open Access Journals (Sweden)

    Amelia Cornish

    2016-11-01

    Full Text Available Population growth and rising consumption of meat, dairy, eggs and fish are forcing the world to face the intersecting challenges of how to sustainably feed a population expected to exceed 9 billion by 2050, while also controlling the impact of food production on the planet, on people and on animals. This review acknowledges the absence of a globally accepted definition of animal welfare and then explores the literature regarding different levels of concern for animal welfare in food production by such stakeholders as veterinarians, farmers, and the general public. It focuses on the evidence that the general public’s level of concern for animal welfare is linked to various demographic and personal characteristics, such as age, gender, religion, location, meat eating, and knowledge of animal welfare. Certain animals have characteristics that influence concern for their welfare, with those species that are considered more intelligent being afforded more concern. There is compelling evidence that the general public’s understanding of animal welfare in food production is poor. Acknowledging that public concern can be a driving force to change current production methods, the authors suggest widespread consciousness raising to redefine socially acceptable methods of food production from animals and to ensure that it remains in step with societal concerns.

  17. FOOD HYPERSENSITIVITY AND PRODUCTS OF ANIMAL ORIGIN RESOURCES

    Directory of Open Access Journals (Sweden)

    A. B. Lisitsyn

    2017-01-01

    Full Text Available The number of people with food hypersensitivity, namely food intolerance and food allergies, grows every year. Food intolerance is classified into following types: enzymopathy; leaky gut syndrome; psychogenic food intolerance; detoxification insufficiency and true food intolerance. Food allergens mainly are glycoproteins, haptensor polypeptides. Most cases of food allergy are IgE-mediated allergic reactions. Recent discoveries in medicine, detailing and classification of food hypersensitivity require further researches to develop modern techniques and product recipes with specified propertiesfor consumers with food hypersensitivity. Existing technologies are based on the elimination and or reduction of the content of the allergenic substance in food. The article provides an overview of causes of food intolerance and food allergy, legislative background, a list of food allergens and methods of control, market profile of hypoallergenic produce and scientific approaches to creating hypoallergenic food products based on raw materials of animal origin.

  18. Animation of Antimicrobial Resistance

    Medline Plus

    Full Text Available ... Español Search FDA Submit search Popular Content Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, ... Biologics Animal & Veterinary Cosmetics Tobacco Products Animal & Veterinary Home Animal & Veterinary Safety & Health Antimicrobial Resistance Animation of ...

  19. A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson’s Research

    Directory of Open Access Journals (Sweden)

    Marco A. S. Baptista

    2013-11-01

    Full Text Available Progress in Parkinson’s disease (PD research and therapeutic development is hindered by many challenges, including a need for robust preclinical animal models. Limited availability of these tools is due to technical hurdles, patent issues, licensing restrictions and the high costs associated with generating and distributing these animal models. Furthermore, the lack of standardization of phenotypic characterization and use of varying methodologies has made it difficult to compare outcome measures across laboratories. In response, The Michael J. Fox Foundation for Parkinson’s Research (MJFF is directly sponsoring the generation, characterization and distribution of preclinical rodent models, enabling increased access to these crucial tools in order to accelerate PD research. To date, MJFF has initiated and funded the generation of 30 different models, which include transgenic or knockout models of PD-relevant genes such as Park1 (also known as Park4 and SNCA, Park8 (LRRK2, Park7 (DJ-1, Park6 (PINK1, Park2 (Parkin, VPS35, EiF4G1 and GBA. The phenotypic characterization of these animals is performed in a uniform and streamlined manner at independent contract research organizations. Finally, MJFF created a central repository at The Jackson Laboratory (JAX that houses both non-MJFF and MJFF-generated preclinical animal models. Funding from MJFF, which subsidizes the costs involved in transfer, rederivation and colony expansion, has directly resulted in over 2500 rodents being distributed to the PD community for research use.

  20. 78 FR 77384 - DSM Nutritional Products; Filing of Food Additive Petition (Animal Use)

    Science.gov (United States)

    2013-12-23

    .... FDA-2013-F-1539] DSM Nutritional Products; Filing of Food Additive Petition (Animal Use) AGENCY: Food... (FDA) is announcing that DSM Nutritional Products has filed a petition proposing that the food additive... U.S.C. 348(b)(5)), notice is given that a food additive petition (FAP 2276) has been filed by DSM...

  1. Critical Overview on Organic Legislation for Animal Production: Towards Conventionalization of the System?

    Directory of Open Access Journals (Sweden)

    Ioannis Hadjigeorgiou

    2013-07-01

    Full Text Available Adoption of organic animal production legislation, particularly at the Community level, is done with a spirit of compromise and an attempt to reach consensus. In this sense, legal tools are used to solve technical problems so that an appreciable number of derogations (exceptions are introduced. These may allow the use of certain feed additives, tethered animals or even application of castration. However, derogations should be avoided in legislation where harmonization is pursued, since they bring about distortion in the marketing of organic products. The validity of these derogations has expiry dates. However, at least the EU was hesitant to proceed with the necessary amendments to lift these derogations so that eliminate ambiguities and block loopholes. In turn, mention is made to geographical issues raised from the exceptions question posed again with the new EU Regulations. Furthermore some thoughts are expressed concerning the relationship between setting standards and the crucial role of values in agriculture, organic in particular, social aspects and pursued policy. Finally, the essential feature of this work is that derogations in legislation inevitably lead to conventionalization of organic animal production, which necessitates the clear definition of “organic”. To substantiate this, relevant arguments are put forward.

  2. The Use of Herbal Drugs in Organic Animal Production: The Case of Ethnoveterinary Medicine in Central Anatolia Region

    Directory of Open Access Journals (Sweden)

    Çağrı Çağlar Sinmez

    2017-12-01

    Full Text Available Organic animal production is a natural breeding system in which animal health is protected by giving priority to alternative medicines and treatment as needed by applying appropriate management and feeding methods based on the physiological requirements of animals. Increasing numbers of strains resistant to antibiotics and antiparasitic drugs used in animal breeding have brought about the search for alternative herbal remedies that lead to drug residues in animal products and lead to important health problems in people consuming these products. In this study, it was aimed to evaluate the therapeutic and protective effects of herbal drugs used in organic animal production in ethnoveterinary medicine in the Central Anatolia Region. The material of the study collected as written and declared facts as well as visual data were obtained from animal breeders in the Central Anatolia Region. The results indicated that 30 herbal drugs were used for the treatment of internal diseases, surgical diseases, obstetric and gynecological problems and parasitic diseases in cattle, sheep, horse, poultry, bee, and dog species. Based on the evaluation of the facts that the use of all kinds of synthetic drugs, especially antibiotics, is prohibited or restricted in organic livestock, it can be said that natural herbal drugs instead of artificial substances will provide positive contributions in the protection and treatment of herd health.

  3. Animal production and health newsletter. No. 44, July 2006

    International Nuclear Information System (INIS)

    2006-07-01

    Three animal disease issues, amongst others, dominated animal health activities in the world; the near eradication of rinderpest (RP), the continued threat of foot-and-mouth disease (FMD) to national and international trade and the ever spreading avian influenza (AI). The importance of early, rapid and sensitive diagnoses of merging diseases, with special reference to AI, can not be overstated and it has prompted our subprogramme to refocus our activities and efforts. The rapid diagnosis and characterization of AI, particularly with respect to molecular tools, are important to determine whether it is H5N1 or another subtype. It is here that the Joint FAO/IAEA Programme can play a role in supporting the actions of the FAO, World organisation for animal health (OIE), WHO and Member States. The subprogramme can provide technical assistance on (1) which tests and protocols to use, (2) technical and laboratory training, (3) expert missions (nominating relevant expert(s) or to perform expert missions by members of the subprogramme), (4) the analysis of AI samples (as primary diagnosis or as confirmation) utilizing the OIE reference status of our Seibersdorf laboratory (i.e. the analysis of translation products of the virus genome) and (5) the provision of technical quality assurance guidelines and support to ensure quality data and reporting

  4. Animal Models of Post-Traumatic Stress Disorder and Recent Neurobiological Insights

    Science.gov (United States)

    Whitaker, Annie M.; Gilpin, Nicholas W.; Edwards, Scott

    2014-01-01

    Post-traumatic stress disorder (PTSD) is a complex psychiatric disorder characterized by the intrusive re-experiencing of past trauma, avoidant behavior, enhanced fear, and hyperarousal following a traumatic event in vulnerable populations. Preclinical animal models do not replicate the human condition in its entirety, but seek to mimic symptoms or endophenotypes associated with PTSD. Although many models of traumatic stress exist, few adequately capture the complex nature of the disorder and the observed individual variability in susceptibility of humans to develop PTSD. In addition, various types of stressors may produce different molecular neuroadaptations that likely contribute to the various behavioral disruptions produced by each model, although certain consistent neurobiological themes related to PTSD have emerged. For example, animal models report traumatic stress- and trauma reminder-induced alterations in neuronal activity in the amygdala and prefrontal cortex, in agreement with the human PTSD literature. Models have also provided a conceptual framework for the often observed combination of PTSD and co-morbid conditions such as alcohol use disorder (AUD). Future studies will continue to refine preclinical PTSD models in hopes of capitalizing on their potential to deliver new and more efficacious treatments for PTSD and associated psychiatric disorders. PMID:25083568

  5. Accuracy of a clinical PET/CT vs. a preclinical μPET system for monitoring treatment effects in tumour xenografts

    Energy Technology Data Exchange (ETDEWEB)

    Palmowski, Karin [Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen (Germany); Department of Pneumology and Critical Care Medicine, Thoraxklinik Heidelberg, University of Heidelberg, Heidelberg (Germany); Winz, Oliver [Department of Nuclear Medicine, RWTH-Aachen University, Aachen (Germany); Rix, Anne; Bzyl, Jessica [Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen (Germany); Behrendt, Florian F.; Verburg, Frederic A.; Mottaghy, Felix M. [Department of Nuclear Medicine, RWTH-Aachen University, Aachen (Germany); Palmowski, Moritz, E-mail: mpalmowski@ukaachen.de [Department of Experimental Molecular Imaging, RWTH-Aachen University, Aachen (Germany); Department of Nuclear Medicine, RWTH-Aachen University, Aachen (Germany); Academic Radiology Baden Baden, Diagnostic and Interventional Radiology, University Medical Center Heidelberg, Heidelberg (Germany)

    2013-08-15

    Purpose: Small animal imaging is of growing importance for preclinical research and drug development. Tumour xenografts implanted in mice can be visualized with a clinical PET/CT (cPET); however, it is unclear whether early treatment effects can be monitored. Thus, we investigated the accuracy of a cPET versus a preclinical μPET using {sup 18}F-FDG for assessing early treatment effects. Materials and methods: The spatial resolution and the quantitative accuracy of a clinical and preclinical PET were evaluated in phantom experiments. To investigate the sensitivity for assessing treatment response, A431 tumour xenografts were implanted in nude mice. Glucose metabolism was measured in untreated controls and in two therapy groups (either one or four days of antiangiogenic treatment). Data was validated by γ-counting of explanted tissues. Results: In phantom experiments, cPET enabled reliable separation of boreholes ≥ 5 mm whereas μPET visualized boreholes ≥ 2 mm. In animal studies, μPET provided significantly higher tumour-to-muscle ratios for untreated control tumours than cPET (3.41 ± 0.87 vs. 1.60 ± .0.28, respectively; p < 0.01). During treatment, cPET detected significant therapy effects at day 4 (p < 0.05) whereas μPET revealed highly significant therapy effects even at day one (p < 0.01). Correspondingly, γ-counting of explanted tumours indicated significant therapy effects at day one and highly significant treatment response at day 4. Correlation with γ-counting was good for cPET (r = 0.74; p < 0.01) and excellent for μPET (r = 0.85; p < 0.01). Conclusion: Clinical PET is suited to investigate tumour xenografts ≥ 5 mm at an advanced time-point of treatment. For imaging smaller tumours or for the sensitive assessment of very early therapy effects, μPET should be preferred.

  6. Measurement of pO2 in a Pre-clinical Model of Rabbit Tumor Using OxyChip, a Paramagnetic Oxygen Sensor.

    Science.gov (United States)

    Hou, H; Khan, N; Kuppusamy, P

    2017-01-01

    The objective of this work was to establish a novel and robust technology, based on electron paramagnetic resonance (EPR) oximetry, as a practical tool for measurement of tumor oxygen. Previously, we have reported on the development of oxygen-sensing paramagnetic crystals (LiNc-BuO) encapsulated in a biocompatible polymer, called OxyChip. In this report we present our recent data on the use of OxyChip for pO 2 measurements in the tumor of a pre-clinical, large-animal rabbit model. The results establish that OxyChip is capable of noninvasive and repeated measurement of pO 2 in a large animal model.

  7. Study partners should be required in preclinical Alzheimer's disease trials.

    Science.gov (United States)

    Grill, Joshua D; Karlawish, Jason

    2017-12-06

    In an effort to intervene earlier in Alzheimer's disease (AD), clinical trials are testing promising candidate therapies in preclinical disease. Preclinical AD trial participants are cognitively normal, functionally independent, and autonomous decision-makers. Yet, like AD dementia trials, preclinical trials require dual enrollment of a participant and a knowledgeable informant, or study partner. The requirement of dyadic enrollment is a barrier to recruitment and may present unique ethical challenges. Despite these limitations, the requirement should continue. Study partners may be essential to ensure participant safety and wellbeing, including overcoming distress related to biomarker disclosure and minimizing risk for catastrophic reactions and suicide. The requirement may maximize participant retention and ensure data integrity, including that study partners are the source of data that will ultimately instruct whether a new treatment has a clinical benefit and meaningful impact on the population health burden associated with AD. Finally, study partners are needed to ensure the scientific and clinical value of trials. Preclinical AD will represent a new model of care, in which persons with no symptoms are informed of probable cognitive decline and eventual dementia. The rationale for early diagnosis in symptomatic AD is equally applicable in preclinical AD-to minimize risk, maximize quality of life, and ensure optimal planning and communication. Family members and other sources of support will likely be essential to the goals of this new model of care for preclinical AD patients and trials must instruct this clinical practice.

  8. 77 FR 71750 - DSM Nutritional Products; Filing of Food Additive Petition (Animal Use)

    Science.gov (United States)

    2012-12-04

    .... FDA-2012-F-1100] DSM Nutritional Products; Filing of Food Additive Petition (Animal Use) AGENCY: Food... (FDA) is announcing that DSM Nutritional Products has filed a petition proposing that the food additive...) (21 U.S.C. 348(b)(5))), notice is given that a food additive petition (FAP 2273) has been filed by DSM...

  9. Animals and their products utilized as medicines by the inhabitants surrounding the Ranthambhore National Park, India

    Directory of Open Access Journals (Sweden)

    Jaroli DP

    2006-11-01

    Full Text Available Abstract The present ethnozoological study describes the traditional knowledge related to the use of different animals and animal-derived products as medicines by the inhabitants of villages surrounding the Ranthambhore National Park of India (Bawaria, Mogya, Meena, which is well known for its very rich biodiversity. The field survey was conducted from May to July 2005 by performing interviews through structured questionnaires with 24 informants (16 men and 8 women, who provided information regarding therapeutic uses of animals. A total of 15 animals and animal products were recorded and they are used for different ethnomedical purposes, including tuberculosis, asthma, paralysis, jaundice, earache, constipation, weakness, snake poisoning. The zootherapeutic knowledge was mostly based on domestic animals, but some protected species like the collared dove (Streptopelia sp., hard shelled turtle (Kachuga tentoria, sambhar (Cervus unicolor were also mentioned as important medicinal resources. We would suggest that this kind of neglected traditional knowledge should be included into the strategies of conservation and management of faunistic resources in the investigated area.

  10. Antibiotic resistance in bacteria associated with food animals: a United States perspective of livestock production.

    Science.gov (United States)

    Mathew, Alan G; Cissell, Robin; Liamthong, S

    2007-01-01

    The use of antimicrobial compounds in food animal production provides demonstrated benefits, including improved animal health, higher production and, in some cases, reduction in foodborne pathogens. However, use of antibiotics for agricultural purposes, particularly for growth enhancement, has come under much scrutiny, as it has been shown to contribute to the increased prevalence of antibiotic-resistant bacteria of human significance. The transfer of antibiotic resistance genes and selection for resistant bacteria can occur through a variety of mechanisms, which may not always be linked to specific antibiotic use. Prevalence data may provide some perspective on occurrence and changes in resistance over time; however, the reasons are diverse and complex. Much consideration has been given this issue on both domestic and international fronts, and various countries have enacted or are considering tighter restrictions or bans on some types of antibiotic use in food animal production. In some cases, banning the use of growth-promoting antibiotics appears to have resulted in decreases in prevalence of some drug resistant bacteria; however, subsequent increases in animal morbidity and mortality, particularly in young animals, have sometimes resulted in higher use of therapeutic antibiotics, which often come from drug families of greater relevance to human medicine. While it is clear that use of antibiotics can over time result in significant pools of resistance genes among bacteria, including human pathogens, the risk posed to humans by resistant organisms from farms and livestock has not been clearly defined. As livestock producers, animal health experts, the medical community, and government agencies consider effective strategies for control, it is critical that science-based information provide the basis for such considerations, and that the risks, benefits, and feasibility of such strategies are fully considered, so that human and animal health can be maintained while

  11. 9 CFR 117.4 - Test animals.

    Science.gov (United States)

    2010-01-01

    ... 9 Animals and Animal Products 1 2010-01-01 2010-01-01 false Test animals. 117.4 Section 117.4 Animals and Animal Products ANIMAL AND PLANT HEALTH INSPECTION SERVICE, DEPARTMENT OF AGRICULTURE VIRUSES, SERUMS, TOXINS, AND ANALOGOUS PRODUCTS; ORGANISMS AND VECTORS ANIMALS AT LICENSED ESTABLISHMENTS § 117.4...

  12. Potential Applications of Flat-Panel Volumetric CT in Morphologic, Functional Small Animal Imaging

    Directory of Open Access Journals (Sweden)

    Susanne Greschus

    2005-08-01

    Full Text Available Noninvasive radiologic imaging has recently gained considerable interest in basic, preclinical research for monitoring disease progression, therapeutic efficacy. In this report, we introduce flat-panel volumetric computed tomography (fpVCT as a powerful new tool for noninvasive imaging of different organ systems in preclinical research. The three-dimensional visualization that is achieved by isotropic high-resolution datasets is illustrated for the skeleton, chest, abdominal organs, brain of mice. The high image quality of chest scans enables the visualization of small lung nodules in an orthotopic lung cancer model, the reliable imaging of therapy side effects such as lung fibrosis. Using contrast-enhanced scans, fpVCT displayed the vascular trees of the brain, liver, kidney down to the subsegmental level. Functional application of fpVCT in dynamic contrast-enhanced scans of the rat brain delivered physiologically reliable data of perfusion, tissue blood volume. Beyond scanning of small animal models as demonstrated here, fpVCT provides the ability to image animals up to the size of primates.

  13. Energy Supply- Production of Fuel from Agricultural and Animal Waste

    Energy Technology Data Exchange (ETDEWEB)

    Gabriel Miller

    2009-03-25

    The Society for Energy and Environmental Research (SEER) was funded in March 2004 by the Department of Energy, under grant DE-FG-36-04GO14268, to produce a study, and oversee construction and implementation, for the thermo-chemical production of fuel from agricultural and animal waste. The grant focuses on the Changing World Technologies (CWT) of West Hempstead, NY, thermal conversion process (TCP), which converts animal residues and industrial food processing biproducts into fuels, and as an additional product, fertilizers. A commercial plant was designed and built by CWT, partially using grant funds, in Carthage, Missouri, to process animal residues from a nearby turkey processing plant. The DOE sponsored program consisted of four tasks. These were: Task 1 Optimization of the CWT Plant in Carthage - This task focused on advancing and optimizing the process plant operated by CWT that converts organic waste to fuel and energy. Task 2 Characterize and Validate Fuels Produced by CWT - This task focused on testing of bio-derived hydrocarbon fuels from the Carthage plant in power generating equipment to determine the regulatory compliance of emissions and overall performance of the fuel. Task 3 Characterize Mixed Waste Streams - This task focused on studies performed at Princeton University to better characterize mixed waste incoming streams from animal and vegetable residues. Task 4 Fundamental Research in Waste Processing Technologies - This task focused on studies performed at the Massachusetts Institute of Technology (MIT) on the chemical reformation reaction of agricultural biomass compounds in a hydrothermal medium. Many of the challenges to optimize, improve and perfect the technology, equipment and processes in order to provide an economically viable means of creating sustainable energy were identified in the DOE Stage Gate Review, whose summary report was issued on July 30, 2004. This summary report appears herein as Appendix 1, and the findings of the report

  14. Sex Differences in Mechanical Allodynia: How Can it be Preclinically Quantified and Analysed?

    Directory of Open Access Journals (Sweden)

    Lauren eNicotra

    2014-02-01

    Full Text Available Translating promising preclinical drug discoveries to successful clinical trials remains a significant hurdle in pain research. Although animal models have significantly contributed to understanding chronic pain pathophysiology, the majority of research has focused on male rodents using testing procedures that produce sex difference data that do not align well with comparable clinical experiences. Additionally, the use of animal pain models presents ongoing ethical challenges demanding continuing refinement of preclinical methods. To this end, this study sought to test a quantitative allodynia assessment technique and associated statistical analysis in a modified graded nerve injury pain model with the aim to further examine sex differences in allodynia. Graded allodynia was established in male and female Sprague Dawley rats by altering the number of sutures placed around the sciatic nerve and quantified by the von Frey test. Linear mixed effects modelling regressed response on each fixed effect (sex, oestrus cycle, pain treatment. On comparison with other common von Frey assessment techniques, utilizing lower threshold filaments than those ordinarily tested, at 1 second intervals, ¬¬appropriately and successfully investigated female mechanical allodynia, revealing significant sex and estrus cycle difference across the graded allodynia that other common behavioral methods were unable to detect. Utilising this different von Frey approach and graded allodynia model, a single suture inflicting less allodynia was sufficient to demonstrate exaggerated female mechanical allodynia (N1S3, t = 3.4; N3S1, t = 7.7 throughout the phases of dioestrus (t = 3.3 and pro-oestrus (t = 3.5. Refining the von Frey testing method, statistical analysis technique and the use of a graded model of chronic pain, allowed for examination of the influences on female mechanical nociception that other von Frey methods cannot provide.

  15. Animal models of Alzheimer disease: historical pitfalls and a path forward.

    Science.gov (United States)

    Cavanaugh, Sarah E; Pippin, John J; Barnard, Neal D

    2014-01-01

    Alzheimer disease (AD) is a medically and financially overwhelming condition, and incidence rates are expected to triple by 2050.Despite decades of research in animal models of AD, the disease remains incompletely understood, with few treatment options. This review summarizes historical and current AD research efforts, with emphasis on the disparity between preclinical animal studies and the reality of human disease and how this has impacted clinical trials. Ultimately, we provide a mechanism for shifting the focus of AD research away from animal models to focus primarily on human biology as a means to improve the applicability of research findings to human disease. Implementation of these alternatives may hasten development of improved strategies to prevent, detect, ameliorate, and possibly cure this devastating disease.

  16. The effect of animated images on persuasion: The mediator role of hedonic responses and the moderator role of product category

    OpenAIRE

    Hussant-Zebian, Rola

    2004-01-01

    This paper aims to highlight the mediator role of hedonic responses in the relation between animated images and attitudinal responses. It has another objective which is to show off the moderator role of product category. To this purpose, we have manipulated two categories of advertising opposing computer animated to non-computer animated images. We have also seetwo product categories : a high involvement product and a low involvement one.

  17. Effect of animal products and extracts on wound healing promotion in topical applications: a review.

    Science.gov (United States)

    Napavichayanun, Supamas; Aramwit, Pornanong

    2017-06-01

    Wound healing is a natural process of body reaction to repair itself after injury. Nonetheless, many internal and external factors such as aging, comorbidity, stress, smoking, alcohol drinking, infections, malnutrition, or wound environment significantly affect the quality and speed of wound healing. The unsuitable conditions may delay wound healing process and cause chronic wound or scar formation. Therefore, many researches have attempted to search for agents that can accelerate wound healing with safety and biocompatibility to human body. Widely studied wound healing agents are those derived from either natural sources including plants and animals or chemical synthesis. The natural products seem to be safer and more biocompatible to human tissue. This review paper demonstrated various kinds of the animal-derived products including chitosan, collagen, honey, anabolic steroids, silk sericin, peptides, and proteoglycan in term of mechanisms of action, advantages, and disadvantages when applied as wound healing accelerator. The benefits of these animal-derived products are wound healing promotion, anti-inflammatory, antimicrobial activity, moisturizing effect, biocompatibility, and safety. However, the drawbacks such as allergy, low stability, batch-to-batch variability, and high extraction and purification costs could not be avoided in some products.

  18. Metabolic Design of Corynebacterium glutamicum for Production of l-Cysteine with Consideration of Sulfur-Supplemented Animal Feed.

    Science.gov (United States)

    Joo, Young-Chul; Hyeon, Jeong Eun; Han, Sung Ok

    2017-06-14

    l-Cysteine is a valuable sulfur-containing amino acid widely used as a nutrition supplement in industrial food production, agriculture, and animal feed. However, this amino acid is mostly produced by acid hydrolysis and extraction from human or animal hairs. In this study, we constructed recombinant Corynebacterium glutamicum strains that overexpress combinatorial genes for l-cysteine production. The aims of this work were to investigate the effect of the combined overexpression of serine acetyltransferase (CysE), O-acetylserine sulfhydrylase (CysK), and the transcriptional regulator CysR on l-cysteine production. The CysR-overexpressing strain accumulated approximately 2.7-fold more intracellular sulfide than the control strain (empty pMT-tac vector). Moreover, in the resulting CysEKR recombinant strain, combinatorial overexpression of genes involved in l-cysteine production successfully enhanced its production by approximately 3.0-fold relative to that in the control strain. This study demonstrates a biotechnological model for the production of animal feed supplements such as l-cysteine using metabolically engineered C. glutamicum.

  19. The impact of increased natural background of soil on the animal production of ruminants in the region of Livno

    International Nuclear Information System (INIS)

    Gradaščević, N.; Saračević, L.; Samek, D.; Mihalj, A.

    2009-01-01

    In this paper, the impact of increased levels of uranium and radium in soil on the levels of activity and radiation-hygienic validity of animal products of ruminants was investigated. Region around Livno town is placed on coal layer with the increased levels of uranium and radium compared with other coals used in Bosnia and Herzegovina. As a result of mixing between coal matrix and soil, increased value of average absorbed dose rate at 1 m above the ground (144 nGy/h) was measured. The highest average value of 238U and 226Ra in the samples of animal products of ruminants was measured in the samples of sheep cheese (0.070 Bq/kg for 238U and 0.207 Bq/kg for 226Ra). The levels of these two radionuclides in the rest of animal product of ruminants were approximately similar and ranged 0.016–0.046 Bq/kg for 238U and 0.028–0.080 Bq/kg for 226Ra. Levels of 40K were in the range of average values for animal products (31.2–86.4 Bq/kg). Calculated annual effective dose by ingestion of the animal products of ruminants were approximately 0.064 mSv with the highest dose contribution of 40K (96.4%). On the base of obtained results, animal products of ruminants produced in observed region, can be considered as valid for human consumption from radiation- hygienic aspect

  20. Bulletin of Animal Health and Production in Africa - Vol 59, No 1 (2011)

    African Journals Online (AJOL)

    Bulletin of Animal Health and Production in Africa. ... Haematological, Carcass Characteristics And Meat Quality Of Intensively Managed West ... activities of the African Baobab (Adansonia digitata) fruit-pulp extract in commercial broilers ...

  1. Guidance for Methods Descriptions Used in Preclinical Imaging Papers

    Directory of Open Access Journals (Sweden)

    David Stout

    2013-10-01

    Full Text Available Preclinical molecular imaging is a rapidly growing field, where new imaging systems, methods, and biological findings are constantly being developed or discovered. Imaging systems and the associated software usually have multiple options for generating data, which is often overlooked but is essential when reporting the methods used to create and analyze data. Similarly, the ways in which animals are housed, handled, and treated to create physiologically based data must be well described in order that the findings be relevant, useful, and reproducible. There are frequently new developments for metabolic imaging methods. Thus, specific reporting requirements are difficult to establish; however, it remains essential to adequately report how the data have been collected, processed, and analyzed. To assist with future manuscript submissions, this article aims to provide guidelines of what details to report for several of the most common imaging modalities. Examples are provided in an attempt to give comprehensive, succinct descriptions of the essential items to report about the experimental process.

  2. High resolution propagation-based imaging system for in vivo dynamic computed tomography of lungs in small animals

    Science.gov (United States)

    Preissner, M.; Murrie, R. P.; Pinar, I.; Werdiger, F.; Carnibella, R. P.; Zosky, G. R.; Fouras, A.; Dubsky, S.

    2018-04-01

    We have developed an x-ray imaging system for in vivo four-dimensional computed tomography (4DCT) of small animals for pre-clinical lung investigations. Our customized laboratory facility is capable of high resolution in vivo imaging at high frame rates. Characterization using phantoms demonstrate a spatial resolution of slightly below 50 μm at imaging rates of 30 Hz, and the ability to quantify material density differences of at least 3%. We benchmark our system against existing small animal pre-clinical CT scanners using a quality factor that combines spatial resolution, image noise, dose and scan time. In vivo 4DCT images obtained on our system demonstrate resolution of important features such as blood vessels and small airways, of which the smallest discernible were measured as 55–60 μm in cross section. Quantitative analysis of the images demonstrate regional differences in ventilation between injured and healthy lungs.

  3. Elimination of salmonella from animal glandular products.

    Science.gov (United States)

    De Fiebre, C W; Burck, K T; Feldman, D

    1969-03-01

    Methods for the elimination of salmonellae from selected powdered pharmaceuticals of animal glandular origin were studied. Terminal heat treatment under carefully controlled conditions was effective for pancreatin-a powder containing proteolytic, amylolytic, and lipolytic enzymes prepared from hog pancreas glands. Use of this method resulted in a significant reduction in the number of salmonella-positive batches and also reduced the testing procedures required to confirm the absence of viable salmonellae among the majority of samples tested. Powders such as stomach substance and thyroid, in which the biological activity is not enzyme in nature, were treated successfully with acidified organic solvents. Other methods were investigated but were not suitable because of a deleterious effect on the biological activity or physical properties of the product or an inability to effect salmonella elimination.

  4. Elimination of Salmonellae from Animal Glandular Products

    Science.gov (United States)

    De Fiebre, Conrad W.; Burck, Kenneth T.; Feldman, David

    1969-01-01

    Methods for the elimination of salmonellae from selected powdered pharmaceuticals of animal glandular origin were studied. Terminal heat treatment under carefully controlled conditions was effective for pancreatin—a powder containing proteolytic, amylolytic, and lipolytic enzymes prepared from hog pancreas glands. Use of this method resulted in a significant reduction in the number of salmonella-positive batches and also reduced the testing procedures required to confirm the absence of viable salmonellae among the majority of samples tested. Powders such as stomach substance and thyroid, in which the biological activity is not enzyme in nature, were treated successfully with acidified organic solvents. Other methods were investigated but were not suitable because of a deleterious effect on the biological activity or physical properties of the product or an inability to effect salmonella elimination. PMID:5780395

  5. A comparative study of zinc protoporphyrin IX-forming properties of animal by-products as sources for improving the color of meat products.

    Science.gov (United States)

    Wakamatsu, Jun-ichi; Murakami, Naoko; Nishimura, Takanori

    2015-05-01

    The objective of this study was to obtain fundamental data for improving the color of meat products by using animal by-products. We investigated zinc protoporphyrin IX (ZnPP)-forming properties of various internal organs from pigs and chickens. ZnPP was formed in the liver, heart and kidney, whereas the porcine spleen and bile, which are involved in the metabolism of heme, did not have ZnPP-forming properties. The optimum pH values were different among the internal organs and the ZnPP-forming properties of porcine organs were better than those of chicken organs. The porcine liver showed the greatest ZnPP-forming properties among all of the internal organs investigated in this study. The optimum pH value for ZnPP formation in the liver was lower than that of skeletal muscle. Oxygen did not inhibit the formation of ZnPP in the liver, unlike in skeletal muscle. Animal by-products such as the liver have good ability for the formation of ZnPP and might be useful for improving the color of meat products. © 2014 Japanese Society of Animal Science.

  6. CO2 production in animals: analysis of potential errors in the doubly labeled water method

    International Nuclear Information System (INIS)

    Nagy, K.A.

    1979-03-01

    Laboratory validation studies indicate that doubly labeled water ( 3 HH 18 O and 2 HH 18 O) measurements of CO 2 production are accurate to within +-9% in nine species of mammals and reptiles, a bird, and an insect. However, in field studies, errors can be much larger under certain circumstances. Isotopic fraction of labeled water can cause large errors in animals whose evaporative water loss comprises a major proportion of total water efflux. Input of CO 2 across lungs and skin caused errors exceeding +80% in kangaroo rats exposed to air containing 3.4% unlabeled CO 2 . Analytical errors of +-1% in isotope concentrations can cause calculated rates of CO 2 production to contain errors exceeding +-70% in some circumstances. These occur: 1) when little decline in isotope concentractions has occured during the measurement period; 2) when final isotope concentrations closely approach background levels; and 3) when the rate of water flux in an animal is high relative to its rate of CO 2 production. The following sources of error are probably negligible in most situations: 1) use of an inappropriate equation for calculating CO 2 production, 2) variations in rates of water or CO 2 flux through time, 3) use of H 2 O-18 dilution space as a measure of body water volume, 4) exchange of 0-18 between water and nonaqueous compounds in animals (including excrement), 5) incomplete mixing of isotopes in the animal, and 6) input of unlabeled water via lungs and skin. Errors in field measurements of CO 2 production can be reduced to acceptable levels (< 10%) by appropriate selection of study subjects and recapture intervals

  7. Animal Health and Productivity Status of Cattle After The Eruption of Mount Merapi

    Directory of Open Access Journals (Sweden)

    Yulvian Sani

    2011-12-01

    Full Text Available The eruption of Merapi from October 26th to November 6th, 2010 has affected social life and environment around the Merapi. The eruption has caused destruction of land and water resources, plants, death of animals and human casualities. The lava, dust and stones released from the eruption of Merapi had caused residential destruction, casualities, agricultural land and plants destruction, and contamination of water. The eruption has directly affected 4 districts including Sleman (Yogyakarta, Magelang, Boyolali and Klaten (Central Java categorized as Disaster Risk Area (DRA. The purpose of this assessment is to analyse the impacts of Merapi eruption in animal health and productivity in particular for dairy and beef cattle. A total of 2.828 heads of cattle was reported died during the eruption of Merapi, and 1.962 heads died at the time of eruption and 36 heads at the arrival on evacuation areas. Animal that found died including 423 heads of beef cattle (0.13% and 2.405 heads of dairy cattle (3.2%. Clinical sains noted after the eruption were reduction of milk production, loss of appetite, diarrhoea, respiratory disturbances, mastitis and collapse. The main problems for livestock were reduction of milk production, collapse of dairy milk corporation activities and contamination of water resources. Other than dairy cattle mortality, the reduction of milk production may be caused by subclinical mastitis and environmental distress due to temperature and noise of eruption for few days. The subclinical mastitis should be further investigated to establish rehabilitation programme for dairy milk agribussiness activity in particular around the DRA of Merapi.

  8. Allergenic potential of novel proteins - What can we learn from animal production?

    Science.gov (United States)

    Ekmay, Ricardo D; Coon, Craig N; Ladics, Gregory S; Herman, Rod A

    2017-10-01

    Currently, risk assessment of the allergenic potential of novel proteins relies heavily on evaluating protein digestibility under normal conditions based on the theory that allergens are more resistant to gastrointestinal digestion than non-allergens. There is also proposed guidance for expanded in vitro digestibility assay conditions to include vulnerable sub-populations. One of the underlying rationales for the expanded guidance is that current in vitro assays do not accurately replicate the range of physiological conditions. Animal scientists have long sought to predict protein and amino acid digestibility for precision nutrition. Monogastric production animals, especially swine, have gastrointestinal systems similar to humans, and evaluating potential allergen digestibility in this context may be beneficial. Currently, there is no compelling evidence that the mechanisms sometimes postulated to be associated with allergenic sensitization, e.g. antacid modification of stomach pH, are valid among production animals. Furthermore, examples are provided where non-biologically representative assays are better at predicting protein and amino acid digestibility compared with those designed to mimic in vivo conditions. Greater emphasis should be made to align in vitro assessments with in vivo data. Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

  9. Animation of Antimicrobial Resistance

    Medline Plus

    Full Text Available ... FDA Submit search Popular Content Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & ... by Product Area Product Areas back Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & ...

  10. Quantifying the transfer of radionuclides to food products from domestic farm animals

    International Nuclear Information System (INIS)

    Howard, B.J.; Beresford, N.A.; Barnett, C.L.; Fesenko, S.

    2009-01-01

    Databases have been compiled to derive parameter values relevant to the transfer of radionuclides from feedstuffs to domestic animal products to provide a revision to the IAEA Handbook on transfer parameters TRS 364. Significant new data inputs have been incorporated into the databases from an extensive review of Russian language information and inclusion of data published since the early 1990s. Fractional gastrointestinal absorption in adult ruminants presented in the revised handbook are generally similar to those recommended for adult humans by the ICRP. Transfer coefficient values are presented in the handbook for a range of radionuclides to farm animal products. For most animal products, transfer coefficient values for elements additional to those in TRS 364 are provided although many data gaps remain. Transfer coefficients generally vary between species with larger species having lower values than smaller species. It has been suggested that the difference is partly due to the inclusion of dietary dry matter intake in the estimation of transfer coefficient and that whilst dietary intake increases with size nutrient concentrations do not. An alternative approach to quantifying transfer by using concentration ratios (CR), which do not consider dietary intake, has been evaluated. CR values compiled for the handbook vary considerably less between species than transfer coefficient values. The advantage of the CR approach is that values derived for one species could be applied to species for which there are no data. However, transfer coefficients will continue to be used as few studies currently report CR values or give data from which they can be estimated.

  11. Assessment of Safety and Functional Efficacy of Stem Cell-Based Therapeutic Approaches Using Retinal Degenerative Animal Models

    Directory of Open Access Journals (Sweden)

    Tai-Chi Lin

    2017-01-01

    Full Text Available Dysfunction and death of retinal pigment epithelium (RPE and or photoreceptors can lead to irreversible vision loss. The eye represents an ideal microenvironment for stem cell-based therapy. It is considered an “immune privileged” site, and the number of cells needed for therapy is relatively low for the area of focused vision (macula. Further, surgical placement of stem cell-derived grafts (RPE, retinal progenitors, and photoreceptor precursors into the vitreous cavity or subretinal space has been well established. For preclinical tests, assessments of stem cell-derived graft survival and functionality are conducted in animal models by various noninvasive approaches and imaging modalities. In vivo experiments conducted in animal models based on replacing photoreceptors and/or RPE cells have shown survival and functionality of the transplanted cells, rescue of the host retina, and improvement of visual function. Based on the positive results obtained from these animal experiments, human clinical trials are being initiated. Despite such progress in stem cell research, ethical, regulatory, safety, and technical difficulties still remain a challenge for the transformation of this technique into a standard clinical approach. In this review, the current status of preclinical safety and efficacy studies for retinal cell replacement therapies conducted in animal models will be discussed.

  12. Animal health and welfare in production systems for organic fattening pigs

    DEFF Research Database (Denmark)

    Lindgren, Kristina; Bochicchio, Davide; Hegelund, Lene

    2014-01-01

    and conventional production. Conventional Danish herds consumed three times as much antibiotics (anthelmintics not included) as the organic herds, whilst there was no difference in mortality rate nor more pigs in need of treatment in the organic herds. Slaughter data indicated that organic pigs had fewer...... and aggression. Minimizing negative environmental impact may conflict with animal welfare, i.e. raising the pigs indoors may not only reduce plant nutrient losses but also reduce the pigs’ activity options. With an increasing number of specialized organic units, implementation of age-segregated production......With the aim to identify European health and welfare strategies in organic pig production, we summarized information about health and welfare status and potential hazards for organic fattening pigs. The results were primarily based on studies of organic production or comparisons between organic...

  13. Characterization of Animal By-Product Hydrolysates to Be Used as Healthy and Bioactive Ingredients in Food

    DEFF Research Database (Denmark)

    Damgaard, Trine Desiree

    The world meat production and consumption has increased rapidly over the last couple of decades, due to population and income growth. In contrast to the meat, the consumption of animal by-products has been declining, leaving large amounts of by-products underutilized. As many by-products are highly...... nutritious as well as being good sources of protein, they represent interesting substrates for the generation of bioactive hydrolysates and peptides. Different porcine and bovine by-products were hydrolysed with a mixture consisting of Alcalase®and Protamex, and tested in relation to antioxidant capacity...... and their “meat factor” effect, i.e. their ability to enhance in vitro iron availability. Hydrolysates of different animal by-products displayed antioxidant capacities as observed by several assays intended to test different antioxidant mechanisms. The radical scavenging capacity of the hydrolysates was found...

  14. Animal production and health newsletter, No. 51, January 2010

    International Nuclear Information System (INIS)

    2010-01-01

    As 2010 is dawning on us, I want to look forward and highlight some of the exciting new nuclear and nuclear related areas that we think will play an important role in the near future. The main constraint to livestock production in many tropical regions of Africa, Asia and Latin America is the scarcity and fluctuations in quality and quantity of the year-around supply of feeds. Animal productivity is restricted by the low nitrogen and high fibre content of the native grasses and crop residues, which form the basis of the diets in these regions. An additional consequence of this poor diet in ruminants is the increased production of methane compared with ruminants fed on better quality forages. Studies on rumen metabolism using isotopes of carbon, hydrogen, sulphur, phosphorus and nitrogen have revealed how the ruminal microbial flora can change depending on the type of forage ingested. In addition, certain plant metabolites reduce the microbial population thereby improving efficiency of feed utilization by up to 10 per cent. The future application of this strategy is that the modulation of fermentation can reduce methane production, hence mitigating greenhouse gas emissions

  15. USHERING IN THE STUDY AND TREATMENT OF PRECLINICAL ALZHEIMER DISEASE

    Science.gov (United States)

    Langbaum, Jessica B.S.; Fleisher, Adam S.; Chen, Kewei; Ayutyanont, Napatkamon; Lopera, Francisco; Quiroz, Yakeel T.; Caselli, Richard J.; Tariot, Pierre N.; Reiman, Eric M.

    2014-01-01

    Researchers have begun to characterize the subtle biological and cognitive processes that precede the clinical onset of Alzheimer disease (AD), and to set the stage for accelerated evaluation of experimental treatments to delay the onset, reduce the risk of or completely prevent clinical decline. Here, we provide an overview of the experimental strategies, and brain imaging and cerebrospinal fluid biomarker measures that are used in early detection and tracking of AD, highlighting at-risk individuals who could be suitable for preclinical monitoring. We discuss how these advances have contributed to reconceptualization of AD as a sequence of biological changes that occur during progression from preclinical AD, to mild cognitive impairment and finally dementia, and we review recently proposed research criteria for preclinical AD. Advances in the study of preclinical AD have driven the recognition that efficacy of at least some AD therapies may depend on initiation of treatment before clinical manifestation of disease, leading to a new era of AD prevention research. PMID:23752908

  16. Chimeric animal models in human stem cell biology.

    Science.gov (United States)

    Glover, Joel C; Boulland, Jean-Luc; Halasi, Gabor; Kasumacic, Nedim

    2009-01-01

    The clinical use of stem cells for regenerative medicine is critically dependent on preclinical studies in animal models. In this review we examine some of the key issues and challenges in the use of animal models to study human stem cell biology-experimental standardization, body size, immunological barriers, cell survival factors, fusion of host and donor cells, and in vivo imaging and tracking. We focus particular attention on the various imaging modalities that can be used to track cells in living animals, comparing their strengths and weaknesses and describing technical developments that are likely to lead to new opportunities for the dynamic assessment of stem cell behavior in vivo. We then provide an overview of some of the most commonly used animal models, their advantages and disadvantages, and examples of their use for xenotypic transplantation of human stem cells, with separate reviews of models involving rodents, ungulates, nonhuman primates, and the chicken embryo. As the use of human somatic, embryonic, and induced pluripotent stem cells increases, so too will the range of applications for these animal models. It is likely that increasingly sophisticated uses of human/animal chimeric models will be developed through advances in genetic manipulation, cell delivery, and in vivo imaging.

  17. Neuraxial Analgesia In Neonates And Infants: Review of Clinical and Preclinical Strategies for the Development of Safety and Efficacy Data

    Science.gov (United States)

    Walker, Suellen M.; Yaksh, Tony L.

    2015-01-01

    Neuraxial agents provide robust pain control, have the potential to improve outcomes, and are an important component of the perioperative care of children. Opioids or clonidine improve analgesia when added to perioperative epidural infusions; analgesia is significantly prolonged by addition of clonidine, ketamine, neostigmine or tramadol to single shot caudal injections of local anesthetic; and neonatal intrathecal anesthesia/analgesia is increasing in some centers. However, it is difficult to determine the relative risk-benefit of different techniques and drugs without detailed and sensitive data related to analgesia requirements, side-effects, and follow-up. Current data related to benefits and complications in neonates and infants are summarized, but variability in current neuraxial drug use reflects the relative lack of high quality evidence. Recent preclinical reports of adverse effects of general anesthetics on the developing brain have increased awareness of the potential benefit of neuraxial anesthesia/analgesia to avoid or reduce general anesthetic dose requirements. However, the developing spinal cord is also vulnerable to drug-related toxicity, and although there are well-established preclinical models and criteria for assessing spinal cord toxicity in adult animals, until recently there had been no systematic evaluation during early life. Therefore, the second half of this review presents preclinical data evaluating age-dependent changes in the pharmacodynamic response to different spinal analgesics, and recent studies evaluating spinal toxicity in specific developmental models. Finally, we advocate use of neuraxial agents with the widest demonstrable safety margin and suggest minimum standards for preclinical evaluation prior to adoption of new analgesics or preparations into routine clinical practice. PMID:22798528

  18. Small animal PET: aspects of performance assessment

    International Nuclear Information System (INIS)

    Weber, Simone; Bauer, Andreas

    2004-01-01

    Dedicated small animal positron emission tomography (PET) systems are increasingly prevalent in industry (e.g. for preclinical drug development) and biological research. Such systems permit researchers to perform animal studies of a longitudinal design characterised by repeated measurements in single animals. With the advent of commercial systems, scanners have become readily available and increasingly popular. As a consequence, technical specifications are becoming more diverse, making scanner systems less broadly applicable. The investigator has, therefore, to make a decision regarding which type of scanner is most suitable for the intended experiments. This decision should be based on gantry characteristics and the physical performance. The first few steps have been taken towards standardisation of the assessment of performance characteristics of dedicated animal PET systems, though such assessment is not yet routinely implemented. In this review, we describe current methods of evaluation of physical performance parameters of small animal PET scanners. Effects of methodologically different approaches on the results are assessed. It is underscored that particular attention has to be paid to spatial resolution, sensitivity, scatter fraction and count rate performance. Differences in performance measurement methods are described with regard to commercially available systems, namely the Concorde MicroPET systems P4 and R4 and the quad-HIDAC. Lastly, consequences of differences in scanner performance parameters are rated with respect to applications of small animal PET. (orig.)

  19. Preclinical evaluation of reconsolidation blockade by clonidine as a potential novel treatment for posttraumatic stress disorder.

    Science.gov (United States)

    Gamache, Karine; Pitman, Roger K; Nader, Karim

    2012-12-01

    Exposure to traumatic events can lead to posttraumatic stress disorder (PTSD). Current PTSD treatments typically only produce partial improvement. Hence, there is a need for preclinical research to identify new candidate drugs and to develop novel therapeutic approaches. Animal studies have indicated that fear memories can be weakened by blocking restabilization after retrieval, a process known as reconsolidation. Furthermore, evidence suggests that there are important alterations of the noradrenergic system in PTSD, and hence it may be of interest to study drugs that target this pathway. Here, we investigated the efficacy of clonidine, an α₂-adrenoreceptor agonist, to block reconsolidation in an animal model of persistent traumatic memories. Using an auditory fear conditioning paradigm in rats, we tested the efficacy of clonidine to weaken fear memory retention when administered systemically after retrieval. We evaluated dosage, number of treatments, and specificity in reconsolidation blockade. We found that postretrieval administration of clonidine disrupts fear-related memories in a dose-dependent manner and that two treatments are sufficient for maximal memory impairment. Furthermore, we determined that this effect is long lasting and specific to reconsolidation processes as shown by the selectivity to affect reactivated memories and the absence of spontaneous recovery and of postreactivation short-term memory impairment. Our results demonstrate the efficacy of systemic administration of clonidine following retrieval to persistently disrupt fear memory retention through reconsolidation blockade. This study provides important preclinical parameters for future therapeutic strategies involving clonidine to block reconsolidation as a novel treatment for PTSD symptoms.

  20. Stress, Burnout and Coping Strategies in Preclinical Medical Students

    Science.gov (United States)

    Fares, Jawad; Al Tabosh, Hayat; Saadeddin, Zein; El Mouhayyar, Christopher; Aridi, Hussam

    2016-01-01

    It is acknowledged that physicians do not seek the same expert aid for themselves as they would offer their patients. In their preclinical years, medical students appear to espouse comparable behavior. To many, medicine is described as a never-ending path that places the student under heavy stress and burnout from the beginning, leaving him/her vulnerable and with insufficient coping methods. Hence, the objective of this study is to 1) explore the prevalence of stress and burnout among preclinical medical students, and 2) propose solutions to decrease stress and burnout and improve medical education in the preclinical years. A detailed scholarly research strategy using Google Scholar, Scopus, Embase, MEDLINE and PubMed was implemented to highlight key themes that are relevant to preclinical medical students’ stress and burnout. Stress varied among different samples of medical students and ranged between 20.9% and 90%. Conversely, burnout ranged between 27% and 75%. Methods that help in reducing the incidence of stress and burnout by promoting strategies that focus on personal engagement, extracurricular activities, positive reinterpretation and expression of emotion, student-led mentorship programs, evaluation systems, career counseling and life coaching should be adopted. PMID:27042604